KER,Paper,source,type,entity,char_start,char_end,context_sentence
de_novo_lipogenesis-fatty_liver,/work/eval_papers/PMID_29173234.pdf,abstract,CHEMICAL,PPARα/carnitine,250,265,"Dietary α-lactalbumin induced fatty liver by enhancing nuclear liver X receptor αβ/sterol regulatory element-binding protein-1c/PPARγ expression and minimising PPARα/carnitine palmitoyltransferase-1 expression and AMP-activated protein kinase α phosphorylation associated with atherogenic dyslipidaemia, insulin resistance and oxidative stress in Balb/c mice."
de_novo_lipogenesis-fatty_liver,/work/eval_papers/PMID_29173234.pdf,abstract,CHEMICAL,dyslipidaemia,379,392,"Dietary α-lactalbumin induced fatty liver by enhancing nuclear liver X receptor αβ/sterol regulatory element-binding protein-1c/PPARγ expression and minimising PPARα/carnitine palmitoyltransferase-1 expression and AMP-activated protein kinase α phosphorylation associated with atherogenic dyslipidaemia, insulin resistance and oxidative stress in Balb/c mice."
de_novo_lipogenesis-fatty_liver,/work/eval_papers/PMID_29173234.pdf,abstract,CHEMICAL,investigate,992,1003,The aim of the present study was to investigate if this atherogenic effect could be due to a possible α-LAC-induced hepatic steatosis.
de_novo_lipogenesis-fatty_liver,/work/eval_papers/PMID_29173234.pdf,abstract,CHEMICAL,NEFA contents,1553,1566,Moderate liver steatosis with increased TAG and NEFA contents was correlated with atherogenic dyslipidaemia.
de_novo_lipogenesis-fatty_liver,/work/eval_papers/PMID_29173234.pdf,abstract,CHEMICAL,dyslipidaemia,1599,1612,Moderate liver steatosis with increased TAG and NEFA contents was correlated with atherogenic dyslipidaemia.
de_novo_lipogenesis-fatty_liver,/work/eval_papers/PMID_29173234.pdf,abstract,CHEMICAL,GSH,2345,2348,These changes were associated with a significant decrease in both p-Thr172-AMP-activated protein kinase α (AMPKα) (inactivation) and p-Ser79-ACC1 (activation) and with a more oxidative liver environment increasing lipid peroxidation and protein oxidation and reducing GSH:GSSG ratio in the α-LAC-fed mice.
de_novo_lipogenesis-fatty_liver,/work/eval_papers/PMID_29173234.pdf,abstract,CHEMICAL,GSSG,2349,2353,These changes were associated with a significant decrease in both p-Thr172-AMP-activated protein kinase α (AMPKα) (inactivation) and p-Ser79-ACC1 (activation) and with a more oxidative liver environment increasing lipid peroxidation and protein oxidation and reducing GSH:GSSG ratio in the α-LAC-fed mice.
de_novo_lipogenesis-fatty_liver,/work/eval_papers/PMID_29173234.pdf,abstract,CHEMICAL,dyslipidaemia,2480,2493,"In conclusion, 4 weeks of 14 % α-LAC feeding induced liver steatosis associated with atherogenic dyslipidaemia, IR and oxidative stress by enhancing nuclear LXRαβ/SREBP-1c/PPARγ expression and diminishing PPARα/CPT-1 expression and AMPKα phosphorylation shifting the hepatic FAO toward fatty acid synthesis in Balb/c mice."
de_novo_lipogenesis-fatty_liver,/work/eval_papers/PMID_29173234.pdf,abstract,SPECIES,Farmacología,664,676,"(2)2Departamento de Farmacología, Facultad de Farmacia,Universidad Complutense,28040 Madrid,Spain."
de_novo_lipogenesis-fatty_liver,/work/eval_papers/PMID_29173234.pdf,abstract,SPECIES,mice,1367,1371,Male Balb/c mice (n 6) were fed with diets containing either chow or 14 % α-LAC for 4 weeks.
de_novo_lipogenesis-fatty_liver,/work/eval_papers/PMID_29173234.pdf,abstract,SPECIES,mice,1462,1466,The α-LAC-fed mice developed abdominal adiposity and IR.
de_novo_lipogenesis-fatty_liver,/work/eval_papers/PMID_29173234.pdf,abstract,SPECIES,mice,2377,2381,These changes were associated with a significant decrease in both p-Thr172-AMP-activated protein kinase α (AMPKα) (inactivation) and p-Ser79-ACC1 (activation) and with a more oxidative liver environment increasing lipid peroxidation and protein oxidation and reducing GSH:GSSG ratio in the α-LAC-fed mice.
de_novo_lipogenesis_fa_synthesis-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_28449683.pdf,abstract,CHEMICAL,Medicine,376,384,"Author information: (1)Institute of Translational Medicine, Nanchang University, 999 Xuefu Load, Honggutan District, Nanchang, 330031, China."
de_novo_lipogenesis_fa_synthesis-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_28449683.pdf,abstract,CHEMICAL,Medicine,572,580,"(3)Institute of Translational Medicine, Nanchang University, 999 Xuefu Load, Honggutan District, Nanchang, 330031, China. dengk26@gmail.com."
de_novo_lipogenesis_fa_synthesis-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_28449683.pdf,abstract,CHEMICAL,Medicine,713,721,"(4)Institute of Translational Medicine, Nanchang University, 999 Xuefu Load, Honggutan District, Nanchang, 330031, China. hongboxin@yahoo.com."
de_novo_lipogenesis_fa_synthesis-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_28449683.pdf,abstract,CHEMICAL,nicotinamide adenine dinucleotide,1239,1272,Nicotinamide phosphoribosyltransferase (NAMPT) has been recently identified as an enzyme involved in nicotinamide adenine dinucleotide (NAD+) biosynthesis and plays an important role in cellular metabolism in variety of organs in mammals.
de_novo_lipogenesis_fa_synthesis-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_28449683.pdf,abstract,CHEMICAL,investigate,1406,1417,The aim of this study was to investigate the effects of NAMPT on high fat diet-induced hepatic steatosis.
de_novo_lipogenesis_fa_synthesis-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_28449683.pdf,abstract,CHEMICAL,sterol,2102,2108,"RESULTS: FK866 significantly promoted liver steatosis in the mice fed with HFD and hepatic lipid accumulation in vitro, accompanied by the increases of the expressions of lipogenic genes such as sterol regulatory element-binding protein 1 (SREBP1) and fatty acid synthase (FASN)."
de_novo_lipogenesis_fa_synthesis-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_28449683.pdf,abstract,CHEMICAL,actions of,2256,2266,Nicotinamide mononucleotide (NMN) and NAD+ significantly rescued the actions of FK866 in vitro.
de_novo_lipogenesis_fa_synthesis-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_28449683.pdf,abstract,CHEMICAL,FK866,2267,2272,Nicotinamide mononucleotide (NMN) and NAD+ significantly rescued the actions of FK866 in vitro.
de_novo_lipogenesis_fa_synthesis-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_28449683.pdf,abstract,CHEMICAL,Our,2672,2675,CONCLUSION: Our results demonstrated that inhibition of NAMPT aggravated the HFD- or oleic acid-induced hepatic steatosis through suppressing Sirt1-mediated signaling pathway.
de_novo_lipogenesis_fa_synthesis-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_28449683.pdf,abstract,SPECIES,mice,150,154,Inhibition of NAMPT aggravates high fat diet-induced hepatic steatosis in mice through regulating Sirt1/AMPKα/SREBP1 signaling pathway.
de_novo_lipogenesis_fa_synthesis-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_28449683.pdf,abstract,SPECIES,mice,1562,1566,METHODS: Hepatic steatosis model was induced by high fat diet (HFD) in C57BL/6 mice in vivo.
de_novo_lipogenesis_fa_synthesis-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_28449683.pdf,abstract,SPECIES,mice,1968,1972,"RESULTS: FK866 significantly promoted liver steatosis in the mice fed with HFD and hepatic lipid accumulation in vitro, accompanied by the increases of the expressions of lipogenic genes such as sterol regulatory element-binding protein 1 (SREBP1) and fatty acid synthase (FASN)."
de_novo_lipogenesis_fa_synthesis-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_28449683.pdf,abstract,SPECIES,FK866,2267,2272,Nicotinamide mononucleotide (NMN) and NAD+ significantly rescued the actions of FK866 in vitro.
de_novo_lipogenesis_fa_synthesis-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_28449683.pdf,abstract,SPECIES,mice,2491,2495,"In addition, FK866 decreased the protein levels of Sirt1 and phospho-AMPKα in liver of the HFD fed mice."
de_novo_lipogenesis_fa_synthesis-novel_oxidative_stress,/work/eval_papers/PMID_29704577.pdf,abstract,CHEMICAL,steroids aggravate,132,150,Food-drug interaction: Anabolic steroids aggravate hepatic lipotoxicity and nonalcoholic fatty liver disease induced by trans fatty acids.
de_novo_lipogenesis_fa_synthesis-novel_oxidative_stress,/work/eval_papers/PMID_29704577.pdf,abstract,CHEMICAL,Alfenas,471,478,"Author information: (1)Institute of Biomedical Sciences, Department of Structural Biology, Federal University of Alfenas, 37130-000, Minas Gerais, Brazil."
de_novo_lipogenesis_fa_synthesis-novel_oxidative_stress,/work/eval_papers/PMID_29704577.pdf,abstract,CHEMICAL,Medicine,628,636,"(2)Department of Nutrition and Health, Federal University of Viçosa, 36570-000, Minas Gerais, Brazil. (3)School of Medicine, Federal University of Jequitinhonha and Mucuri Valleys, 39100-000, Minas Gerais, Brazil."
de_novo_lipogenesis_fa_synthesis-novel_oxidative_stress,/work/eval_papers/PMID_29704577.pdf,abstract,CHEMICAL,Alfenas,916,923,"(5)Institute of Biomedical Sciences, Department of Structural Biology, Federal University of Alfenas, 37130-000, Minas Gerais, Brazil."
de_novo_lipogenesis_fa_synthesis-novel_oxidative_stress,/work/eval_papers/PMID_29704577.pdf,abstract,CHEMICAL,address,969,976,Electronic address: romulo.novaes@unifal-mg.edu.br.
de_novo_lipogenesis_fa_synthesis-novel_oxidative_stress,/work/eval_papers/PMID_29704577.pdf,abstract,CHEMICAL,steroids,1057,1065,"Remains unknown if dietary lipids and anabolic steroids (AS) can interact to modify energy metabolism, hepatic structure and function."
de_novo_lipogenesis_fa_synthesis-novel_oxidative_stress,/work/eval_papers/PMID_29704577.pdf,abstract,CHEMICAL,cholesterol,1596,1607,"When combined with a HFD, AS reduced plasma HDL cholesterol levels."
de_novo_lipogenesis_fa_synthesis-novel_oxidative_stress,/work/eval_papers/PMID_29704577.pdf,abstract,CHEMICAL,levels,1776,1782,"It also upregulated SREBP-1, PPARα, SCD-1 and ACOX1 gene expression; plasma and hepatic triglyceride levels; oxidative stress; circulating hepatic transaminase levels and NAFLD severity."
de_novo_lipogenesis_fa_synthesis-novel_oxidative_stress,/work/eval_papers/PMID_29704577.pdf,abstract,CHEMICAL,Our,1803,1806,"Our finding indicated that the activity of antioxidant enzymes such as catalase, glutathione-s-transferase and superoxide dismutase was attenuated by HFD, an effect whose implications for AS-induced hepatotoxicity requires further investigation."
de_novo_lipogenesis_fa_synthesis-novel_oxidative_stress,/work/eval_papers/PMID_29704577.pdf,abstract,CHEMICAL,superoxide,1914,1924,"Our finding indicated that the activity of antioxidant enzymes such as catalase, glutathione-s-transferase and superoxide dismutase was attenuated by HFD, an effect whose implications for AS-induced hepatotoxicity requires further investigation."
de_novo_lipogenesis_fa_synthesis-novel_oxidative_stress,/work/eval_papers/PMID_29704577.pdf,abstract,CHEMICAL,redox,2340,2345,"Increased lipid, protein and DNA oxidative damage as well as worsening NAFLD in response to the interaction of HFD and AS were also potentially associated with the ability of AS to amplify the activation of regulatory lipid metabolism genes that are also involved in the control of cellular redox balance."
de_novo_lipogenesis_fa_synthesis-novel_oxidative_stress,/work/eval_papers/PMID_29704577.pdf,abstract,SPECIES,mice,1293,1297,"We investigated the impact of AS on gene expression, lipid profile, redox status and the development of nonalcoholic fatty liver disease (NAFLD) in mice treated with a diet rich in trans fatty acids."
de_novo_lipogenesis_fa_synthesis-novel_oxidative_stress,/work/eval_papers/PMID_29704577.pdf,abstract,SPECIES,mice,1365,1369,Seventy-two C57BL/6 mice were equally randomized into six groups and treated with a standard diet (SD) or high-fat diet (HFD) alone or combined with testosterone cypionate (10 or 20 mg/kg) for 12 weeks.
de_novo_lipogenesis_fa_synthesis-protein_kinase_changes_novel_ampk,/work/eval_papers/PMID_32324591.pdf,abstract,CHEMICAL,23;12(8):7350,31,44,1. Aging (Albany NY). 2020 Apr 23;12(8):7350-7362.
de_novo_lipogenesis_fa_synthesis-protein_kinase_changes_novel_ampk,/work/eval_papers/PMID_32324591.pdf,abstract,CHEMICAL,L(2,228,231,"Zhou Y(1), Zhong L(2), Yu S(3), Shen W(2), Cai C(2), Yu H(2)."
de_novo_lipogenesis_fa_synthesis-protein_kinase_changes_novel_ampk,/work/eval_papers/PMID_32324591.pdf,abstract,CHEMICAL,NAFLD has been,735,749,SCD1 is a key enzyme controlling lipid metabolism and a link between its activity and NAFLD has been proposed.
de_novo_lipogenesis_fa_synthesis-protein_kinase_changes_novel_ampk,/work/eval_papers/PMID_32324591.pdf,abstract,CHEMICAL,sodium palmitate,1168,1184,"To investigate the molecular mechanisms through which SCD1 regulates lipophagy in hepatic steatosis, the model of hepatic steatosis was established by inducing mouse primary hepatocytes with sodium palmitate and feeding C57BL/6 mice with HFD."
de_novo_lipogenesis_fa_synthesis-protein_kinase_changes_novel_ampk,/work/eval_papers/PMID_32324591.pdf,abstract,CHEMICAL,sodium,1247,1253,"Our results indicated that sodium palmitate-treated hepatocytes exhibited increased SCD1 expression, AMPK inactivation and defective lipophagy."
de_novo_lipogenesis_fa_synthesis-protein_kinase_changes_novel_ampk,/work/eval_papers/PMID_32324591.pdf,abstract,CHEMICAL,Although,1489,1497,"Although SCD1 overexpression led to decreased AMPK activity and lipophagy, lipid deposition was increased in hepatocytes."
de_novo_lipogenesis_fa_synthesis-protein_kinase_changes_novel_ampk,/work/eval_papers/PMID_32324591.pdf,abstract,CHEMICAL,AMPK,1644,1648,SCD1 regulated lipophagy through AMPK to affect lipid metabolism in mouse primary hepatocytes.
de_novo_lipogenesis_fa_synthesis-protein_kinase_changes_novel_ampk,/work/eval_papers/PMID_32324591.pdf,abstract,CHEMICAL,CAY10566(an,1746,1757,"Additionally, compared to HFD-fed mice, CAY10566(an SCD1-specific inhibitor)-treated mice exhibited significantly decreased hepatic steatosis and hepatic lipid droplet accumulation, as well as enhanced AMPK activity and lipophagy."
de_novo_lipogenesis_fa_synthesis-protein_kinase_changes_novel_ampk,/work/eval_papers/PMID_32324591.pdf,abstract,SPECIES,mouse,1137,1142,"To investigate the molecular mechanisms through which SCD1 regulates lipophagy in hepatic steatosis, the model of hepatic steatosis was established by inducing mouse primary hepatocytes with sodium palmitate and feeding C57BL/6 mice with HFD."
de_novo_lipogenesis_fa_synthesis-protein_kinase_changes_novel_ampk,/work/eval_papers/PMID_32324591.pdf,abstract,SPECIES,mice,1205,1209,"To investigate the molecular mechanisms through which SCD1 regulates lipophagy in hepatic steatosis, the model of hepatic steatosis was established by inducing mouse primary hepatocytes with sodium palmitate and feeding C57BL/6 mice with HFD."
de_novo_lipogenesis_fa_synthesis-protein_kinase_changes_novel_ampk,/work/eval_papers/PMID_32324591.pdf,abstract,SPECIES,HFD,1215,1218,"To investigate the molecular mechanisms through which SCD1 regulates lipophagy in hepatic steatosis, the model of hepatic steatosis was established by inducing mouse primary hepatocytes with sodium palmitate and feeding C57BL/6 mice with HFD."
de_novo_lipogenesis_fa_synthesis-protein_kinase_changes_novel_ampk,/work/eval_papers/PMID_32324591.pdf,abstract,SPECIES,mouse,1679,1684,SCD1 regulated lipophagy through AMPK to affect lipid metabolism in mouse primary hepatocytes.
de_novo_lipogenesis_fa_synthesis-protein_kinase_changes_novel_ampk,/work/eval_papers/PMID_32324591.pdf,abstract,SPECIES,mice,1740,1744,"Additionally, compared to HFD-fed mice, CAY10566(an SCD1-specific inhibitor)-treated mice exhibited significantly decreased hepatic steatosis and hepatic lipid droplet accumulation, as well as enhanced AMPK activity and lipophagy."
de_novo_lipogenesis_fa_synthesis-protein_kinase_changes_novel_ampk,/work/eval_papers/PMID_32324591.pdf,abstract,SPECIES,mice,1791,1795,"Additionally, compared to HFD-fed mice, CAY10566(an SCD1-specific inhibitor)-treated mice exhibited significantly decreased hepatic steatosis and hepatic lipid droplet accumulation, as well as enhanced AMPK activity and lipophagy."
er_stress-novel_fibrosis,/work/eval_papers/PMID_32593710.pdf,abstract,CHEMICAL,Rio,563,566,"Author information: (1)Laboratório de Fisiopatologia, Divisão de Pesquisa Integrada em Produtos Bioativos e Biociências (DPBio), Polo Novo Cavaleiros, Universidade Federal do Rio de Janeiro, Campus UFRJ-Macaé, Macaé, RJ, Brazil."
er_stress-novel_fibrosis,/work/eval_papers/PMID_32593710.pdf,abstract,CHEMICAL,Rio,1030,1033,"(4)Laboratório de Fisiopatologia, Divisão de Pesquisa Integrada em Produtos Bioativos e Biociências (DPBio), Polo Novo Cavaleiros, Universidade Federal do Rio de Janeiro, Campus UFRJ-Macaé, Macaé, RJ, Brazil; Setor de Ciências Biológicas e da Saúde (SEBISA), Departamento de Biologia Geral, Universidade Estadual de Ponta Grossa (UEPG), Ponta Grossa, PR, Brazil."
er_stress-novel_fibrosis,/work/eval_papers/PMID_32593710.pdf,abstract,CHEMICAL,address,1249,1256,Electronic address: raribeiro@uepg.br.
er_stress-novel_fibrosis,/work/eval_papers/PMID_32593710.pdf,abstract,CHEMICAL,Bisphenol,1283,1292,AIMS: Bisphenol (BP)-A exposure can impair glucose and lipid metabolism.
er_stress-novel_fibrosis,/work/eval_papers/PMID_32593710.pdf,abstract,CHEMICAL,BPA,1568,1571,"Herein, we evaluated the effects of BPA exposure on adiposity, glucose homeostasis and hepatic steatosis in ovariectomized (OVX) mice fed on a high-fat diet (HFD)."
er_stress-novel_fibrosis,/work/eval_papers/PMID_32593710.pdf,abstract,CHEMICAL,BPA,2267,2270,BPA did not alter adiposity or glucose homeostasis disruptions induced by HFD.
er_stress-novel_fibrosis,/work/eval_papers/PMID_32593710.pdf,abstract,CHEMICAL,BPA,2687,2690,"Furthermore, BPA caused mild steatosis in OVX CBPA females, increasing the hepatic total lipids and mRNAs for Srebf1, Scd1, Hspa5, Hyou1 and Atf6."
er_stress-novel_fibrosis,/work/eval_papers/PMID_32593710.pdf,abstract,CHEMICAL,BPA,2835,2838,SIGNIFICANCE: BPA aggravated hepatic steatosis in OVX mice.
er_stress-novel_fibrosis,/work/eval_papers/PMID_32593710.pdf,abstract,CHEMICAL,BPA,2918,2921,"Especially when combined with a HFD, BPA caused NAFLD progression, which was partly mediated by chronic ER stress and the TGF-β1 pathway."
er_stress-novel_fibrosis,/work/eval_papers/PMID_32593710.pdf,abstract,SPECIES,mice,151,155,Bisphenol-A exposure worsens hepatic steatosis in ovariectomized mice fed on a high-fat diet: Role of endoplasmic reticulum stress and fibrogenic pathways.
er_stress-novel_fibrosis,/work/eval_papers/PMID_32593710.pdf,abstract,SPECIES,Universidade,1166,1178,"(4)Laboratório de Fisiopatologia, Divisão de Pesquisa Integrada em Produtos Bioativos e Biociências (DPBio), Polo Novo Cavaleiros, Universidade Federal do Rio de Janeiro, Campus UFRJ-Macaé, Macaé, RJ, Brazil; Setor de Ciências Biológicas e da Saúde (SEBISA), Departamento de Biologia Geral, Universidade Estadual de Ponta Grossa (UEPG), Ponta Grossa, PR, Brazil."
er_stress-novel_fibrosis,/work/eval_papers/PMID_32593710.pdf,abstract,SPECIES,mice,1729,1733,"MAIN METHODS: Adult Swiss female mice were OVX and submitted to a normolipidic diet or HFD and drinking water without [control (OVX CTL) and OVX HFD groups, respectively] or with 1 μg/mL BPA (OVX CBPA and OVX HBPA groups, respectively), for 3 months."
er_stress-novel_fibrosis,/work/eval_papers/PMID_32593710.pdf,abstract,SPECIES,OVX CBPA,1888,1896,"MAIN METHODS: Adult Swiss female mice were OVX and submitted to a normolipidic diet or HFD and drinking water without [control (OVX CTL) and OVX HFD groups, respectively] or with 1 μg/mL BPA (OVX CBPA and OVX HBPA groups, respectively), for 3 months."
er_stress-novel_fibrosis,/work/eval_papers/PMID_32593710.pdf,abstract,SPECIES,HFD,2341,2344,BPA did not alter adiposity or glucose homeostasis disruptions induced by HFD.
er_stress-vldl_secretion,/work/eval_papers/PMID_28777337.pdf,abstract,CHEMICAL,anti-cancer,1613,1624,"Tunicamycin, a pharmacological ER stress inducer, is used to develop an anti-cancer drug."
er_stress-vldl_secretion,/work/eval_papers/PMID_28777337.pdf,abstract,CHEMICAL,tunicamycin,1655,1666,"However, the effects of tunicamycin on hepatic energy metabolism have not been well elucidated."
er_stress-vldl_secretion,/work/eval_papers/PMID_28777337.pdf,abstract,CHEMICAL,tunicamycin,1769,1780,Mice were intraperitoneally injected with tunicamycin or vehicle.
er_stress-vldl_secretion,/work/eval_papers/PMID_28777337.pdf,abstract,CHEMICAL,Tunicamycin,1965,1976,"Tunicamycin significantly induced hepatic a yellowish color and ER stress, as well as increasing serum levels of aspartate transaminase and alanine transaminase."
er_stress-vldl_secretion,/work/eval_papers/PMID_28777337.pdf,abstract,CHEMICAL,levels,2068,2074,"Tunicamycin significantly induced hepatic a yellowish color and ER stress, as well as increasing serum levels of aspartate transaminase and alanine transaminase."
er_stress-vldl_secretion,/work/eval_papers/PMID_28777337.pdf,abstract,CHEMICAL,aspartate,2078,2087,"Tunicamycin significantly induced hepatic a yellowish color and ER stress, as well as increasing serum levels of aspartate transaminase and alanine transaminase."
er_stress-vldl_secretion,/work/eval_papers/PMID_28777337.pdf,abstract,CHEMICAL,alanine,2105,2112,"Tunicamycin significantly induced hepatic a yellowish color and ER stress, as well as increasing serum levels of aspartate transaminase and alanine transaminase."
er_stress-vldl_secretion,/work/eval_papers/PMID_28777337.pdf,abstract,CHEMICAL,tunicamycin,2136,2147,"Besides, tunicamycin remarkably increased hepatic triglyceride content and suppressed the expression of apolipoprotein B100."
er_stress-vldl_secretion,/work/eval_papers/PMID_28777337.pdf,abstract,CHEMICAL,levels,2306,2312,"In addition, tunicamycin-treated mice had lower serum levels of triglyceride, apolipoprotein B, low-density lipoprotein cholesterol and high-density lipoprotein cholesterol."
er_stress-vldl_secretion,/work/eval_papers/PMID_28777337.pdf,abstract,CHEMICAL,triglyceride,2316,2328,"In addition, tunicamycin-treated mice had lower serum levels of triglyceride, apolipoprotein B, low-density lipoprotein cholesterol and high-density lipoprotein cholesterol."
er_stress-vldl_secretion,/work/eval_papers/PMID_28777337.pdf,abstract,CHEMICAL,cholesterol,2372,2383,"In addition, tunicamycin-treated mice had lower serum levels of triglyceride, apolipoprotein B, low-density lipoprotein cholesterol and high-density lipoprotein cholesterol."
er_stress-vldl_secretion,/work/eval_papers/PMID_28777337.pdf,abstract,CHEMICAL,cholesterol,2413,2424,"In addition, tunicamycin-treated mice had lower serum levels of triglyceride, apolipoprotein B, low-density lipoprotein cholesterol and high-density lipoprotein cholesterol."
er_stress-vldl_secretion,/work/eval_papers/PMID_28777337.pdf,abstract,CHEMICAL,tunicamycin,2507,2518,"Gene expression of peroxisome proliferator-activated receptor α was decreased by tunicamycin, but the protein level was increased."
er_stress-vldl_secretion,/work/eval_papers/PMID_28777337.pdf,abstract,CHEMICAL,Tunicamycin,2852,2863,Tunicamycin alters hepatic energy homeostasis by increasing triglyceride accumulation and decreasing glycogen content.
er_stress-vldl_secretion,/work/eval_papers/PMID_28777337.pdf,abstract,SPECIES,Mice,154,158,Endoplasmic Reticulum Stress Inducer Tunicamycin Alters Hepatic Energy Homeostasis in Mice.
er_stress-vldl_secretion,/work/eval_papers/PMID_28777337.pdf,abstract,SPECIES,Mice,1727,1731,Mice were intraperitoneally injected with tunicamycin or vehicle.
er_stress-vldl_secretion,/work/eval_papers/PMID_28777337.pdf,abstract,SPECIES,mice,2285,2289,"In addition, tunicamycin-treated mice had lower serum levels of triglyceride, apolipoprotein B, low-density lipoprotein cholesterol and high-density lipoprotein cholesterol."
er_stress-vldl_secretion,/work/eval_papers/PMID_28777337.pdf,abstract,SPECIES,mice,2657,2661,"Furthermore, blood glucose level and hepatic glycogen content were decreased in tunicamycin-treated mice."
fa_uptake-steatosis,/work/eval_papers/PMID_33762794.pdf,abstract,CHEMICAL,2:1,1364,1367,Cells were exposed to perfluorobutanesulfonic acid with or without 300 μmol/L fatty acid mixture (oleic acid:palmitic acid = 2:1) conjugated by bovine serum albumin as an inducer of steatosis for 48 hours.
fa_uptake-steatosis,/work/eval_papers/PMID_33762794.pdf,abstract,CHEMICAL,steatosis,1421,1430,Cells were exposed to perfluorobutanesulfonic acid with or without 300 μmol/L fatty acid mixture (oleic acid:palmitic acid = 2:1) conjugated by bovine serum albumin as an inducer of steatosis for 48 hours.
fa_uptake-steatosis,/work/eval_papers/PMID_33762794.pdf,abstract,CHEMICAL,calcium,1960,1967,"Perfluorobutanesulfonic acid treatment also promoted the production of reactive oxygen species, an endoplasmic reticulum stress marker and cytosolic calcium."
fa_uptake-steatosis,/work/eval_papers/PMID_33762794.pdf,abstract,SPECIES,human hepatoma cell line,1199,1223,"Therefore, the effects of perfluorobutanesulfonic acid exposure on fat accumulation in a human hepatoma cell line were examined."
liver_triglyceride_accumulation-er_stress,/work/eval_papers/PMID_34685712.pdf,abstract,CHEMICAL,investigate,704,715,"The present study aimed to investigate if mechanistic target of rapamycin complex 1 (mTORC1) plays a role in FFA-induced organelle dysfunction, thereby contributing to the development of ALD."
liver_triglyceride_accumulation-er_stress,/work/eval_papers/PMID_34685712.pdf,abstract,CHEMICAL,rapamycin,741,750,"The present study aimed to investigate if mechanistic target of rapamycin complex 1 (mTORC1) plays a role in FFA-induced organelle dysfunction, thereby contributing to the development of ALD."
liver_triglyceride_accumulation-er_stress,/work/eval_papers/PMID_34685712.pdf,abstract,CHEMICAL,define,900,906,Cell studies were conducted to define the causal role and underlying mechanism of FFA-activated mTORC1 signaling in hepatocellular cell injury.
liver_triglyceride_accumulation-er_stress,/work/eval_papers/PMID_34685712.pdf,abstract,CHEMICAL,alcohol,1063,1070,C57BL/6J wild-type mice were subjected to chronic alcohol feeding with or without rapamycin to inhibit mTORC1 activation.
liver_triglyceride_accumulation-er_stress,/work/eval_papers/PMID_34685712.pdf,abstract,CHEMICAL,rapamycin,1095,1104,C57BL/6J wild-type mice were subjected to chronic alcohol feeding with or without rapamycin to inhibit mTORC1 activation.
liver_triglyceride_accumulation-er_stress,/work/eval_papers/PMID_34685712.pdf,abstract,CHEMICAL,LAMP2,1208,1213,We revealed that palmitic acid (PA)-induced ER stress and suppression of LAMP2 and autophagy flux were mTORC1-dependent as rapamycin reversed such deleterious effects.
liver_triglyceride_accumulation-er_stress,/work/eval_papers/PMID_34685712.pdf,abstract,CHEMICAL,rapamycin,1258,1267,We revealed that palmitic acid (PA)-induced ER stress and suppression of LAMP2 and autophagy flux were mTORC1-dependent as rapamycin reversed such deleterious effects.
liver_triglyceride_accumulation-er_stress,/work/eval_papers/PMID_34685712.pdf,abstract,CHEMICAL,rapamycin,1412,1421,"Supplementation with rapamycin to alcohol-fed mice attenuated mTORC1 activation and ER stress, restored LAMP2 protein, and improved autophagy, leading to amelioration of alcohol-induced liver injury."
liver_triglyceride_accumulation-er_stress,/work/eval_papers/PMID_34685712.pdf,abstract,SPECIES,mice,1032,1036,C57BL/6J wild-type mice were subjected to chronic alcohol feeding with or without rapamycin to inhibit mTORC1 activation.
liver_triglyceride_accumulation-er_stress,/work/eval_papers/PMID_34685712.pdf,abstract,SPECIES,mice,1437,1441,"Supplementation with rapamycin to alcohol-fed mice attenuated mTORC1 activation and ER stress, restored LAMP2 protein, and improved autophagy, leading to amelioration of alcohol-induced liver injury."
liver_triglyceride_accumulation-er_stress,/work/eval_papers/PMID_34685712.pdf,abstract,SPECIES,patients,1665,1673,Induction of mTORC1 signaling and CHOP were also detected in the liver of patients with severe alcoholic hepatitis.
liver_triglyceride_accumulation-er_stress,/work/eval_papers/PMID_29597210.pdf,abstract,CHEMICAL,prevented,1309,1318,"However, BO prevented these changes."
liver_triglyceride_accumulation-er_stress,/work/eval_papers/PMID_29597210.pdf,abstract,CHEMICAL,adenosine,1714,1723,"Furthermore, BO suppressed palmitate-induced c-Jun N-terminal kinase (JNK) phosphorylation through the 5&apos; adenosine monophosphate-activated protein kinase (AMPK)-dependent pathway."
liver_triglyceride_accumulation-er_stress,/work/eval_papers/PMID_29597210.pdf,abstract,SPECIES,Seongnam,369,377,"Author information: (1)Research Administration Team, Seoul National University Bundang Hospital, Seongnam, Republic of Korea. (2)Southern Forest Resources Research Center, National Institute of Forest Science, Jinju, Republic of Korea."
liver_triglyceride_accumulation-er_stress,/work/eval_papers/PMID_29597210.pdf,abstract,SPECIES,patients,678,686,Hepatic lipid accumulation and apoptosis is elevated in patients with non-alcoholic steatohepatitis and is closely associated with severity.
liver_triglyceride_accumulation-er_stress,/work/eval_papers/PMID_29597210.pdf,abstract,SPECIES,mouse,995,1000,"In the present study, we examined bee-bee tree oil (BO)-mediated protective effects on palmitate-induced lipid accumulation and apoptosis in mouse primary hepatocytes."
liver_triglyceride_accumulation-er_stress,/work/eval_papers/PMID_32593710.pdf,abstract,CHEMICAL,Rio,563,566,"Author information: (1)Laboratório de Fisiopatologia, Divisão de Pesquisa Integrada em Produtos Bioativos e Biociências (DPBio), Polo Novo Cavaleiros, Universidade Federal do Rio de Janeiro, Campus UFRJ-Macaé, Macaé, RJ, Brazil."
liver_triglyceride_accumulation-er_stress,/work/eval_papers/PMID_32593710.pdf,abstract,CHEMICAL,Rio,1030,1033,"(4)Laboratório de Fisiopatologia, Divisão de Pesquisa Integrada em Produtos Bioativos e Biociências (DPBio), Polo Novo Cavaleiros, Universidade Federal do Rio de Janeiro, Campus UFRJ-Macaé, Macaé, RJ, Brazil; Setor de Ciências Biológicas e da Saúde (SEBISA), Departamento de Biologia Geral, Universidade Estadual de Ponta Grossa (UEPG), Ponta Grossa, PR, Brazil."
liver_triglyceride_accumulation-er_stress,/work/eval_papers/PMID_32593710.pdf,abstract,CHEMICAL,address,1249,1256,Electronic address: raribeiro@uepg.br.
liver_triglyceride_accumulation-er_stress,/work/eval_papers/PMID_32593710.pdf,abstract,CHEMICAL,Bisphenol,1283,1292,AIMS: Bisphenol (BP)-A exposure can impair glucose and lipid metabolism.
liver_triglyceride_accumulation-er_stress,/work/eval_papers/PMID_32593710.pdf,abstract,CHEMICAL,BPA,1568,1571,"Herein, we evaluated the effects of BPA exposure on adiposity, glucose homeostasis and hepatic steatosis in ovariectomized (OVX) mice fed on a high-fat diet (HFD)."
liver_triglyceride_accumulation-er_stress,/work/eval_papers/PMID_32593710.pdf,abstract,CHEMICAL,BPA,2267,2270,BPA did not alter adiposity or glucose homeostasis disruptions induced by HFD.
liver_triglyceride_accumulation-er_stress,/work/eval_papers/PMID_32593710.pdf,abstract,CHEMICAL,BPA,2687,2690,"Furthermore, BPA caused mild steatosis in OVX CBPA females, increasing the hepatic total lipids and mRNAs for Srebf1, Scd1, Hspa5, Hyou1 and Atf6."
liver_triglyceride_accumulation-er_stress,/work/eval_papers/PMID_32593710.pdf,abstract,CHEMICAL,BPA,2835,2838,SIGNIFICANCE: BPA aggravated hepatic steatosis in OVX mice.
liver_triglyceride_accumulation-er_stress,/work/eval_papers/PMID_32593710.pdf,abstract,CHEMICAL,BPA,2918,2921,"Especially when combined with a HFD, BPA caused NAFLD progression, which was partly mediated by chronic ER stress and the TGF-β1 pathway."
liver_triglyceride_accumulation-er_stress,/work/eval_papers/PMID_32593710.pdf,abstract,SPECIES,mice,151,155,Bisphenol-A exposure worsens hepatic steatosis in ovariectomized mice fed on a high-fat diet: Role of endoplasmic reticulum stress and fibrogenic pathways.
liver_triglyceride_accumulation-er_stress,/work/eval_papers/PMID_32593710.pdf,abstract,SPECIES,Universidade,1166,1178,"(4)Laboratório de Fisiopatologia, Divisão de Pesquisa Integrada em Produtos Bioativos e Biociências (DPBio), Polo Novo Cavaleiros, Universidade Federal do Rio de Janeiro, Campus UFRJ-Macaé, Macaé, RJ, Brazil; Setor de Ciências Biológicas e da Saúde (SEBISA), Departamento de Biologia Geral, Universidade Estadual de Ponta Grossa (UEPG), Ponta Grossa, PR, Brazil."
liver_triglyceride_accumulation-er_stress,/work/eval_papers/PMID_32593710.pdf,abstract,SPECIES,mice,1729,1733,"MAIN METHODS: Adult Swiss female mice were OVX and submitted to a normolipidic diet or HFD and drinking water without [control (OVX CTL) and OVX HFD groups, respectively] or with 1 μg/mL BPA (OVX CBPA and OVX HBPA groups, respectively), for 3 months."
liver_triglyceride_accumulation-er_stress,/work/eval_papers/PMID_32593710.pdf,abstract,SPECIES,OVX CBPA,1888,1896,"MAIN METHODS: Adult Swiss female mice were OVX and submitted to a normolipidic diet or HFD and drinking water without [control (OVX CTL) and OVX HFD groups, respectively] or with 1 μg/mL BPA (OVX CBPA and OVX HBPA groups, respectively), for 3 months."
liver_triglyceride_accumulation-er_stress,/work/eval_papers/PMID_32593710.pdf,abstract,SPECIES,HFD,2341,2344,BPA did not alter adiposity or glucose homeostasis disruptions induced by HFD.
liver_triglyceride_accumulation-liver_triglyceride_accumulation,/work/eval_papers/PMID_34029162.pdf,abstract,CHEMICAL,Shi,250,253,"Shi Y(1), Pizzini J(1), Wang H(2), Das F(1), Abdul Azees PA(1)(2), Ghosh Choudhury G(1), Barnes JL(1), Zang M(3)(4)(5), Weintraub ST(6), Yeh CK(2)(4)(5), Katz MS(1)(5), Kamat A(1)(4)(5)."
liver_triglyceride_accumulation-liver_triglyceride_accumulation,/work/eval_papers/PMID_34029162.pdf,abstract,CHEMICAL,Das,285,288,"Shi Y(1), Pizzini J(1), Wang H(2), Das F(1), Abdul Azees PA(1)(2), Ghosh Choudhury G(1), Barnes JL(1), Zang M(3)(4)(5), Weintraub ST(6), Yeh CK(2)(4)(5), Katz MS(1)(5), Kamat A(1)(4)(5)."
liver_triglyceride_accumulation-liver_triglyceride_accumulation,/work/eval_papers/PMID_34029162.pdf,abstract,CHEMICAL,Barnes,339,345,"Shi Y(1), Pizzini J(1), Wang H(2), Das F(1), Abdul Azees PA(1)(2), Ghosh Choudhury G(1), Barnes JL(1), Zang M(3)(4)(5), Weintraub ST(6), Yeh CK(2)(4)(5), Katz MS(1)(5), Kamat A(1)(4)(5)."
liver_triglyceride_accumulation-liver_triglyceride_accumulation,/work/eval_papers/PMID_34029162.pdf,abstract,CHEMICAL,Medicine,474,482,"Author information: (1)Department of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, Texas."
liver_triglyceride_accumulation-liver_triglyceride_accumulation,/work/eval_papers/PMID_34029162.pdf,abstract,CHEMICAL,Medicine,709,717,"(3)Department of Molecular Medicine, University of Texas Health Science Center at San Antonio, Texas."
liver_triglyceride_accumulation-liver_triglyceride_accumulation,/work/eval_papers/PMID_34029162.pdf,abstract,CHEMICAL,state,1619,1624,"Obesity and aging, two principal risk factors for NAFLD, are associated with a hyperadrenergic state."
liver_triglyceride_accumulation-liver_triglyceride_accumulation,/work/eval_papers/PMID_34029162.pdf,abstract,CHEMICAL,formoterol,1991,2001,"In this study we demonstrate that injection of formoterol, a highly selective β2-AR agonist, to mice acutely results in hepatic TG accumulation."
liver_triglyceride_accumulation-liver_triglyceride_accumulation,/work/eval_papers/PMID_34029162.pdf,abstract,CHEMICAL,define,2116,2122,"Further, we have sought to define the intrahepatic mechanisms underlying β2-AR mediated steatosis by investigating changes in hepatic expression and cellular localization of enzymes, transcription factors, and coactivators involved in processes of lipid accrual and disposition-and also functional aspects thereof-in livers of formoterol-treated animals."
liver_triglyceride_accumulation-liver_triglyceride_accumulation,/work/eval_papers/PMID_34029162.pdf,abstract,CHEMICAL,Our,2444,2447,"Our results suggest that β2-AR activation by formoterol leads to increased hepatic TG synthesis and de novo lipogenesis, increased but incomplete β-oxidation of fatty acids with accumulation of potentially toxic long-chain acylcarnitine intermediates, and reduced TG secretion-all previously invoked as contributors to fatty liver disease."
liver_triglyceride_accumulation-liver_triglyceride_accumulation,/work/eval_papers/PMID_34029162.pdf,abstract,CHEMICAL,β2-AR,2469,2474,"Our results suggest that β2-AR activation by formoterol leads to increased hepatic TG synthesis and de novo lipogenesis, increased but incomplete β-oxidation of fatty acids with accumulation of potentially toxic long-chain acylcarnitine intermediates, and reduced TG secretion-all previously invoked as contributors to fatty liver disease."
liver_triglyceride_accumulation-liver_triglyceride_accumulation,/work/eval_papers/PMID_34029162.pdf,abstract,CHEMICAL,formoterol,2489,2499,"Our results suggest that β2-AR activation by formoterol leads to increased hepatic TG synthesis and de novo lipogenesis, increased but incomplete β-oxidation of fatty acids with accumulation of potentially toxic long-chain acylcarnitine intermediates, and reduced TG secretion-all previously invoked as contributors to fatty liver disease."
liver_triglyceride_accumulation-liver_triglyceride_accumulation,/work/eval_papers/PMID_34029162.pdf,abstract,CHEMICAL,formoterol,2880,2890,"Experiments are ongoing to determine whether sustained activation of hepatic β2-AR signaling by formoterol might be utilized to model fatty liver changes occurring in hyperadrenergic states of obesity and aging, and thereby identify novel molecular targets for the prevention or treatment of NAFLD.NEW & NOTEWORTHY Results of our study suggest that β2-adrenergic receptor (β2-AR) activation by agonist formoterol leads to increased hepatic TG synthesis and de novo lipogenesis, incomplete β-oxidation of fatty acids with accumulation of long-chain acylcarnitine intermediates, and reduced TG secretion."
liver_triglyceride_accumulation-liver_triglyceride_accumulation,/work/eval_papers/PMID_34029162.pdf,abstract,CHEMICAL,formoterol,3186,3196,"Experiments are ongoing to determine whether sustained activation of hepatic β2-AR signaling by formoterol might be utilized to model fatty liver changes occurring in hyperadrenergic states of obesity and aging, and thereby identify novel molecular targets for the prevention or treatment of NAFLD.NEW & NOTEWORTHY Results of our study suggest that β2-adrenergic receptor (β2-AR) activation by agonist formoterol leads to increased hepatic TG synthesis and de novo lipogenesis, incomplete β-oxidation of fatty acids with accumulation of long-chain acylcarnitine intermediates, and reduced TG secretion."
liver_triglyceride_accumulation-liver_triglyceride_accumulation,/work/eval_papers/PMID_34029162.pdf,abstract,CHEMICAL,F.D.,3744,3748,"DOI: 10.1152/ajpendo.00651.2020 PMCID: PMC8321826 PMID: 34029162 [Indexed for MEDLINE] Conflict of interest statement: Y.S., J.P., H.W., F.D., P.A.A., G.G-C., M.Z., S.T.W., C-K.Y., M.S.K., and A.K. have nothing to disclose."
liver_triglyceride_accumulation-liver_triglyceride_accumulation,/work/eval_papers/PMID_34029162.pdf,abstract,SPECIES,mice,175,179,Epub 2021 May 24. β(2)-Adrenergic receptor agonist induced hepatic steatosis in mice: modeling nonalcoholic fatty liver disease in hyperadrenergic states.
liver_triglyceride_accumulation-liver_triglyceride_accumulation,/work/eval_papers/PMID_34029162.pdf,abstract,SPECIES,mice,2040,2044,"In this study we demonstrate that injection of formoterol, a highly selective β2-AR agonist, to mice acutely results in hepatic TG accumulation."
liver_triglyceride_accumulation-liver_triglyceride_accumulation,/work/eval_papers/PMID_34029162.pdf,abstract,SPECIES,J.P.,3732,3736,"DOI: 10.1152/ajpendo.00651.2020 PMCID: PMC8321826 PMID: 34029162 [Indexed for MEDLINE] Conflict of interest statement: Y.S., J.P., H.W., F.D., P.A.A., G.G-C., M.Z., S.T.W., C-K.Y., M.S.K., and A.K. have nothing to disclose."
liver_triglyceride_accumulation-liver_triglyceride_accumulation,/work/eval_papers/PMID_34029162.pdf,abstract,SPECIES,C-K.Y.,3780,3786,"DOI: 10.1152/ajpendo.00651.2020 PMCID: PMC8321826 PMID: 34029162 [Indexed for MEDLINE] Conflict of interest statement: Y.S., J.P., H.W., F.D., P.A.A., G.G-C., M.Z., S.T.W., C-K.Y., M.S.K., and A.K. have nothing to disclose."
liver_triglyceride_accumulation-novel_lipolysis,/work/eval_papers/PMID_29526820.pdf,abstract,CHEMICAL,Zhu JJ(2,199,207,"Sun P(1), Zhu JJ(2), Wang T(2), Huang Q(2), Zhou YR(2), Yu BW(2), Jiang HL(2), Wang HY(3)."
liver_triglyceride_accumulation-novel_lipolysis,/work/eval_papers/PMID_29526820.pdf,abstract,CHEMICAL,Key,415,418,"Author information: (1)Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Shanghai 201203, China; Key Laboratory of Human Functional Genomics of Jiangsu Province, Department of Biochemistry and Molecular Biology, Nanjing Medical University, 140 Hanzhong Road, Nanjing 210029, China."
liver_triglyceride_accumulation-novel_lipolysis,/work/eval_papers/PMID_29526820.pdf,abstract,CHEMICAL,140,558,561,"Author information: (1)Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Shanghai 201203, China; Key Laboratory of Human Functional Genomics of Jiangsu Province, Department of Biochemistry and Molecular Biology, Nanjing Medical University, 140 Hanzhong Road, Nanjing 210029, China."
liver_triglyceride_accumulation-novel_lipolysis,/work/eval_papers/PMID_29526820.pdf,abstract,CHEMICAL,address,841,848,Electronic address: hywang@simm.ac.cn.
liver_triglyceride_accumulation-novel_lipolysis,/work/eval_papers/PMID_29526820.pdf,abstract,CHEMICAL,benzbromarone,1033,1046,"Previous studies have reported that benzbromarone is metabolized via cytochrome P450, thus causing mitochondrial toxicity in hepatocytes."
liver_triglyceride_accumulation-novel_lipolysis,/work/eval_papers/PMID_29526820.pdf,abstract,CHEMICAL,via,1062,1065,"Previous studies have reported that benzbromarone is metabolized via cytochrome P450, thus causing mitochondrial toxicity in hepatocytes."
liver_triglyceride_accumulation-novel_lipolysis,/work/eval_papers/PMID_29526820.pdf,abstract,CHEMICAL,thus,1083,1087,"Previous studies have reported that benzbromarone is metabolized via cytochrome P450, thus causing mitochondrial toxicity in hepatocytes."
liver_triglyceride_accumulation-novel_lipolysis,/work/eval_papers/PMID_29526820.pdf,abstract,CHEMICAL,levels,2161,2167,"In addition, in benzbromarone-treated hyperuricemic patients, serum transaminase levels were positively correlated with patients' obesity level."
liver_triglyceride_accumulation-novel_lipolysis,/work/eval_papers/PMID_29526820.pdf,abstract,SPECIES,Human,433,438,"Author information: (1)Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Shanghai 201203, China; Key Laboratory of Human Functional Genomics of Jiangsu Province, Department of Biochemistry and Molecular Biology, Nanjing Medical University, 140 Hanzhong Road, Nanjing 210029, China."
liver_triglyceride_accumulation-novel_lipolysis,/work/eval_papers/PMID_29526820.pdf,abstract,SPECIES,patients,961,969,"As a widely used anti-gout drug, benzbromarone has been found to induce hepatic toxicity in patients during clinical treatment."
liver_triglyceride_accumulation-novel_lipolysis,/work/eval_papers/PMID_29526820.pdf,abstract,SPECIES,mouse,1290,1295,"In this study, we found that benzbromarone significantly aggravated hepatic steatosis in both obese db/db mice and high fat diet (HFD)-induced obese (DIO) mouse models."
liver_triglyceride_accumulation-novel_lipolysis,/work/eval_papers/PMID_29526820.pdf,abstract,SPECIES,human hepatoma HepG2 cells,1741,1767,"In accordance with the in vivo results, an in vitro experiment using human hepatoma HepG2 cells also confirmed that benzbromarone promoted intracellular lipid accumulation under high free fatty acids (FFAs) conditions by regulating the expression of lipid metabolism genes."
liver_triglyceride_accumulation-novel_lipolysis,/work/eval_papers/PMID_29526820.pdf,abstract,SPECIES,patients,2132,2140,"In addition, in benzbromarone-treated hyperuricemic patients, serum transaminase levels were positively correlated with patients' obesity level."
liver_triglyceride_accumulation-novel_lipolysis,/work/eval_papers/PMID_29526820.pdf,abstract,SPECIES,patients,2200,2208,"In addition, in benzbromarone-treated hyperuricemic patients, serum transaminase levels were positively correlated with patients' obesity level."
liver_triglyceride_accumulation-nuclear_receptor_changes_ppara,/work/eval_papers/PMID_34029162.pdf,abstract,CHEMICAL,Shi,250,253,"Shi Y(1), Pizzini J(1), Wang H(2), Das F(1), Abdul Azees PA(1)(2), Ghosh Choudhury G(1), Barnes JL(1), Zang M(3)(4)(5), Weintraub ST(6), Yeh CK(2)(4)(5), Katz MS(1)(5), Kamat A(1)(4)(5)."
liver_triglyceride_accumulation-nuclear_receptor_changes_ppara,/work/eval_papers/PMID_34029162.pdf,abstract,CHEMICAL,Das,285,288,"Shi Y(1), Pizzini J(1), Wang H(2), Das F(1), Abdul Azees PA(1)(2), Ghosh Choudhury G(1), Barnes JL(1), Zang M(3)(4)(5), Weintraub ST(6), Yeh CK(2)(4)(5), Katz MS(1)(5), Kamat A(1)(4)(5)."
liver_triglyceride_accumulation-nuclear_receptor_changes_ppara,/work/eval_papers/PMID_34029162.pdf,abstract,CHEMICAL,Barnes,339,345,"Shi Y(1), Pizzini J(1), Wang H(2), Das F(1), Abdul Azees PA(1)(2), Ghosh Choudhury G(1), Barnes JL(1), Zang M(3)(4)(5), Weintraub ST(6), Yeh CK(2)(4)(5), Katz MS(1)(5), Kamat A(1)(4)(5)."
liver_triglyceride_accumulation-nuclear_receptor_changes_ppara,/work/eval_papers/PMID_34029162.pdf,abstract,CHEMICAL,Medicine,474,482,"Author information: (1)Department of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, Texas."
liver_triglyceride_accumulation-nuclear_receptor_changes_ppara,/work/eval_papers/PMID_34029162.pdf,abstract,CHEMICAL,Medicine,709,717,"(3)Department of Molecular Medicine, University of Texas Health Science Center at San Antonio, Texas."
liver_triglyceride_accumulation-nuclear_receptor_changes_ppara,/work/eval_papers/PMID_34029162.pdf,abstract,CHEMICAL,state,1619,1624,"Obesity and aging, two principal risk factors for NAFLD, are associated with a hyperadrenergic state."
liver_triglyceride_accumulation-nuclear_receptor_changes_ppara,/work/eval_papers/PMID_34029162.pdf,abstract,CHEMICAL,formoterol,1991,2001,"In this study we demonstrate that injection of formoterol, a highly selective β2-AR agonist, to mice acutely results in hepatic TG accumulation."
liver_triglyceride_accumulation-nuclear_receptor_changes_ppara,/work/eval_papers/PMID_34029162.pdf,abstract,CHEMICAL,define,2116,2122,"Further, we have sought to define the intrahepatic mechanisms underlying β2-AR mediated steatosis by investigating changes in hepatic expression and cellular localization of enzymes, transcription factors, and coactivators involved in processes of lipid accrual and disposition-and also functional aspects thereof-in livers of formoterol-treated animals."
liver_triglyceride_accumulation-nuclear_receptor_changes_ppara,/work/eval_papers/PMID_34029162.pdf,abstract,CHEMICAL,Our,2444,2447,"Our results suggest that β2-AR activation by formoterol leads to increased hepatic TG synthesis and de novo lipogenesis, increased but incomplete β-oxidation of fatty acids with accumulation of potentially toxic long-chain acylcarnitine intermediates, and reduced TG secretion-all previously invoked as contributors to fatty liver disease."
liver_triglyceride_accumulation-nuclear_receptor_changes_ppara,/work/eval_papers/PMID_34029162.pdf,abstract,CHEMICAL,β2-AR,2469,2474,"Our results suggest that β2-AR activation by formoterol leads to increased hepatic TG synthesis and de novo lipogenesis, increased but incomplete β-oxidation of fatty acids with accumulation of potentially toxic long-chain acylcarnitine intermediates, and reduced TG secretion-all previously invoked as contributors to fatty liver disease."
liver_triglyceride_accumulation-nuclear_receptor_changes_ppara,/work/eval_papers/PMID_34029162.pdf,abstract,CHEMICAL,formoterol,2489,2499,"Our results suggest that β2-AR activation by formoterol leads to increased hepatic TG synthesis and de novo lipogenesis, increased but incomplete β-oxidation of fatty acids with accumulation of potentially toxic long-chain acylcarnitine intermediates, and reduced TG secretion-all previously invoked as contributors to fatty liver disease."
liver_triglyceride_accumulation-nuclear_receptor_changes_ppara,/work/eval_papers/PMID_34029162.pdf,abstract,CHEMICAL,formoterol,2880,2890,"Experiments are ongoing to determine whether sustained activation of hepatic β2-AR signaling by formoterol might be utilized to model fatty liver changes occurring in hyperadrenergic states of obesity and aging, and thereby identify novel molecular targets for the prevention or treatment of NAFLD.NEW & NOTEWORTHY Results of our study suggest that β2-adrenergic receptor (β2-AR) activation by agonist formoterol leads to increased hepatic TG synthesis and de novo lipogenesis, incomplete β-oxidation of fatty acids with accumulation of long-chain acylcarnitine intermediates, and reduced TG secretion."
liver_triglyceride_accumulation-nuclear_receptor_changes_ppara,/work/eval_papers/PMID_34029162.pdf,abstract,CHEMICAL,formoterol,3186,3196,"Experiments are ongoing to determine whether sustained activation of hepatic β2-AR signaling by formoterol might be utilized to model fatty liver changes occurring in hyperadrenergic states of obesity and aging, and thereby identify novel molecular targets for the prevention or treatment of NAFLD.NEW & NOTEWORTHY Results of our study suggest that β2-adrenergic receptor (β2-AR) activation by agonist formoterol leads to increased hepatic TG synthesis and de novo lipogenesis, incomplete β-oxidation of fatty acids with accumulation of long-chain acylcarnitine intermediates, and reduced TG secretion."
liver_triglyceride_accumulation-nuclear_receptor_changes_ppara,/work/eval_papers/PMID_34029162.pdf,abstract,CHEMICAL,F.D.,3744,3748,"DOI: 10.1152/ajpendo.00651.2020 PMCID: PMC8321826 PMID: 34029162 [Indexed for MEDLINE] Conflict of interest statement: Y.S., J.P., H.W., F.D., P.A.A., G.G-C., M.Z., S.T.W., C-K.Y., M.S.K., and A.K. have nothing to disclose."
liver_triglyceride_accumulation-nuclear_receptor_changes_ppara,/work/eval_papers/PMID_34029162.pdf,abstract,SPECIES,mice,175,179,Epub 2021 May 24. β(2)-Adrenergic receptor agonist induced hepatic steatosis in mice: modeling nonalcoholic fatty liver disease in hyperadrenergic states.
liver_triglyceride_accumulation-nuclear_receptor_changes_ppara,/work/eval_papers/PMID_34029162.pdf,abstract,SPECIES,mice,2040,2044,"In this study we demonstrate that injection of formoterol, a highly selective β2-AR agonist, to mice acutely results in hepatic TG accumulation."
liver_triglyceride_accumulation-nuclear_receptor_changes_ppara,/work/eval_papers/PMID_34029162.pdf,abstract,SPECIES,J.P.,3732,3736,"DOI: 10.1152/ajpendo.00651.2020 PMCID: PMC8321826 PMID: 34029162 [Indexed for MEDLINE] Conflict of interest statement: Y.S., J.P., H.W., F.D., P.A.A., G.G-C., M.Z., S.T.W., C-K.Y., M.S.K., and A.K. have nothing to disclose."
liver_triglyceride_accumulation-nuclear_receptor_changes_ppara,/work/eval_papers/PMID_34029162.pdf,abstract,SPECIES,C-K.Y.,3780,3786,"DOI: 10.1152/ajpendo.00651.2020 PMCID: PMC8321826 PMID: 34029162 [Indexed for MEDLINE] Conflict of interest statement: Y.S., J.P., H.W., F.D., P.A.A., G.G-C., M.Z., S.T.W., C-K.Y., M.S.K., and A.K. have nothing to disclose."
liver_triglyceride_accumulation-nucleus_distortion,/work/eval_papers/PMID_29526820.pdf,abstract,CHEMICAL,Zhu JJ(2,199,207,"Sun P(1), Zhu JJ(2), Wang T(2), Huang Q(2), Zhou YR(2), Yu BW(2), Jiang HL(2), Wang HY(3)."
liver_triglyceride_accumulation-nucleus_distortion,/work/eval_papers/PMID_29526820.pdf,abstract,CHEMICAL,Key,415,418,"Author information: (1)Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Shanghai 201203, China; Key Laboratory of Human Functional Genomics of Jiangsu Province, Department of Biochemistry and Molecular Biology, Nanjing Medical University, 140 Hanzhong Road, Nanjing 210029, China."
liver_triglyceride_accumulation-nucleus_distortion,/work/eval_papers/PMID_29526820.pdf,abstract,CHEMICAL,140,558,561,"Author information: (1)Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Shanghai 201203, China; Key Laboratory of Human Functional Genomics of Jiangsu Province, Department of Biochemistry and Molecular Biology, Nanjing Medical University, 140 Hanzhong Road, Nanjing 210029, China."
liver_triglyceride_accumulation-nucleus_distortion,/work/eval_papers/PMID_29526820.pdf,abstract,CHEMICAL,address,841,848,Electronic address: hywang@simm.ac.cn.
liver_triglyceride_accumulation-nucleus_distortion,/work/eval_papers/PMID_29526820.pdf,abstract,CHEMICAL,benzbromarone,1033,1046,"Previous studies have reported that benzbromarone is metabolized via cytochrome P450, thus causing mitochondrial toxicity in hepatocytes."
liver_triglyceride_accumulation-nucleus_distortion,/work/eval_papers/PMID_29526820.pdf,abstract,CHEMICAL,via,1062,1065,"Previous studies have reported that benzbromarone is metabolized via cytochrome P450, thus causing mitochondrial toxicity in hepatocytes."
liver_triglyceride_accumulation-nucleus_distortion,/work/eval_papers/PMID_29526820.pdf,abstract,CHEMICAL,thus,1083,1087,"Previous studies have reported that benzbromarone is metabolized via cytochrome P450, thus causing mitochondrial toxicity in hepatocytes."
liver_triglyceride_accumulation-nucleus_distortion,/work/eval_papers/PMID_29526820.pdf,abstract,CHEMICAL,levels,2161,2167,"In addition, in benzbromarone-treated hyperuricemic patients, serum transaminase levels were positively correlated with patients' obesity level."
liver_triglyceride_accumulation-nucleus_distortion,/work/eval_papers/PMID_29526820.pdf,abstract,SPECIES,Human,433,438,"Author information: (1)Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Shanghai 201203, China; Key Laboratory of Human Functional Genomics of Jiangsu Province, Department of Biochemistry and Molecular Biology, Nanjing Medical University, 140 Hanzhong Road, Nanjing 210029, China."
liver_triglyceride_accumulation-nucleus_distortion,/work/eval_papers/PMID_29526820.pdf,abstract,SPECIES,patients,961,969,"As a widely used anti-gout drug, benzbromarone has been found to induce hepatic toxicity in patients during clinical treatment."
liver_triglyceride_accumulation-nucleus_distortion,/work/eval_papers/PMID_29526820.pdf,abstract,SPECIES,mouse,1290,1295,"In this study, we found that benzbromarone significantly aggravated hepatic steatosis in both obese db/db mice and high fat diet (HFD)-induced obese (DIO) mouse models."
liver_triglyceride_accumulation-nucleus_distortion,/work/eval_papers/PMID_29526820.pdf,abstract,SPECIES,human hepatoma HepG2 cells,1741,1767,"In accordance with the in vivo results, an in vitro experiment using human hepatoma HepG2 cells also confirmed that benzbromarone promoted intracellular lipid accumulation under high free fatty acids (FFAs) conditions by regulating the expression of lipid metabolism genes."
liver_triglyceride_accumulation-nucleus_distortion,/work/eval_papers/PMID_29526820.pdf,abstract,SPECIES,patients,2132,2140,"In addition, in benzbromarone-treated hyperuricemic patients, serum transaminase levels were positively correlated with patients' obesity level."
liver_triglyceride_accumulation-nucleus_distortion,/work/eval_papers/PMID_29526820.pdf,abstract,SPECIES,patients,2200,2208,"In addition, in benzbromarone-treated hyperuricemic patients, serum transaminase levels were positively correlated with patients' obesity level."
liver_triglyceride_accumulation-vldl_secretion,/work/eval_papers/PMID_34801933.pdf,abstract,CHEMICAL,dexamethasone,124,137,The influence of dexamethasone on hepatic fatty acids metabolism and transport in human steatotic HepG2 cell line exposed to palmitate.
liver_triglyceride_accumulation-vldl_secretion,/work/eval_papers/PMID_34801933.pdf,abstract,CHEMICAL,address,469,476,Electronic address: klaudia.sztolsztener@umb.edu.pl.
liver_triglyceride_accumulation-vldl_secretion,/work/eval_papers/PMID_34801933.pdf,abstract,CHEMICAL,address,631,638,Electronic address: ewa.harasim-symbor@umb.edu.pl.
liver_triglyceride_accumulation-vldl_secretion,/work/eval_papers/PMID_34801933.pdf,abstract,CHEMICAL,address,791,798,Electronic address: adrian.chabowski@umb.edu.pl.
liver_triglyceride_accumulation-vldl_secretion,/work/eval_papers/PMID_34801933.pdf,abstract,CHEMICAL,address,949,956,Electronic address: karolina.konstantynowicz-nowicka@umb.edu.pl.
liver_triglyceride_accumulation-vldl_secretion,/work/eval_papers/PMID_34801933.pdf,abstract,CHEMICAL,Dexamethasone,1003,1016,Dexamethasone (DEX) is a synthetic glucocorticoid with anti-inflammatory properties.
liver_triglyceride_accumulation-vldl_secretion,/work/eval_papers/PMID_34801933.pdf,abstract,CHEMICAL,dexamethasone,1292,1305,The HepG2 cells were incubated with palmitic acid (PA) and/or dexamethasone in two different time expositions (16 h and 40 h).
liver_triglyceride_accumulation-vldl_secretion,/work/eval_papers/PMID_34801933.pdf,abstract,CHEMICAL,dexamethasone,1661,1674,"The treatment of HepG2 with dexamethasone and palmitate enhanced lipid transport to the cell via increased especially FABPpm expression and resulted in the increased triacylglycerol (TAG), diacylglycerol (DAG) and ceramide deposition."
liver_triglyceride_accumulation-vldl_secretion,/work/eval_papers/PMID_34801933.pdf,abstract,CHEMICAL,exacerbated lipotoxicity,2224,2248,We may speculate that although protective lipid secretion into media and decrease in inflammatory FA precursors dexamethasone treatment exacerbated lipotoxicity in HepG2 cells.
liver_triglyceride_accumulation-vldl_secretion,/work/eval_papers/PMID_34801933.pdf,abstract,SPECIES,human,189,194,The influence of dexamethasone on hepatic fatty acids metabolism and transport in human steatotic HepG2 cell line exposed to palmitate.
mitochondrial_beta_oxidation-mitochondrial_disruption,/work/eval_papers/PMID_32410680.pdf,abstract,CHEMICAL,O(3)(6)(7,337,346,"Berge RK(1)(2), Cacabelos D(3)(4), Señarís R(4), Nordrehaug JE(3)(5), Nygård O(3)(6)(7), Skorve J(3), Bjørndal B(3)."
mitochondrial_beta_oxidation-mitochondrial_disruption,/work/eval_papers/PMID_32410680.pdf,abstract,CHEMICAL,nicotinamide adenine dinucleotide,1230,1263,"BACKGROUND: Non-alcoholic fatty liver disease is often associated with obesity, insulin resistance, dyslipidemia, and the metabolic syndrome in addition to mitochondrial dysfunction and nicotinamide adenine dinucleotide (NAD+) deficiency."
mitochondrial_beta_oxidation-mitochondrial_disruption,/work/eval_papers/PMID_32410680.pdf,abstract,CHEMICAL,investigate,1312,1323,"The aim of this study was to investigate how inhibition of mitochondrial fatty acid oxidation using the compound tetradecylthiopropionic acid (TTP) would affect hepatic triacylglycerol level and plasma levels of kynurenine (Kyn) metabolites and nicotinamide. METHODS: 12 C57BL/6 mice were fed a control diet, or an intervention diet supplemented with 0.9% (w/w) tetradecylthiopropionic acid for 14 days."
mitochondrial_beta_oxidation-mitochondrial_disruption,/work/eval_papers/PMID_32410680.pdf,abstract,CHEMICAL,levels,1485,1491,"The aim of this study was to investigate how inhibition of mitochondrial fatty acid oxidation using the compound tetradecylthiopropionic acid (TTP) would affect hepatic triacylglycerol level and plasma levels of kynurenine (Kyn) metabolites and nicotinamide. METHODS: 12 C57BL/6 mice were fed a control diet, or an intervention diet supplemented with 0.9% (w/w) tetradecylthiopropionic acid for 14 days."
mitochondrial_beta_oxidation-mitochondrial_disruption,/work/eval_papers/PMID_32410680.pdf,abstract,CHEMICAL,kynurenine,1495,1505,"The aim of this study was to investigate how inhibition of mitochondrial fatty acid oxidation using the compound tetradecylthiopropionic acid (TTP) would affect hepatic triacylglycerol level and plasma levels of kynurenine (Kyn) metabolites and nicotinamide. METHODS: 12 C57BL/6 mice were fed a control diet, or an intervention diet supplemented with 0.9% (w/w) tetradecylthiopropionic acid for 14 days."
mitochondrial_beta_oxidation-mitochondrial_disruption,/work/eval_papers/PMID_32410680.pdf,abstract,CHEMICAL,status,1899,1905,Metabolites in the tryptophan/kynurenine pathway and total antioxidant status were measured in plasma.
mitochondrial_beta_oxidation-mitochondrial_disruption,/work/eval_papers/PMID_32410680.pdf,abstract,CHEMICAL,levels,2242,2248,"The liver content of the oxidized form of NAD+ was increased, as well as the ratio of NAD+/NADH, and these changes were associated by increased hepatic mRNA levels of NAD synthetase and nicotinamide mononucleotide adenyltransferase-3."
mitochondrial_beta_oxidation-mitochondrial_disruption,/work/eval_papers/PMID_32410680.pdf,abstract,CHEMICAL,nicotinamide,2271,2283,"The liver content of the oxidized form of NAD+ was increased, as well as the ratio of NAD+/NADH, and these changes were associated by increased hepatic mRNA levels of NAD synthetase and nicotinamide mononucleotide adenyltransferase-3."
mitochondrial_beta_oxidation-mitochondrial_disruption,/work/eval_papers/PMID_32410680.pdf,abstract,CHEMICAL,nicotinamide,2403,2415,The downstream metabolites of kynurenine were reduced in plasma whereas the plasma nicotinamide content was increased.
mitochondrial_beta_oxidation-mitochondrial_disruption,/work/eval_papers/PMID_32410680.pdf,abstract,CHEMICAL,levels,2914,2920,CONCLUSION: Fatty liver induced by short-time treatment with tetradecylthiopropionic acid decreased the levels of kynurenine metabolites but increased the plasma levels of NAD+ and nicotinamide.
mitochondrial_beta_oxidation-mitochondrial_disruption,/work/eval_papers/PMID_32410680.pdf,abstract,CHEMICAL,nicotinamide,3081,3093,Most probably the increase of NAD+ and nicotinamide are generated through the Preiss Handler pathway and/or salvage pathway and not through the de novo pathway.
mitochondrial_beta_oxidation-mitochondrial_disruption,/work/eval_papers/PMID_32410680.pdf,abstract,CHEMICAL,nicotinamide adenine dinucleotide,3354,3387,The take home message is that non-alcoholic fatty liver disease is associated with the metabolic syndrome in addition to mitochondrial dysfunction and nicotinamide adenine dinucleotide (NAD+) deficiency.
mitochondrial_beta_oxidation-mitochondrial_disruption,/work/eval_papers/PMID_32410680.pdf,abstract,CHEMICAL,levels,3555,3561,"Inducing fatty liver in mice by inhibition of fatty acid oxidation resulted in a concomitant change in kynurenine metabolites increasing the plasma levels of nicotinamides and the hepatic NAD+/NADH ratio, probably without affecting the de novo pathway of kynurenines."
mitochondrial_beta_oxidation-mitochondrial_disruption,/work/eval_papers/PMID_32410680.pdf,abstract,SPECIES,mice,1562,1566,"The aim of this study was to investigate how inhibition of mitochondrial fatty acid oxidation using the compound tetradecylthiopropionic acid (TTP) would affect hepatic triacylglycerol level and plasma levels of kynurenine (Kyn) metabolites and nicotinamide. METHODS: 12 C57BL/6 mice were fed a control diet, or an intervention diet supplemented with 0.9% (w/w) tetradecylthiopropionic acid for 14 days."
mitochondrial_beta_oxidation-mitochondrial_disruption,/work/eval_papers/PMID_32410680.pdf,abstract,SPECIES,mice,3431,3435,"Inducing fatty liver in mice by inhibition of fatty acid oxidation resulted in a concomitant change in kynurenine metabolites increasing the plasma levels of nicotinamides and the hepatic NAD+/NADH ratio, probably without affecting the de novo pathway of kynurenines."
mitochondrial_beta_oxidation-mitochondrial_disruption,/work/eval_papers/PMID_31866205.pdf,abstract,CHEMICAL,Dev,3,6,1. Dev Cell. 2020 Jan 27;52(2):196-209.e9. doi: 10.1016/j.devcel.2019.11.012.
mitochondrial_beta_oxidation-mitochondrial_disruption,/work/eval_papers/PMID_31866205.pdf,abstract,CHEMICAL,2019,83,87,Epub 2019 Dec 19.
mitochondrial_beta_oxidation-mitochondrial_disruption,/work/eval_papers/PMID_31866205.pdf,abstract,CHEMICAL,Liu,224,227,"Liu L(1), Xie B(2), Fan M(2), Candas-Green D(2), Jiang JX(3), Wei R(4), Wang Y(5), Chen HW(6), Hu Y(7), Li JJ(8)."
mitochondrial_beta_oxidation-mitochondrial_disruption,/work/eval_papers/PMID_31866205.pdf,abstract,CHEMICAL,Fan,244,247,"Liu L(1), Xie B(2), Fan M(2), Candas-Green D(2), Jiang JX(3), Wei R(4), Wang Y(5), Chen HW(6), Hu Y(7), Li JJ(8)."
mitochondrial_beta_oxidation-mitochondrial_disruption,/work/eval_papers/PMID_31866205.pdf,abstract,CHEMICAL,Candas-Green,254,266,"Liu L(1), Xie B(2), Fan M(2), Candas-Green D(2), Jiang JX(3), Wei R(4), Wang Y(5), Chen HW(6), Hu Y(7), Li JJ(8)."
mitochondrial_beta_oxidation-mitochondrial_disruption,/work/eval_papers/PMID_31866205.pdf,abstract,CHEMICAL,Medicine,405,413,"Author information: (1)Department of Radiation Oncology, School of Medicine, University of California, Davis, Sacramento, CA, USA; Institute of Liver Diseases, Shuguan Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China."
mitochondrial_beta_oxidation-mitochondrial_disruption,/work/eval_papers/PMID_31866205.pdf,abstract,CHEMICAL,Medicine,559,567,"Author information: (1)Department of Radiation Oncology, School of Medicine, University of California, Davis, Sacramento, CA, USA; Institute of Liver Diseases, Shuguan Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China."
mitochondrial_beta_oxidation-mitochondrial_disruption,/work/eval_papers/PMID_31866205.pdf,abstract,CHEMICAL,Medicine,633,641,"(2)Department of Radiation Oncology, School of Medicine, University of California, Davis, Sacramento, CA, USA."
mitochondrial_beta_oxidation-mitochondrial_disruption,/work/eval_papers/PMID_31866205.pdf,abstract,CHEMICAL,Medicine,723,731,"(3)Department of Internal Medicine, Division of Gastroenterology and Hepatology, School of Medicine, University of California, Davis, Sacramento, CA, USA."
mitochondrial_beta_oxidation-mitochondrial_disruption,/work/eval_papers/PMID_31866205.pdf,abstract,CHEMICAL,Medicine,788,796,"(3)Department of Internal Medicine, Division of Gastroenterology and Hepatology, School of Medicine, University of California, Davis, Sacramento, CA, USA."
mitochondrial_beta_oxidation-mitochondrial_disruption,/work/eval_papers/PMID_31866205.pdf,abstract,CHEMICAL,Medicine,899,907,"(4)Department of Radiation Oncology, School of Medicine, University of California, Davis, Sacramento, CA, USA; Lewis Katz School of Medicine, Temple University, Philadelphia, PA, USA."
mitochondrial_beta_oxidation-mitochondrial_disruption,/work/eval_papers/PMID_31866205.pdf,abstract,CHEMICAL,Medicine,984,992,"(4)Department of Radiation Oncology, School of Medicine, University of California, Davis, Sacramento, CA, USA; Lewis Katz School of Medicine, Temple University, Philadelphia, PA, USA."
mitochondrial_beta_oxidation-mitochondrial_disruption,/work/eval_papers/PMID_31866205.pdf,abstract,CHEMICAL,Medicine,1185,1193,"(6)Department of Biochemistry and Molecular Medicine, School of Medicine, University of California, Davis, Sacramento, CA, USA; Comprehensive Cancer Center, University of California, Davis, Sacramento, CA, USA."
mitochondrial_beta_oxidation-mitochondrial_disruption,/work/eval_papers/PMID_31866205.pdf,abstract,CHEMICAL,Medicine,1425,1433,"(7)Institute of Liver Diseases, Shuguan Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China."
mitochondrial_beta_oxidation-mitochondrial_disruption,/work/eval_papers/PMID_31866205.pdf,abstract,CHEMICAL,Medicine,1499,1507,"(8)Department of Radiation Oncology, School of Medicine, University of California, Davis, Sacramento, CA, USA; Comprehensive Cancer Center, University of California, Davis, Sacramento, CA, USA."
mitochondrial_beta_oxidation-mitochondrial_disruption,/work/eval_papers/PMID_31866205.pdf,abstract,CHEMICAL,address,1657,1664,Electronic address: jijli@ucdavis.edu.
mitochondrial_beta_oxidation-mitochondrial_disruption,/work/eval_papers/PMID_31866205.pdf,abstract,CHEMICAL,cancer because of SFA-induced lipotoxicity,1834,1876,"Saturated fatty acids (SFAs) (the ""bad"" fat), especially palmitate (PA), in the human diet are blamed for potential health risks such as obesity and cancer because of SFA-induced lipotoxicity."
mitochondrial_beta_oxidation-mitochondrial_disruption,/work/eval_papers/PMID_31866205.pdf,abstract,CHEMICAL,carbon tetrachloride,2299,2319,"Here, we demonstrate that although high-level PA (HPA) indeed induces lipotoxic effects in liver cells, low-level PA (LPA) increases mitochondrial functions and alleviates the injuries induced by HPA or hepatoxic agent carbon tetrachloride (CCl4)."
mitochondrial_beta_oxidation-mitochondrial_disruption,/work/eval_papers/PMID_31866205.pdf,abstract,CHEMICAL,levels,2440,2446,"LPA treatment in mice enhanced liver mitochondrial activity and reduced CCl4 hepatotoxicity with improved blood levels of aspartate aminotransferase (AST), alanine transaminase (ALT), and mitochondrial aspartate transaminase (m-AST)."
mitochondrial_beta_oxidation-mitochondrial_disruption,/work/eval_papers/PMID_31866205.pdf,abstract,CHEMICAL,aspartate,2450,2459,"LPA treatment in mice enhanced liver mitochondrial activity and reduced CCl4 hepatotoxicity with improved blood levels of aspartate aminotransferase (AST), alanine transaminase (ALT), and mitochondrial aspartate transaminase (m-AST)."
mitochondrial_beta_oxidation-mitochondrial_disruption,/work/eval_papers/PMID_31866205.pdf,abstract,CHEMICAL,alanine,2484,2491,"LPA treatment in mice enhanced liver mitochondrial activity and reduced CCl4 hepatotoxicity with improved blood levels of aspartate aminotransferase (AST), alanine transaminase (ALT), and mitochondrial aspartate transaminase (m-AST)."
mitochondrial_beta_oxidation-mitochondrial_disruption,/work/eval_papers/PMID_31866205.pdf,abstract,CHEMICAL,PMC6996588,2973,2983,DOI: 10.1016/j.devcel.2019.11.012 PMCID: PMC6996588 PMID: 31866205 [Indexed for MEDLINE] Conflict of interest statement: Declaration of Interests The authors declare no competing interests.
mitochondrial_beta_oxidation-mitochondrial_disruption,/work/eval_papers/PMID_31866205.pdf,abstract,SPECIES,USA,464,467,"Author information: (1)Department of Radiation Oncology, School of Medicine, University of California, Davis, Sacramento, CA, USA; Institute of Liver Diseases, Shuguan Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China."
mitochondrial_beta_oxidation-mitochondrial_disruption,/work/eval_papers/PMID_31866205.pdf,abstract,SPECIES,USA,958,961,"(4)Department of Radiation Oncology, School of Medicine, University of California, Davis, Sacramento, CA, USA; Lewis Katz School of Medicine, Temple University, Philadelphia, PA, USA."
mitochondrial_beta_oxidation-mitochondrial_disruption,/work/eval_papers/PMID_31866205.pdf,abstract,SPECIES,USA,1031,1034,"(4)Department of Radiation Oncology, School of Medicine, University of California, Davis, Sacramento, CA, USA; Lewis Katz School of Medicine, Temple University, Philadelphia, PA, USA."
mitochondrial_beta_oxidation-mitochondrial_disruption,/work/eval_papers/PMID_31866205.pdf,abstract,SPECIES,USA,1244,1247,"(6)Department of Biochemistry and Molecular Medicine, School of Medicine, University of California, Davis, Sacramento, CA, USA; Comprehensive Cancer Center, University of California, Davis, Sacramento, CA, USA."
mitochondrial_beta_oxidation-mitochondrial_disruption,/work/eval_papers/PMID_31866205.pdf,abstract,SPECIES,USA,1558,1561,"(8)Department of Radiation Oncology, School of Medicine, University of California, Davis, Sacramento, CA, USA; Comprehensive Cancer Center, University of California, Davis, Sacramento, CA, USA."
mitochondrial_beta_oxidation-mitochondrial_disruption,/work/eval_papers/PMID_31866205.pdf,abstract,SPECIES,human,1765,1770,"Saturated fatty acids (SFAs) (the ""bad"" fat), especially palmitate (PA), in the human diet are blamed for potential health risks such as obesity and cancer because of SFA-induced lipotoxicity."
mitochondrial_beta_oxidation-mitochondrial_disruption,/work/eval_papers/PMID_31866205.pdf,abstract,SPECIES,mice,2345,2349,"LPA treatment in mice enhanced liver mitochondrial activity and reduced CCl4 hepatotoxicity with improved blood levels of aspartate aminotransferase (AST), alanine transaminase (ALT), and mitochondrial aspartate transaminase (m-AST)."
mitochondrial_beta_oxidation-novel_oxidative_stress,/work/eval_papers/PMID_32165129.pdf,abstract,CHEMICAL,Biomedicine,398,409,"Author information: (1)Division of Clinical Pharmacology & Toxicology, University Hospital Basel, Switzerland; Department of Biomedicine, University of Basel, Switzerland."
mitochondrial_beta_oxidation-novel_oxidative_stress,/work/eval_papers/PMID_32165129.pdf,abstract,CHEMICAL,Biomedicine,550,561,"(2)Division of Clinical Pharmacology & Toxicology, University Hospital Basel, Switzerland; Department of Biomedicine, University of Basel, Switzerland; Swiss Center for Applied Human Toxicology (SCAHT), Switzerland."
mitochondrial_beta_oxidation-novel_oxidative_stress,/work/eval_papers/PMID_32165129.pdf,abstract,CHEMICAL,address,672,679,Electronic address: Stephan.kraehenbuehl@usb.ch.
mitochondrial_beta_oxidation-novel_oxidative_stress,/work/eval_papers/PMID_32165129.pdf,abstract,CHEMICAL,caused,2321,2327,"Valproate caused cell death mainly by apoptosis, which may be a consequence of mitochondrial oxidative stress and increased hepatocellular concentration of free fatty acids."
mitochondrial_beta_oxidation-novel_oxidative_stress,/work/eval_papers/PMID_32165129.pdf,abstract,SPECIES,Human,622,627,"(2)Division of Clinical Pharmacology & Toxicology, University Hospital Basel, Switzerland; Department of Biomedicine, University of Basel, Switzerland; Swiss Center for Applied Human Toxicology (SCAHT), Switzerland."
mitochondrial_beta_oxidation-novel_oxidative_stress,/work/eval_papers/PMID_32165129.pdf,abstract,SPECIES,human cell,820,830,"Treatment with valproate is associated with hepatic steatosis, but the mechanisms are not fully elucidated in human cell systems."
mitochondrial_beta_oxidation-novel_oxidative_stress,/work/eval_papers/PMID_32165129.pdf,abstract,SPECIES,human hepatoma cell line,952,976,"We therefore investigated the effects of valproate on fatty acid and triglyceride metabolism in HepaRG cells, a human hepatoma cell line."
mitochondrial_beta_oxidation-novel_oxidative_stress,/work/eval_papers/PMID_34681291.pdf,abstract,CHEMICAL,Tebuconazole,588,600,"Tebuconazole (TEB), a triazole fungicide, is frequently applied to agriculture for the increase of food production."
mitochondrial_beta_oxidation-novel_oxidative_stress,/work/eval_papers/PMID_34681291.pdf,abstract,CHEMICAL,Although,704,712,"Although TEB causes liver toxicity, its effects on cellular lipid accumulation are rarely investigated."
mitochondrial_beta_oxidation-novel_oxidative_stress,/work/eval_papers/PMID_34681291.pdf,abstract,SPECIES,human,1762,1767,Our data suggest that human exposure to TEB may be a risk factor for non-alcoholic fatty liver disease.
mitochondrial_disruption-fa_uptake,/work/eval_papers/PMID_31026768.pdf,abstract,CHEMICAL,2019,74,78,doi: 10.1016/j.redox.2019.101205. Epub 2019 Apr 19.
mitochondrial_disruption-fa_uptake,/work/eval_papers/PMID_31026768.pdf,abstract,CHEMICAL,toxicant-associated steatohepatitis,142,177,Vinyl chloride-induced interaction of nonalcoholic and toxicant-associated steatohepatitis: Protection by the ALDH2 activator Alda-1.
mitochondrial_disruption-fa_uptake,/work/eval_papers/PMID_31026768.pdf,abstract,CHEMICAL,Alcohol,564,571,"Author information: (1)Department of Pharmacology and Toxicology, University of Louisville Health Sciences Center, Louisville, KY, 40202, USA; Hepatobiology and Toxicology Program, University of Louisville Health Sciences Center, Louisville, KY, 40202, USA; University of Louisville Alcohol Research Center, University of Louisville Health Sciences Center, Louisville, KY, 40202, USA. Electronic address: l0chen26@foxmail.com."
mitochondrial_disruption-fa_uptake,/work/eval_papers/PMID_31026768.pdf,abstract,CHEMICAL,address,677,684,"Author information: (1)Department of Pharmacology and Toxicology, University of Louisville Health Sciences Center, Louisville, KY, 40202, USA; Hepatobiology and Toxicology Program, University of Louisville Health Sciences Center, Louisville, KY, 40202, USA; University of Louisville Alcohol Research Center, University of Louisville Health Sciences Center, Louisville, KY, 40202, USA. Electronic address: l0chen26@foxmail.com."
mitochondrial_disruption-fa_uptake,/work/eval_papers/PMID_31026768.pdf,abstract,CHEMICAL,Alcohol,971,978,"(2)Department of Pharmacology and Toxicology, University of Louisville Health Sciences Center, Louisville, KY, 40202, USA; Hepatobiology and Toxicology Program, University of Louisville Health Sciences Center, Louisville, KY, 40202, USA; University of Louisville Alcohol Research Center, University of Louisville Health Sciences Center, Louisville, KY, 40202, USA."
mitochondrial_disruption-fa_uptake,/work/eval_papers/PMID_31026768.pdf,abstract,CHEMICAL,address,1084,1091,Electronic address: all159@med.miami.edu.
mitochondrial_disruption-fa_uptake,/work/eval_papers/PMID_31026768.pdf,abstract,CHEMICAL,Alcohol,1378,1385,"(3)Department of Pharmacology and Toxicology, University of Louisville Health Sciences Center, Louisville, KY, 40202, USA; Hepatobiology and Toxicology Program, University of Louisville Health Sciences Center, Louisville, KY, 40202, USA; University of Louisville Alcohol Research Center, University of Louisville Health Sciences Center, Louisville, KY, 40202, USA."
mitochondrial_disruption-fa_uptake,/work/eval_papers/PMID_31026768.pdf,abstract,CHEMICAL,address,1491,1498,Electronic address: gavin.poff@louisville.edu.
mitochondrial_disruption-fa_uptake,/work/eval_papers/PMID_31026768.pdf,abstract,CHEMICAL,City,1631,1635,"(4)Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, Kansas City, KS, 66160, USA."
mitochondrial_disruption-fa_uptake,/work/eval_papers/PMID_31026768.pdf,abstract,CHEMICAL,address,1664,1671,Electronic address: wxding@kumc.edu.
mitochondrial_disruption-fa_uptake,/work/eval_papers/PMID_31026768.pdf,abstract,CHEMICAL,Medicine,1707,1715,"(5)Department of Medicine, Division of Gastroenterology, Hepatology and Nutrition, University of Pittsburgh, Pittsburgh, PA, 15213, USA."
mitochondrial_disruption-fa_uptake,/work/eval_papers/PMID_31026768.pdf,abstract,CHEMICAL,address,1838,1845,Electronic address: jibeier@pitt.edu.
mitochondrial_disruption-fa_uptake,/work/eval_papers/PMID_31026768.pdf,abstract,CHEMICAL,play key roles,2256,2270,Mitochondrial oxidative injury and subsequent metabolic dysfunction appeared to play key roles in mediating this interaction.
mitochondrial_disruption-fa_uptake,/work/eval_papers/PMID_31026768.pdf,abstract,CHEMICAL,this,2284,2288,Mitochondrial oxidative injury and subsequent metabolic dysfunction appeared to play key roles in mediating this interaction.
mitochondrial_disruption-fa_uptake,/work/eval_papers/PMID_31026768.pdf,abstract,CHEMICAL,aldehyde,2316,2324,Mitochondrial aldehyde dehydrogenase 2 (ALDH2) serves as a key line of defense against endogenous and exogenous reactive aldehydes.
mitochondrial_disruption-fa_uptake,/work/eval_papers/PMID_31026768.pdf,abstract,CHEMICAL,Alda-1,2738,2744,"Some mice received Alda-1 (20 mg/kg i.p., 3 × /week) for the last 3 weeks of diet/VC exposure."
mitochondrial_disruption-fa_uptake,/work/eval_papers/PMID_31026768.pdf,abstract,CHEMICAL,low-dose,2938,2946,"As observed previously, low-dose VC did not cause liver injury in control mice; while liver injury caused by HFD was enhanced by VC."
mitochondrial_disruption-fa_uptake,/work/eval_papers/PMID_31026768.pdf,abstract,CHEMICAL,Alda-1,3100,3106,"Alda-1 attenuated oxidative stress, liver injury, and dysmetabolism in mice exposed to HFD+VC under these conditions."
mitochondrial_disruption-fa_uptake,/work/eval_papers/PMID_31026768.pdf,abstract,CHEMICAL,Alda-1,3309,3315,"Importantly, alterations in mitochondrial function caused by VC and HFD were diminished by Alda-1."
mitochondrial_disruption-fa_uptake,/work/eval_papers/PMID_31026768.pdf,abstract,CHEMICAL,Alda-1,3467,3473,"Here, Alda-1 suppressed PINK1/PARKIN-mediated mitophagy."
mitochondrial_disruption-fa_uptake,/work/eval_papers/PMID_31026768.pdf,abstract,CHEMICAL,Alda-1,3689,3695,"The ALDH2 activator Alda-1 conferred protection against liver damage under these conditions, most likely via increasing clearance of aldehydes and preserving mitochondrial respiratory function."
mitochondrial_disruption-fa_uptake,/work/eval_papers/PMID_31026768.pdf,abstract,CHEMICAL,2019,3875,3879,Copyright © 2019 The Authors. Published by Elsevier B.V. All rights reserved.
mitochondrial_disruption-fa_uptake,/work/eval_papers/PMID_31026768.pdf,abstract,SPECIES,l0chen26@foxmail.com,686,706,"Author information: (1)Department of Pharmacology and Toxicology, University of Louisville Health Sciences Center, Louisville, KY, 40202, USA; Hepatobiology and Toxicology Program, University of Louisville Health Sciences Center, Louisville, KY, 40202, USA; University of Louisville Alcohol Research Center, University of Louisville Health Sciences Center, Louisville, KY, 40202, USA. Electronic address: l0chen26@foxmail.com."
mitochondrial_disruption-fa_uptake,/work/eval_papers/PMID_31026768.pdf,abstract,SPECIES,Pittsburgh,1799,1809,"(5)Department of Medicine, Division of Gastroenterology, Hepatology and Nutrition, University of Pittsburgh, Pittsburgh, PA, 15213, USA."
mitochondrial_disruption-fa_uptake,/work/eval_papers/PMID_31026768.pdf,abstract,SPECIES,Mice,2571,2575,"Mice were exposed to low VC concentrations (<1 ppm), or room air for 6 h/day, 5 days/week for 12 weeks, while on HFD or low-fat control diet (LFD)."
mitochondrial_disruption-fa_uptake,/work/eval_papers/PMID_31026768.pdf,abstract,SPECIES,mice,2724,2728,"Some mice received Alda-1 (20 mg/kg i.p., 3 × /week) for the last 3 weeks of diet/VC exposure."
mitochondrial_disruption-fa_uptake,/work/eval_papers/PMID_31026768.pdf,abstract,SPECIES,mice,2988,2992,"As observed previously, low-dose VC did not cause liver injury in control mice; while liver injury caused by HFD was enhanced by VC."
mitochondrial_disruption-fa_uptake,/work/eval_papers/PMID_31026768.pdf,abstract,SPECIES,VC.,3043,3046,"As observed previously, low-dose VC did not cause liver injury in control mice; while liver injury caused by HFD was enhanced by VC."
mitochondrial_disruption-fa_uptake,/work/eval_papers/PMID_31026768.pdf,abstract,SPECIES,mice,3086,3090,VC decreased hepatic ALDH2 activity of mice fed HFD.
mitochondrial_disruption-fa_uptake,/work/eval_papers/PMID_31026768.pdf,abstract,SPECIES,mice,3171,3175,"Alda-1 attenuated oxidative stress, liver injury, and dysmetabolism in mice exposed to HFD+VC under these conditions."
mitochondrial_disruption-fa_uptake,/work/eval_papers/PMID_31026768.pdf,abstract,SPECIES,HFD were diminished,3286,3305,"Importantly, alterations in mitochondrial function caused by VC and HFD were diminished by Alda-1."
mitochondrial_disruption-liver_triglyceride_accumulation,/work/eval_papers/PMID_31026768.pdf,abstract,CHEMICAL,2019,74,78,doi: 10.1016/j.redox.2019.101205. Epub 2019 Apr 19.
mitochondrial_disruption-liver_triglyceride_accumulation,/work/eval_papers/PMID_31026768.pdf,abstract,CHEMICAL,toxicant-associated steatohepatitis,142,177,Vinyl chloride-induced interaction of nonalcoholic and toxicant-associated steatohepatitis: Protection by the ALDH2 activator Alda-1.
mitochondrial_disruption-liver_triglyceride_accumulation,/work/eval_papers/PMID_31026768.pdf,abstract,CHEMICAL,Alcohol,564,571,"Author information: (1)Department of Pharmacology and Toxicology, University of Louisville Health Sciences Center, Louisville, KY, 40202, USA; Hepatobiology and Toxicology Program, University of Louisville Health Sciences Center, Louisville, KY, 40202, USA; University of Louisville Alcohol Research Center, University of Louisville Health Sciences Center, Louisville, KY, 40202, USA. Electronic address: l0chen26@foxmail.com."
mitochondrial_disruption-liver_triglyceride_accumulation,/work/eval_papers/PMID_31026768.pdf,abstract,CHEMICAL,address,677,684,"Author information: (1)Department of Pharmacology and Toxicology, University of Louisville Health Sciences Center, Louisville, KY, 40202, USA; Hepatobiology and Toxicology Program, University of Louisville Health Sciences Center, Louisville, KY, 40202, USA; University of Louisville Alcohol Research Center, University of Louisville Health Sciences Center, Louisville, KY, 40202, USA. Electronic address: l0chen26@foxmail.com."
mitochondrial_disruption-liver_triglyceride_accumulation,/work/eval_papers/PMID_31026768.pdf,abstract,CHEMICAL,Alcohol,971,978,"(2)Department of Pharmacology and Toxicology, University of Louisville Health Sciences Center, Louisville, KY, 40202, USA; Hepatobiology and Toxicology Program, University of Louisville Health Sciences Center, Louisville, KY, 40202, USA; University of Louisville Alcohol Research Center, University of Louisville Health Sciences Center, Louisville, KY, 40202, USA."
mitochondrial_disruption-liver_triglyceride_accumulation,/work/eval_papers/PMID_31026768.pdf,abstract,CHEMICAL,address,1084,1091,Electronic address: all159@med.miami.edu.
mitochondrial_disruption-liver_triglyceride_accumulation,/work/eval_papers/PMID_31026768.pdf,abstract,CHEMICAL,Alcohol,1378,1385,"(3)Department of Pharmacology and Toxicology, University of Louisville Health Sciences Center, Louisville, KY, 40202, USA; Hepatobiology and Toxicology Program, University of Louisville Health Sciences Center, Louisville, KY, 40202, USA; University of Louisville Alcohol Research Center, University of Louisville Health Sciences Center, Louisville, KY, 40202, USA."
mitochondrial_disruption-liver_triglyceride_accumulation,/work/eval_papers/PMID_31026768.pdf,abstract,CHEMICAL,address,1491,1498,Electronic address: gavin.poff@louisville.edu.
mitochondrial_disruption-liver_triglyceride_accumulation,/work/eval_papers/PMID_31026768.pdf,abstract,CHEMICAL,City,1631,1635,"(4)Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, Kansas City, KS, 66160, USA."
mitochondrial_disruption-liver_triglyceride_accumulation,/work/eval_papers/PMID_31026768.pdf,abstract,CHEMICAL,address,1664,1671,Electronic address: wxding@kumc.edu.
mitochondrial_disruption-liver_triglyceride_accumulation,/work/eval_papers/PMID_31026768.pdf,abstract,CHEMICAL,Medicine,1707,1715,"(5)Department of Medicine, Division of Gastroenterology, Hepatology and Nutrition, University of Pittsburgh, Pittsburgh, PA, 15213, USA."
mitochondrial_disruption-liver_triglyceride_accumulation,/work/eval_papers/PMID_31026768.pdf,abstract,CHEMICAL,address,1838,1845,Electronic address: jibeier@pitt.edu.
mitochondrial_disruption-liver_triglyceride_accumulation,/work/eval_papers/PMID_31026768.pdf,abstract,CHEMICAL,play key roles,2256,2270,Mitochondrial oxidative injury and subsequent metabolic dysfunction appeared to play key roles in mediating this interaction.
mitochondrial_disruption-liver_triglyceride_accumulation,/work/eval_papers/PMID_31026768.pdf,abstract,CHEMICAL,this,2284,2288,Mitochondrial oxidative injury and subsequent metabolic dysfunction appeared to play key roles in mediating this interaction.
mitochondrial_disruption-liver_triglyceride_accumulation,/work/eval_papers/PMID_31026768.pdf,abstract,CHEMICAL,aldehyde,2316,2324,Mitochondrial aldehyde dehydrogenase 2 (ALDH2) serves as a key line of defense against endogenous and exogenous reactive aldehydes.
mitochondrial_disruption-liver_triglyceride_accumulation,/work/eval_papers/PMID_31026768.pdf,abstract,CHEMICAL,Alda-1,2738,2744,"Some mice received Alda-1 (20 mg/kg i.p., 3 × /week) for the last 3 weeks of diet/VC exposure."
mitochondrial_disruption-liver_triglyceride_accumulation,/work/eval_papers/PMID_31026768.pdf,abstract,CHEMICAL,low-dose,2938,2946,"As observed previously, low-dose VC did not cause liver injury in control mice; while liver injury caused by HFD was enhanced by VC."
mitochondrial_disruption-liver_triglyceride_accumulation,/work/eval_papers/PMID_31026768.pdf,abstract,CHEMICAL,Alda-1,3100,3106,"Alda-1 attenuated oxidative stress, liver injury, and dysmetabolism in mice exposed to HFD+VC under these conditions."
mitochondrial_disruption-liver_triglyceride_accumulation,/work/eval_papers/PMID_31026768.pdf,abstract,CHEMICAL,Alda-1,3309,3315,"Importantly, alterations in mitochondrial function caused by VC and HFD were diminished by Alda-1."
mitochondrial_disruption-liver_triglyceride_accumulation,/work/eval_papers/PMID_31026768.pdf,abstract,CHEMICAL,Alda-1,3467,3473,"Here, Alda-1 suppressed PINK1/PARKIN-mediated mitophagy."
mitochondrial_disruption-liver_triglyceride_accumulation,/work/eval_papers/PMID_31026768.pdf,abstract,CHEMICAL,Alda-1,3689,3695,"The ALDH2 activator Alda-1 conferred protection against liver damage under these conditions, most likely via increasing clearance of aldehydes and preserving mitochondrial respiratory function."
mitochondrial_disruption-liver_triglyceride_accumulation,/work/eval_papers/PMID_31026768.pdf,abstract,CHEMICAL,2019,3875,3879,Copyright © 2019 The Authors. Published by Elsevier B.V. All rights reserved.
mitochondrial_disruption-liver_triglyceride_accumulation,/work/eval_papers/PMID_31026768.pdf,abstract,SPECIES,l0chen26@foxmail.com,686,706,"Author information: (1)Department of Pharmacology and Toxicology, University of Louisville Health Sciences Center, Louisville, KY, 40202, USA; Hepatobiology and Toxicology Program, University of Louisville Health Sciences Center, Louisville, KY, 40202, USA; University of Louisville Alcohol Research Center, University of Louisville Health Sciences Center, Louisville, KY, 40202, USA. Electronic address: l0chen26@foxmail.com."
mitochondrial_disruption-liver_triglyceride_accumulation,/work/eval_papers/PMID_31026768.pdf,abstract,SPECIES,Pittsburgh,1799,1809,"(5)Department of Medicine, Division of Gastroenterology, Hepatology and Nutrition, University of Pittsburgh, Pittsburgh, PA, 15213, USA."
mitochondrial_disruption-liver_triglyceride_accumulation,/work/eval_papers/PMID_31026768.pdf,abstract,SPECIES,Mice,2571,2575,"Mice were exposed to low VC concentrations (<1 ppm), or room air for 6 h/day, 5 days/week for 12 weeks, while on HFD or low-fat control diet (LFD)."
mitochondrial_disruption-liver_triglyceride_accumulation,/work/eval_papers/PMID_31026768.pdf,abstract,SPECIES,mice,2724,2728,"Some mice received Alda-1 (20 mg/kg i.p., 3 × /week) for the last 3 weeks of diet/VC exposure."
mitochondrial_disruption-liver_triglyceride_accumulation,/work/eval_papers/PMID_31026768.pdf,abstract,SPECIES,mice,2988,2992,"As observed previously, low-dose VC did not cause liver injury in control mice; while liver injury caused by HFD was enhanced by VC."
mitochondrial_disruption-liver_triglyceride_accumulation,/work/eval_papers/PMID_31026768.pdf,abstract,SPECIES,VC.,3043,3046,"As observed previously, low-dose VC did not cause liver injury in control mice; while liver injury caused by HFD was enhanced by VC."
mitochondrial_disruption-liver_triglyceride_accumulation,/work/eval_papers/PMID_31026768.pdf,abstract,SPECIES,mice,3086,3090,VC decreased hepatic ALDH2 activity of mice fed HFD.
mitochondrial_disruption-liver_triglyceride_accumulation,/work/eval_papers/PMID_31026768.pdf,abstract,SPECIES,mice,3171,3175,"Alda-1 attenuated oxidative stress, liver injury, and dysmetabolism in mice exposed to HFD+VC under these conditions."
mitochondrial_disruption-liver_triglyceride_accumulation,/work/eval_papers/PMID_31026768.pdf,abstract,SPECIES,HFD were diminished,3286,3305,"Importantly, alterations in mitochondrial function caused by VC and HFD were diminished by Alda-1."
mitochondrial_disruption-liver_triglyceride_accumulation,/work/eval_papers/PMID_31682409.pdf,abstract,CHEMICAL,2019,24,28,1. Environ Sci Technol. 2019 Dec 3;53(23):13992-14000. doi: 10.1021/acs.est.9b05131. Epub 2019 Nov 14.
mitochondrial_disruption-liver_triglyceride_accumulation,/work/eval_papers/PMID_31682409.pdf,abstract,CHEMICAL,2019,90,94,1. Environ Sci Technol. 2019 Dec 3;53(23):13992-14000. doi: 10.1021/acs.est.9b05131. Epub 2019 Nov 14.
mitochondrial_disruption-liver_triglyceride_accumulation,/work/eval_papers/PMID_31682409.pdf,abstract,CHEMICAL,Cadmium,240,247,Inhibition of Mitochondrial Fatty Acid Oxidation Contributes to Development of Nonalcoholic Fatty Liver Disease Induced by Environmental Cadmium Exposure.
mitochondrial_disruption-liver_triglyceride_accumulation,/work/eval_papers/PMID_31682409.pdf,abstract,CHEMICAL,Cadmium,302,309,Cadmium (Cd) is one of the most prevalent toxic metal pollutants widely distributed in water and soil environments.
mitochondrial_disruption-liver_triglyceride_accumulation,/work/eval_papers/PMID_31682409.pdf,abstract,CHEMICAL,Our,1510,1513,"Our findings suggest that exposure to environmental Cd is a tangible risk factor for NAFLD, and the induced public health risks deserve greater attention."
mitochondrial_disruption-liver_triglyceride_accumulation,/work/eval_papers/PMID_31682409.pdf,abstract,SPECIES,Gao,264,267,"He X, Gao J, Hou H, Qi Z, Chen H, Zhang XX."
mitochondrial_disruption-liver_triglyceride_accumulation,/work/eval_papers/PMID_31682409.pdf,abstract,SPECIES,human,564,569,"Epidemiological studies have shown that exposure to Cd is implicated in the prevalence of nonalcoholic fatty liver disease (NAFLD) in middle-aged human population, but biological evidence is lacking and its toxicological mechanism remains unclear for the disease predisposition from environmental Cd exposure."
mitochondrial_disruption-liver_triglyceride_accumulation,/work/eval_papers/PMID_31682409.pdf,abstract,SPECIES,mouse,780,785,"In this study, we established a chronic Cd-exposure mouse model mimicking the liver Cd deposition in middle-aged human population to determine whether the environmental Cd exposure can induce NAFLD."
mitochondrial_disruption-liver_triglyceride_accumulation,/work/eval_papers/PMID_31682409.pdf,abstract,SPECIES,human,841,846,"In this study, we established a chronic Cd-exposure mouse model mimicking the liver Cd deposition in middle-aged human population to determine whether the environmental Cd exposure can induce NAFLD."
mitochondrial_disruption-liver_triglyceride_accumulation,/work/eval_papers/PMID_31682409.pdf,abstract,SPECIES,mice,1128,1132,"Results showed that hepatic Cd burden at levels of 0.95 and 6.04 μg/g wet weight resulting from 20-week Cd exposure at different doses induced NAFLD and nonalcoholic steatohepatitis-like phenotypes in mice, respectively."
mitochondrial_disruption-liver_triglyceride_accumulation,/work/eval_papers/PMID_29529605.pdf,abstract,CHEMICAL,investigate,379,390,"Therefore, the aim of this study was to investigate the regulatory mechanism of acetic acid on hepatic lipid metabolism in BRL-3A cells."
mitochondrial_disruption-liver_triglyceride_accumulation,/work/eval_papers/PMID_29529605.pdf,abstract,CHEMICAL,sodium acetate,555,569,METHODS: We cultured and treated BRL-3A cells with different concentrations of sodium acetate (neutralized acetic acid) and BML-275 (an AMPKα inhibitor).
mitochondrial_disruption-liver_triglyceride_accumulation,/work/eval_papers/PMID_29529605.pdf,abstract,CHEMICAL,BML-275,600,607,METHODS: We cultured and treated BRL-3A cells with different concentrations of sodium acetate (neutralized acetic acid) and BML-275 (an AMPKα inhibitor).
mitochondrial_disruption-liver_triglyceride_accumulation,/work/eval_papers/PMID_29529605.pdf,abstract,CHEMICAL,levels,1168,1174,These changes ultimate led to increasing levels of lipid oxidation in BRL-3A cells.
mitochondrial_disruption-liver_triglyceride_accumulation,/work/eval_papers/PMID_29529605.pdf,abstract,CHEMICAL,S. Karger,1822,1831,"Published by S. Karger AG, Basel."
mitochondrial_disruption-liver_triglyceride_accumulation,/work/eval_papers/PMID_29529605.pdf,abstract,CHEMICAL,PMID: 29529605,1866,1880,DOI: 10.1159/000487980 PMID: 29529605 [Indexed for MEDLINE]
mitochondrial_disruption-novel_lipid_peroxidation,/work/eval_papers/PMID_30557836.pdf,abstract,CHEMICAL,2019,24,28,1. Biomed Pharmacother. 2019 Feb;110:869-877.
mitochondrial_disruption-novel_lipid_peroxidation,/work/eval_papers/PMID_30557836.pdf,abstract,CHEMICAL,Ilorin,420,426,"Author information: (1)HOPE Cardiometabolic Research Team, Department of Physiology, College of Health Sciences, University of Ilorin, Nigeria."
mitochondrial_disruption-novel_lipid_peroxidation,/work/eval_papers/PMID_30557836.pdf,abstract,CHEMICAL,Ilorin,544,550,"(2)HOPE Cardiometabolic Research Team, Department of Physiology, College of Health Sciences, University of Ilorin, Nigeria."
mitochondrial_disruption-novel_lipid_peroxidation,/work/eval_papers/PMID_30557836.pdf,abstract,CHEMICAL,address,572,579,Electronic address: tunjilaw@unilorin.edu.ng. Dipeptidyl peptidase-4 (DPP-4) inhibition has been shown to exert beneficial effects against insulin resistance (IR) and type 2 diabetes.
mitochondrial_disruption-novel_lipid_peroxidation,/work/eval_papers/PMID_30557836.pdf,abstract,CHEMICAL,adenosine,1024,1033,"We therefore, hypothesized that DPP-4 inhibition ameliorates COC-induced glucose dysregulation and hepatic triglyceride (TG) accumulation through adenosine deaminase (ADA) /xanthine oxidase (XO) /uric acid-dependent pathway."
mitochondrial_disruption-novel_lipid_peroxidation,/work/eval_papers/PMID_30557836.pdf,abstract,CHEMICAL,malondialdehyde,1714,1729,"COC treatment also resulted in increased plasma and hepatic TG, TG/HDL-cholesterol ratio, malondialdehyde, uric acid (plasma; 25.2 ± 0.6 mg/dl; hepatic 128.9 ± 8.0 mg/100 mg tissue), lactate dehydrogenase, DPP-4, ADA and XO (plasma;10.5 ± 1.1 U/L; hepatic 21.2 ± 1.4 U/g protein) activities."
mitochondrial_disruption-novel_lipid_peroxidation,/work/eval_papers/PMID_30557836.pdf,abstract,CHEMICAL,lactate,1807,1814,"COC treatment also resulted in increased plasma and hepatic TG, TG/HDL-cholesterol ratio, malondialdehyde, uric acid (plasma; 25.2 ± 0.6 mg/dl; hepatic 128.9 ± 8.0 mg/100 mg tissue), lactate dehydrogenase, DPP-4, ADA and XO (plasma;10.5 ± 1.1 U/L; hepatic 21.2 ± 1.4 U/g protein) activities."
mitochondrial_disruption-novel_lipid_peroxidation,/work/eval_papers/PMID_30557836.pdf,abstract,CHEMICAL,U/L,1867,1870,"COC treatment also resulted in increased plasma and hepatic TG, TG/HDL-cholesterol ratio, malondialdehyde, uric acid (plasma; 25.2 ± 0.6 mg/dl; hepatic 128.9 ± 8.0 mg/100 mg tissue), lactate dehydrogenase, DPP-4, ADA and XO (plasma;10.5 ± 1.1 U/L; hepatic 21.2 ± 1.4 U/g protein) activities."
mitochondrial_disruption-novel_lipid_peroxidation,/work/eval_papers/PMID_30557836.pdf,abstract,CHEMICAL,nitric oxide,1950,1962,"Likewise, COC led to reduction in nitric oxide level."
mitochondrial_disruption-novel_lipid_peroxidation,/work/eval_papers/PMID_30557836.pdf,abstract,CHEMICAL,"U/L, hepatic; 8.7 ±",2186,2205,"However, DPP-4 inhibition significantly ameliorated these alterations induced by COC treatment through suppression of uric acid (plasma; 15.1 ± 1.0 mg/dl, hepatic; 75.6 ± 5.0 mg/100 mg tissue), XO (plasma; 4.1 ± 0.9 U/L, hepatic; 8.7 ± 0.4 U/g protein), ADA and DPP-4 activities suggesting their involvement in glucose dysregulation and hepatic TG accumulation induced by COC treatment."
mitochondrial_disruption-novel_oxidative_stress,/work/eval_papers/PMID_32231762.pdf,abstract,CHEMICAL,Medicine,457,465,"(2)Centre for Education, Faculty of Life Sciences and Medicine, King's College London SE1 1UL, United Kingdom."
mitochondrial_disruption-novel_oxidative_stress,/work/eval_papers/PMID_32231762.pdf,abstract,CHEMICAL,SE1,489,492,"(2)Centre for Education, Faculty of Life Sciences and Medicine, King's College London SE1 1UL, United Kingdom."
mitochondrial_disruption-novel_oxidative_stress,/work/eval_papers/PMID_32231762.pdf,abstract,CHEMICAL,Medicine,609,617,"(3)Nebraska and Western Iowa Veterans Administration Medical Center and Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE 68198, United States."
mitochondrial_disruption-novel_oxidative_stress,/work/eval_papers/PMID_32231762.pdf,abstract,CHEMICAL,DHA,1677,1680,"METHODS: HepG2-derived VL-17A cells were treated with normal (1:1, 4:1) and high (15:1, 25:1) ratios of omega-6: omega-3 fatty acids [arachidonic acid (AA): docosahexaenoic acid (DHA)] at various time points."
mitochondrial_disruption-novel_oxidative_stress,/work/eval_papers/PMID_32231762.pdf,abstract,CHEMICAL,ATP,2678,2681,"Furthermore, the high ratio increased ROS production (P < 0.01; 74%-115%) and reduced mitochondrial respiratory functions such as basal and maximal respiration, ATP production, spare respiratory capacity and proton leak (P < 0.01; 35%-68%)."
mitochondrial_disruption-novel_oxidative_stress,/work/eval_papers/PMID_32231762.pdf,abstract,CHEMICAL,triglyceride,2796,2808,"CONCLUSION: High AA:DHA ratio induced triglyceride accumulation, increased oxidative stress and disrupted mitochondrial functions."
mitochondrial_disruption-novel_oxidative_stress,/work/eval_papers/PMID_32231762.pdf,abstract,SPECIES,human hepatoma cells,194,214,High omega arachidonic acid/docosahexaenoic acid ratio induces mitochondrial dysfunction and altered lipid metabolism in human hepatoma cells.
novel_ap_1_pathway-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_33900847.pdf,abstract,CHEMICAL,Liu,229,232,"Xie D(1), Zhao H(1), Lu J(1), He F(1), Liu W(1), Yu W(1), Wang Q(1), Hisatome I(2), Yamamoto T(3), Koyama H(3), Cheng J(1)(3)."
novel_ap_1_pathway-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_33900847.pdf,abstract,CHEMICAL,Medicine,452,460,"(2)Division of Regenerative Medicine and Therapeutics, Institute of Regenerative Medicine and Biofunction, Graduate School of Medical Sciences, Tottori University, Yonago, Japan."
novel_ap_1_pathway-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_33900847.pdf,abstract,CHEMICAL,Medicine,505,513,"(2)Division of Regenerative Medicine and Therapeutics, Institute of Regenerative Medicine and Biofunction, Graduate School of Medical Sciences, Tottori University, Yonago, Japan."
novel_ap_1_pathway-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_33900847.pdf,abstract,CHEMICAL,Medicine,686,694,"(3)Department of Diabetes, Endocrinology and Clinical Immunology, Hyogo College of Medicine, Nishinomiya, Japan."
novel_ap_1_pathway-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_33900847.pdf,abstract,CHEMICAL,urate,1019,1024,"In this study, we established a urate oxidase-knockout (Uox-KO) mouse model by clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9 technology."
novel_ap_1_pathway-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_33900847.pdf,abstract,CHEMICAL,medium,1249,1255,"To study the correlation between HUA and NAFLD, human HepG2 hepatoma cells were treated in culture medium with high level of uric acid."
novel_ap_1_pathway-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_33900847.pdf,abstract,CHEMICAL,ROS/JNK/AP-1,2119,2131,These data suggest that ROS/JNK/AP-1 signaling plays an important role in HUA-mediated fat accumulation in liver.
novel_ap_1_pathway-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_33900847.pdf,abstract,SPECIES,repeats,1116,1123,"In this study, we established a urate oxidase-knockout (Uox-KO) mouse model by clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9 technology."
novel_ap_1_pathway-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_33900847.pdf,abstract,SPECIES,human HepG2 hepatoma cells,1198,1224,"To study the correlation between HUA and NAFLD, human HepG2 hepatoma cells were treated in culture medium with high level of uric acid."
novel_ap_1_pathway-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_33900847.pdf,abstract,SPECIES,SP600125,1566,1574,"Furthermore, inhibiting JNK activation by a JNK-specific inhibitor, SP600125, decreased fat accumulation and lipogenic gene expression induced by HUA."
novel_ap_1_pathway-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_33900847.pdf,abstract,SPECIES,AP-1,1828,1832,HUA activated AP-1 to upregulate lipogenic gene expression via JNK activation.
novel_autophagy-er_stress,/work/eval_papers/PMID_34685712.pdf,abstract,CHEMICAL,investigate,704,715,"The present study aimed to investigate if mechanistic target of rapamycin complex 1 (mTORC1) plays a role in FFA-induced organelle dysfunction, thereby contributing to the development of ALD."
novel_autophagy-er_stress,/work/eval_papers/PMID_34685712.pdf,abstract,CHEMICAL,rapamycin,741,750,"The present study aimed to investigate if mechanistic target of rapamycin complex 1 (mTORC1) plays a role in FFA-induced organelle dysfunction, thereby contributing to the development of ALD."
novel_autophagy-er_stress,/work/eval_papers/PMID_34685712.pdf,abstract,CHEMICAL,define,900,906,Cell studies were conducted to define the causal role and underlying mechanism of FFA-activated mTORC1 signaling in hepatocellular cell injury.
novel_autophagy-er_stress,/work/eval_papers/PMID_34685712.pdf,abstract,CHEMICAL,alcohol,1063,1070,C57BL/6J wild-type mice were subjected to chronic alcohol feeding with or without rapamycin to inhibit mTORC1 activation.
novel_autophagy-er_stress,/work/eval_papers/PMID_34685712.pdf,abstract,CHEMICAL,rapamycin,1095,1104,C57BL/6J wild-type mice were subjected to chronic alcohol feeding with or without rapamycin to inhibit mTORC1 activation.
novel_autophagy-er_stress,/work/eval_papers/PMID_34685712.pdf,abstract,CHEMICAL,LAMP2,1208,1213,We revealed that palmitic acid (PA)-induced ER stress and suppression of LAMP2 and autophagy flux were mTORC1-dependent as rapamycin reversed such deleterious effects.
novel_autophagy-er_stress,/work/eval_papers/PMID_34685712.pdf,abstract,CHEMICAL,rapamycin,1258,1267,We revealed that palmitic acid (PA)-induced ER stress and suppression of LAMP2 and autophagy flux were mTORC1-dependent as rapamycin reversed such deleterious effects.
novel_autophagy-er_stress,/work/eval_papers/PMID_34685712.pdf,abstract,CHEMICAL,rapamycin,1412,1421,"Supplementation with rapamycin to alcohol-fed mice attenuated mTORC1 activation and ER stress, restored LAMP2 protein, and improved autophagy, leading to amelioration of alcohol-induced liver injury."
novel_autophagy-er_stress,/work/eval_papers/PMID_34685712.pdf,abstract,SPECIES,mice,1032,1036,C57BL/6J wild-type mice were subjected to chronic alcohol feeding with or without rapamycin to inhibit mTORC1 activation.
novel_autophagy-er_stress,/work/eval_papers/PMID_34685712.pdf,abstract,SPECIES,mice,1437,1441,"Supplementation with rapamycin to alcohol-fed mice attenuated mTORC1 activation and ER stress, restored LAMP2 protein, and improved autophagy, leading to amelioration of alcohol-induced liver injury."
novel_autophagy-er_stress,/work/eval_papers/PMID_34685712.pdf,abstract,SPECIES,patients,1665,1673,Induction of mTORC1 signaling and CHOP were also detected in the liver of patients with severe alcoholic hepatitis.
novel_ceramide_synthesis-fatty_liver,/work/eval_papers/PMID_28933423.pdf,abstract,CHEMICAL,Liu,266,269,"Dong YQ(1), Zhang XZ(1), Sun LL(1), Zhang SY(1), Liu B(1), Liu HY(1), Wang X(1), Jiang CT(1)."
novel_ceramide_synthesis-fatty_liver,/work/eval_papers/PMID_28933423.pdf,abstract,CHEMICAL,Liu,276,279,"Dong YQ(1), Zhang XZ(1), Sun LL(1), Zhang SY(1), Liu B(1), Liu HY(1), Wang X(1), Jiang CT(1)."
novel_ceramide_synthesis-fatty_liver,/work/eval_papers/PMID_28933423.pdf,abstract,CHEMICAL,investigate,718,729,"In this study, we applied a metabolomic approach to investigate the changes in the metabolite profile due to HHcy-induced hepatic steatosis and the effects of omega-3 PUFA (polyunsaturated fatty acid) supplementation in mice."
novel_ceramide_synthesis-fatty_liver,/work/eval_papers/PMID_28933423.pdf,abstract,CHEMICAL,cholesterol,1139,1150,Hepatic triglycerides and cholesterol were further assayed.
novel_ceramide_synthesis-fatty_liver,/work/eval_papers/PMID_28933423.pdf,abstract,CHEMICAL,levels,2117,2123,"Furthermore, downregulation of ceramide levels through omega-3 PUFA supplementation ameliorates hepatic lipid accumulation."
novel_ceramide_synthesis-fatty_liver,/work/eval_papers/PMID_28933423.pdf,abstract,SPECIES,mice,170,174,Omega-3 PUFA ameliorates hyperhomocysteinemia-induced hepatic steatosis in mice by inhibiting hepatic ceramide synthesis.
novel_ceramide_synthesis-fatty_liver,/work/eval_papers/PMID_28933423.pdf,abstract,SPECIES,mice,886,890,"In this study, we applied a metabolomic approach to investigate the changes in the metabolite profile due to HHcy-induced hepatic steatosis and the effects of omega-3 PUFA (polyunsaturated fatty acid) supplementation in mice."
novel_ceramide_synthesis-fatty_liver,/work/eval_papers/PMID_28933423.pdf,abstract,SPECIES,mice,912,916,"HHcy was induced in mice by giving DL-Hcy (1.8 g/L) in drinking water for 6 weeks, then the mice were sacrificed, and the metabolic profiles of the liver and plasma were analyzed through UPLC-ESI-QTOFMS-based lipidomics."
novel_ceramide_synthesis-fatty_liver,/work/eval_papers/PMID_28933423.pdf,abstract,SPECIES,mice,984,988,"HHcy was induced in mice by giving DL-Hcy (1.8 g/L) in drinking water for 6 weeks, then the mice were sacrificed, and the metabolic profiles of the liver and plasma were analyzed through UPLC-ESI-QTOFMS-based lipidomics."
novel_ceramide_synthesis-fatty_liver,/work/eval_papers/PMID_28933423.pdf,abstract,SPECIES,mice,1292,1296,"Compared with control mice, HHcy mice exhibited hepatic steatosis with a notable increase in ceramide-related metabolites and subsequent upregulation of ceramide synthesis genes such as Sptlc3, Degs2, Cer4 and Smpd4."
novel_changes_in_gut_microbiome-liver_triglyceride_accumulation,/work/eval_papers/PMID_25736031.pdf,abstract,CHEMICAL,address,515,522,"Author information: (1)Nutrition Biology Laboratory, EA4466, Faculty of Pharmacy, Paris Descartes University, Sorbonne Paris Cité, Paris, France. Electronic address: pira_jegatheesan@hotmail.com."
novel_changes_in_gut_microbiome-liver_triglyceride_accumulation,/work/eval_papers/PMID_25736031.pdf,abstract,CHEMICAL,address,691,698,"(2)Nutrition Biology Laboratory, EA4466, Faculty of Pharmacy, Paris Descartes University, Sorbonne Paris Cité, Paris, France. Electronic address: dianesbeutheu@yahoo.fr."
novel_changes_in_gut_microbiome-liver_triglyceride_accumulation,/work/eval_papers/PMID_25736031.pdf,abstract,CHEMICAL,address,861,868,"(3)Nutrition Biology Laboratory, EA4466, Faculty of Pharmacy, Paris Descartes University, Sorbonne Paris Cité, Paris, France. Electronic address: gabrielle.ventura@nutrition-paris5.org. (4)Clinical Chemistry Department, Hôpitaux Universitaires Paris Centre, APHP, Paris, France. Electronic address: gilles.sarfati@cch.aphp.fr."
novel_changes_in_gut_microbiome-liver_triglyceride_accumulation,/work/eval_papers/PMID_25736031.pdf,abstract,CHEMICAL,address,1014,1021,"(3)Nutrition Biology Laboratory, EA4466, Faculty of Pharmacy, Paris Descartes University, Sorbonne Paris Cité, Paris, France. Electronic address: gabrielle.ventura@nutrition-paris5.org. (4)Clinical Chemistry Department, Hôpitaux Universitaires Paris Centre, APHP, Paris, France. Electronic address: gilles.sarfati@cch.aphp.fr."
novel_changes_in_gut_microbiome-liver_triglyceride_accumulation,/work/eval_papers/PMID_25736031.pdf,abstract,CHEMICAL,address,1188,1195,"(5)Nutrition Biology Laboratory, EA4466, Faculty of Pharmacy, Paris Descartes University, Sorbonne Paris Cité, Paris, France. Electronic address: esther.nubret@parisdescartes.fr. (6)Microbiology, EA4065, Faculty of Pharmacy, Paris Descartes University, Sorbonne Paris Cité, Paris, France. Electronic address: nathalie.kapel@psl.aphp.fr."
novel_changes_in_gut_microbiome-liver_triglyceride_accumulation,/work/eval_papers/PMID_25736031.pdf,abstract,CHEMICAL,address,1351,1358,"(5)Nutrition Biology Laboratory, EA4466, Faculty of Pharmacy, Paris Descartes University, Sorbonne Paris Cité, Paris, France. Electronic address: esther.nubret@parisdescartes.fr. (6)Microbiology, EA4065, Faculty of Pharmacy, Paris Descartes University, Sorbonne Paris Cité, Paris, France. Electronic address: nathalie.kapel@psl.aphp.fr."
novel_changes_in_gut_microbiome-liver_triglyceride_accumulation,/work/eval_papers/PMID_25736031.pdf,abstract,CHEMICAL,address,1509,1516,"(7)Microbiology, EA4065, Faculty of Pharmacy, Paris Descartes University, Sorbonne Paris Cité, Paris, France. Electronic address: anne-judith.waligora@parisdescartes.fr."
novel_changes_in_gut_microbiome-liver_triglyceride_accumulation,/work/eval_papers/PMID_25736031.pdf,abstract,CHEMICAL,address,1687,1694,Electronic address: ina.bergheim@uni-jena.de.
novel_changes_in_gut_microbiome-liver_triglyceride_accumulation,/work/eval_papers/PMID_25736031.pdf,abstract,CHEMICAL,address,1949,1956,"(9)Nutrition Biology Laboratory, EA4466, Faculty of Pharmacy, Paris Descartes University, Sorbonne Paris Cité, Paris, France; Clinical Chemistry Department, Hôpitaux Universitaires Paris Centre, APHP, Paris, France. Electronic address: luc.cynober@univ-paris5.fr."
novel_changes_in_gut_microbiome-liver_triglyceride_accumulation,/work/eval_papers/PMID_25736031.pdf,abstract,CHEMICAL,address,2214,2221,"(10)Nutrition Biology Laboratory, EA4466, Faculty of Pharmacy, Paris Descartes University, Sorbonne Paris Cité, Paris, France; Clinical Chemistry Department, Hôpitaux Universitaires Paris Centre, APHP, Paris, France. Electronic address: jean-pascal.de-bandt@parisdescartes.fr."
novel_changes_in_gut_microbiome-liver_triglyceride_accumulation,/work/eval_papers/PMID_25736031.pdf,abstract,CHEMICAL,Citrulline,2454,2464,"Citrulline, Glutamine and Arginine may improve insulin sensitivity and have beneficial effects on gut trophicity."
novel_changes_in_gut_microbiome-liver_triglyceride_accumulation,/work/eval_papers/PMID_25736031.pdf,abstract,CHEMICAL,Glutamine,2466,2475,"Citrulline, Glutamine and Arginine may improve insulin sensitivity and have beneficial effects on gut trophicity."
novel_changes_in_gut_microbiome-liver_triglyceride_accumulation,/work/eval_papers/PMID_25736031.pdf,abstract,CHEMICAL,Arginine,2480,2488,"Citrulline, Glutamine and Arginine may improve insulin sensitivity and have beneficial effects on gut trophicity."
novel_changes_in_gut_microbiome-liver_triglyceride_accumulation,/work/eval_papers/PMID_25736031.pdf,abstract,CHEMICAL,Our,2568,2571,Our aim was to evaluate their effects on liver and gut functions in a rat model of fructose-induced non-alcoholic fatty liver disease.
novel_changes_in_gut_microbiome-liver_triglyceride_accumulation,/work/eval_papers/PMID_25736031.pdf,abstract,CHEMICAL,Citrulline,2817,2827,METHODS: Male Sprague-Dawley rats (n = 58) received a 4-week fructose (60%) diet or standard chow with or without Citrulline (0.15 g/d) or an isomolar amount of Arginine or Glutamine.
novel_changes_in_gut_microbiome-liver_triglyceride_accumulation,/work/eval_papers/PMID_25736031.pdf,abstract,CHEMICAL,g/d,2834,2837,METHODS: Male Sprague-Dawley rats (n = 58) received a 4-week fructose (60%) diet or standard chow with or without Citrulline (0.15 g/d) or an isomolar amount of Arginine or Glutamine.
novel_changes_in_gut_microbiome-liver_triglyceride_accumulation,/work/eval_papers/PMID_25736031.pdf,abstract,CHEMICAL,Arginine,2864,2872,METHODS: Male Sprague-Dawley rats (n = 58) received a 4-week fructose (60%) diet or standard chow with or without Citrulline (0.15 g/d) or an isomolar amount of Arginine or Glutamine.
novel_changes_in_gut_microbiome-liver_triglyceride_accumulation,/work/eval_papers/PMID_25736031.pdf,abstract,CHEMICAL,glucose,3016,3023,"At week 4, nutritional and metabolic status (plasma glucose, insulin, cholesterol, triglycerides and amino acids, net intestinal absorption) was determined; steatosis (hepatic triglycerides content, histological examination) and hepatic function (plasma aspartate aminotransferase, alanine aminotransferase, alkaline phosphatase, bilirubin) were assessed; and gut barrier integrity (myeloperoxidase activity, portal endotoxemia, tight junction protein expression and localization) and intestinal and hepatic inflammation were evaluated."
novel_changes_in_gut_microbiome-liver_triglyceride_accumulation,/work/eval_papers/PMID_25736031.pdf,abstract,CHEMICAL,cholesterol,3034,3045,"At week 4, nutritional and metabolic status (plasma glucose, insulin, cholesterol, triglycerides and amino acids, net intestinal absorption) was determined; steatosis (hepatic triglycerides content, histological examination) and hepatic function (plasma aspartate aminotransferase, alanine aminotransferase, alkaline phosphatase, bilirubin) were assessed; and gut barrier integrity (myeloperoxidase activity, portal endotoxemia, tight junction protein expression and localization) and intestinal and hepatic inflammation were evaluated."
novel_changes_in_gut_microbiome-liver_triglyceride_accumulation,/work/eval_papers/PMID_25736031.pdf,abstract,CHEMICAL,aspartate,3218,3227,"At week 4, nutritional and metabolic status (plasma glucose, insulin, cholesterol, triglycerides and amino acids, net intestinal absorption) was determined; steatosis (hepatic triglycerides content, histological examination) and hepatic function (plasma aspartate aminotransferase, alanine aminotransferase, alkaline phosphatase, bilirubin) were assessed; and gut barrier integrity (myeloperoxidase activity, portal endotoxemia, tight junction protein expression and localization) and intestinal and hepatic inflammation were evaluated."
novel_changes_in_gut_microbiome-liver_triglyceride_accumulation,/work/eval_papers/PMID_25736031.pdf,abstract,CHEMICAL,alanine,3246,3253,"At week 4, nutritional and metabolic status (plasma glucose, insulin, cholesterol, triglycerides and amino acids, net intestinal absorption) was determined; steatosis (hepatic triglycerides content, histological examination) and hepatic function (plasma aspartate aminotransferase, alanine aminotransferase, alkaline phosphatase, bilirubin) were assessed; and gut barrier integrity (myeloperoxidase activity, portal endotoxemia, tight junction protein expression and localization) and intestinal and hepatic inflammation were evaluated."
novel_changes_in_gut_microbiome-liver_triglyceride_accumulation,/work/eval_papers/PMID_25736031.pdf,abstract,CHEMICAL,bilirubin,3294,3303,"At week 4, nutritional and metabolic status (plasma glucose, insulin, cholesterol, triglycerides and amino acids, net intestinal absorption) was determined; steatosis (hepatic triglycerides content, histological examination) and hepatic function (plasma aspartate aminotransferase, alanine aminotransferase, alkaline phosphatase, bilirubin) were assessed; and gut barrier integrity (myeloperoxidase activity, portal endotoxemia, tight junction protein expression and localization) and intestinal and hepatic inflammation were evaluated."
novel_changes_in_gut_microbiome-liver_triglyceride_accumulation,/work/eval_papers/PMID_25736031.pdf,abstract,CHEMICAL,Bifidobacterium,3781,3796,Fructose significantly decreased Bifidobacterium and Lactobacillus and tended to increase endotoxemia.
novel_changes_in_gut_microbiome-liver_triglyceride_accumulation,/work/eval_papers/PMID_25736031.pdf,abstract,CHEMICAL,Arginine,3851,3859,Arginine and Glutamine supplements were ineffective but Citrulline supplementation prevented hypertriglyceridemia and attenuated liver fat accumulation.
novel_changes_in_gut_microbiome-liver_triglyceride_accumulation,/work/eval_papers/PMID_25736031.pdf,abstract,CHEMICAL,Glutamine,3864,3873,Arginine and Glutamine supplements were ineffective but Citrulline supplementation prevented hypertriglyceridemia and attenuated liver fat accumulation.
novel_changes_in_gut_microbiome-liver_triglyceride_accumulation,/work/eval_papers/PMID_25736031.pdf,abstract,CHEMICAL,prevented hypertriglyceridemia,3934,3964,Arginine and Glutamine supplements were ineffective but Citrulline supplementation prevented hypertriglyceridemia and attenuated liver fat accumulation.
novel_changes_in_gut_microbiome-liver_triglyceride_accumulation,/work/eval_papers/PMID_25736031.pdf,abstract,CHEMICAL,Citrulline,4110,4120,"CONCLUSION: While nitrogen supply alone can attenuate fructose-induced non-alcoholic fatty liver disease, Citrulline appears to act directly on hepatic lipid metabolism by partially preventing hypertriglyceridemia and steatosis."
novel_changes_in_gut_microbiome-liver_triglyceride_accumulation,/work/eval_papers/PMID_25736031.pdf,abstract,SPECIES,pira_jegatheesan@hotmail.com,524,552,"Author information: (1)Nutrition Biology Laboratory, EA4466, Faculty of Pharmacy, Paris Descartes University, Sorbonne Paris Cité, Paris, France. Electronic address: pira_jegatheesan@hotmail.com."
novel_changes_in_gut_microbiome-liver_triglyceride_accumulation,/work/eval_papers/PMID_25736031.pdf,abstract,SPECIES,gilles.sarfati@cch.aphp.fr,1023,1049,"(3)Nutrition Biology Laboratory, EA4466, Faculty of Pharmacy, Paris Descartes University, Sorbonne Paris Cité, Paris, France. Electronic address: gabrielle.ventura@nutrition-paris5.org. (4)Clinical Chemistry Department, Hôpitaux Universitaires Paris Centre, APHP, Paris, France. Electronic address: gilles.sarfati@cch.aphp.fr."
novel_changes_in_gut_microbiome-liver_triglyceride_accumulation,/work/eval_papers/PMID_25736031.pdf,abstract,SPECIES,SD Model,1584,1592,"(8)Institut of Nutrition, SD Model Systems of Molecular Nutrition, Friedrich-Schiller University Jena, Jena, Germany."
novel_changes_in_gut_microbiome-liver_triglyceride_accumulation,/work/eval_papers/PMID_25736031.pdf,abstract,SPECIES,luc.cynober@univ-paris5.fr,1958,1984,"(9)Nutrition Biology Laboratory, EA4466, Faculty of Pharmacy, Paris Descartes University, Sorbonne Paris Cité, Paris, France; Clinical Chemistry Department, Hôpitaux Universitaires Paris Centre, APHP, Paris, France. Electronic address: luc.cynober@univ-paris5.fr."
novel_changes_in_gut_microbiome-liver_triglyceride_accumulation,/work/eval_papers/PMID_25736031.pdf,abstract,SPECIES,Sprague-Dawley rats,2717,2736,METHODS: Male Sprague-Dawley rats (n = 58) received a 4-week fructose (60%) diet or standard chow with or without Citrulline (0.15 g/d) or an isomolar amount of Arginine or Glutamine.
novel_cholesterol_accumulation-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_31470036.pdf,abstract,CHEMICAL,2019,80,84,Epub 2019 Aug 27.
novel_cholesterol_accumulation-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_31470036.pdf,abstract,CHEMICAL,Bisphenol A,93,104,Bisphenol A exposure induces cholesterol synthesis and hepatic steatosis in C57BL/6 mice by down-regulating the DNA methylation levels of SREBP-2.
novel_cholesterol_accumulation-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_31470036.pdf,abstract,CHEMICAL,cholesterol,122,133,Bisphenol A exposure induces cholesterol synthesis and hepatic steatosis in C57BL/6 mice by down-regulating the DNA methylation levels of SREBP-2.
novel_cholesterol_accumulation-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_31470036.pdf,abstract,CHEMICAL,levels,221,227,Bisphenol A exposure induces cholesterol synthesis and hepatic steatosis in C57BL/6 mice by down-regulating the DNA methylation levels of SREBP-2.
novel_cholesterol_accumulation-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_31470036.pdf,abstract,CHEMICAL,Zou,261,264,"Li Q(1), Zhang H(1), Zou J(2), Mai H(3), Su D(4), Feng X(5), Feng D(6)."
novel_cholesterol_accumulation-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_31470036.pdf,abstract,CHEMICAL,Key,356,359,"Author information: (1)Guangdong Provincial Key Laboratory of Food, Nutrition and Health, Department of Nutrition, School of Public Health, Sun Yat-sen University, 510080, China."
novel_cholesterol_accumulation-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_31470036.pdf,abstract,CHEMICAL,Key,881,884,", China. (5)Guangdong Provincial Key Laboratory of Food, Nutrition and Health, Department of Nutrition, School of Public Health, Sun Yat-sen University, 510080, China. Electronic address: fengx@mail.sysu.edu.cn."
novel_cholesterol_accumulation-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_31470036.pdf,abstract,CHEMICAL,address,1027,1034,", China. (5)Guangdong Provincial Key Laboratory of Food, Nutrition and Health, Department of Nutrition, School of Public Health, Sun Yat-sen University, 510080, China. Electronic address: fengx@mail.sysu.edu.cn."
novel_cholesterol_accumulation-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_31470036.pdf,abstract,CHEMICAL,Key,1084,1087,"(6)Guangdong Provincial Key Laboratory of Food, Nutrition and Health, Department of Nutrition, School of Public Health, Sun Yat-sen University, 510080, China; Guangzhou Key Laboratory of Environmental Pollution and Health Risk Assessment, Department of Occupational and Environmental Health, School of Public Health, SunYat-sen University, 510080, China. Electronic address: fengdan3@mail.sysu.edu.cn."
novel_cholesterol_accumulation-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_31470036.pdf,abstract,CHEMICAL,Key,1229,1232,"(6)Guangdong Provincial Key Laboratory of Food, Nutrition and Health, Department of Nutrition, School of Public Health, Sun Yat-sen University, 510080, China; Guangzhou Key Laboratory of Environmental Pollution and Health Risk Assessment, Department of Occupational and Environmental Health, School of Public Health, SunYat-sen University, 510080, China. Electronic address: fengdan3@mail.sysu.edu.cn."
novel_cholesterol_accumulation-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_31470036.pdf,abstract,CHEMICAL,address,1426,1433,"(6)Guangdong Provincial Key Laboratory of Food, Nutrition and Health, Department of Nutrition, School of Public Health, Sun Yat-sen University, 510080, China; Guangzhou Key Laboratory of Environmental Pollution and Health Risk Assessment, Department of Occupational and Environmental Health, School of Public Health, SunYat-sen University, 510080, China. Electronic address: fengdan3@mail.sysu.edu.cn."
novel_cholesterol_accumulation-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_31470036.pdf,abstract,CHEMICAL,Bisphenol A,1462,1473,"Bisphenol A (BPA), a major plasticizers that are commonly used for lining of beverage or food-storage containers, has been shown to increase cholesterol levels with molecular mechanism not clear."
novel_cholesterol_accumulation-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_31470036.pdf,abstract,CHEMICAL,BPA,1475,1478,"Bisphenol A (BPA), a major plasticizers that are commonly used for lining of beverage or food-storage containers, has been shown to increase cholesterol levels with molecular mechanism not clear."
novel_cholesterol_accumulation-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_31470036.pdf,abstract,CHEMICAL,cholesterol,1603,1614,"Bisphenol A (BPA), a major plasticizers that are commonly used for lining of beverage or food-storage containers, has been shown to increase cholesterol levels with molecular mechanism not clear."
novel_cholesterol_accumulation-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_31470036.pdf,abstract,CHEMICAL,investigate,1689,1700,The present study was aimed to investigate the effects of BPA exposure on liver cholesterol synthesis and hepatic steatosis in male C57BL/6 mice and its underlying mechanisms.
novel_cholesterol_accumulation-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_31470036.pdf,abstract,CHEMICAL,BPA,1716,1719,The present study was aimed to investigate the effects of BPA exposure on liver cholesterol synthesis and hepatic steatosis in male C57BL/6 mice and its underlying mechanisms.
novel_cholesterol_accumulation-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_31470036.pdf,abstract,CHEMICAL,cholesterol,1738,1749,The present study was aimed to investigate the effects of BPA exposure on liver cholesterol synthesis and hepatic steatosis in male C57BL/6 mice and its underlying mechanisms.
novel_cholesterol_accumulation-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_31470036.pdf,abstract,CHEMICAL,BPA,1916,1919,"Male C57BL/6 mice were exposed to different doses (50, 500 and 5000 μg/kg/day) of BPA through diet for 16 weeks."
novel_cholesterol_accumulation-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_31470036.pdf,abstract,CHEMICAL,BPA,1995,1998,Exposure to low doses (50 and 500 μg/kg/day) of BPA increased hepatic cholesterol content and the expression levels of hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGCR) and sterol regulatory element binding proteins-2 (SREBP-2).
novel_cholesterol_accumulation-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_31470036.pdf,abstract,CHEMICAL,cholesterol,2017,2028,Exposure to low doses (50 and 500 μg/kg/day) of BPA increased hepatic cholesterol content and the expression levels of hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGCR) and sterol regulatory element binding proteins-2 (SREBP-2).
novel_cholesterol_accumulation-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_31470036.pdf,abstract,CHEMICAL,levels of hepatic 3-hydroxy-3-methylglutaryl coenzyme A,2056,2111,Exposure to low doses (50 and 500 μg/kg/day) of BPA increased hepatic cholesterol content and the expression levels of hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGCR) and sterol regulatory element binding proteins-2 (SREBP-2).
novel_cholesterol_accumulation-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_31470036.pdf,abstract,CHEMICAL,low-dose BPA,2251,2263,DNA methylation analysis further showed that mice exposed to low-dose BPA decreased the DNA methylation levels of SREBP-2.
novel_cholesterol_accumulation-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_31470036.pdf,abstract,CHEMICAL,levels,2294,2300,DNA methylation analysis further showed that mice exposed to low-dose BPA decreased the DNA methylation levels of SREBP-2.
novel_cholesterol_accumulation-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_31470036.pdf,abstract,CHEMICAL,BPA,2336,2339,"Moreover, low doses of BPA exposure increased the expression levels of SREBP-1c and stearoyl-CoA desaturase 1 in the liver, and induced hepatic lipid synthesis and fat accumulation."
novel_cholesterol_accumulation-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_31470036.pdf,abstract,CHEMICAL,levels,2374,2380,"Moreover, low doses of BPA exposure increased the expression levels of SREBP-1c and stearoyl-CoA desaturase 1 in the liver, and induced hepatic lipid synthesis and fat accumulation."
novel_cholesterol_accumulation-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_31470036.pdf,abstract,CHEMICAL,SREBP-1c,2384,2392,"Moreover, low doses of BPA exposure increased the expression levels of SREBP-1c and stearoyl-CoA desaturase 1 in the liver, and induced hepatic lipid synthesis and fat accumulation."
novel_cholesterol_accumulation-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_31470036.pdf,abstract,CHEMICAL,Our,2495,2498,"Our results suggest that low-dose BPA exposure could induce hepatic cholesterol synthesis through decreasing the DNA methylation levels of SREBP-2 and subsequently up-regulating the expression of genes related to cholesterol synthesis in the liver, which causes cholesterol accumulation and further induces liver lipid synthesis and hepatic steatosis."
novel_cholesterol_accumulation-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_31470036.pdf,abstract,CHEMICAL,low-dose BPA,2520,2532,"Our results suggest that low-dose BPA exposure could induce hepatic cholesterol synthesis through decreasing the DNA methylation levels of SREBP-2 and subsequently up-regulating the expression of genes related to cholesterol synthesis in the liver, which causes cholesterol accumulation and further induces liver lipid synthesis and hepatic steatosis."
novel_cholesterol_accumulation-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_31470036.pdf,abstract,CHEMICAL,cholesterol,2563,2574,"Our results suggest that low-dose BPA exposure could induce hepatic cholesterol synthesis through decreasing the DNA methylation levels of SREBP-2 and subsequently up-regulating the expression of genes related to cholesterol synthesis in the liver, which causes cholesterol accumulation and further induces liver lipid synthesis and hepatic steatosis."
novel_cholesterol_accumulation-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_31470036.pdf,abstract,CHEMICAL,through,2585,2592,"Our results suggest that low-dose BPA exposure could induce hepatic cholesterol synthesis through decreasing the DNA methylation levels of SREBP-2 and subsequently up-regulating the expression of genes related to cholesterol synthesis in the liver, which causes cholesterol accumulation and further induces liver lipid synthesis and hepatic steatosis."
novel_cholesterol_accumulation-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_31470036.pdf,abstract,CHEMICAL,levels,2624,2630,"Our results suggest that low-dose BPA exposure could induce hepatic cholesterol synthesis through decreasing the DNA methylation levels of SREBP-2 and subsequently up-regulating the expression of genes related to cholesterol synthesis in the liver, which causes cholesterol accumulation and further induces liver lipid synthesis and hepatic steatosis."
novel_cholesterol_accumulation-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_31470036.pdf,abstract,CHEMICAL,cholesterol,2708,2719,"Our results suggest that low-dose BPA exposure could induce hepatic cholesterol synthesis through decreasing the DNA methylation levels of SREBP-2 and subsequently up-regulating the expression of genes related to cholesterol synthesis in the liver, which causes cholesterol accumulation and further induces liver lipid synthesis and hepatic steatosis."
novel_cholesterol_accumulation-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_31470036.pdf,abstract,CHEMICAL,cholesterol,2757,2768,"Our results suggest that low-dose BPA exposure could induce hepatic cholesterol synthesis through decreasing the DNA methylation levels of SREBP-2 and subsequently up-regulating the expression of genes related to cholesterol synthesis in the liver, which causes cholesterol accumulation and further induces liver lipid synthesis and hepatic steatosis."
novel_cholesterol_accumulation-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_31470036.pdf,abstract,SPECIES,mice,1798,1802,The present study was aimed to investigate the effects of BPA exposure on liver cholesterol synthesis and hepatic steatosis in male C57BL/6 mice and its underlying mechanisms.
novel_cholesterol_accumulation-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_31470036.pdf,abstract,SPECIES,mice,1847,1851,"Male C57BL/6 mice were exposed to different doses (50, 500 and 5000 μg/kg/day) of BPA through diet for 16 weeks."
novel_cholesterol_accumulation-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_31470036.pdf,abstract,SPECIES,mice,2235,2239,DNA methylation analysis further showed that mice exposed to low-dose BPA decreased the DNA methylation levels of SREBP-2.
novel_cyp450-liver_triglyceride_accumulation,/work/eval_papers/PMID_34439562.pdf,abstract,CHEMICAL,Curcumin,78,86,Curcumin Suppresses the Lipid Accumulation and Oxidative Stress Induced by Benzo[a]pyrene Toxicity in HepG2 Cells.
novel_cyp450-liver_triglyceride_accumulation,/work/eval_papers/PMID_34439562.pdf,abstract,CHEMICAL,curcumin,787,795,"This study aimed to uncover the mechanism of curcumin, the major curcuminoid in turmeric (Curcuma longa), in modulating the lipid accumulation and oxidative stress mediated by B[a]P cytotoxicity in HepG2 cells."
novel_cyp450-liver_triglyceride_accumulation,/work/eval_papers/PMID_34439562.pdf,abstract,CHEMICAL,Curcumin,953,961,Curcumin treatment reduced the B[a]P-induced lipid accumulation and reactive oxygen spicies (ROS) upregulation and recovered the cell viability.
novel_cyp450-liver_triglyceride_accumulation,/work/eval_papers/PMID_34439562.pdf,abstract,CHEMICAL,phase-II,1585,1593,"Moreover, the curcumin-induced reduction in ROS generation decreased the nuclear translocation of Nuclear factor erythroid-2-related factor 2 (Nrf2) and the expression of phase-II detoxifying enzymes."
novel_cyp450-liver_triglyceride_accumulation,/work/eval_papers/PMID_34439562.pdf,abstract,CHEMICAL,curcumin,1643,1651,These results indicate that curcumin suppresses B[a]P-induced lipid accumulation and ROS generation which can potentially induce nonalcoholic fatty liver disease (NAFLD) and can shed a light on the detoxifying effect of curcumin.
novel_cyp450-liver_triglyceride_accumulation,/work/eval_papers/PMID_34439562.pdf,abstract,CHEMICAL,curcumin,1835,1843,These results indicate that curcumin suppresses B[a]P-induced lipid accumulation and ROS generation which can potentially induce nonalcoholic fatty liver disease (NAFLD) and can shed a light on the detoxifying effect of curcumin.
novel_deptor-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_29457836.pdf,abstract,CHEMICAL,Fan,420,423,"Chen H(1)(2), Shen F(1)(2)(3), Sherban A(4), Nocon A(4), Li Y(4)(5), Wang H(6), Xu MJ(6), Rui X(4), Han J(4), Jiang B(4), Lee D(1)(2), Li N(1)(2)(7), Keyhani-Nejad F(1)(2), Fan JG(3), Liu F(2), Kamat A(8), Musi N(2)(8), Guarente L(9), Pacher P(6), Gao B(6), Zang M(1)(2)(8)."
novel_deptor-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_29457836.pdf,abstract,CHEMICAL,Liu,431,434,"Chen H(1)(2), Shen F(1)(2)(3), Sherban A(4), Nocon A(4), Li Y(4)(5), Wang H(6), Xu MJ(6), Rui X(4), Han J(4), Jiang B(4), Lee D(1)(2), Li N(1)(2)(7), Keyhani-Nejad F(1)(2), Fan JG(3), Liu F(2), Kamat A(8), Musi N(2)(8), Guarente L(9), Pacher P(6), Gao B(6), Zang M(1)(2)(8)."
novel_deptor-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_29457836.pdf,abstract,CHEMICAL,Medicine,569,577,"Author information: (1)Department of Molecular Medicine, University of Texas Health San Antonio, San Antonio, TX."
novel_deptor-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_29457836.pdf,abstract,CHEMICAL,Medicine,847,855,"(3)Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China."
novel_deptor-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_29457836.pdf,abstract,CHEMICAL,Medicine,905,913,"(4)Boston University School of Medicine, Boston, MA."
novel_deptor-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_29457836.pdf,abstract,CHEMICAL,Alcohol Abuse,1135,1148,"(6)Laboratory of Liver Diseases, Laboratory of Cardiovascular Physiology and Tissue Injury, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD."
novel_deptor-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_29457836.pdf,abstract,CHEMICAL,Alcoholism,1153,1163,"(6)Laboratory of Liver Diseases, Laboratory of Cardiovascular Physiology and Tissue Injury, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD."
novel_deptor-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_29457836.pdf,abstract,CHEMICAL,Medicine,1280,1288,"(7)Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. (8)Geriatric Research, Education and Clinical Center, South Texas Veterans Health Care System, San Antonio, TX."
novel_deptor-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_29457836.pdf,abstract,CHEMICAL,Biology,1436,1443,"(9)Department of Biology, Paul F. Glenn Laboratory, Massachusetts Institute of Technology, Cambridge, MA."
novel_deptor-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_29457836.pdf,abstract,CHEMICAL,alcohol,1633,1640,"However, how chronic alcohol consumption causes hepatic lipid accumulation remains elusive."
novel_deptor-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_29457836.pdf,abstract,CHEMICAL,rapamycin,1780,1789,"The present study demonstrates that activation of the mechanistic target of rapamycin complex 1 (mTORC1) plays a causal role in alcoholic steatosis, inflammation, and liver injury."
novel_deptor-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_29457836.pdf,abstract,CHEMICAL,rapamycin,3035,3044,"Pharmacological intervention with rapamycin alleviated the ability of alcohol to up-regulate lipogenesis, to down-regulate fatty acid oxidation, and to induce steatogenic phenotypes."
novel_deptor-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_29457836.pdf,abstract,CHEMICAL,alcohol,3071,3078,"Pharmacological intervention with rapamycin alleviated the ability of alcohol to up-regulate lipogenesis, to down-regulate fatty acid oxidation, and to induce steatogenic phenotypes."
novel_deptor-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_29457836.pdf,abstract,CHEMICAL,up-regulate,3082,3093,"Pharmacological intervention with rapamycin alleviated the ability of alcohol to up-regulate lipogenesis, to down-regulate fatty acid oxidation, and to induce steatogenic phenotypes."
novel_deptor-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_29457836.pdf,abstract,CHEMICAL,down-regulate,3110,3123,"Pharmacological intervention with rapamycin alleviated the ability of alcohol to up-regulate lipogenesis, to down-regulate fatty acid oxidation, and to induce steatogenic phenotypes."
novel_deptor-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_29457836.pdf,abstract,CHEMICAL,ALD,3721,3724,CONCLUSION: The dysregulation of SIRT1-DEPTOR-mTORC1 signaling is a critical determinant of ALD pathology; targeting SIRT1 and DEPTOR and selectively inhibiting mTORC1-S6K1 signaling may have therapeutic potential for treating ALD in humans.
novel_deptor-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_29457836.pdf,abstract,SPECIES,Cardiovascular,1068,1082,"(6)Laboratory of Liver Diseases, Laboratory of Cardiovascular Physiology and Tissue Injury, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD."
novel_deptor-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_29457836.pdf,abstract,SPECIES,mice,2324,2328,Aberrant activation of mTORC1 was likely attributed to the defects of the DEP domain-containing mTOR-interacting protein (DEPTOR) and the nicotinamide adenine dinucleotide-dependent deacetylase sirtuin 1 (SIRT1) in the liver of chronic-plus-binge ethanol-fed mice and in the liver of patients with ALD.
novel_deptor-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_29457836.pdf,abstract,SPECIES,patients,2349,2357,Aberrant activation of mTORC1 was likely attributed to the defects of the DEP domain-containing mTOR-interacting protein (DEPTOR) and the nicotinamide adenine dinucleotide-dependent deacetylase sirtuin 1 (SIRT1) in the liver of chronic-plus-binge ethanol-fed mice and in the liver of patients with ALD.
novel_deptor-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_29457836.pdf,abstract,SPECIES,mice,3488,3492,"Furthermore, hepatocyte-specific deletion of SIRT1 disrupted DEPTOR function, enhanced mTORC1 activity, and exacerbated alcoholic fatty liver, inflammation, and liver injury in mice."
novel_deptor-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_29457836.pdf,abstract,SPECIES,humans,3728,3734,CONCLUSION: The dysregulation of SIRT1-DEPTOR-mTORC1 signaling is a critical determinant of ALD pathology; targeting SIRT1 and DEPTOR and selectively inhibiting mTORC1-S6K1 signaling may have therapeutic potential for treating ALD in humans.
novel_deptor-protein_kinase_changes_novel_mtorc1,/work/eval_papers/PMID_29457836.pdf,abstract,CHEMICAL,Fan,420,423,"Chen H(1)(2), Shen F(1)(2)(3), Sherban A(4), Nocon A(4), Li Y(4)(5), Wang H(6), Xu MJ(6), Rui X(4), Han J(4), Jiang B(4), Lee D(1)(2), Li N(1)(2)(7), Keyhani-Nejad F(1)(2), Fan JG(3), Liu F(2), Kamat A(8), Musi N(2)(8), Guarente L(9), Pacher P(6), Gao B(6), Zang M(1)(2)(8)."
novel_deptor-protein_kinase_changes_novel_mtorc1,/work/eval_papers/PMID_29457836.pdf,abstract,CHEMICAL,Liu,431,434,"Chen H(1)(2), Shen F(1)(2)(3), Sherban A(4), Nocon A(4), Li Y(4)(5), Wang H(6), Xu MJ(6), Rui X(4), Han J(4), Jiang B(4), Lee D(1)(2), Li N(1)(2)(7), Keyhani-Nejad F(1)(2), Fan JG(3), Liu F(2), Kamat A(8), Musi N(2)(8), Guarente L(9), Pacher P(6), Gao B(6), Zang M(1)(2)(8)."
novel_deptor-protein_kinase_changes_novel_mtorc1,/work/eval_papers/PMID_29457836.pdf,abstract,CHEMICAL,Medicine,569,577,"Author information: (1)Department of Molecular Medicine, University of Texas Health San Antonio, San Antonio, TX."
novel_deptor-protein_kinase_changes_novel_mtorc1,/work/eval_papers/PMID_29457836.pdf,abstract,CHEMICAL,Medicine,847,855,"(3)Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China."
novel_deptor-protein_kinase_changes_novel_mtorc1,/work/eval_papers/PMID_29457836.pdf,abstract,CHEMICAL,Medicine,905,913,"(4)Boston University School of Medicine, Boston, MA."
novel_deptor-protein_kinase_changes_novel_mtorc1,/work/eval_papers/PMID_29457836.pdf,abstract,CHEMICAL,Alcohol Abuse,1135,1148,"(6)Laboratory of Liver Diseases, Laboratory of Cardiovascular Physiology and Tissue Injury, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD."
novel_deptor-protein_kinase_changes_novel_mtorc1,/work/eval_papers/PMID_29457836.pdf,abstract,CHEMICAL,Alcoholism,1153,1163,"(6)Laboratory of Liver Diseases, Laboratory of Cardiovascular Physiology and Tissue Injury, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD."
novel_deptor-protein_kinase_changes_novel_mtorc1,/work/eval_papers/PMID_29457836.pdf,abstract,CHEMICAL,Medicine,1280,1288,"(7)Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. (8)Geriatric Research, Education and Clinical Center, South Texas Veterans Health Care System, San Antonio, TX."
novel_deptor-protein_kinase_changes_novel_mtorc1,/work/eval_papers/PMID_29457836.pdf,abstract,CHEMICAL,Biology,1436,1443,"(9)Department of Biology, Paul F. Glenn Laboratory, Massachusetts Institute of Technology, Cambridge, MA."
novel_deptor-protein_kinase_changes_novel_mtorc1,/work/eval_papers/PMID_29457836.pdf,abstract,CHEMICAL,alcohol,1633,1640,"However, how chronic alcohol consumption causes hepatic lipid accumulation remains elusive."
novel_deptor-protein_kinase_changes_novel_mtorc1,/work/eval_papers/PMID_29457836.pdf,abstract,CHEMICAL,rapamycin,1780,1789,"The present study demonstrates that activation of the mechanistic target of rapamycin complex 1 (mTORC1) plays a causal role in alcoholic steatosis, inflammation, and liver injury."
novel_deptor-protein_kinase_changes_novel_mtorc1,/work/eval_papers/PMID_29457836.pdf,abstract,CHEMICAL,rapamycin,3035,3044,"Pharmacological intervention with rapamycin alleviated the ability of alcohol to up-regulate lipogenesis, to down-regulate fatty acid oxidation, and to induce steatogenic phenotypes."
novel_deptor-protein_kinase_changes_novel_mtorc1,/work/eval_papers/PMID_29457836.pdf,abstract,CHEMICAL,alcohol,3071,3078,"Pharmacological intervention with rapamycin alleviated the ability of alcohol to up-regulate lipogenesis, to down-regulate fatty acid oxidation, and to induce steatogenic phenotypes."
novel_deptor-protein_kinase_changes_novel_mtorc1,/work/eval_papers/PMID_29457836.pdf,abstract,CHEMICAL,up-regulate,3082,3093,"Pharmacological intervention with rapamycin alleviated the ability of alcohol to up-regulate lipogenesis, to down-regulate fatty acid oxidation, and to induce steatogenic phenotypes."
novel_deptor-protein_kinase_changes_novel_mtorc1,/work/eval_papers/PMID_29457836.pdf,abstract,CHEMICAL,down-regulate,3110,3123,"Pharmacological intervention with rapamycin alleviated the ability of alcohol to up-regulate lipogenesis, to down-regulate fatty acid oxidation, and to induce steatogenic phenotypes."
novel_deptor-protein_kinase_changes_novel_mtorc1,/work/eval_papers/PMID_29457836.pdf,abstract,CHEMICAL,ALD,3721,3724,CONCLUSION: The dysregulation of SIRT1-DEPTOR-mTORC1 signaling is a critical determinant of ALD pathology; targeting SIRT1 and DEPTOR and selectively inhibiting mTORC1-S6K1 signaling may have therapeutic potential for treating ALD in humans.
novel_deptor-protein_kinase_changes_novel_mtorc1,/work/eval_papers/PMID_29457836.pdf,abstract,SPECIES,Cardiovascular,1068,1082,"(6)Laboratory of Liver Diseases, Laboratory of Cardiovascular Physiology and Tissue Injury, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD."
novel_deptor-protein_kinase_changes_novel_mtorc1,/work/eval_papers/PMID_29457836.pdf,abstract,SPECIES,mice,2324,2328,Aberrant activation of mTORC1 was likely attributed to the defects of the DEP domain-containing mTOR-interacting protein (DEPTOR) and the nicotinamide adenine dinucleotide-dependent deacetylase sirtuin 1 (SIRT1) in the liver of chronic-plus-binge ethanol-fed mice and in the liver of patients with ALD.
novel_deptor-protein_kinase_changes_novel_mtorc1,/work/eval_papers/PMID_29457836.pdf,abstract,SPECIES,patients,2349,2357,Aberrant activation of mTORC1 was likely attributed to the defects of the DEP domain-containing mTOR-interacting protein (DEPTOR) and the nicotinamide adenine dinucleotide-dependent deacetylase sirtuin 1 (SIRT1) in the liver of chronic-plus-binge ethanol-fed mice and in the liver of patients with ALD.
novel_deptor-protein_kinase_changes_novel_mtorc1,/work/eval_papers/PMID_29457836.pdf,abstract,SPECIES,mice,3488,3492,"Furthermore, hepatocyte-specific deletion of SIRT1 disrupted DEPTOR function, enhanced mTORC1 activity, and exacerbated alcoholic fatty liver, inflammation, and liver injury in mice."
novel_deptor-protein_kinase_changes_novel_mtorc1,/work/eval_papers/PMID_29457836.pdf,abstract,SPECIES,humans,3728,3734,CONCLUSION: The dysregulation of SIRT1-DEPTOR-mTORC1 signaling is a critical determinant of ALD pathology; targeting SIRT1 and DEPTOR and selectively inhibiting mTORC1-S6K1 signaling may have therapeutic potential for treating ALD in humans.
novel_dipeptidyl_peptidase_4_(dpp_4)-liver_triglyceride_accumulation,/work/eval_papers/PMID_30557836.pdf,abstract,CHEMICAL,2019,24,28,1. Biomed Pharmacother. 2019 Feb;110:869-877.
novel_dipeptidyl_peptidase_4_(dpp_4)-liver_triglyceride_accumulation,/work/eval_papers/PMID_30557836.pdf,abstract,CHEMICAL,Ilorin,420,426,"Author information: (1)HOPE Cardiometabolic Research Team, Department of Physiology, College of Health Sciences, University of Ilorin, Nigeria."
novel_dipeptidyl_peptidase_4_(dpp_4)-liver_triglyceride_accumulation,/work/eval_papers/PMID_30557836.pdf,abstract,CHEMICAL,Ilorin,544,550,"(2)HOPE Cardiometabolic Research Team, Department of Physiology, College of Health Sciences, University of Ilorin, Nigeria."
novel_dipeptidyl_peptidase_4_(dpp_4)-liver_triglyceride_accumulation,/work/eval_papers/PMID_30557836.pdf,abstract,CHEMICAL,address,572,579,Electronic address: tunjilaw@unilorin.edu.ng. Dipeptidyl peptidase-4 (DPP-4) inhibition has been shown to exert beneficial effects against insulin resistance (IR) and type 2 diabetes.
novel_dipeptidyl_peptidase_4_(dpp_4)-liver_triglyceride_accumulation,/work/eval_papers/PMID_30557836.pdf,abstract,CHEMICAL,adenosine,1024,1033,"We therefore, hypothesized that DPP-4 inhibition ameliorates COC-induced glucose dysregulation and hepatic triglyceride (TG) accumulation through adenosine deaminase (ADA) /xanthine oxidase (XO) /uric acid-dependent pathway."
novel_dipeptidyl_peptidase_4_(dpp_4)-liver_triglyceride_accumulation,/work/eval_papers/PMID_30557836.pdf,abstract,CHEMICAL,malondialdehyde,1714,1729,"COC treatment also resulted in increased plasma and hepatic TG, TG/HDL-cholesterol ratio, malondialdehyde, uric acid (plasma; 25.2 ± 0.6 mg/dl; hepatic 128.9 ± 8.0 mg/100 mg tissue), lactate dehydrogenase, DPP-4, ADA and XO (plasma;10.5 ± 1.1 U/L; hepatic 21.2 ± 1.4 U/g protein) activities."
novel_dipeptidyl_peptidase_4_(dpp_4)-liver_triglyceride_accumulation,/work/eval_papers/PMID_30557836.pdf,abstract,CHEMICAL,lactate,1807,1814,"COC treatment also resulted in increased plasma and hepatic TG, TG/HDL-cholesterol ratio, malondialdehyde, uric acid (plasma; 25.2 ± 0.6 mg/dl; hepatic 128.9 ± 8.0 mg/100 mg tissue), lactate dehydrogenase, DPP-4, ADA and XO (plasma;10.5 ± 1.1 U/L; hepatic 21.2 ± 1.4 U/g protein) activities."
novel_dipeptidyl_peptidase_4_(dpp_4)-liver_triglyceride_accumulation,/work/eval_papers/PMID_30557836.pdf,abstract,CHEMICAL,U/L,1867,1870,"COC treatment also resulted in increased plasma and hepatic TG, TG/HDL-cholesterol ratio, malondialdehyde, uric acid (plasma; 25.2 ± 0.6 mg/dl; hepatic 128.9 ± 8.0 mg/100 mg tissue), lactate dehydrogenase, DPP-4, ADA and XO (plasma;10.5 ± 1.1 U/L; hepatic 21.2 ± 1.4 U/g protein) activities."
novel_dipeptidyl_peptidase_4_(dpp_4)-liver_triglyceride_accumulation,/work/eval_papers/PMID_30557836.pdf,abstract,CHEMICAL,nitric oxide,1950,1962,"Likewise, COC led to reduction in nitric oxide level."
novel_dipeptidyl_peptidase_4_(dpp_4)-liver_triglyceride_accumulation,/work/eval_papers/PMID_30557836.pdf,abstract,CHEMICAL,"U/L, hepatic; 8.7 ±",2186,2205,"However, DPP-4 inhibition significantly ameliorated these alterations induced by COC treatment through suppression of uric acid (plasma; 15.1 ± 1.0 mg/dl, hepatic; 75.6 ± 5.0 mg/100 mg tissue), XO (plasma; 4.1 ± 0.9 U/L, hepatic; 8.7 ± 0.4 U/g protein), ADA and DPP-4 activities suggesting their involvement in glucose dysregulation and hepatic TG accumulation induced by COC treatment."
novel_fibrosis-novel_apoptosis,/work/eval_papers/PMID_32593710.pdf,abstract,CHEMICAL,Rio,563,566,"Author information: (1)Laboratório de Fisiopatologia, Divisão de Pesquisa Integrada em Produtos Bioativos e Biociências (DPBio), Polo Novo Cavaleiros, Universidade Federal do Rio de Janeiro, Campus UFRJ-Macaé, Macaé, RJ, Brazil."
novel_fibrosis-novel_apoptosis,/work/eval_papers/PMID_32593710.pdf,abstract,CHEMICAL,Rio,1030,1033,"(4)Laboratório de Fisiopatologia, Divisão de Pesquisa Integrada em Produtos Bioativos e Biociências (DPBio), Polo Novo Cavaleiros, Universidade Federal do Rio de Janeiro, Campus UFRJ-Macaé, Macaé, RJ, Brazil; Setor de Ciências Biológicas e da Saúde (SEBISA), Departamento de Biologia Geral, Universidade Estadual de Ponta Grossa (UEPG), Ponta Grossa, PR, Brazil."
novel_fibrosis-novel_apoptosis,/work/eval_papers/PMID_32593710.pdf,abstract,CHEMICAL,address,1249,1256,Electronic address: raribeiro@uepg.br.
novel_fibrosis-novel_apoptosis,/work/eval_papers/PMID_32593710.pdf,abstract,CHEMICAL,Bisphenol,1283,1292,AIMS: Bisphenol (BP)-A exposure can impair glucose and lipid metabolism.
novel_fibrosis-novel_apoptosis,/work/eval_papers/PMID_32593710.pdf,abstract,CHEMICAL,BPA,1568,1571,"Herein, we evaluated the effects of BPA exposure on adiposity, glucose homeostasis and hepatic steatosis in ovariectomized (OVX) mice fed on a high-fat diet (HFD)."
novel_fibrosis-novel_apoptosis,/work/eval_papers/PMID_32593710.pdf,abstract,CHEMICAL,BPA,2267,2270,BPA did not alter adiposity or glucose homeostasis disruptions induced by HFD.
novel_fibrosis-novel_apoptosis,/work/eval_papers/PMID_32593710.pdf,abstract,CHEMICAL,BPA,2687,2690,"Furthermore, BPA caused mild steatosis in OVX CBPA females, increasing the hepatic total lipids and mRNAs for Srebf1, Scd1, Hspa5, Hyou1 and Atf6."
novel_fibrosis-novel_apoptosis,/work/eval_papers/PMID_32593710.pdf,abstract,CHEMICAL,BPA,2835,2838,SIGNIFICANCE: BPA aggravated hepatic steatosis in OVX mice.
novel_fibrosis-novel_apoptosis,/work/eval_papers/PMID_32593710.pdf,abstract,CHEMICAL,BPA,2918,2921,"Especially when combined with a HFD, BPA caused NAFLD progression, which was partly mediated by chronic ER stress and the TGF-β1 pathway."
novel_fibrosis-novel_apoptosis,/work/eval_papers/PMID_32593710.pdf,abstract,SPECIES,mice,151,155,Bisphenol-A exposure worsens hepatic steatosis in ovariectomized mice fed on a high-fat diet: Role of endoplasmic reticulum stress and fibrogenic pathways.
novel_fibrosis-novel_apoptosis,/work/eval_papers/PMID_32593710.pdf,abstract,SPECIES,Universidade,1166,1178,"(4)Laboratório de Fisiopatologia, Divisão de Pesquisa Integrada em Produtos Bioativos e Biociências (DPBio), Polo Novo Cavaleiros, Universidade Federal do Rio de Janeiro, Campus UFRJ-Macaé, Macaé, RJ, Brazil; Setor de Ciências Biológicas e da Saúde (SEBISA), Departamento de Biologia Geral, Universidade Estadual de Ponta Grossa (UEPG), Ponta Grossa, PR, Brazil."
novel_fibrosis-novel_apoptosis,/work/eval_papers/PMID_32593710.pdf,abstract,SPECIES,mice,1729,1733,"MAIN METHODS: Adult Swiss female mice were OVX and submitted to a normolipidic diet or HFD and drinking water without [control (OVX CTL) and OVX HFD groups, respectively] or with 1 μg/mL BPA (OVX CBPA and OVX HBPA groups, respectively), for 3 months."
novel_fibrosis-novel_apoptosis,/work/eval_papers/PMID_32593710.pdf,abstract,SPECIES,OVX CBPA,1888,1896,"MAIN METHODS: Adult Swiss female mice were OVX and submitted to a normolipidic diet or HFD and drinking water without [control (OVX CTL) and OVX HFD groups, respectively] or with 1 μg/mL BPA (OVX CBPA and OVX HBPA groups, respectively), for 3 months."
novel_fibrosis-novel_apoptosis,/work/eval_papers/PMID_32593710.pdf,abstract,SPECIES,HFD,2341,2344,BPA did not alter adiposity or glucose homeostasis disruptions induced by HFD.
novel_galactose_metabolism-steatosis,/work/eval_papers/PMID_29630881.pdf,abstract,CHEMICAL,L(2,224,227,"Guo C(1), Chen L(2), Huang J(3), Wang Y(3), Shi C(3), Gao J(3), Hong Y(3), Chen T(1), Qiu L(4)."
novel_galactose_metabolism-steatosis,/work/eval_papers/PMID_29630881.pdf,abstract,CHEMICAL,Shi,253,256,"Guo C(1), Chen L(2), Huang J(3), Wang Y(3), Shi C(3), Gao J(3), Hong Y(3), Chen T(1), Qiu L(4)."
novel_galactose_metabolism-steatosis,/work/eval_papers/PMID_29630881.pdf,abstract,CHEMICAL,Key,436,439,"Author information: (1)School of Life Sciences, Longyan University, Longyan, 364012, People's Republic of China; Fujian Provincial Key Laboratory for the Prevention and Control of Animal Infectious Diseases and Biotechnology, Longyan, 364012, People's Republic of China; Key Laboratory of Preventive Veterinary Medicine and Biotechnology (Longyan University), Fujian Province University, Longyan, 364012, People's Republic of China."
novel_galactose_metabolism-steatosis,/work/eval_papers/PMID_29630881.pdf,abstract,CHEMICAL,Key,576,579,"Author information: (1)School of Life Sciences, Longyan University, Longyan, 364012, People's Republic of China; Fujian Provincial Key Laboratory for the Prevention and Control of Animal Infectious Diseases and Biotechnology, Longyan, 364012, People's Republic of China; Key Laboratory of Preventive Veterinary Medicine and Biotechnology (Longyan University), Fujian Province University, Longyan, 364012, People's Republic of China."
novel_galactose_metabolism-steatosis,/work/eval_papers/PMID_29630881.pdf,abstract,CHEMICAL,Medicine,616,624,"Author information: (1)School of Life Sciences, Longyan University, Longyan, 364012, People's Republic of China; Fujian Provincial Key Laboratory for the Prevention and Control of Animal Infectious Diseases and Biotechnology, Longyan, 364012, People's Republic of China; Key Laboratory of Preventive Veterinary Medicine and Biotechnology (Longyan University), Fujian Province University, Longyan, 364012, People's Republic of China."
novel_galactose_metabolism-steatosis,/work/eval_papers/PMID_29630881.pdf,abstract,CHEMICAL,Key,1029,1032,"(4)School of Life Sciences, Longyan University, Longyan, 364012, People's Republic of China; Fujian Provincial Key Laboratory for the Prevention and Control of Animal Infectious Diseases and Biotechnology, Longyan, 364012, People's Republic of China; Key Laboratory of Preventive Veterinary Medicine and Biotechnology (Longyan University), Fujian Province University, Longyan, 364012, People's Republic of China."
novel_galactose_metabolism-steatosis,/work/eval_papers/PMID_29630881.pdf,abstract,CHEMICAL,Key,1169,1172,"(4)School of Life Sciences, Longyan University, Longyan, 364012, People's Republic of China; Fujian Provincial Key Laboratory for the Prevention and Control of Animal Infectious Diseases and Biotechnology, Longyan, 364012, People's Republic of China; Key Laboratory of Preventive Veterinary Medicine and Biotechnology (Longyan University), Fujian Province University, Longyan, 364012, People's Republic of China."
novel_galactose_metabolism-steatosis,/work/eval_papers/PMID_29630881.pdf,abstract,CHEMICAL,Medicine,1209,1217,"(4)School of Life Sciences, Longyan University, Longyan, 364012, People's Republic of China; Fujian Provincial Key Laboratory for the Prevention and Control of Animal Infectious Diseases and Biotechnology, Longyan, 364012, People's Republic of China; Key Laboratory of Preventive Veterinary Medicine and Biotechnology (Longyan University), Fujian Province University, Longyan, 364012, People's Republic of China."
novel_galactose_metabolism-steatosis,/work/eval_papers/PMID_29630881.pdf,abstract,CHEMICAL,address,1342,1349,Electronic address: qlongxin@tom.com.
novel_galactose_metabolism-steatosis,/work/eval_papers/PMID_29630881.pdf,abstract,CHEMICAL,galactose,2051,2060,"Ethanol-induced galactose metabolism and fatty acid biosynthesis are important for the induction of hepatic steatosis, while AR inhibitor impaired galactose metabolism without perturbing fatty acid biosynthesis."
novel_galactose_metabolism-steatosis,/work/eval_papers/PMID_29630881.pdf,abstract,CHEMICAL,galactose,2413,2422,Sorbitol in galactose metabolism and stearic acid in saturated fatty acid biosynthesis were potential biomarkers responsible for ethanol or ethanol plus AR inhibitor treatment.
novel_galactose_metabolism-steatosis,/work/eval_papers/PMID_29630881.pdf,abstract,SPECIES,mice,130,134,Aldose reductase inhibitor protects mice from alcoholic steatosis by repressing saturated fatty acid biosynthesis.
novel_galactose_metabolism-steatosis,/work/eval_papers/PMID_29630881.pdf,abstract,SPECIES,mice,1762,1766,"To clarify the mechanism whereby AR inhibitor improves alcoholic hepatic steatosis, herein we investigated the effect of AR inhibitor on hepatic metabolism in mice fed a Lieber-DeCarli liquid diet with 5% ethanol."
novel_galactose_metabolism-steatosis,/work/eval_papers/PMID_29630881.pdf,abstract,SPECIES,mice,1925,1929,"Nontargeted metabolomics showed carbohydrates and lipids were characteristic categories in ethanol diet-fed mice with or without AR inhibitor treatment, whereas AR inhibitor mainly affected carbohydrates and peptides."
novel_glucose_metabolism-liver_triglyceride_accumulation,/work/eval_papers/PMID_31857090.pdf,abstract,CHEMICAL,2019,84,88,Epub 2019 Dec 16.
novel_glucose_metabolism-liver_triglyceride_accumulation,/work/eval_papers/PMID_31857090.pdf,abstract,CHEMICAL,Sodium acetate,97,111,Sodium acetate protects against nicotine-induced excess hepatic lipid in male rats by suppressing xanthine oxidase activity.
novel_glucose_metabolism-liver_triglyceride_accumulation,/work/eval_papers/PMID_31857090.pdf,abstract,CHEMICAL,Ilorin,417,423,"Author information: (1)HOPE Cardiometabolic Research Team & College of Health Sciences, University of Ilorin, Ilorin, Nigeria; Department of Physiology, College of Health Sciences, University of Ilorin, Ilorin, Nigeria."
novel_glucose_metabolism-liver_triglyceride_accumulation,/work/eval_papers/PMID_31857090.pdf,abstract,CHEMICAL,Ilorin,425,431,"Author information: (1)HOPE Cardiometabolic Research Team & College of Health Sciences, University of Ilorin, Ilorin, Nigeria; Department of Physiology, College of Health Sciences, University of Ilorin, Ilorin, Nigeria."
novel_glucose_metabolism-liver_triglyceride_accumulation,/work/eval_papers/PMID_31857090.pdf,abstract,CHEMICAL,Ilorin,510,516,"Author information: (1)HOPE Cardiometabolic Research Team & College of Health Sciences, University of Ilorin, Ilorin, Nigeria; Department of Physiology, College of Health Sciences, University of Ilorin, Ilorin, Nigeria."
novel_glucose_metabolism-liver_triglyceride_accumulation,/work/eval_papers/PMID_31857090.pdf,abstract,CHEMICAL,Ilorin,518,524,"Author information: (1)HOPE Cardiometabolic Research Team & College of Health Sciences, University of Ilorin, Ilorin, Nigeria; Department of Physiology, College of Health Sciences, University of Ilorin, Ilorin, Nigeria."
novel_glucose_metabolism-liver_triglyceride_accumulation,/work/eval_papers/PMID_31857090.pdf,abstract,CHEMICAL,Ilorin,606,612,"(2)Department of Physiology, College of Health Sciences, University of Ilorin, Ilorin, Nigeria."
novel_glucose_metabolism-liver_triglyceride_accumulation,/work/eval_papers/PMID_31857090.pdf,abstract,CHEMICAL,Ilorin,614,620,"(2)Department of Physiology, College of Health Sciences, University of Ilorin, Ilorin, Nigeria."
novel_glucose_metabolism-liver_triglyceride_accumulation,/work/eval_papers/PMID_31857090.pdf,abstract,CHEMICAL,Ilorin,713,719,"(3)HOPE Cardiometabolic Research Team & College of Health Sciences, University of Ilorin, Ilorin, Nigeria; Department of Physiology, College of Health Sciences, University of Ilorin, Ilorin, Nigeria."
novel_glucose_metabolism-liver_triglyceride_accumulation,/work/eval_papers/PMID_31857090.pdf,abstract,CHEMICAL,Ilorin,721,727,"(3)HOPE Cardiometabolic Research Team & College of Health Sciences, University of Ilorin, Ilorin, Nigeria; Department of Physiology, College of Health Sciences, University of Ilorin, Ilorin, Nigeria."
novel_glucose_metabolism-liver_triglyceride_accumulation,/work/eval_papers/PMID_31857090.pdf,abstract,CHEMICAL,Ilorin,806,812,"(3)HOPE Cardiometabolic Research Team & College of Health Sciences, University of Ilorin, Ilorin, Nigeria; Department of Physiology, College of Health Sciences, University of Ilorin, Ilorin, Nigeria."
novel_glucose_metabolism-liver_triglyceride_accumulation,/work/eval_papers/PMID_31857090.pdf,abstract,CHEMICAL,Ilorin,814,820,"(3)HOPE Cardiometabolic Research Team & College of Health Sciences, University of Ilorin, Ilorin, Nigeria; Department of Physiology, College of Health Sciences, University of Ilorin, Ilorin, Nigeria."
novel_glucose_metabolism-liver_triglyceride_accumulation,/work/eval_papers/PMID_31857090.pdf,abstract,CHEMICAL,address,842,849,Electronic address: tunjilaw@unilorin.edu.ng.
novel_glucose_metabolism-liver_triglyceride_accumulation,/work/eval_papers/PMID_31857090.pdf,abstract,CHEMICAL,xanthine,1062,1070,Increased activity of xanthine oxidase (XO) exerts both inflammatory and oxidative effects and has been implicated in metabolic derangements including non-alcoholic fatty liver disease.
novel_glucose_metabolism-liver_triglyceride_accumulation,/work/eval_papers/PMID_31857090.pdf,abstract,CHEMICAL,acetate,1396,1403,"In the present study, we evaluated the preventive effects of a SCFA, acetate, on nicotine-induced dysmetabolism and fatty liver."
novel_glucose_metabolism-liver_triglyceride_accumulation,/work/eval_papers/PMID_31857090.pdf,abstract,CHEMICAL,sodium,1562,1568,"Twenty-four male Wistar rats (n = 6/group): vehicle-treatment (p.o.), nicotine-treated (1.0 mg/kg; p.o.), sodium acetate-treated (200 mg/kg; p.o.) and nicotine + sodium acetate-treated groups."
novel_glucose_metabolism-liver_triglyceride_accumulation,/work/eval_papers/PMID_31857090.pdf,abstract,CHEMICAL,nicotine,1607,1615,"Twenty-four male Wistar rats (n = 6/group): vehicle-treatment (p.o.), nicotine-treated (1.0 mg/kg; p.o.), sodium acetate-treated (200 mg/kg; p.o.) and nicotine + sodium acetate-treated groups."
novel_glucose_metabolism-liver_triglyceride_accumulation,/work/eval_papers/PMID_31857090.pdf,abstract,CHEMICAL,sodium,1618,1624,"Twenty-four male Wistar rats (n = 6/group): vehicle-treatment (p.o.), nicotine-treated (1.0 mg/kg; p.o.), sodium acetate-treated (200 mg/kg; p.o.) and nicotine + sodium acetate-treated groups."
novel_glucose_metabolism-liver_triglyceride_accumulation,/work/eval_papers/PMID_31857090.pdf,abstract,CHEMICAL,triglyceride,1808,1820,"Plasma and hepatic free fatty acid, triglyceride (TG), glutathione peroxidase, adenosine deaminase (ADA), XO and uric acid (UA) were measured."
novel_glucose_metabolism-liver_triglyceride_accumulation,/work/eval_papers/PMID_31857090.pdf,abstract,CHEMICAL,glutathione,1827,1838,"Plasma and hepatic free fatty acid, triglyceride (TG), glutathione peroxidase, adenosine deaminase (ADA), XO and uric acid (UA) were measured."
novel_glucose_metabolism-liver_triglyceride_accumulation,/work/eval_papers/PMID_31857090.pdf,abstract,CHEMICAL,adenosine,1851,1860,"Plasma and hepatic free fatty acid, triglyceride (TG), glutathione peroxidase, adenosine deaminase (ADA), XO and uric acid (UA) were measured."
novel_glucose_metabolism-liver_triglyceride_accumulation,/work/eval_papers/PMID_31857090.pdf,abstract,CHEMICAL,Nicotine,1915,1923,"Nicotine exposure resulted in reduced body weight, liver weight, visceral adiposity, glycogen content and glycogen synthase activity."
novel_glucose_metabolism-liver_triglyceride_accumulation,/work/eval_papers/PMID_31857090.pdf,abstract,CHEMICAL,nicotine,2073,2081,"Conversely, exposure to nicotine increased fasting plasma glucose, lactate, IR, plasma and hepatic TG, free fatty acid, TG/HDL-cholesterol ratio, lipid peroxidation, liver function enzymes, plasma and hepatic UA, XO and ADA activities."
novel_glucose_metabolism-liver_triglyceride_accumulation,/work/eval_papers/PMID_31857090.pdf,abstract,CHEMICAL,glucose,2107,2114,"Conversely, exposure to nicotine increased fasting plasma glucose, lactate, IR, plasma and hepatic TG, free fatty acid, TG/HDL-cholesterol ratio, lipid peroxidation, liver function enzymes, plasma and hepatic UA, XO and ADA activities."
novel_glucose_metabolism-liver_triglyceride_accumulation,/work/eval_papers/PMID_31857090.pdf,abstract,CHEMICAL,nicotine,2397,2405,"However, plasma and hepatic glucose-6-phosphate dehydrogenase-dependent antioxidant defense was not affected by nicotine."
novel_glucose_metabolism-liver_triglyceride_accumulation,/work/eval_papers/PMID_31857090.pdf,abstract,CHEMICAL,acetate,2434,2441,Concomitant treatment with acetate ameliorated nicotine-induced effects.
novel_glucose_metabolism-liver_triglyceride_accumulation,/work/eval_papers/PMID_31857090.pdf,abstract,CHEMICAL,nicotine,2524,2532,"Taken together, these results indicate that nicotine exposure leads to excess deposition of lipid in the liver by enhancing XO activity."
novel_glucose_metabolism-liver_triglyceride_accumulation,/work/eval_papers/PMID_31857090.pdf,abstract,CHEMICAL,acetate,2645,2652,The results also imply that acetate confers hepatoprotection and is accompanied by decreased XO activity.
novel_inflammation-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_33302084.pdf,abstract,CHEMICAL,Liu,195,198,"Liu J(1), Dong C(2), Zhai Z(3), Tang L(1), Wang L(4)."
novel_inflammation-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_33302084.pdf,abstract,CHEMICAL,Key,443,446,"Author information: (1)College of Animal Science and Veterinary Medicine, Shandong Agricultural University, 61 Daizong Street, Tai'an City, Shandong Province, 271018, China; Shandong Provincial Key Laboratory of Animal Biotechnology and Disease Control and Prevention, Shandong Agricultural University, 61 Daizong Street, Tai'an City, Shandong Province, 271018, China; Shandong Provincial Engineering Technology Research Center of Animal Disease Control and Prevention, Shandong Agricultural University, 61 Daizong Street, Tai'an City, Shandong Province, 271018, China."
novel_inflammation-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_33302084.pdf,abstract,CHEMICAL,Key,1235,1238,"(4)College of Animal Science and Veterinary Medicine, Shandong Agricultural University, 61 Daizong Street, Tai'an City, Shandong Province, 271018, China; Shandong Provincial Key Laboratory of Animal Biotechnology and Disease Control and Prevention, Shandong Agricultural University, 61 Daizong Street, Tai'an City, Shandong Province, 271018, China; Shandong Provincial Engineering Technology Research Center of Animal Disease Control and Prevention, Shandong Agricultural University, 61 Daizong Street, Tai'an City, Shandong Province, 271018, China."
novel_inflammation-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_33302084.pdf,abstract,CHEMICAL,address,1622,1629,Electronic address: wanglin2013@sdau.edu.cn.
novel_inflammation-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_33302084.pdf,abstract,CHEMICAL,glyphosate,1668,1678,"Residues of glyphosate (GLY) are widely detected in aquatic systems, raising potential environmental threats and public health concerns, but the mechanism underlying GLY-induced hepatotoxicity in fish has not been fully elucidated yet."
novel_inflammation-liver_triglyceride_accumulation,/work/eval_papers/PMID_33302084.pdf,abstract,CHEMICAL,Liu,195,198,"Liu J(1), Dong C(2), Zhai Z(3), Tang L(1), Wang L(4)."
novel_inflammation-liver_triglyceride_accumulation,/work/eval_papers/PMID_33302084.pdf,abstract,CHEMICAL,Key,443,446,"Author information: (1)College of Animal Science and Veterinary Medicine, Shandong Agricultural University, 61 Daizong Street, Tai'an City, Shandong Province, 271018, China; Shandong Provincial Key Laboratory of Animal Biotechnology and Disease Control and Prevention, Shandong Agricultural University, 61 Daizong Street, Tai'an City, Shandong Province, 271018, China; Shandong Provincial Engineering Technology Research Center of Animal Disease Control and Prevention, Shandong Agricultural University, 61 Daizong Street, Tai'an City, Shandong Province, 271018, China."
novel_inflammation-liver_triglyceride_accumulation,/work/eval_papers/PMID_33302084.pdf,abstract,CHEMICAL,Key,1235,1238,"(4)College of Animal Science and Veterinary Medicine, Shandong Agricultural University, 61 Daizong Street, Tai'an City, Shandong Province, 271018, China; Shandong Provincial Key Laboratory of Animal Biotechnology and Disease Control and Prevention, Shandong Agricultural University, 61 Daizong Street, Tai'an City, Shandong Province, 271018, China; Shandong Provincial Engineering Technology Research Center of Animal Disease Control and Prevention, Shandong Agricultural University, 61 Daizong Street, Tai'an City, Shandong Province, 271018, China."
novel_inflammation-liver_triglyceride_accumulation,/work/eval_papers/PMID_33302084.pdf,abstract,CHEMICAL,address,1622,1629,Electronic address: wanglin2013@sdau.edu.cn.
novel_inflammation-liver_triglyceride_accumulation,/work/eval_papers/PMID_33302084.pdf,abstract,CHEMICAL,glyphosate,1668,1678,"Residues of glyphosate (GLY) are widely detected in aquatic systems, raising potential environmental threats and public health concerns, but the mechanism underlying GLY-induced hepatotoxicity in fish has not been fully elucidated yet."
novel_inflammation-mitochondrial_beta_oxidation,/work/eval_papers/PMID_33302084.pdf,abstract,CHEMICAL,Liu,195,198,"Liu J(1), Dong C(2), Zhai Z(3), Tang L(1), Wang L(4)."
novel_inflammation-mitochondrial_beta_oxidation,/work/eval_papers/PMID_33302084.pdf,abstract,CHEMICAL,Key,443,446,"Author information: (1)College of Animal Science and Veterinary Medicine, Shandong Agricultural University, 61 Daizong Street, Tai'an City, Shandong Province, 271018, China; Shandong Provincial Key Laboratory of Animal Biotechnology and Disease Control and Prevention, Shandong Agricultural University, 61 Daizong Street, Tai'an City, Shandong Province, 271018, China; Shandong Provincial Engineering Technology Research Center of Animal Disease Control and Prevention, Shandong Agricultural University, 61 Daizong Street, Tai'an City, Shandong Province, 271018, China."
novel_inflammation-mitochondrial_beta_oxidation,/work/eval_papers/PMID_33302084.pdf,abstract,CHEMICAL,Key,1235,1238,"(4)College of Animal Science and Veterinary Medicine, Shandong Agricultural University, 61 Daizong Street, Tai'an City, Shandong Province, 271018, China; Shandong Provincial Key Laboratory of Animal Biotechnology and Disease Control and Prevention, Shandong Agricultural University, 61 Daizong Street, Tai'an City, Shandong Province, 271018, China; Shandong Provincial Engineering Technology Research Center of Animal Disease Control and Prevention, Shandong Agricultural University, 61 Daizong Street, Tai'an City, Shandong Province, 271018, China."
novel_inflammation-mitochondrial_beta_oxidation,/work/eval_papers/PMID_33302084.pdf,abstract,CHEMICAL,address,1622,1629,Electronic address: wanglin2013@sdau.edu.cn.
novel_inflammation-mitochondrial_beta_oxidation,/work/eval_papers/PMID_33302084.pdf,abstract,CHEMICAL,glyphosate,1668,1678,"Residues of glyphosate (GLY) are widely detected in aquatic systems, raising potential environmental threats and public health concerns, but the mechanism underlying GLY-induced hepatotoxicity in fish has not been fully elucidated yet."
novel_inflammation-novel_oxidative_stress,/work/eval_papers/PMID_31026768.pdf,abstract,CHEMICAL,2019,74,78,doi: 10.1016/j.redox.2019.101205. Epub 2019 Apr 19.
novel_inflammation-novel_oxidative_stress,/work/eval_papers/PMID_31026768.pdf,abstract,CHEMICAL,toxicant-associated steatohepatitis,142,177,Vinyl chloride-induced interaction of nonalcoholic and toxicant-associated steatohepatitis: Protection by the ALDH2 activator Alda-1.
novel_inflammation-novel_oxidative_stress,/work/eval_papers/PMID_31026768.pdf,abstract,CHEMICAL,Alcohol,564,571,"Author information: (1)Department of Pharmacology and Toxicology, University of Louisville Health Sciences Center, Louisville, KY, 40202, USA; Hepatobiology and Toxicology Program, University of Louisville Health Sciences Center, Louisville, KY, 40202, USA; University of Louisville Alcohol Research Center, University of Louisville Health Sciences Center, Louisville, KY, 40202, USA. Electronic address: l0chen26@foxmail.com."
novel_inflammation-novel_oxidative_stress,/work/eval_papers/PMID_31026768.pdf,abstract,CHEMICAL,address,677,684,"Author information: (1)Department of Pharmacology and Toxicology, University of Louisville Health Sciences Center, Louisville, KY, 40202, USA; Hepatobiology and Toxicology Program, University of Louisville Health Sciences Center, Louisville, KY, 40202, USA; University of Louisville Alcohol Research Center, University of Louisville Health Sciences Center, Louisville, KY, 40202, USA. Electronic address: l0chen26@foxmail.com."
novel_inflammation-novel_oxidative_stress,/work/eval_papers/PMID_31026768.pdf,abstract,CHEMICAL,Alcohol,971,978,"(2)Department of Pharmacology and Toxicology, University of Louisville Health Sciences Center, Louisville, KY, 40202, USA; Hepatobiology and Toxicology Program, University of Louisville Health Sciences Center, Louisville, KY, 40202, USA; University of Louisville Alcohol Research Center, University of Louisville Health Sciences Center, Louisville, KY, 40202, USA."
novel_inflammation-novel_oxidative_stress,/work/eval_papers/PMID_31026768.pdf,abstract,CHEMICAL,address,1084,1091,Electronic address: all159@med.miami.edu.
novel_inflammation-novel_oxidative_stress,/work/eval_papers/PMID_31026768.pdf,abstract,CHEMICAL,Alcohol,1378,1385,"(3)Department of Pharmacology and Toxicology, University of Louisville Health Sciences Center, Louisville, KY, 40202, USA; Hepatobiology and Toxicology Program, University of Louisville Health Sciences Center, Louisville, KY, 40202, USA; University of Louisville Alcohol Research Center, University of Louisville Health Sciences Center, Louisville, KY, 40202, USA."
novel_inflammation-novel_oxidative_stress,/work/eval_papers/PMID_31026768.pdf,abstract,CHEMICAL,address,1491,1498,Electronic address: gavin.poff@louisville.edu.
novel_inflammation-novel_oxidative_stress,/work/eval_papers/PMID_31026768.pdf,abstract,CHEMICAL,City,1631,1635,"(4)Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, Kansas City, KS, 66160, USA."
novel_inflammation-novel_oxidative_stress,/work/eval_papers/PMID_31026768.pdf,abstract,CHEMICAL,address,1664,1671,Electronic address: wxding@kumc.edu.
novel_inflammation-novel_oxidative_stress,/work/eval_papers/PMID_31026768.pdf,abstract,CHEMICAL,Medicine,1707,1715,"(5)Department of Medicine, Division of Gastroenterology, Hepatology and Nutrition, University of Pittsburgh, Pittsburgh, PA, 15213, USA."
novel_inflammation-novel_oxidative_stress,/work/eval_papers/PMID_31026768.pdf,abstract,CHEMICAL,address,1838,1845,Electronic address: jibeier@pitt.edu.
novel_inflammation-novel_oxidative_stress,/work/eval_papers/PMID_31026768.pdf,abstract,CHEMICAL,play key roles,2256,2270,Mitochondrial oxidative injury and subsequent metabolic dysfunction appeared to play key roles in mediating this interaction.
novel_inflammation-novel_oxidative_stress,/work/eval_papers/PMID_31026768.pdf,abstract,CHEMICAL,this,2284,2288,Mitochondrial oxidative injury and subsequent metabolic dysfunction appeared to play key roles in mediating this interaction.
novel_inflammation-novel_oxidative_stress,/work/eval_papers/PMID_31026768.pdf,abstract,CHEMICAL,aldehyde,2316,2324,Mitochondrial aldehyde dehydrogenase 2 (ALDH2) serves as a key line of defense against endogenous and exogenous reactive aldehydes.
novel_inflammation-novel_oxidative_stress,/work/eval_papers/PMID_31026768.pdf,abstract,CHEMICAL,Alda-1,2738,2744,"Some mice received Alda-1 (20 mg/kg i.p., 3 × /week) for the last 3 weeks of diet/VC exposure."
novel_inflammation-novel_oxidative_stress,/work/eval_papers/PMID_31026768.pdf,abstract,CHEMICAL,low-dose,2938,2946,"As observed previously, low-dose VC did not cause liver injury in control mice; while liver injury caused by HFD was enhanced by VC."
novel_inflammation-novel_oxidative_stress,/work/eval_papers/PMID_31026768.pdf,abstract,CHEMICAL,Alda-1,3100,3106,"Alda-1 attenuated oxidative stress, liver injury, and dysmetabolism in mice exposed to HFD+VC under these conditions."
novel_inflammation-novel_oxidative_stress,/work/eval_papers/PMID_31026768.pdf,abstract,CHEMICAL,Alda-1,3309,3315,"Importantly, alterations in mitochondrial function caused by VC and HFD were diminished by Alda-1."
novel_inflammation-novel_oxidative_stress,/work/eval_papers/PMID_31026768.pdf,abstract,CHEMICAL,Alda-1,3467,3473,"Here, Alda-1 suppressed PINK1/PARKIN-mediated mitophagy."
novel_inflammation-novel_oxidative_stress,/work/eval_papers/PMID_31026768.pdf,abstract,CHEMICAL,Alda-1,3689,3695,"The ALDH2 activator Alda-1 conferred protection against liver damage under these conditions, most likely via increasing clearance of aldehydes and preserving mitochondrial respiratory function."
novel_inflammation-novel_oxidative_stress,/work/eval_papers/PMID_31026768.pdf,abstract,CHEMICAL,2019,3875,3879,Copyright © 2019 The Authors. Published by Elsevier B.V. All rights reserved.
novel_inflammation-novel_oxidative_stress,/work/eval_papers/PMID_31026768.pdf,abstract,SPECIES,l0chen26@foxmail.com,686,706,"Author information: (1)Department of Pharmacology and Toxicology, University of Louisville Health Sciences Center, Louisville, KY, 40202, USA; Hepatobiology and Toxicology Program, University of Louisville Health Sciences Center, Louisville, KY, 40202, USA; University of Louisville Alcohol Research Center, University of Louisville Health Sciences Center, Louisville, KY, 40202, USA. Electronic address: l0chen26@foxmail.com."
novel_inflammation-novel_oxidative_stress,/work/eval_papers/PMID_31026768.pdf,abstract,SPECIES,Pittsburgh,1799,1809,"(5)Department of Medicine, Division of Gastroenterology, Hepatology and Nutrition, University of Pittsburgh, Pittsburgh, PA, 15213, USA."
novel_inflammation-novel_oxidative_stress,/work/eval_papers/PMID_31026768.pdf,abstract,SPECIES,Mice,2571,2575,"Mice were exposed to low VC concentrations (<1 ppm), or room air for 6 h/day, 5 days/week for 12 weeks, while on HFD or low-fat control diet (LFD)."
novel_inflammation-novel_oxidative_stress,/work/eval_papers/PMID_31026768.pdf,abstract,SPECIES,mice,2724,2728,"Some mice received Alda-1 (20 mg/kg i.p., 3 × /week) for the last 3 weeks of diet/VC exposure."
novel_inflammation-novel_oxidative_stress,/work/eval_papers/PMID_31026768.pdf,abstract,SPECIES,mice,2988,2992,"As observed previously, low-dose VC did not cause liver injury in control mice; while liver injury caused by HFD was enhanced by VC."
novel_inflammation-novel_oxidative_stress,/work/eval_papers/PMID_31026768.pdf,abstract,SPECIES,VC.,3043,3046,"As observed previously, low-dose VC did not cause liver injury in control mice; while liver injury caused by HFD was enhanced by VC."
novel_inflammation-novel_oxidative_stress,/work/eval_papers/PMID_31026768.pdf,abstract,SPECIES,mice,3086,3090,VC decreased hepatic ALDH2 activity of mice fed HFD.
novel_inflammation-novel_oxidative_stress,/work/eval_papers/PMID_31026768.pdf,abstract,SPECIES,mice,3171,3175,"Alda-1 attenuated oxidative stress, liver injury, and dysmetabolism in mice exposed to HFD+VC under these conditions."
novel_inflammation-novel_oxidative_stress,/work/eval_papers/PMID_31026768.pdf,abstract,SPECIES,HFD were diminished,3286,3305,"Importantly, alterations in mitochondrial function caused by VC and HFD were diminished by Alda-1."
novel_inflammation-nuclear_receptor_changes_ppara,/work/eval_papers/PMID_32206109.pdf,abstract,CHEMICAL,Medicine,907,915,"(6)Department of Rehabilitation Medicine, Jiangsu Province People's Hospital and Nanjing Medical University First Affiliated Hospital, Nanjing, Jiangsu 210029, China."
novel_inflammation-nuclear_receptor_changes_ppara,/work/eval_papers/PMID_32206109.pdf,abstract,CHEMICAL,MEK1/2,1867,1873,"PPARα agonists or antagonists of MEK1/2 and ERK1/2 were used to identify the NIK-induced regulation of PPARα, MEK1/2, and ERK1/2."
novel_inflammation-nuclear_receptor_changes_ppara,/work/eval_papers/PMID_32206109.pdf,abstract,SPECIES,People,934,940,"(6)Department of Rehabilitation Medicine, Jiangsu Province People's Hospital and Nanjing Medical University First Affiliated Hospital, Nanjing, Jiangsu 210029, China."
novel_inflammation-nuclear_receptor_changes_ppara,/work/eval_papers/PMID_32206109.pdf,abstract,SPECIES,mice,1512,1516,Methods: Alcoholic steatosis was induced in mice by chronic-plus-binge ethanol feeding.
novel_inflammation-nuclear_receptor_changes_ppara,/work/eval_papers/PMID_32206109.pdf,abstract,SPECIES,ERK1/2,1956,1962,"PPARα agonists or antagonists of MEK1/2 and ERK1/2 were used to identify the NIK-induced regulation of PPARα, MEK1/2, and ERK1/2."
novel_inflammation-nuclear_receptor_changes_ppara,/work/eval_papers/PMID_32206109.pdf,abstract,SPECIES,mice,2206,2210,Results: Hepatocyte-specific deletion of NIK protected mice from alcoholic steatosis by sustaining hepatic fatty acid oxidation.
novel_inflammation-nuclear_receptor_changes_ppara,/work/eval_papers/PMID_32206109.pdf,abstract,SPECIES,mice,2875,2879,"Importantly, pharmacological intervention against NIK significantly attenuated alcoholic steatosis in ethanol-fed mice."
novel_insulin_resistance-liver_triglyceride_accumulation,/work/eval_papers/PMID_29675927.pdf,abstract,CHEMICAL,AKT,154,157,Tributyltin reduces the levels of serum adiponectin and activity of AKT and induces metabolic syndrome in male mice.
novel_insulin_resistance-liver_triglyceride_accumulation,/work/eval_papers/PMID_29675927.pdf,abstract,CHEMICAL,Control,442,449,"(2)Department of Toxicology, Shandong Center for Disease Control and Prevention, Jinan, Shandong, 250014, China."
novel_insulin_resistance-liver_triglyceride_accumulation,/work/eval_papers/PMID_29675927.pdf,abstract,CHEMICAL,TBT,676,679,"However, the adverse effects of TBT on metabolism are incompletely understood."
novel_insulin_resistance-liver_triglyceride_accumulation,/work/eval_papers/PMID_29675927.pdf,abstract,CHEMICAL,AKT,1107,1110,"We analyzed the effects of these exposures on the fat depot weights, serum lipid profile, serum leptin and adiponectin, hepatic lipid accumulation, and activity of AKT in the liver and skeletal muscle isolated from mice 8 mins after receiving an insulin injection."
novel_insulin_resistance-liver_triglyceride_accumulation,/work/eval_papers/PMID_29675927.pdf,abstract,CHEMICAL,TBT,1564,1567,These results showed that TBT exposure induced peripheral insulin resistance and metabolic syndrome in mice.
novel_insulin_resistance-liver_triglyceride_accumulation,/work/eval_papers/PMID_29675927.pdf,abstract,SPECIES,mice,197,201,Tributyltin reduces the levels of serum adiponectin and activity of AKT and induces metabolic syndrome in male mice.
novel_insulin_resistance-liver_triglyceride_accumulation,/work/eval_papers/PMID_29675927.pdf,abstract,SPECIES,mice,1532,1536,"Pubertal exposure to TBTCl resulted in a higher body weight, increased epididymal and liver fat accumulation, hyperlipidemia, an elevated low-density lipoprotein/high-density lipoprotein ratio, serum adiponectin deficiency, worse glucose tolerance, and lower insulin-dependent AKT phosphorylation in the liver and muscle in mice."
novel_insulin_resistance-liver_triglyceride_accumulation,/work/eval_papers/PMID_29675927.pdf,abstract,SPECIES,mice,1641,1645,These results showed that TBT exposure induced peripheral insulin resistance and metabolic syndrome in mice.
novel_insulin_sensitization-liver_triglyceride_accumulation,/work/eval_papers/PMID_34206460.pdf,abstract,CHEMICAL,Clozapine,70,79,"Clozapine Worsens Glucose Intolerance, Nonalcoholic Fatty Liver Disease, Kidney Damage, and Retinal Injury and Increases Renal Reactive Oxygen Species Production and Chromium Loss in Obese Mice. Chang GR(1), Liu HY(2), Yang WC(3), Wang CM(1), Wu CF(1), Lin JW(2), Lin WL(2)(4), Wang YC(5)(6)(7)(8), Lin TC(1), Liao HJ(1), Hou PH(9)(10), Chan CH(11), Lin CF(12)."
novel_insulin_sensitization-liver_triglyceride_accumulation,/work/eval_papers/PMID_34206460.pdf,abstract,CHEMICAL,Glucose,88,95,"Clozapine Worsens Glucose Intolerance, Nonalcoholic Fatty Liver Disease, Kidney Damage, and Retinal Injury and Increases Renal Reactive Oxygen Species Production and Chromium Loss in Obese Mice. Chang GR(1), Liu HY(2), Yang WC(3), Wang CM(1), Wu CF(1), Lin JW(2), Lin WL(2)(4), Wang YC(5)(6)(7)(8), Lin TC(1), Liao HJ(1), Hou PH(9)(10), Chan CH(11), Lin CF(12)."
novel_insulin_sensitization-liver_triglyceride_accumulation,/work/eval_papers/PMID_34206460.pdf,abstract,CHEMICAL,Liu,278,281,"Clozapine Worsens Glucose Intolerance, Nonalcoholic Fatty Liver Disease, Kidney Damage, and Retinal Injury and Increases Renal Reactive Oxygen Species Production and Chromium Loss in Obese Mice. Chang GR(1), Liu HY(2), Yang WC(3), Wang CM(1), Wu CF(1), Lin JW(2), Lin WL(2)(4), Wang YC(5)(6)(7)(8), Lin TC(1), Liao HJ(1), Hou PH(9)(10), Chan CH(11), Lin CF(12)."
novel_insulin_sensitization-liver_triglyceride_accumulation,/work/eval_papers/PMID_34206460.pdf,abstract,CHEMICAL,Lin,323,326,"Clozapine Worsens Glucose Intolerance, Nonalcoholic Fatty Liver Disease, Kidney Damage, and Retinal Injury and Increases Renal Reactive Oxygen Species Production and Chromium Loss in Obese Mice. Chang GR(1), Liu HY(2), Yang WC(3), Wang CM(1), Wu CF(1), Lin JW(2), Lin WL(2)(4), Wang YC(5)(6)(7)(8), Lin TC(1), Liao HJ(1), Hou PH(9)(10), Chan CH(11), Lin CF(12)."
novel_insulin_sensitization-liver_triglyceride_accumulation,/work/eval_papers/PMID_34206460.pdf,abstract,CHEMICAL,Lioufeng,1127,1135,"(6)Department of Medical Laboratory Science and Biotechnology, Asia University, 500 Lioufeng Road, Wufeng District, Taichung 413305, Taiwan. (7)Division of Cardiovascular Medicine, China Medical University Hospital, 2 Yude Road, North District, Taichung 404332, Taiwan. (8)College of Medicine, China Medical University, 91 Hsueh-Shih Road, North District, Taichung 404333, Taiwan. (9)Department of Psychiatry, Taichung Veterans General Hospital, 4 Section, 1650 Taiwan Boulevard, Taichung 407219, Taiwan."
novel_insulin_sensitization-liver_triglyceride_accumulation,/work/eval_papers/PMID_34206460.pdf,abstract,CHEMICAL,Medicine,1214,1222,"(6)Department of Medical Laboratory Science and Biotechnology, Asia University, 500 Lioufeng Road, Wufeng District, Taichung 413305, Taiwan. (7)Division of Cardiovascular Medicine, China Medical University Hospital, 2 Yude Road, North District, Taichung 404332, Taiwan. (8)College of Medicine, China Medical University, 91 Hsueh-Shih Road, North District, Taichung 404333, Taiwan. (9)Department of Psychiatry, Taichung Veterans General Hospital, 4 Section, 1650 Taiwan Boulevard, Taichung 407219, Taiwan."
novel_insulin_sensitization-liver_triglyceride_accumulation,/work/eval_papers/PMID_34206460.pdf,abstract,CHEMICAL,Medicine,1327,1335,"(6)Department of Medical Laboratory Science and Biotechnology, Asia University, 500 Lioufeng Road, Wufeng District, Taichung 413305, Taiwan. (7)Division of Cardiovascular Medicine, China Medical University Hospital, 2 Yude Road, North District, Taichung 404332, Taiwan. (8)College of Medicine, China Medical University, 91 Hsueh-Shih Road, North District, Taichung 404333, Taiwan. (9)Department of Psychiatry, Taichung Veterans General Hospital, 4 Section, 1650 Taiwan Boulevard, Taichung 407219, Taiwan."
novel_insulin_sensitization-liver_triglyceride_accumulation,/work/eval_papers/PMID_34206460.pdf,abstract,CHEMICAL,Medicine,1563,1571,"(10)Faculty of Medicine, National Yang Ming Chiao Tung University, 2 Section, 155 Linong Street, Beitou District, Taipei 112304, Taiwan."
novel_insulin_sensitization-liver_triglyceride_accumulation,/work/eval_papers/PMID_34206460.pdf,abstract,CHEMICAL,Clozapine,1985,1994,Clozapine is widely employed in the treatment of schizophrenia.
novel_insulin_sensitization-liver_triglyceride_accumulation,/work/eval_papers/PMID_34206460.pdf,abstract,CHEMICAL,clozapine have,2163,2177,"Compared with that of atypical first-generation antipsychotics, atypical second-generation antipsychotics such as clozapine have less severe side effects and may positively affect obesity and blood glucose level."
novel_insulin_sensitization-liver_triglyceride_accumulation,/work/eval_papers/PMID_34206460.pdf,abstract,CHEMICAL,clozapine's adverse metabolic effects-such,2294,2336,"However, no systematic study of clozapine's adverse metabolic effects-such as changes in kidney and liver function, body weight, glucose and triglyceride levels, and retinopathy-was conducted."
novel_insulin_sensitization-liver_triglyceride_accumulation,/work/eval_papers/PMID_34206460.pdf,abstract,CHEMICAL,glucose,2391,2398,"However, no systematic study of clozapine's adverse metabolic effects-such as changes in kidney and liver function, body weight, glucose and triglyceride levels, and retinopathy-was conducted."
novel_insulin_sensitization-liver_triglyceride_accumulation,/work/eval_papers/PMID_34206460.pdf,abstract,CHEMICAL,clozapine,2486,2495,"This research investigated how clozapine affects weight, the bodily distribution of chromium, liver damage, fatty liver scores, glucose homeostasis, renal impairment, and retinopathy in mice fed a high fat diet (HFD)."
novel_insulin_sensitization-liver_triglyceride_accumulation,/work/eval_papers/PMID_34206460.pdf,abstract,CHEMICAL,chromium,2539,2547,"This research investigated how clozapine affects weight, the bodily distribution of chromium, liver damage, fatty liver scores, glucose homeostasis, renal impairment, and retinopathy in mice fed a high fat diet (HFD)."
novel_insulin_sensitization-liver_triglyceride_accumulation,/work/eval_papers/PMID_34206460.pdf,abstract,CHEMICAL,clozapine,2716,2725,"We discovered that obese mice treated with clozapine gained more weight and had greater kidney, liver, and retroperitoneal and epididymal fat pad masses; higher daily food efficiency; higher serum or hepatic triglyceride, aspartate aminotransferase, alanine aminotransferase, blood urea nitrogen, and creatinine levels; and higher hepatic lipid regulation marker expression than did the HFD-fed control mice."
novel_insulin_sensitization-liver_triglyceride_accumulation,/work/eval_papers/PMID_34206460.pdf,abstract,CHEMICAL,aspartate,2895,2904,"We discovered that obese mice treated with clozapine gained more weight and had greater kidney, liver, and retroperitoneal and epididymal fat pad masses; higher daily food efficiency; higher serum or hepatic triglyceride, aspartate aminotransferase, alanine aminotransferase, blood urea nitrogen, and creatinine levels; and higher hepatic lipid regulation marker expression than did the HFD-fed control mice."
novel_insulin_sensitization-liver_triglyceride_accumulation,/work/eval_papers/PMID_34206460.pdf,abstract,CHEMICAL,alanine,2923,2930,"We discovered that obese mice treated with clozapine gained more weight and had greater kidney, liver, and retroperitoneal and epididymal fat pad masses; higher daily food efficiency; higher serum or hepatic triglyceride, aspartate aminotransferase, alanine aminotransferase, blood urea nitrogen, and creatinine levels; and higher hepatic lipid regulation marker expression than did the HFD-fed control mice."
novel_insulin_sensitization-liver_triglyceride_accumulation,/work/eval_papers/PMID_34206460.pdf,abstract,CHEMICAL,blood urea nitrogen,2949,2968,"We discovered that obese mice treated with clozapine gained more weight and had greater kidney, liver, and retroperitoneal and epididymal fat pad masses; higher daily food efficiency; higher serum or hepatic triglyceride, aspartate aminotransferase, alanine aminotransferase, blood urea nitrogen, and creatinine levels; and higher hepatic lipid regulation marker expression than did the HFD-fed control mice."
novel_insulin_sensitization-liver_triglyceride_accumulation,/work/eval_papers/PMID_34206460.pdf,abstract,CHEMICAL,creatinine,2974,2984,"We discovered that obese mice treated with clozapine gained more weight and had greater kidney, liver, and retroperitoneal and epididymal fat pad masses; higher daily food efficiency; higher serum or hepatic triglyceride, aspartate aminotransferase, alanine aminotransferase, blood urea nitrogen, and creatinine levels; and higher hepatic lipid regulation marker expression than did the HFD-fed control mice."
novel_insulin_sensitization-liver_triglyceride_accumulation,/work/eval_papers/PMID_34206460.pdf,abstract,CHEMICAL,clozapine,3099,3108,"Furthermore, the clozapine group mice exhibited insulin resistance, poorer insulin sensitivity, greater glucose intolerance, and less Akt phosphorylation; their GLUT4 expression was lower, they had renal damage, more reactive oxygen species, and IL-1 expression, and, finally, their levels of antioxidative enzymes (superoxide dismutase, glutathione peroxidase, and catalase) were lower."
novel_insulin_sensitization-liver_triglyceride_accumulation,/work/eval_papers/PMID_34206460.pdf,abstract,CHEMICAL,Akt,3216,3219,"Furthermore, the clozapine group mice exhibited insulin resistance, poorer insulin sensitivity, greater glucose intolerance, and less Akt phosphorylation; their GLUT4 expression was lower, they had renal damage, more reactive oxygen species, and IL-1 expression, and, finally, their levels of antioxidative enzymes (superoxide dismutase, glutathione peroxidase, and catalase) were lower."
novel_insulin_sensitization-liver_triglyceride_accumulation,/work/eval_papers/PMID_34206460.pdf,abstract,CHEMICAL,levels,3365,3371,"Furthermore, the clozapine group mice exhibited insulin resistance, poorer insulin sensitivity, greater glucose intolerance, and less Akt phosphorylation; their GLUT4 expression was lower, they had renal damage, more reactive oxygen species, and IL-1 expression, and, finally, their levels of antioxidative enzymes (superoxide dismutase, glutathione peroxidase, and catalase) were lower."
novel_insulin_sensitization-liver_triglyceride_accumulation,/work/eval_papers/PMID_34206460.pdf,abstract,CHEMICAL,superoxide,3398,3408,"Furthermore, the clozapine group mice exhibited insulin resistance, poorer insulin sensitivity, greater glucose intolerance, and less Akt phosphorylation; their GLUT4 expression was lower, they had renal damage, more reactive oxygen species, and IL-1 expression, and, finally, their levels of antioxidative enzymes (superoxide dismutase, glutathione peroxidase, and catalase) were lower."
novel_insulin_sensitization-liver_triglyceride_accumulation,/work/eval_papers/PMID_34206460.pdf,abstract,CHEMICAL,glutathione,3420,3431,"Furthermore, the clozapine group mice exhibited insulin resistance, poorer insulin sensitivity, greater glucose intolerance, and less Akt phosphorylation; their GLUT4 expression was lower, they had renal damage, more reactive oxygen species, and IL-1 expression, and, finally, their levels of antioxidative enzymes (superoxide dismutase, glutathione peroxidase, and catalase) were lower."
novel_insulin_sensitization-liver_triglyceride_accumulation,/work/eval_papers/PMID_34206460.pdf,abstract,CHEMICAL,clozapine,3480,3489,"Moreover, clozapine reduced the thickness of retinal cell layers and increased iNOS and NF-κB expression; a net negative chromium balance occurred because more chromium was excreted through urine, and this influenced chromium mobilization, which did not help overcome the hyperglycemia."
novel_insulin_sensitization-liver_triglyceride_accumulation,/work/eval_papers/PMID_34206460.pdf,abstract,CHEMICAL,clozapine,3761,3770,"Our clozapine group had considerably higher fatty liver scores, which was supported by the findings of lowered adiponectin protein levels and increased FASN protein, PNPLA3 protein, FABP4 mRNA, and SREBP1 mRNA levels."
novel_insulin_sensitization-liver_triglyceride_accumulation,/work/eval_papers/PMID_34206460.pdf,abstract,CHEMICAL,levels,3888,3894,"Our clozapine group had considerably higher fatty liver scores, which was supported by the findings of lowered adiponectin protein levels and increased FASN protein, PNPLA3 protein, FABP4 mRNA, and SREBP1 mRNA levels."
novel_insulin_sensitization-liver_triglyceride_accumulation,/work/eval_papers/PMID_34206460.pdf,abstract,CHEMICAL,clozapine,3992,4001,"We conclude that clozapine can worsen nonalcoholic fatty liver disease, diabetes, and kidney and retinal injury."
novel_insulin_sensitization-liver_triglyceride_accumulation,/work/eval_papers/PMID_34206460.pdf,abstract,CHEMICAL,clozapine,4127,4136,"Therefore, long-term administration of clozapine warrants higher attention."
novel_insulin_sensitization-liver_triglyceride_accumulation,/work/eval_papers/PMID_34206460.pdf,abstract,SPECIES,Mice,259,263,"Clozapine Worsens Glucose Intolerance, Nonalcoholic Fatty Liver Disease, Kidney Damage, and Retinal Injury and Increases Renal Reactive Oxygen Species Production and Chromium Loss in Obese Mice. Chang GR(1), Liu HY(2), Yang WC(3), Wang CM(1), Wu CF(1), Lin JW(2), Lin WL(2)(4), Wang YC(5)(6)(7)(8), Lin TC(1), Liao HJ(1), Hou PH(9)(10), Chan CH(11), Lin CF(12)."
novel_insulin_sensitization-liver_triglyceride_accumulation,/work/eval_papers/PMID_34206460.pdf,abstract,SPECIES,mice,2641,2645,"This research investigated how clozapine affects weight, the bodily distribution of chromium, liver damage, fatty liver scores, glucose homeostasis, renal impairment, and retinopathy in mice fed a high fat diet (HFD)."
novel_insulin_sensitization-liver_triglyceride_accumulation,/work/eval_papers/PMID_34206460.pdf,abstract,SPECIES,mice,2698,2702,"We discovered that obese mice treated with clozapine gained more weight and had greater kidney, liver, and retroperitoneal and epididymal fat pad masses; higher daily food efficiency; higher serum or hepatic triglyceride, aspartate aminotransferase, alanine aminotransferase, blood urea nitrogen, and creatinine levels; and higher hepatic lipid regulation marker expression than did the HFD-fed control mice."
novel_insulin_sensitization-liver_triglyceride_accumulation,/work/eval_papers/PMID_34206460.pdf,abstract,SPECIES,mice,3115,3119,"Furthermore, the clozapine group mice exhibited insulin resistance, poorer insulin sensitivity, greater glucose intolerance, and less Akt phosphorylation; their GLUT4 expression was lower, they had renal damage, more reactive oxygen species, and IL-1 expression, and, finally, their levels of antioxidative enzymes (superoxide dismutase, glutathione peroxidase, and catalase) were lower."
novel_insulin_sensitization-liver_triglyceride_accumulation,/work/eval_papers/PMID_34206460.pdf,abstract,SPECIES,clozapine can worsen,3992,4012,"We conclude that clozapine can worsen nonalcoholic fatty liver disease, diabetes, and kidney and retinal injury."
novel_ir/igf1r_signaling_pathway-steatosis,/work/eval_papers/PMID_33105604.pdf,abstract,CHEMICAL,Medicine,556,564,"Author information: (1)Department of Endocrinology and Metabolism, Graduate School of Medicine, Yokohama City University, Yokohama 236-0004, Japan."
novel_ir/igf1r_signaling_pathway-steatosis,/work/eval_papers/PMID_33105604.pdf,abstract,CHEMICAL,Medicine,885,893,"(4)Department of Clinical Medicine, University of Bergen, P.O. Box 7803 Bergen, Norway."
novel_ir/igf1r_signaling_pathway-steatosis,/work/eval_papers/PMID_33105604.pdf,abstract,CHEMICAL,(5)Graduate,947,958,"(5)Graduate School of Health Science, Gunma Paz University, Takasaki 370-0006, Japan."
novel_ir/igf1r_signaling_pathway-steatosis,/work/eval_papers/PMID_33105604.pdf,abstract,CHEMICAL,OSI-906,1303,1310,"We previously reported that the systemic inhibition of insulin receptor (IR) and IGF-1 receptor (IGF1R) by the administration of OSI-906 (linsitinib), a dual IR/IGF1R inhibitor, induced glucose intolerance, hepatic steatosis, and lipoatrophy in mice."
novel_ir/igf1r_signaling_pathway-steatosis,/work/eval_papers/PMID_33105604.pdf,abstract,CHEMICAL,nicotinamide,2121,2133,"Hepatic quantitative proteomic and phosphoproteomic analyses revealed that perilipin-2 (PLIN2), major urinary protein 20 (MUP20), cytochrome P450 2b10 (CYP2B10), and nicotinamide N-methyltransferase (NNMT) are possibly involved in the process of the amelioration of hepatic steatosis by linagliptin."
novel_ir/igf1r_signaling_pathway-steatosis,/work/eval_papers/PMID_33105604.pdf,abstract,SPECIES,Mice,144,148,Linagliptin Ameliorates Hepatic Steatosis via Non-Canonical Mechanisms in Mice Treated with a Dual Inhibitor of Insulin Receptor and IGF-1 Receptor.
novel_ir/igf1r_signaling_pathway-steatosis,/work/eval_papers/PMID_33105604.pdf,abstract,SPECIES,mice,1419,1423,"We previously reported that the systemic inhibition of insulin receptor (IR) and IGF-1 receptor (IGF1R) by the administration of OSI-906 (linsitinib), a dual IR/IGF1R inhibitor, induced glucose intolerance, hepatic steatosis, and lipoatrophy in mice."
novel_ir/igf1r_signaling_pathway-steatosis,/work/eval_papers/PMID_33105604.pdf,abstract,SPECIES,mice,1550,1554,"In the present study, we investigated the effects of a DPP-4 inhibitor, linagliptin, on hepatic steatosis in OSI-906-treated mice."
novel_ir/igf1r_signaling_pathway-steatosis,/work/eval_papers/PMID_33105604.pdf,abstract,SPECIES,linagliptin,2242,2253,"Hepatic quantitative proteomic and phosphoproteomic analyses revealed that perilipin-2 (PLIN2), major urinary protein 20 (MUP20), cytochrome P450 2b10 (CYP2B10), and nicotinamide N-methyltransferase (NNMT) are possibly involved in the process of the amelioration of hepatic steatosis by linagliptin."
novel_jak2/stat5_pathway-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_31491605.pdf,abstract,CHEMICAL,2019,27,31,1. Ecotoxicol Environ Saf. 2019 Nov 30;184:109611. doi: 10.1016/j.ecoenv.2019.109611. Epub 2019 Sep 3.
novel_jak2/stat5_pathway-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_31491605.pdf,abstract,CHEMICAL,2019,91,95,1. Ecotoxicol Environ Saf. 2019 Nov 30;184:109611. doi: 10.1016/j.ecoenv.2019.109611. Epub 2019 Sep 3.
novel_jak2/stat5_pathway-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_31491605.pdf,abstract,CHEMICAL,Shi,285,288,"Zhang Y(1), Wang S(2), Zhao T(1), Yang L(1), Guo S(1), Shi Y(1), Zhang X(1), Zhou L(3), Ye L(4)."
novel_jak2/stat5_pathway-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_31491605.pdf,abstract,CHEMICAL,Changchun,446,455,"Author information: (1)Department of Occupational and Environmental Health, School of Public Health, Jilin University, Changchun, China."
novel_jak2/stat5_pathway-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_31491605.pdf,abstract,CHEMICAL,Changchun,538,547,"(2)Department of Emergency, China-Japan Union Hospital, Jilin University, Changchun, China."
novel_jak2/stat5_pathway-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_31491605.pdf,abstract,CHEMICAL,Changchun,655,664,"(3)Department of Occupational and Environmental Health, School of Public Health, Jilin University, Changchun, China."
novel_jak2/stat5_pathway-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_31491605.pdf,abstract,CHEMICAL,address,684,691,Electronic address: zhoulttg@163.com.
novel_jak2/stat5_pathway-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_31491605.pdf,abstract,CHEMICAL,Changchun,810,819,"(4)Department of Occupational and Environmental Health, School of Public Health, Jilin University, Changchun, China."
novel_jak2/stat5_pathway-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_31491605.pdf,abstract,CHEMICAL,address,839,846,Electronic address: jlyelin@163.com.
novel_jak2/stat5_pathway-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_31491605.pdf,abstract,CHEMICAL,non-alcoholic,1030,1043,"Mono-2-ethylhexyl phthalate (MEHP), as the major metabolite of Di-(2-ethylhexyl) phthalate (DEHP), can induce lipid accumulation in hepatocytes and further leads to non-alcoholic fatty liver disease (NAFLD), while the underlying mechanism is unclear."
novel_jak2/stat5_pathway-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_31491605.pdf,abstract,CHEMICAL,Oil-Red-O staining,1386,1404,"BRL-3A hepatocytes were exposed to MEHP (0, 10, 50, 100 and 200 μM) for 24 h and 48 h. Then the lipid droplets in cells were observed by Oil-Red-O staining and quantified by isopropyl alcohol."
novel_jak2/stat5_pathway-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_31491605.pdf,abstract,CHEMICAL,alcohol,1433,1440,"BRL-3A hepatocytes were exposed to MEHP (0, 10, 50, 100 and 200 μM) for 24 h and 48 h. Then the lipid droplets in cells were observed by Oil-Red-O staining and quantified by isopropyl alcohol."
novel_jak2/stat5_pathway-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_31491605.pdf,abstract,CHEMICAL,levels,2020,2026,"In addition, the SOD levels were gradually decreased and the TBARS levels were increased in MEHP-treated groups."
novel_jak2/stat5_pathway-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_31491605.pdf,abstract,CHEMICAL,levels,2190,2196,"Furthermore, the ALT and AST levels were elevated after MEHP exposure."
novel_jak2/stat5_pathway-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_31491605.pdf,abstract,CHEMICAL,10.1016/j.ecoenv.2019.109611 PMID,2462,2495,Copyright © 2019. Published by Elsevier Inc. DOI: 10.1016/j.ecoenv.2019.109611 PMID: 31491605 [Indexed for MEDLINE]
novel_jak2/stat5_pathway-nuclear_receptor_changes_pparg,/work/eval_papers/PMID_31491605.pdf,abstract,CHEMICAL,2019,27,31,1. Ecotoxicol Environ Saf. 2019 Nov 30;184:109611. doi: 10.1016/j.ecoenv.2019.109611. Epub 2019 Sep 3.
novel_jak2/stat5_pathway-nuclear_receptor_changes_pparg,/work/eval_papers/PMID_31491605.pdf,abstract,CHEMICAL,2019,91,95,1. Ecotoxicol Environ Saf. 2019 Nov 30;184:109611. doi: 10.1016/j.ecoenv.2019.109611. Epub 2019 Sep 3.
novel_jak2/stat5_pathway-nuclear_receptor_changes_pparg,/work/eval_papers/PMID_31491605.pdf,abstract,CHEMICAL,Shi,285,288,"Zhang Y(1), Wang S(2), Zhao T(1), Yang L(1), Guo S(1), Shi Y(1), Zhang X(1), Zhou L(3), Ye L(4)."
novel_jak2/stat5_pathway-nuclear_receptor_changes_pparg,/work/eval_papers/PMID_31491605.pdf,abstract,CHEMICAL,Changchun,446,455,"Author information: (1)Department of Occupational and Environmental Health, School of Public Health, Jilin University, Changchun, China."
novel_jak2/stat5_pathway-nuclear_receptor_changes_pparg,/work/eval_papers/PMID_31491605.pdf,abstract,CHEMICAL,Changchun,538,547,"(2)Department of Emergency, China-Japan Union Hospital, Jilin University, Changchun, China."
novel_jak2/stat5_pathway-nuclear_receptor_changes_pparg,/work/eval_papers/PMID_31491605.pdf,abstract,CHEMICAL,Changchun,655,664,"(3)Department of Occupational and Environmental Health, School of Public Health, Jilin University, Changchun, China."
novel_jak2/stat5_pathway-nuclear_receptor_changes_pparg,/work/eval_papers/PMID_31491605.pdf,abstract,CHEMICAL,address,684,691,Electronic address: zhoulttg@163.com.
novel_jak2/stat5_pathway-nuclear_receptor_changes_pparg,/work/eval_papers/PMID_31491605.pdf,abstract,CHEMICAL,Changchun,810,819,"(4)Department of Occupational and Environmental Health, School of Public Health, Jilin University, Changchun, China."
novel_jak2/stat5_pathway-nuclear_receptor_changes_pparg,/work/eval_papers/PMID_31491605.pdf,abstract,CHEMICAL,address,839,846,Electronic address: jlyelin@163.com.
novel_jak2/stat5_pathway-nuclear_receptor_changes_pparg,/work/eval_papers/PMID_31491605.pdf,abstract,CHEMICAL,non-alcoholic,1030,1043,"Mono-2-ethylhexyl phthalate (MEHP), as the major metabolite of Di-(2-ethylhexyl) phthalate (DEHP), can induce lipid accumulation in hepatocytes and further leads to non-alcoholic fatty liver disease (NAFLD), while the underlying mechanism is unclear."
novel_jak2/stat5_pathway-nuclear_receptor_changes_pparg,/work/eval_papers/PMID_31491605.pdf,abstract,CHEMICAL,Oil-Red-O staining,1386,1404,"BRL-3A hepatocytes were exposed to MEHP (0, 10, 50, 100 and 200 μM) for 24 h and 48 h. Then the lipid droplets in cells were observed by Oil-Red-O staining and quantified by isopropyl alcohol."
novel_jak2/stat5_pathway-nuclear_receptor_changes_pparg,/work/eval_papers/PMID_31491605.pdf,abstract,CHEMICAL,alcohol,1433,1440,"BRL-3A hepatocytes were exposed to MEHP (0, 10, 50, 100 and 200 μM) for 24 h and 48 h. Then the lipid droplets in cells were observed by Oil-Red-O staining and quantified by isopropyl alcohol."
novel_jak2/stat5_pathway-nuclear_receptor_changes_pparg,/work/eval_papers/PMID_31491605.pdf,abstract,CHEMICAL,levels,2020,2026,"In addition, the SOD levels were gradually decreased and the TBARS levels were increased in MEHP-treated groups."
novel_jak2/stat5_pathway-nuclear_receptor_changes_pparg,/work/eval_papers/PMID_31491605.pdf,abstract,CHEMICAL,levels,2190,2196,"Furthermore, the ALT and AST levels were elevated after MEHP exposure."
novel_jak2/stat5_pathway-nuclear_receptor_changes_pparg,/work/eval_papers/PMID_31491605.pdf,abstract,CHEMICAL,10.1016/j.ecoenv.2019.109611 PMID,2462,2495,Copyright © 2019. Published by Elsevier Inc. DOI: 10.1016/j.ecoenv.2019.109611 PMID: 31491605 [Indexed for MEDLINE]
novel_jnk_pathway-novel_ap_1_pathway,/work/eval_papers/PMID_33900847.pdf,abstract,CHEMICAL,Liu,229,232,"Xie D(1), Zhao H(1), Lu J(1), He F(1), Liu W(1), Yu W(1), Wang Q(1), Hisatome I(2), Yamamoto T(3), Koyama H(3), Cheng J(1)(3)."
novel_jnk_pathway-novel_ap_1_pathway,/work/eval_papers/PMID_33900847.pdf,abstract,CHEMICAL,Medicine,452,460,"(2)Division of Regenerative Medicine and Therapeutics, Institute of Regenerative Medicine and Biofunction, Graduate School of Medical Sciences, Tottori University, Yonago, Japan."
novel_jnk_pathway-novel_ap_1_pathway,/work/eval_papers/PMID_33900847.pdf,abstract,CHEMICAL,Medicine,505,513,"(2)Division of Regenerative Medicine and Therapeutics, Institute of Regenerative Medicine and Biofunction, Graduate School of Medical Sciences, Tottori University, Yonago, Japan."
novel_jnk_pathway-novel_ap_1_pathway,/work/eval_papers/PMID_33900847.pdf,abstract,CHEMICAL,Medicine,686,694,"(3)Department of Diabetes, Endocrinology and Clinical Immunology, Hyogo College of Medicine, Nishinomiya, Japan."
novel_jnk_pathway-novel_ap_1_pathway,/work/eval_papers/PMID_33900847.pdf,abstract,CHEMICAL,urate,1019,1024,"In this study, we established a urate oxidase-knockout (Uox-KO) mouse model by clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9 technology."
novel_jnk_pathway-novel_ap_1_pathway,/work/eval_papers/PMID_33900847.pdf,abstract,CHEMICAL,medium,1249,1255,"To study the correlation between HUA and NAFLD, human HepG2 hepatoma cells were treated in culture medium with high level of uric acid."
novel_jnk_pathway-novel_ap_1_pathway,/work/eval_papers/PMID_33900847.pdf,abstract,CHEMICAL,ROS/JNK/AP-1,2119,2131,These data suggest that ROS/JNK/AP-1 signaling plays an important role in HUA-mediated fat accumulation in liver.
novel_jnk_pathway-novel_ap_1_pathway,/work/eval_papers/PMID_33900847.pdf,abstract,SPECIES,repeats,1116,1123,"In this study, we established a urate oxidase-knockout (Uox-KO) mouse model by clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9 technology."
novel_jnk_pathway-novel_ap_1_pathway,/work/eval_papers/PMID_33900847.pdf,abstract,SPECIES,human HepG2 hepatoma cells,1198,1224,"To study the correlation between HUA and NAFLD, human HepG2 hepatoma cells were treated in culture medium with high level of uric acid."
novel_jnk_pathway-novel_ap_1_pathway,/work/eval_papers/PMID_33900847.pdf,abstract,SPECIES,SP600125,1566,1574,"Furthermore, inhibiting JNK activation by a JNK-specific inhibitor, SP600125, decreased fat accumulation and lipogenic gene expression induced by HUA."
novel_jnk_pathway-novel_ap_1_pathway,/work/eval_papers/PMID_33900847.pdf,abstract,SPECIES,AP-1,1828,1832,HUA activated AP-1 to upregulate lipogenic gene expression via JNK activation.
novel_lipolysis-nuclear_receptor_changes_ppara,/work/eval_papers/PMID_30452912.pdf,abstract,CHEMICAL,2019 Jan,20,28,1. Eur J Pharmacol. 2019 Jan 15;843:162-176. doi: 10.1016/j.ejphar.2018.11.018. Epub 2018 Nov 16.
novel_lipolysis-nuclear_receptor_changes_ppara,/work/eval_papers/PMID_30452912.pdf,abstract,CHEMICAL,adipose,120,127,Elevated lipolysis in adipose tissue by doxorubicin via PPARα activation associated with hepatic steatosis and insulin resistance.
novel_lipolysis-nuclear_receptor_changes_ppara,/work/eval_papers/PMID_30452912.pdf,abstract,CHEMICAL,doxorubicin,138,149,Elevated lipolysis in adipose tissue by doxorubicin via PPARα activation associated with hepatic steatosis and insulin resistance.
novel_lipolysis-nuclear_receptor_changes_ppara,/work/eval_papers/PMID_30452912.pdf,abstract,CHEMICAL,K B,240,243,"Renu K(1), K B S(1), Parthiban S(1), S S(1), George A(2), P B TP(3), Suman S(4), V G A(5), Arunachalam S(6)."
novel_lipolysis-nuclear_receptor_changes_ppara,/work/eval_papers/PMID_30452912.pdf,abstract,CHEMICAL,P B,287,290,"Renu K(1), K B S(1), Parthiban S(1), S S(1), George A(2), P B TP(3), Suman S(4), V G A(5), Arunachalam S(6)."
novel_lipolysis-nuclear_receptor_changes_ppara,/work/eval_papers/PMID_30452912.pdf,abstract,CHEMICAL,VIT,434,437,"Author information: (1)Department of Biomedical Sciences, School of Biosciences and Technology, VIT, Vellore, Tamil Nadu 632014, India. (2)Jubilee Centre for Medical Research, Jubilee Mission Medical College and Research Institute, Thrissur, Kerala, India."
novel_lipolysis-nuclear_receptor_changes_ppara,/work/eval_papers/PMID_30452912.pdf,abstract,CHEMICAL,NRB,845,848,"(4)Department of Oncology, Lombardi Comprehensive Cancer Center (LCCC), Georgetown University Medical Center (GUMC), E504, NRB, 3970 Reservoir Rd."
novel_lipolysis-nuclear_receptor_changes_ppara,/work/eval_papers/PMID_30452912.pdf,abstract,CHEMICAL,VIT,972,975,"(5)Department of Biomedical Sciences, School of Biosciences and Technology, VIT, Vellore, Tamil Nadu 632014, India."
novel_lipolysis-nuclear_receptor_changes_ppara,/work/eval_papers/PMID_30452912.pdf,abstract,CHEMICAL,address,1023,1030,Electronic address: abilash.vg@vit.ac.in.
novel_lipolysis-nuclear_receptor_changes_ppara,/work/eval_papers/PMID_30452912.pdf,abstract,CHEMICAL,address,1185,1192,"(6)Department of Biotechnology, Kalasalingam Academy of Research and Education, Krishnankoil 626126, Tamil Nadu, India. Electronic address: sankarganesh@klu.ac.in."
novel_lipolysis-nuclear_receptor_changes_ppara,/work/eval_papers/PMID_30452912.pdf,abstract,CHEMICAL,Doxorubicin,1317,1328,Doxorubicin would disturb the lipid metabolism both in adipose and liver.
novel_lipolysis-nuclear_receptor_changes_ppara,/work/eval_papers/PMID_30452912.pdf,abstract,CHEMICAL,doxorubicin,1414,1425,Here we projected that doxorubicin would impede lipogenesis and elevated lipolysis in adipose tissue would elevate the circulatory lipid profile and leads to insulin resistance.
novel_lipolysis-nuclear_receptor_changes_ppara,/work/eval_papers/PMID_30452912.pdf,abstract,CHEMICAL,adipose,1477,1484,Here we projected that doxorubicin would impede lipogenesis and elevated lipolysis in adipose tissue would elevate the circulatory lipid profile and leads to insulin resistance.
novel_lipolysis-nuclear_receptor_changes_ppara,/work/eval_papers/PMID_30452912.pdf,abstract,CHEMICAL,doxorubicin,1747,1758,Further exacerbated lipid profile in circulation would impair the lipid metabolism in hepatic tissue which leads to fatty liver condition and consequently related disease during doxorubicin treatment.
novel_lipolysis-nuclear_receptor_changes_ppara,/work/eval_papers/PMID_30452912.pdf,abstract,CHEMICAL,Doxorubicin,1770,1781,Doxorubicin impairs the lipogenesis through PPARγ and augments lipolysis and fatty acid oxidation through ATGL and PPARα in adipose tissue.
novel_lipolysis-nuclear_receptor_changes_ppara,/work/eval_papers/PMID_30452912.pdf,abstract,CHEMICAL,adipose,1940,1947,"Increased fatty acid level by adipose tissue in circulation would translocate into the liver and dysregulates AHR, PXR, PPARγ, ATGL and Apo B,which further develop insulin resistance and hepatic steatosis condition."
novel_lipolysis-nuclear_receptor_changes_ppara,/work/eval_papers/PMID_30452912.pdf,abstract,CHEMICAL,Apo B,2046,2051,"Increased fatty acid level by adipose tissue in circulation would translocate into the liver and dysregulates AHR, PXR, PPARγ, ATGL and Apo B,which further develop insulin resistance and hepatic steatosis condition."
novel_lipolysis-nuclear_receptor_changes_ppara,/work/eval_papers/PMID_30452912.pdf,abstract,SPECIES,doxorubicin,1747,1758,Further exacerbated lipid profile in circulation would impair the lipid metabolism in hepatic tissue which leads to fatty liver condition and consequently related disease during doxorubicin treatment.
novel_lipophagy-steatosis,/work/eval_papers/PMID_30138652.pdf,abstract,CHEMICAL,carbon,127,133,Lipid accumulation in multi-walled carbon nanotube-exposed HepG2 cells: Possible role of lipophagy pathway.
novel_lipophagy-steatosis,/work/eval_papers/PMID_30138652.pdf,abstract,CHEMICAL,Liu,222,225,"Zhao C(1), Zhou Y(2), Liu L(3), Long J(1), Liu H(1), Li J(4), Cao Y(5)."
novel_lipophagy-steatosis,/work/eval_papers/PMID_30138652.pdf,abstract,CHEMICAL,Liu,243,246,"Zhao C(1), Zhou Y(2), Liu L(3), Long J(1), Liu H(1), Li J(4), Cao Y(5)."
novel_lipophagy-steatosis,/work/eval_papers/PMID_30138652.pdf,abstract,CHEMICAL,address,1076,1083,Electronic address: juanli@xtu.edu.cn.
novel_lipophagy-steatosis,/work/eval_papers/PMID_30138652.pdf,abstract,CHEMICAL,address,1405,1412,Electronic address: caoyi39@xtu.edu.cn.
novel_lipophagy-steatosis,/work/eval_papers/PMID_30138652.pdf,abstract,CHEMICAL,carbon nanotubes,1564,1580,"Nanoparticle (NP) exposure might promote hepatic steatosis, but relatively few studies investigated the influence of multi-walled carbon nanotubes (MWCNTs) on lipid accumulation in hepatocytes in vitro."
novel_lipophagy-steatosis,/work/eval_papers/PMID_30138652.pdf,abstract,CHEMICAL,Pristine,1788,1796,"Pristine (XFM19) and carboxylated MWCNTs (XFM21) were internalized, accompanying cytotoxicity, lysosomal destabilization, and intracellular reactive oxygen species (ROS) production."
novel_lipoprotein_lipase_(lpl)_and_receptor_(ldlr)-liver_triglyceride_accumulation,/work/eval_papers/PMID_31473330.pdf,abstract,CHEMICAL,2019,44,48,1. Comp Biochem Physiol B Biochem Mol Biol. 2019 Dec;238:110335. doi: 10.1016/j.cbpb.2019.110335. Epub 2019 Aug 29.
novel_lipoprotein_lipase_(lpl)_and_receptor_(ldlr)-liver_triglyceride_accumulation,/work/eval_papers/PMID_31473330.pdf,abstract,CHEMICAL,2019,103,107,1. Comp Biochem Physiol B Biochem Mol Biol. 2019 Dec;238:110335. doi: 10.1016/j.cbpb.2019.110335. Epub 2019 Aug 29.
novel_lipoprotein_lipase_(lpl)_and_receptor_(ldlr)-liver_triglyceride_accumulation,/work/eval_papers/PMID_31473330.pdf,abstract,CHEMICAL,address,1301,1308,"(5)Guangxi Tilapia Genetic Breeding Center, Guangxi Academy of Fishery Sciences, Nanning 530021, China. Electronic address: zhouyi1982cn@126.com."
novel_lipoprotein_lipase_(lpl)_and_receptor_(ldlr)-liver_triglyceride_accumulation,/work/eval_papers/PMID_31473330.pdf,abstract,CHEMICAL,address,1783,1790,Electronic address: lfylzc123@163.com.
novel_lipoprotein_lipase_(lpl)_and_receptor_(ldlr)-liver_triglyceride_accumulation,/work/eval_papers/PMID_31473330.pdf,abstract,CHEMICAL,steroid,1835,1842,Estradiol (E2) is a sex steroid hormone that modulates multiple physiological processes in teleosts.
novel_lipoprotein_lipase_(lpl)_and_receptor_(ldlr)-liver_triglyceride_accumulation,/work/eval_papers/PMID_31473330.pdf,abstract,CHEMICAL,ICI,2132,2135,"The hybrid tilapias were injected with different concentrations of E2 (0 mg/kg, 10 mg/kg, 25 mg/kg and 50 mg/kg) and ICI 182,780 (ICI) (35 mg/kg) (an E2 receptor antagonist)."
novel_lipoprotein_lipase_(lpl)_and_receptor_(ldlr)-liver_triglyceride_accumulation,/work/eval_papers/PMID_31473330.pdf,abstract,CHEMICAL,ICI,2145,2148,"The hybrid tilapias were injected with different concentrations of E2 (0 mg/kg, 10 mg/kg, 25 mg/kg and 50 mg/kg) and ICI 182,780 (ICI) (35 mg/kg) (an E2 receptor antagonist)."
novel_lipoprotein_lipase_(lpl)_and_receptor_(ldlr)-liver_triglyceride_accumulation,/work/eval_papers/PMID_31473330.pdf,abstract,CHEMICAL,cholesterol,2302,2313,"Serum total cholesterol (TC), triglyceride (TG), high-density lipoprotein (HDL), low-density lipoprotein (LDL) and nonesterified fatty acids (NEFAs) were assayed from the fish in different groups."
novel_lipoprotein_lipase_(lpl)_and_receptor_(ldlr)-liver_triglyceride_accumulation,/work/eval_papers/PMID_31473330.pdf,abstract,CHEMICAL,tended to upregulate TC,2809,2832,"Simultaneously, the E2 injections tended to upregulate TC, TG, LDL, and HDL in the serum."
novel_lipoprotein_lipase_(lpl)_and_receptor_(ldlr)-liver_triglyceride_accumulation,/work/eval_papers/PMID_31473330.pdf,abstract,CHEMICAL,LDLR,2979,2983,The 50 mg/kg E2 group showed a significantly higher expression of the VLDL assembly genes but depressed levels of LDLR and LRP1.
novel_lipoprotein_lipase_(lpl)_and_receptor_(ldlr)-liver_triglyceride_accumulation,/work/eval_papers/PMID_31473330.pdf,abstract,CHEMICAL,ICI,3125,3128,"The ICI injection inhibited the expression of MTP, LPL, LRP1, CD36, FABP11a, ACO1 and FAS in tilapia livers."
novel_lipoprotein_lipase_(lpl)_and_receptor_(ldlr)-liver_triglyceride_accumulation,/work/eval_papers/PMID_31473330.pdf,abstract,CHEMICAL,FAS,3207,3210,"The ICI injection inhibited the expression of MTP, LPL, LRP1, CD36, FABP11a, ACO1 and FAS in tilapia livers."
novel_lipoprotein_lipase_(lpl)_and_receptor_(ldlr)-liver_triglyceride_accumulation,/work/eval_papers/PMID_31473330.pdf,abstract,CHEMICAL,provide,3611,3618,"Overall, the results suggest a role for E2 in fish lipid metabolisms that provide new clues to illustrate the sex steroid function in energy metabolism in livers."
novel_lipoprotein_lipase_(lpl)_and_receptor_(ldlr)-liver_triglyceride_accumulation,/work/eval_papers/PMID_31473330.pdf,abstract,CHEMICAL,steroid,3651,3658,"Overall, the results suggest a role for E2 in fish lipid metabolisms that provide new clues to illustrate the sex steroid function in energy metabolism in livers."
novel_lipoprotein_lipase_(lpl)_and_receptor_(ldlr)-liver_triglyceride_accumulation,/work/eval_papers/PMID_31473330.pdf,abstract,SPECIES,CD36,3183,3187,"The ICI injection inhibited the expression of MTP, LPL, LRP1, CD36, FABP11a, ACO1 and FAS in tilapia livers."
novel_lysosomal_biogenesis-liver_triglyceride_accumulation,/work/eval_papers/PMID_29782848.pdf,abstract,CHEMICAL,Krishnamurthy,308,321,"Chao X(1), Wang S(1), Zhao K(1), Li Y(1), Williams JA(1), Li T(1), Chavan H(1), Krishnamurthy P(1), He XC(2), Li L(2), Ballabio A(3), Ni HM(1), Ding WX(4)."
novel_lysosomal_biogenesis-liver_triglyceride_accumulation,/work/eval_papers/PMID_29782848.pdf,abstract,CHEMICAL,Medicine,709,717,"(2)Stowers Institute for Medical Research, Kansas City, Missouri; Department of Pathology, University of Kansas Medical Center, Kansas City, Kansas. (3)Telethon Institute of Genetics and Medicine, TIGEM, Pozzuoli, Naples, Italy; Medical Genetics, Department of Translational Medicine, Federico II University, Naples, Italy; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas."
novel_lysosomal_biogenesis-liver_triglyceride_accumulation,/work/eval_papers/PMID_29782848.pdf,abstract,CHEMICAL,TIGEM,719,724,"(2)Stowers Institute for Medical Research, Kansas City, Missouri; Department of Pathology, University of Kansas Medical Center, Kansas City, Kansas. (3)Telethon Institute of Genetics and Medicine, TIGEM, Pozzuoli, Naples, Italy; Medical Genetics, Department of Translational Medicine, Federico II University, Naples, Italy; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas."
novel_lysosomal_biogenesis-liver_triglyceride_accumulation,/work/eval_papers/PMID_29782848.pdf,abstract,CHEMICAL,Medicine,797,805,"(2)Stowers Institute for Medical Research, Kansas City, Missouri; Department of Pathology, University of Kansas Medical Center, Kansas City, Kansas. (3)Telethon Institute of Genetics and Medicine, TIGEM, Pozzuoli, Naples, Italy; Medical Genetics, Department of Translational Medicine, Federico II University, Naples, Italy; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas."
novel_lysosomal_biogenesis-liver_triglyceride_accumulation,/work/eval_papers/PMID_29782848.pdf,abstract,CHEMICAL,Medicine,908,916,"(2)Stowers Institute for Medical Research, Kansas City, Missouri; Department of Pathology, University of Kansas Medical Center, Kansas City, Kansas. (3)Telethon Institute of Genetics and Medicine, TIGEM, Pozzuoli, Naples, Italy; Medical Genetics, Department of Translational Medicine, Federico II University, Naples, Italy; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas."
novel_lysosomal_biogenesis-liver_triglyceride_accumulation,/work/eval_papers/PMID_29782848.pdf,abstract,CHEMICAL,address,1063,1070,Electronic address: wxding@kumc.edu. Comment in Autophagy. 2018;14(9):1646-1648.
novel_lysosomal_biogenesis-liver_triglyceride_accumulation,/work/eval_papers/PMID_29782848.pdf,abstract,CHEMICAL,AIMS,1240,1244,BACKGROUND & AIMS: Defects in lysosome function and autophagy contribute to the pathogenesis of alcoholic liver disease.
novel_lysosomal_biogenesis-liver_triglyceride_accumulation,/work/eval_papers/PMID_29782848.pdf,abstract,CHEMICAL,alcohol,1388,1395,"We investigated the mechanisms by which alcohol consumption affects these processes by evaluating the functions of transcription factor EB (TFEB), which regulates lysosomal biogenesis."
novel_lysosomal_biogenesis-liver_triglyceride_accumulation,/work/eval_papers/PMID_29782848.pdf,abstract,CHEMICAL,TFEB,1619,1623,"METHODS: We performed studies with GFP-LC3 mice, mice with liver-specific deletion of TFEB, mice with disruption of the transcription factor E3 gene (TFE3-knockout mice), mice with disruption of the Tefb and Tfe3 genes (TFEB and TFE3 double-knockout mice), and Tfebflox/flox albumin cre-negative mice (controls)."
novel_lysosomal_biogenesis-liver_triglyceride_accumulation,/work/eval_papers/PMID_29782848.pdf,abstract,CHEMICAL,rapamycin,2180,2189,"Mice were placed on diets of regular ethanol feeding plus an acute binge to induce liver damage (ethanol diet); some mice also were given injections of torin-1, an inhibitor of the kinase activity of the mechanistic target of rapamycin (mTOR)."
novel_lysosomal_biogenesis-liver_triglyceride_accumulation,/work/eval_papers/PMID_29782848.pdf,abstract,CHEMICAL,levels,2375,2381,We analyzed levels of TFEB in liver tissues from patients with alcoholic hepatitis and from healthy donors (controls) by immunohistochemistry.
novel_lysosomal_biogenesis-liver_triglyceride_accumulation,/work/eval_papers/PMID_29782848.pdf,abstract,CHEMICAL,levels,2569,2575,"RESULTS: Liver tissues from mice on the ethanol diet had lower levels of total and nuclear TFEB compared with control mice, and hepatocytes had decreased lysosome biogenesis and autophagy."
novel_lysosomal_biogenesis-liver_triglyceride_accumulation,/work/eval_papers/PMID_29782848.pdf,abstract,CHEMICAL,levels,2871,2877,Administration of torin-1 increased liver levels of TFEB and decreased steatosis and liver injury induced by ethanol.
novel_lysosomal_biogenesis-liver_triglyceride_accumulation,/work/eval_papers/PMID_29782848.pdf,abstract,CHEMICAL,levels,3383,3389,Liver tissues from patients with alcohol-induced hepatitis had lower nuclear levels of TFEB than control tissues.
novel_lysosomal_biogenesis-liver_triglyceride_accumulation,/work/eval_papers/PMID_29782848.pdf,abstract,CHEMICAL,ethanol,3447,3454,"CONCLUSIONS: We found that ethanol feeding plus an acute binge decreased hepatic expression of TFEB, which is required for lysosomal biogenesis and autophagy."
novel_lysosomal_biogenesis-liver_triglyceride_accumulation,/work/eval_papers/PMID_29782848.pdf,abstract,CHEMICAL,levels,3625,3631,Strategies to block mTOR activity or increase levels of TFEB might be developed to protect the liver from ethanol-induced damage.
novel_lysosomal_biogenesis-liver_triglyceride_accumulation,/work/eval_papers/PMID_29782848.pdf,abstract,CHEMICAL,protect,3662,3669,Strategies to block mTOR activity or increase levels of TFEB might be developed to protect the liver from ethanol-induced damage.
novel_lysosomal_biogenesis-liver_triglyceride_accumulation,/work/eval_papers/PMID_29782848.pdf,abstract,SPECIES,Mice,222,226,Impaired TFEB-Mediated Lysosome Biogenesis and Autophagy Promote Chronic Ethanol-Induced Liver Injury and Steatosis in Mice.
novel_lysosomal_biogenesis-liver_triglyceride_accumulation,/work/eval_papers/PMID_29782848.pdf,abstract,SPECIES,Italy,744,749,"(2)Stowers Institute for Medical Research, Kansas City, Missouri; Department of Pathology, University of Kansas Medical Center, Kansas City, Kansas. (3)Telethon Institute of Genetics and Medicine, TIGEM, Pozzuoli, Naples, Italy; Medical Genetics, Department of Translational Medicine, Federico II University, Naples, Italy; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas."
novel_lysosomal_biogenesis-liver_triglyceride_accumulation,/work/eval_papers/PMID_29782848.pdf,abstract,SPECIES,Italy,839,844,"(2)Stowers Institute for Medical Research, Kansas City, Missouri; Department of Pathology, University of Kansas Medical Center, Kansas City, Kansas. (3)Telethon Institute of Genetics and Medicine, TIGEM, Pozzuoli, Naples, Italy; Medical Genetics, Department of Translational Medicine, Federico II University, Naples, Italy; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas."
novel_lysosomal_biogenesis-liver_triglyceride_accumulation,/work/eval_papers/PMID_29782848.pdf,abstract,SPECIES,Human,874,879,"(2)Stowers Institute for Medical Research, Kansas City, Missouri; Department of Pathology, University of Kansas Medical Center, Kansas City, Kansas. (3)Telethon Institute of Genetics and Medicine, TIGEM, Pozzuoli, Naples, Italy; Medical Genetics, Department of Translational Medicine, Federico II University, Naples, Italy; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas."
novel_lysosomal_biogenesis-liver_triglyceride_accumulation,/work/eval_papers/PMID_29782848.pdf,abstract,SPECIES,mice,1582,1586,"METHODS: We performed studies with GFP-LC3 mice, mice with liver-specific deletion of TFEB, mice with disruption of the transcription factor E3 gene (TFE3-knockout mice), mice with disruption of the Tefb and Tfe3 genes (TFEB and TFE3 double-knockout mice), and Tfebflox/flox albumin cre-negative mice (controls)."
novel_lysosomal_biogenesis-liver_triglyceride_accumulation,/work/eval_papers/PMID_29782848.pdf,abstract,SPECIES,mice,1625,1629,"METHODS: We performed studies with GFP-LC3 mice, mice with liver-specific deletion of TFEB, mice with disruption of the transcription factor E3 gene (TFE3-knockout mice), mice with disruption of the Tefb and Tfe3 genes (TFEB and TFE3 double-knockout mice), and Tfebflox/flox albumin cre-negative mice (controls)."
novel_lysosomal_biogenesis-liver_triglyceride_accumulation,/work/eval_papers/PMID_29782848.pdf,abstract,SPECIES,mice,1704,1708,"METHODS: We performed studies with GFP-LC3 mice, mice with liver-specific deletion of TFEB, mice with disruption of the transcription factor E3 gene (TFE3-knockout mice), mice with disruption of the Tefb and Tfe3 genes (TFEB and TFE3 double-knockout mice), and Tfebflox/flox albumin cre-negative mice (controls)."
novel_lysosomal_biogenesis-liver_triglyceride_accumulation,/work/eval_papers/PMID_29782848.pdf,abstract,SPECIES,mice,1829,1833,"METHODS: We performed studies with GFP-LC3 mice, mice with liver-specific deletion of TFEB, mice with disruption of the transcription factor E3 gene (TFE3-knockout mice), mice with disruption of the Tefb and Tfe3 genes (TFEB and TFE3 double-knockout mice), and Tfebflox/flox albumin cre-negative mice (controls)."
novel_lysosomal_biogenesis-liver_triglyceride_accumulation,/work/eval_papers/PMID_29782848.pdf,abstract,SPECIES,mouse,1940,1945,TFEB was overexpressed from adenoviral vectors or knocked down with small interfering RNAs in mouse livers.
novel_lysosomal_biogenesis-liver_triglyceride_accumulation,/work/eval_papers/PMID_29782848.pdf,abstract,SPECIES,mice,2071,2075,"Mice were placed on diets of regular ethanol feeding plus an acute binge to induce liver damage (ethanol diet); some mice also were given injections of torin-1, an inhibitor of the kinase activity of the mechanistic target of rapamycin (mTOR)."
novel_lysosomal_biogenesis-liver_triglyceride_accumulation,/work/eval_papers/PMID_29782848.pdf,abstract,SPECIES,patients,2412,2420,We analyzed levels of TFEB in liver tissues from patients with alcoholic hepatitis and from healthy donors (controls) by immunohistochemistry.
novel_lysosomal_biogenesis-liver_triglyceride_accumulation,/work/eval_papers/PMID_29782848.pdf,abstract,SPECIES,mice,2534,2538,"RESULTS: Liver tissues from mice on the ethanol diet had lower levels of total and nuclear TFEB compared with control mice, and hepatocytes had decreased lysosome biogenesis and autophagy."
novel_lysosomal_biogenesis-liver_triglyceride_accumulation,/work/eval_papers/PMID_29782848.pdf,abstract,SPECIES,mice,2712,2716,"Hepatocytes from mice on the ethanol diet had increased translocation of mTOR into lysosomes, resulting in increased mTOR activation."
novel_lysosomal_biogenesis-liver_triglyceride_accumulation,/work/eval_papers/PMID_29782848.pdf,abstract,SPECIES,mice,3125,3129,Mice that overexpressed TFEB in the liver developed less severe ethanol-induced liver injury and had increased lysosomal biogenesis and mitochondrial bioenergetics compared with mice carrying a control vector.
novel_lysosomal_biogenesis-liver_triglyceride_accumulation,/work/eval_papers/PMID_29782848.pdf,abstract,SPECIES,Mice,3157,3161,Mice with knockdown of TFEB and TFEB-TFE3 double-knockout mice developed more severe liver injury in response to the ethanol diet than control mice.
novel_lysosomal_biogenesis-liver_triglyceride_accumulation,/work/eval_papers/PMID_29782848.pdf,abstract,SPECIES,patients,3325,3333,Liver tissues from patients with alcohol-induced hepatitis had lower nuclear levels of TFEB than control tissues.
novel_lysosomal_biogenesis-novel_autophagy,/work/eval_papers/PMID_29782848.pdf,abstract,CHEMICAL,Krishnamurthy,308,321,"Chao X(1), Wang S(1), Zhao K(1), Li Y(1), Williams JA(1), Li T(1), Chavan H(1), Krishnamurthy P(1), He XC(2), Li L(2), Ballabio A(3), Ni HM(1), Ding WX(4)."
novel_lysosomal_biogenesis-novel_autophagy,/work/eval_papers/PMID_29782848.pdf,abstract,CHEMICAL,Medicine,709,717,"(2)Stowers Institute for Medical Research, Kansas City, Missouri; Department of Pathology, University of Kansas Medical Center, Kansas City, Kansas. (3)Telethon Institute of Genetics and Medicine, TIGEM, Pozzuoli, Naples, Italy; Medical Genetics, Department of Translational Medicine, Federico II University, Naples, Italy; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas."
novel_lysosomal_biogenesis-novel_autophagy,/work/eval_papers/PMID_29782848.pdf,abstract,CHEMICAL,TIGEM,719,724,"(2)Stowers Institute for Medical Research, Kansas City, Missouri; Department of Pathology, University of Kansas Medical Center, Kansas City, Kansas. (3)Telethon Institute of Genetics and Medicine, TIGEM, Pozzuoli, Naples, Italy; Medical Genetics, Department of Translational Medicine, Federico II University, Naples, Italy; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas."
novel_lysosomal_biogenesis-novel_autophagy,/work/eval_papers/PMID_29782848.pdf,abstract,CHEMICAL,Medicine,797,805,"(2)Stowers Institute for Medical Research, Kansas City, Missouri; Department of Pathology, University of Kansas Medical Center, Kansas City, Kansas. (3)Telethon Institute of Genetics and Medicine, TIGEM, Pozzuoli, Naples, Italy; Medical Genetics, Department of Translational Medicine, Federico II University, Naples, Italy; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas."
novel_lysosomal_biogenesis-novel_autophagy,/work/eval_papers/PMID_29782848.pdf,abstract,CHEMICAL,Medicine,908,916,"(2)Stowers Institute for Medical Research, Kansas City, Missouri; Department of Pathology, University of Kansas Medical Center, Kansas City, Kansas. (3)Telethon Institute of Genetics and Medicine, TIGEM, Pozzuoli, Naples, Italy; Medical Genetics, Department of Translational Medicine, Federico II University, Naples, Italy; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas."
novel_lysosomal_biogenesis-novel_autophagy,/work/eval_papers/PMID_29782848.pdf,abstract,CHEMICAL,address,1063,1070,Electronic address: wxding@kumc.edu. Comment in Autophagy. 2018;14(9):1646-1648.
novel_lysosomal_biogenesis-novel_autophagy,/work/eval_papers/PMID_29782848.pdf,abstract,CHEMICAL,AIMS,1240,1244,BACKGROUND & AIMS: Defects in lysosome function and autophagy contribute to the pathogenesis of alcoholic liver disease.
novel_lysosomal_biogenesis-novel_autophagy,/work/eval_papers/PMID_29782848.pdf,abstract,CHEMICAL,alcohol,1388,1395,"We investigated the mechanisms by which alcohol consumption affects these processes by evaluating the functions of transcription factor EB (TFEB), which regulates lysosomal biogenesis."
novel_lysosomal_biogenesis-novel_autophagy,/work/eval_papers/PMID_29782848.pdf,abstract,CHEMICAL,TFEB,1619,1623,"METHODS: We performed studies with GFP-LC3 mice, mice with liver-specific deletion of TFEB, mice with disruption of the transcription factor E3 gene (TFE3-knockout mice), mice with disruption of the Tefb and Tfe3 genes (TFEB and TFE3 double-knockout mice), and Tfebflox/flox albumin cre-negative mice (controls)."
novel_lysosomal_biogenesis-novel_autophagy,/work/eval_papers/PMID_29782848.pdf,abstract,CHEMICAL,rapamycin,2180,2189,"Mice were placed on diets of regular ethanol feeding plus an acute binge to induce liver damage (ethanol diet); some mice also were given injections of torin-1, an inhibitor of the kinase activity of the mechanistic target of rapamycin (mTOR)."
novel_lysosomal_biogenesis-novel_autophagy,/work/eval_papers/PMID_29782848.pdf,abstract,CHEMICAL,levels,2375,2381,We analyzed levels of TFEB in liver tissues from patients with alcoholic hepatitis and from healthy donors (controls) by immunohistochemistry.
novel_lysosomal_biogenesis-novel_autophagy,/work/eval_papers/PMID_29782848.pdf,abstract,CHEMICAL,levels,2569,2575,"RESULTS: Liver tissues from mice on the ethanol diet had lower levels of total and nuclear TFEB compared with control mice, and hepatocytes had decreased lysosome biogenesis and autophagy."
novel_lysosomal_biogenesis-novel_autophagy,/work/eval_papers/PMID_29782848.pdf,abstract,CHEMICAL,levels,2871,2877,Administration of torin-1 increased liver levels of TFEB and decreased steatosis and liver injury induced by ethanol.
novel_lysosomal_biogenesis-novel_autophagy,/work/eval_papers/PMID_29782848.pdf,abstract,CHEMICAL,levels,3383,3389,Liver tissues from patients with alcohol-induced hepatitis had lower nuclear levels of TFEB than control tissues.
novel_lysosomal_biogenesis-novel_autophagy,/work/eval_papers/PMID_29782848.pdf,abstract,CHEMICAL,ethanol,3447,3454,"CONCLUSIONS: We found that ethanol feeding plus an acute binge decreased hepatic expression of TFEB, which is required for lysosomal biogenesis and autophagy."
novel_lysosomal_biogenesis-novel_autophagy,/work/eval_papers/PMID_29782848.pdf,abstract,CHEMICAL,levels,3625,3631,Strategies to block mTOR activity or increase levels of TFEB might be developed to protect the liver from ethanol-induced damage.
novel_lysosomal_biogenesis-novel_autophagy,/work/eval_papers/PMID_29782848.pdf,abstract,CHEMICAL,protect,3662,3669,Strategies to block mTOR activity or increase levels of TFEB might be developed to protect the liver from ethanol-induced damage.
novel_lysosomal_biogenesis-novel_autophagy,/work/eval_papers/PMID_29782848.pdf,abstract,SPECIES,Mice,222,226,Impaired TFEB-Mediated Lysosome Biogenesis and Autophagy Promote Chronic Ethanol-Induced Liver Injury and Steatosis in Mice.
novel_lysosomal_biogenesis-novel_autophagy,/work/eval_papers/PMID_29782848.pdf,abstract,SPECIES,Italy,744,749,"(2)Stowers Institute for Medical Research, Kansas City, Missouri; Department of Pathology, University of Kansas Medical Center, Kansas City, Kansas. (3)Telethon Institute of Genetics and Medicine, TIGEM, Pozzuoli, Naples, Italy; Medical Genetics, Department of Translational Medicine, Federico II University, Naples, Italy; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas."
novel_lysosomal_biogenesis-novel_autophagy,/work/eval_papers/PMID_29782848.pdf,abstract,SPECIES,Italy,839,844,"(2)Stowers Institute for Medical Research, Kansas City, Missouri; Department of Pathology, University of Kansas Medical Center, Kansas City, Kansas. (3)Telethon Institute of Genetics and Medicine, TIGEM, Pozzuoli, Naples, Italy; Medical Genetics, Department of Translational Medicine, Federico II University, Naples, Italy; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas."
novel_lysosomal_biogenesis-novel_autophagy,/work/eval_papers/PMID_29782848.pdf,abstract,SPECIES,Human,874,879,"(2)Stowers Institute for Medical Research, Kansas City, Missouri; Department of Pathology, University of Kansas Medical Center, Kansas City, Kansas. (3)Telethon Institute of Genetics and Medicine, TIGEM, Pozzuoli, Naples, Italy; Medical Genetics, Department of Translational Medicine, Federico II University, Naples, Italy; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas."
novel_lysosomal_biogenesis-novel_autophagy,/work/eval_papers/PMID_29782848.pdf,abstract,SPECIES,mice,1582,1586,"METHODS: We performed studies with GFP-LC3 mice, mice with liver-specific deletion of TFEB, mice with disruption of the transcription factor E3 gene (TFE3-knockout mice), mice with disruption of the Tefb and Tfe3 genes (TFEB and TFE3 double-knockout mice), and Tfebflox/flox albumin cre-negative mice (controls)."
novel_lysosomal_biogenesis-novel_autophagy,/work/eval_papers/PMID_29782848.pdf,abstract,SPECIES,mice,1625,1629,"METHODS: We performed studies with GFP-LC3 mice, mice with liver-specific deletion of TFEB, mice with disruption of the transcription factor E3 gene (TFE3-knockout mice), mice with disruption of the Tefb and Tfe3 genes (TFEB and TFE3 double-knockout mice), and Tfebflox/flox albumin cre-negative mice (controls)."
novel_lysosomal_biogenesis-novel_autophagy,/work/eval_papers/PMID_29782848.pdf,abstract,SPECIES,mice,1704,1708,"METHODS: We performed studies with GFP-LC3 mice, mice with liver-specific deletion of TFEB, mice with disruption of the transcription factor E3 gene (TFE3-knockout mice), mice with disruption of the Tefb and Tfe3 genes (TFEB and TFE3 double-knockout mice), and Tfebflox/flox albumin cre-negative mice (controls)."
novel_lysosomal_biogenesis-novel_autophagy,/work/eval_papers/PMID_29782848.pdf,abstract,SPECIES,mice,1829,1833,"METHODS: We performed studies with GFP-LC3 mice, mice with liver-specific deletion of TFEB, mice with disruption of the transcription factor E3 gene (TFE3-knockout mice), mice with disruption of the Tefb and Tfe3 genes (TFEB and TFE3 double-knockout mice), and Tfebflox/flox albumin cre-negative mice (controls)."
novel_lysosomal_biogenesis-novel_autophagy,/work/eval_papers/PMID_29782848.pdf,abstract,SPECIES,mouse,1940,1945,TFEB was overexpressed from adenoviral vectors or knocked down with small interfering RNAs in mouse livers.
novel_lysosomal_biogenesis-novel_autophagy,/work/eval_papers/PMID_29782848.pdf,abstract,SPECIES,mice,2071,2075,"Mice were placed on diets of regular ethanol feeding plus an acute binge to induce liver damage (ethanol diet); some mice also were given injections of torin-1, an inhibitor of the kinase activity of the mechanistic target of rapamycin (mTOR)."
novel_lysosomal_biogenesis-novel_autophagy,/work/eval_papers/PMID_29782848.pdf,abstract,SPECIES,patients,2412,2420,We analyzed levels of TFEB in liver tissues from patients with alcoholic hepatitis and from healthy donors (controls) by immunohistochemistry.
novel_lysosomal_biogenesis-novel_autophagy,/work/eval_papers/PMID_29782848.pdf,abstract,SPECIES,mice,2534,2538,"RESULTS: Liver tissues from mice on the ethanol diet had lower levels of total and nuclear TFEB compared with control mice, and hepatocytes had decreased lysosome biogenesis and autophagy."
novel_lysosomal_biogenesis-novel_autophagy,/work/eval_papers/PMID_29782848.pdf,abstract,SPECIES,mice,2712,2716,"Hepatocytes from mice on the ethanol diet had increased translocation of mTOR into lysosomes, resulting in increased mTOR activation."
novel_lysosomal_biogenesis-novel_autophagy,/work/eval_papers/PMID_29782848.pdf,abstract,SPECIES,mice,3125,3129,Mice that overexpressed TFEB in the liver developed less severe ethanol-induced liver injury and had increased lysosomal biogenesis and mitochondrial bioenergetics compared with mice carrying a control vector.
novel_lysosomal_biogenesis-novel_autophagy,/work/eval_papers/PMID_29782848.pdf,abstract,SPECIES,Mice,3157,3161,Mice with knockdown of TFEB and TFEB-TFE3 double-knockout mice developed more severe liver injury in response to the ethanol diet than control mice.
novel_lysosomal_biogenesis-novel_autophagy,/work/eval_papers/PMID_29782848.pdf,abstract,SPECIES,patients,3325,3333,Liver tissues from patients with alcohol-induced hepatitis had lower nuclear levels of TFEB than control tissues.
novel_methionine_cycle_disruption-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_32585865.pdf,abstract,CHEMICAL,Medicine,433,441,"(2)Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE 68198, USA."
novel_methionine_cycle_disruption-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_32585865.pdf,abstract,CHEMICAL,Biology,522,529,"(3)Departments of Biology and Chemistry, St. Olaf College, Northfield, MN 55057, USA."
novel_methionine_cycle_disruption-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_32585865.pdf,abstract,CHEMICAL,SAH,1152,1155,"Based on these considerations, we hypothesized that an experimental increase in intracellular SAH alone will result in similar steatotic changes to those seen after alcohol exposure."
novel_methionine_cycle_disruption-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_32585865.pdf,abstract,CHEMICAL,alcohol,1223,1230,"Based on these considerations, we hypothesized that an experimental increase in intracellular SAH alone will result in similar steatotic changes to those seen after alcohol exposure."
novel_methionine_cycle_disruption-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_32585865.pdf,abstract,CHEMICAL,3-deazaadenosine,1411,1427,METHODS: Freshly isolated rat hepatocytes grown on collagen-coated plates were exposed to serum-free medium containing 50 µmol/L oleic acid and varying concentrations of 3-deazaadenosine (DZA) to experimentally elevate intracellular SAH levels.
novel_methionine_cycle_disruption-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_32585865.pdf,abstract,CHEMICAL,levels,1751,1757,The rise in triglycerides and LDs accompanied increases in mRNA and protein levels of several LD-associated proteins known to regulate LD number and size.
novel_methionine_cycle_disruption-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_32585865.pdf,abstract,CHEMICAL,SAH,2100,2103,"Collectively, our results indicate that the elevation of intracellular SAH is sufficient to promote fat accumulation in hepatocytes, which is similar to that seen after alcohol exposure."
novel_methionine_cycle_disruption-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_32585865.pdf,abstract,CHEMICAL,seen,2187,2191,"Collectively, our results indicate that the elevation of intracellular SAH is sufficient to promote fat accumulation in hepatocytes, which is similar to that seen after alcohol exposure."
novel_methionine_cycle_disruption-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_32585865.pdf,abstract,CHEMICAL,alcohol,2198,2205,"Collectively, our results indicate that the elevation of intracellular SAH is sufficient to promote fat accumulation in hepatocytes, which is similar to that seen after alcohol exposure."
novel_methionine_cycle_disruption-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_32585865.pdf,abstract,SPECIES,USA,499,502,"(2)Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE 68198, USA."
novel_methionine_cycle_disruption-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_32585865.pdf,abstract,SPECIES,USA,697,700,"(4)Department of Biochemistry & Molecular Biology, University of Nebraska Medical Center, Omaha, NE 68198, USA."
novel_methionine_cycle_disruption-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_32585865.pdf,abstract,SPECIES,rat hepatocytes grown,1267,1288,METHODS: Freshly isolated rat hepatocytes grown on collagen-coated plates were exposed to serum-free medium containing 50 µmol/L oleic acid and varying concentrations of 3-deazaadenosine (DZA) to experimentally elevate intracellular SAH levels.
novel_methionine_cycle_disruption-fa_uptake,/work/eval_papers/PMID_32585865.pdf,abstract,CHEMICAL,Medicine,433,441,"(2)Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE 68198, USA."
novel_methionine_cycle_disruption-fa_uptake,/work/eval_papers/PMID_32585865.pdf,abstract,CHEMICAL,Biology,522,529,"(3)Departments of Biology and Chemistry, St. Olaf College, Northfield, MN 55057, USA."
novel_methionine_cycle_disruption-fa_uptake,/work/eval_papers/PMID_32585865.pdf,abstract,CHEMICAL,SAH,1152,1155,"Based on these considerations, we hypothesized that an experimental increase in intracellular SAH alone will result in similar steatotic changes to those seen after alcohol exposure."
novel_methionine_cycle_disruption-fa_uptake,/work/eval_papers/PMID_32585865.pdf,abstract,CHEMICAL,alcohol,1223,1230,"Based on these considerations, we hypothesized that an experimental increase in intracellular SAH alone will result in similar steatotic changes to those seen after alcohol exposure."
novel_methionine_cycle_disruption-fa_uptake,/work/eval_papers/PMID_32585865.pdf,abstract,CHEMICAL,3-deazaadenosine,1411,1427,METHODS: Freshly isolated rat hepatocytes grown on collagen-coated plates were exposed to serum-free medium containing 50 µmol/L oleic acid and varying concentrations of 3-deazaadenosine (DZA) to experimentally elevate intracellular SAH levels.
novel_methionine_cycle_disruption-fa_uptake,/work/eval_papers/PMID_32585865.pdf,abstract,CHEMICAL,levels,1751,1757,The rise in triglycerides and LDs accompanied increases in mRNA and protein levels of several LD-associated proteins known to regulate LD number and size.
novel_methionine_cycle_disruption-fa_uptake,/work/eval_papers/PMID_32585865.pdf,abstract,CHEMICAL,SAH,2100,2103,"Collectively, our results indicate that the elevation of intracellular SAH is sufficient to promote fat accumulation in hepatocytes, which is similar to that seen after alcohol exposure."
novel_methionine_cycle_disruption-fa_uptake,/work/eval_papers/PMID_32585865.pdf,abstract,CHEMICAL,seen,2187,2191,"Collectively, our results indicate that the elevation of intracellular SAH is sufficient to promote fat accumulation in hepatocytes, which is similar to that seen after alcohol exposure."
novel_methionine_cycle_disruption-fa_uptake,/work/eval_papers/PMID_32585865.pdf,abstract,CHEMICAL,alcohol,2198,2205,"Collectively, our results indicate that the elevation of intracellular SAH is sufficient to promote fat accumulation in hepatocytes, which is similar to that seen after alcohol exposure."
novel_methionine_cycle_disruption-fa_uptake,/work/eval_papers/PMID_32585865.pdf,abstract,SPECIES,USA,499,502,"(2)Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE 68198, USA."
novel_methionine_cycle_disruption-fa_uptake,/work/eval_papers/PMID_32585865.pdf,abstract,SPECIES,USA,697,700,"(4)Department of Biochemistry & Molecular Biology, University of Nebraska Medical Center, Omaha, NE 68198, USA."
novel_methionine_cycle_disruption-fa_uptake,/work/eval_papers/PMID_32585865.pdf,abstract,SPECIES,rat hepatocytes grown,1267,1288,METHODS: Freshly isolated rat hepatocytes grown on collagen-coated plates were exposed to serum-free medium containing 50 µmol/L oleic acid and varying concentrations of 3-deazaadenosine (DZA) to experimentally elevate intracellular SAH levels.
novel_methionine_cycle_disruption-liver_triglyceride_accumulation,/work/eval_papers/PMID_32585865.pdf,abstract,CHEMICAL,Medicine,433,441,"(2)Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE 68198, USA."
novel_methionine_cycle_disruption-liver_triglyceride_accumulation,/work/eval_papers/PMID_32585865.pdf,abstract,CHEMICAL,Biology,522,529,"(3)Departments of Biology and Chemistry, St. Olaf College, Northfield, MN 55057, USA."
novel_methionine_cycle_disruption-liver_triglyceride_accumulation,/work/eval_papers/PMID_32585865.pdf,abstract,CHEMICAL,SAH,1152,1155,"Based on these considerations, we hypothesized that an experimental increase in intracellular SAH alone will result in similar steatotic changes to those seen after alcohol exposure."
novel_methionine_cycle_disruption-liver_triglyceride_accumulation,/work/eval_papers/PMID_32585865.pdf,abstract,CHEMICAL,alcohol,1223,1230,"Based on these considerations, we hypothesized that an experimental increase in intracellular SAH alone will result in similar steatotic changes to those seen after alcohol exposure."
novel_methionine_cycle_disruption-liver_triglyceride_accumulation,/work/eval_papers/PMID_32585865.pdf,abstract,CHEMICAL,3-deazaadenosine,1411,1427,METHODS: Freshly isolated rat hepatocytes grown on collagen-coated plates were exposed to serum-free medium containing 50 µmol/L oleic acid and varying concentrations of 3-deazaadenosine (DZA) to experimentally elevate intracellular SAH levels.
novel_methionine_cycle_disruption-liver_triglyceride_accumulation,/work/eval_papers/PMID_32585865.pdf,abstract,CHEMICAL,levels,1751,1757,The rise in triglycerides and LDs accompanied increases in mRNA and protein levels of several LD-associated proteins known to regulate LD number and size.
novel_methionine_cycle_disruption-liver_triglyceride_accumulation,/work/eval_papers/PMID_32585865.pdf,abstract,CHEMICAL,SAH,2100,2103,"Collectively, our results indicate that the elevation of intracellular SAH is sufficient to promote fat accumulation in hepatocytes, which is similar to that seen after alcohol exposure."
novel_methionine_cycle_disruption-liver_triglyceride_accumulation,/work/eval_papers/PMID_32585865.pdf,abstract,CHEMICAL,seen,2187,2191,"Collectively, our results indicate that the elevation of intracellular SAH is sufficient to promote fat accumulation in hepatocytes, which is similar to that seen after alcohol exposure."
novel_methionine_cycle_disruption-liver_triglyceride_accumulation,/work/eval_papers/PMID_32585865.pdf,abstract,CHEMICAL,alcohol,2198,2205,"Collectively, our results indicate that the elevation of intracellular SAH is sufficient to promote fat accumulation in hepatocytes, which is similar to that seen after alcohol exposure."
novel_methionine_cycle_disruption-liver_triglyceride_accumulation,/work/eval_papers/PMID_32585865.pdf,abstract,SPECIES,USA,499,502,"(2)Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE 68198, USA."
novel_methionine_cycle_disruption-liver_triglyceride_accumulation,/work/eval_papers/PMID_32585865.pdf,abstract,SPECIES,USA,697,700,"(4)Department of Biochemistry & Molecular Biology, University of Nebraska Medical Center, Omaha, NE 68198, USA."
novel_methionine_cycle_disruption-liver_triglyceride_accumulation,/work/eval_papers/PMID_32585865.pdf,abstract,SPECIES,rat hepatocytes grown,1267,1288,METHODS: Freshly isolated rat hepatocytes grown on collagen-coated plates were exposed to serum-free medium containing 50 µmol/L oleic acid and varying concentrations of 3-deazaadenosine (DZA) to experimentally elevate intracellular SAH levels.
novel_methionine_cycle_disruption-novel_lipolysis,/work/eval_papers/PMID_32585865.pdf,abstract,CHEMICAL,Medicine,433,441,"(2)Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE 68198, USA."
novel_methionine_cycle_disruption-novel_lipolysis,/work/eval_papers/PMID_32585865.pdf,abstract,CHEMICAL,Biology,522,529,"(3)Departments of Biology and Chemistry, St. Olaf College, Northfield, MN 55057, USA."
novel_methionine_cycle_disruption-novel_lipolysis,/work/eval_papers/PMID_32585865.pdf,abstract,CHEMICAL,SAH,1152,1155,"Based on these considerations, we hypothesized that an experimental increase in intracellular SAH alone will result in similar steatotic changes to those seen after alcohol exposure."
novel_methionine_cycle_disruption-novel_lipolysis,/work/eval_papers/PMID_32585865.pdf,abstract,CHEMICAL,alcohol,1223,1230,"Based on these considerations, we hypothesized that an experimental increase in intracellular SAH alone will result in similar steatotic changes to those seen after alcohol exposure."
novel_methionine_cycle_disruption-novel_lipolysis,/work/eval_papers/PMID_32585865.pdf,abstract,CHEMICAL,3-deazaadenosine,1411,1427,METHODS: Freshly isolated rat hepatocytes grown on collagen-coated plates were exposed to serum-free medium containing 50 µmol/L oleic acid and varying concentrations of 3-deazaadenosine (DZA) to experimentally elevate intracellular SAH levels.
novel_methionine_cycle_disruption-novel_lipolysis,/work/eval_papers/PMID_32585865.pdf,abstract,CHEMICAL,levels,1751,1757,The rise in triglycerides and LDs accompanied increases in mRNA and protein levels of several LD-associated proteins known to regulate LD number and size.
novel_methionine_cycle_disruption-novel_lipolysis,/work/eval_papers/PMID_32585865.pdf,abstract,CHEMICAL,SAH,2100,2103,"Collectively, our results indicate that the elevation of intracellular SAH is sufficient to promote fat accumulation in hepatocytes, which is similar to that seen after alcohol exposure."
novel_methionine_cycle_disruption-novel_lipolysis,/work/eval_papers/PMID_32585865.pdf,abstract,CHEMICAL,seen,2187,2191,"Collectively, our results indicate that the elevation of intracellular SAH is sufficient to promote fat accumulation in hepatocytes, which is similar to that seen after alcohol exposure."
novel_methionine_cycle_disruption-novel_lipolysis,/work/eval_papers/PMID_32585865.pdf,abstract,CHEMICAL,alcohol,2198,2205,"Collectively, our results indicate that the elevation of intracellular SAH is sufficient to promote fat accumulation in hepatocytes, which is similar to that seen after alcohol exposure."
novel_methionine_cycle_disruption-novel_lipolysis,/work/eval_papers/PMID_32585865.pdf,abstract,SPECIES,USA,499,502,"(2)Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE 68198, USA."
novel_methionine_cycle_disruption-novel_lipolysis,/work/eval_papers/PMID_32585865.pdf,abstract,SPECIES,USA,697,700,"(4)Department of Biochemistry & Molecular Biology, University of Nebraska Medical Center, Omaha, NE 68198, USA."
novel_methionine_cycle_disruption-novel_lipolysis,/work/eval_papers/PMID_32585865.pdf,abstract,SPECIES,rat hepatocytes grown,1267,1288,METHODS: Freshly isolated rat hepatocytes grown on collagen-coated plates were exposed to serum-free medium containing 50 µmol/L oleic acid and varying concentrations of 3-deazaadenosine (DZA) to experimentally elevate intracellular SAH levels.
novel_mitophagy-liver_triglyceride_accumulation,/work/eval_papers/PMID_34246650.pdf,abstract,CHEMICAL,Medicine,658,666,"Author information: (1)Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Hefei, PR China; Institute for Liver Diseases of Anhui Medical University, School of Pharmacy, Anhui Medical University, Hefei, 230032, China; Anhui Institute of Innovative Drugs, Key Laboratory of Anti-inflammatory and Immune Medicine, Ministry of Education, Hefei, 230032, China."
novel_mitophagy-liver_triglyceride_accumulation,/work/eval_papers/PMID_34246650.pdf,abstract,CHEMICAL,Medicine,1015,1023,"(2)Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Hefei, PR China; Institute for Liver Diseases of Anhui Medical University, School of Pharmacy, Anhui Medical University, Hefei, 230032, China; Anhui Institute of Innovative Drugs, Key Laboratory of Anti-inflammatory and Immune Medicine, Ministry of Education, Hefei, 230032, China. Electronic address: huchengmu@ahmu.edu.cn."
novel_mitophagy-liver_triglyceride_accumulation,/work/eval_papers/PMID_34246650.pdf,abstract,CHEMICAL,address,1081,1088,"(2)Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Hefei, PR China; Institute for Liver Diseases of Anhui Medical University, School of Pharmacy, Anhui Medical University, Hefei, 230032, China; Anhui Institute of Innovative Drugs, Key Laboratory of Anti-inflammatory and Immune Medicine, Ministry of Education, Hefei, 230032, China. Electronic address: huchengmu@ahmu.edu.cn."
novel_mitophagy-liver_triglyceride_accumulation,/work/eval_papers/PMID_34246650.pdf,abstract,CHEMICAL,Acetaminophen,1266,1279,"Acetaminophen (APAP) is a commonly used painkiller, but it can aggravate lipid deposition in the liver and cause liver injury when used in fatty liver disease."
novel_mitophagy-liver_triglyceride_accumulation,/work/eval_papers/PMID_34246650.pdf,abstract,CHEMICAL,proteins,1919,1927,"The levels of CAV-1 and autophagy-related proteins (LC3-II/I and Beclin-1) had decreased, whereas SREBP-1c had increased in A/O (alcohol and oleic acid) and APAP-co-treated L02 cells."
novel_mitophagy-liver_triglyceride_accumulation,/work/eval_papers/PMID_34246650.pdf,abstract,CHEMICAL,alcohol,2006,2013,"The levels of CAV-1 and autophagy-related proteins (LC3-II/I and Beclin-1) had decreased, whereas SREBP-1c had increased in A/O (alcohol and oleic acid) and APAP-co-treated L02 cells."
novel_mitophagy-liver_triglyceride_accumulation,/work/eval_papers/PMID_34246650.pdf,abstract,CHEMICAL,proteins,2271,2279,"When CAV-1 was downregulated, the levels of Pink-1, Parkin, and autophagy-related proteins (LC3-II/I and Beclin-1) were decreased, whereas SREBP-1c was increased."
novel_mitophagy-liver_triglyceride_accumulation,/work/eval_papers/PMID_34246650.pdf,abstract,CHEMICAL,PMID: 34246650,2854,2868,DOI: 10.1016/j.ejphar.2021.174324 PMID: 34246650 [Indexed for MEDLINE]
novel_mitophagy-liver_triglyceride_accumulation,/work/eval_papers/PMID_34246650.pdf,abstract,SPECIES,mice,1679,1683,This study shows that lipid accumulation was more severe in APAP groups than in alcohol-treated mice.
novel_mitophagy-liver_triglyceride_accumulation,/work/eval_papers/PMID_34246650.pdf,abstract,SPECIES,mice,1853,1857,"The CAV-1 stent-like domain (CSD, 82-101 amino acids of caveolin-1), used to upregulate CAV-1 expression, could reduce lipid accumulation and activate autophagy in AFL mice treated with APAP."
novel_nampt-novel_sirt1,/work/eval_papers/PMID_28449683.pdf,abstract,CHEMICAL,Medicine,376,384,"Author information: (1)Institute of Translational Medicine, Nanchang University, 999 Xuefu Load, Honggutan District, Nanchang, 330031, China."
novel_nampt-novel_sirt1,/work/eval_papers/PMID_28449683.pdf,abstract,CHEMICAL,Medicine,572,580,"(3)Institute of Translational Medicine, Nanchang University, 999 Xuefu Load, Honggutan District, Nanchang, 330031, China. dengk26@gmail.com."
novel_nampt-novel_sirt1,/work/eval_papers/PMID_28449683.pdf,abstract,CHEMICAL,Medicine,713,721,"(4)Institute of Translational Medicine, Nanchang University, 999 Xuefu Load, Honggutan District, Nanchang, 330031, China. hongboxin@yahoo.com."
novel_nampt-novel_sirt1,/work/eval_papers/PMID_28449683.pdf,abstract,CHEMICAL,nicotinamide adenine dinucleotide,1239,1272,Nicotinamide phosphoribosyltransferase (NAMPT) has been recently identified as an enzyme involved in nicotinamide adenine dinucleotide (NAD+) biosynthesis and plays an important role in cellular metabolism in variety of organs in mammals.
novel_nampt-novel_sirt1,/work/eval_papers/PMID_28449683.pdf,abstract,CHEMICAL,investigate,1406,1417,The aim of this study was to investigate the effects of NAMPT on high fat diet-induced hepatic steatosis.
novel_nampt-novel_sirt1,/work/eval_papers/PMID_28449683.pdf,abstract,CHEMICAL,sterol,2102,2108,"RESULTS: FK866 significantly promoted liver steatosis in the mice fed with HFD and hepatic lipid accumulation in vitro, accompanied by the increases of the expressions of lipogenic genes such as sterol regulatory element-binding protein 1 (SREBP1) and fatty acid synthase (FASN)."
novel_nampt-novel_sirt1,/work/eval_papers/PMID_28449683.pdf,abstract,CHEMICAL,actions of,2256,2266,Nicotinamide mononucleotide (NMN) and NAD+ significantly rescued the actions of FK866 in vitro.
novel_nampt-novel_sirt1,/work/eval_papers/PMID_28449683.pdf,abstract,CHEMICAL,FK866,2267,2272,Nicotinamide mononucleotide (NMN) and NAD+ significantly rescued the actions of FK866 in vitro.
novel_nampt-novel_sirt1,/work/eval_papers/PMID_28449683.pdf,abstract,CHEMICAL,Our,2672,2675,CONCLUSION: Our results demonstrated that inhibition of NAMPT aggravated the HFD- or oleic acid-induced hepatic steatosis through suppressing Sirt1-mediated signaling pathway.
novel_nampt-novel_sirt1,/work/eval_papers/PMID_28449683.pdf,abstract,SPECIES,mice,150,154,Inhibition of NAMPT aggravates high fat diet-induced hepatic steatosis in mice through regulating Sirt1/AMPKα/SREBP1 signaling pathway.
novel_nampt-novel_sirt1,/work/eval_papers/PMID_28449683.pdf,abstract,SPECIES,mice,1562,1566,METHODS: Hepatic steatosis model was induced by high fat diet (HFD) in C57BL/6 mice in vivo.
novel_nampt-novel_sirt1,/work/eval_papers/PMID_28449683.pdf,abstract,SPECIES,mice,1968,1972,"RESULTS: FK866 significantly promoted liver steatosis in the mice fed with HFD and hepatic lipid accumulation in vitro, accompanied by the increases of the expressions of lipogenic genes such as sterol regulatory element-binding protein 1 (SREBP1) and fatty acid synthase (FASN)."
novel_nampt-novel_sirt1,/work/eval_papers/PMID_28449683.pdf,abstract,SPECIES,FK866,2267,2272,Nicotinamide mononucleotide (NMN) and NAD+ significantly rescued the actions of FK866 in vitro.
novel_nampt-novel_sirt1,/work/eval_papers/PMID_28449683.pdf,abstract,SPECIES,mice,2491,2495,"In addition, FK866 decreased the protein levels of Sirt1 and phospho-AMPKα in liver of the HFD fed mice."
novel_nf_kb_inducing_kinase_(nik)-nuclear_receptor_changes_ppara,/work/eval_papers/PMID_32206109.pdf,abstract,CHEMICAL,Medicine,907,915,"(6)Department of Rehabilitation Medicine, Jiangsu Province People's Hospital and Nanjing Medical University First Affiliated Hospital, Nanjing, Jiangsu 210029, China."
novel_nf_kb_inducing_kinase_(nik)-nuclear_receptor_changes_ppara,/work/eval_papers/PMID_32206109.pdf,abstract,CHEMICAL,MEK1/2,1867,1873,"PPARα agonists or antagonists of MEK1/2 and ERK1/2 were used to identify the NIK-induced regulation of PPARα, MEK1/2, and ERK1/2."
novel_nf_kb_inducing_kinase_(nik)-nuclear_receptor_changes_ppara,/work/eval_papers/PMID_32206109.pdf,abstract,SPECIES,People,934,940,"(6)Department of Rehabilitation Medicine, Jiangsu Province People's Hospital and Nanjing Medical University First Affiliated Hospital, Nanjing, Jiangsu 210029, China."
novel_nf_kb_inducing_kinase_(nik)-nuclear_receptor_changes_ppara,/work/eval_papers/PMID_32206109.pdf,abstract,SPECIES,mice,1512,1516,Methods: Alcoholic steatosis was induced in mice by chronic-plus-binge ethanol feeding.
novel_nf_kb_inducing_kinase_(nik)-nuclear_receptor_changes_ppara,/work/eval_papers/PMID_32206109.pdf,abstract,SPECIES,ERK1/2,1956,1962,"PPARα agonists or antagonists of MEK1/2 and ERK1/2 were used to identify the NIK-induced regulation of PPARα, MEK1/2, and ERK1/2."
novel_nf_kb_inducing_kinase_(nik)-nuclear_receptor_changes_ppara,/work/eval_papers/PMID_32206109.pdf,abstract,SPECIES,mice,2206,2210,Results: Hepatocyte-specific deletion of NIK protected mice from alcoholic steatosis by sustaining hepatic fatty acid oxidation.
novel_nf_kb_inducing_kinase_(nik)-nuclear_receptor_changes_ppara,/work/eval_papers/PMID_32206109.pdf,abstract,SPECIES,mice,2875,2879,"Importantly, pharmacological intervention against NIK significantly attenuated alcoholic steatosis in ethanol-fed mice."
novel_nlrp3_inflammasome-novel_inflammation,/work/eval_papers/PMID_32687983.pdf,abstract,CHEMICAL,Medicine,686,694,"Author information: (1)Environmental Health and Disease Laboratory, Department of Environmental Health Sciences, Arnold School of Public Health, University of South Carolina, Columbia, SC, USA; Department of Family and Community Medicine, College of Medicine, Taibah University, Madinah, Saudi Arabia. (2)Environmental Health and Disease Laboratory, Department of Environmental Health Sciences, Arnold School of Public Health, University of South Carolina, Columbia, SC, USA."
novel_nlrp3_inflammasome-novel_inflammation,/work/eval_papers/PMID_32687983.pdf,abstract,CHEMICAL,Climate,959,966,"(3)NIEHS Center for Oceans and Human Health on Climate Change Interactions, Department of Environmental Health Sciences, University of South Carolina, USA."
novel_nlrp3_inflammasome-novel_inflammation,/work/eval_papers/PMID_32687983.pdf,abstract,CHEMICAL,TX 76798-7266,1133,1146,"(4)Department of Environmental Science, Baylor University, Waco, TX 76798-7266, USA."
novel_nlrp3_inflammasome-novel_inflammation,/work/eval_papers/PMID_32687983.pdf,abstract,CHEMICAL,Biology,1170,1177,"(5)Department of Biology, Chemistry, and Environmental Health Science, Benedict College, Columbia, SC, 29204, USA."
novel_nlrp3_inflammasome-novel_inflammation,/work/eval_papers/PMID_32687983.pdf,abstract,CHEMICAL,Medicine,1364,1372,"(6)Department of Pathology, Microbiology and Immunology, University of South Carolina School of Medicine, Columbia, SC, USA."
novel_nlrp3_inflammasome-novel_inflammation,/work/eval_papers/PMID_32687983.pdf,abstract,CHEMICAL,NIEHS,1567,1572,"(7)Environmental Health and Disease Laboratory, Department of Environmental Health Sciences, Arnold School of Public Health, University of South Carolina, Columbia, SC, USA; NIEHS Center for Oceans and Human Health on Climate Change Interactions, Department of Environmental Health Sciences, University of South Carolina, USA. Electronic address: schatt@mailbox.sc.edu."
novel_nlrp3_inflammasome-novel_inflammation,/work/eval_papers/PMID_32687983.pdf,abstract,CHEMICAL,Climate,1611,1618,"(7)Environmental Health and Disease Laboratory, Department of Environmental Health Sciences, Arnold School of Public Health, University of South Carolina, Columbia, SC, USA; NIEHS Center for Oceans and Human Health on Climate Change Interactions, Department of Environmental Health Sciences, University of South Carolina, USA. Electronic address: schatt@mailbox.sc.edu."
novel_nlrp3_inflammasome-novel_inflammation,/work/eval_papers/PMID_32687983.pdf,abstract,CHEMICAL,address,1731,1738,"(7)Environmental Health and Disease Laboratory, Department of Environmental Health Sciences, Arnold School of Public Health, University of South Carolina, Columbia, SC, USA; NIEHS Center for Oceans and Human Health on Climate Change Interactions, Department of Environmental Health Sciences, University of South Carolina, USA. Electronic address: schatt@mailbox.sc.edu."
novel_nlrp3_inflammasome-novel_inflammation,/work/eval_papers/PMID_32687983.pdf,abstract,CHEMICAL,potentiate,2062,2072,"The present report tests the hypothesis that early life exposure to microcystin (MC), a principal component of harmful algal blooms followed by a juvenile exposure to high-fat diet feeding potentiate the development of nonalcoholic fatty liver disease phenotype in adulthood."
novel_nlrp3_inflammasome-novel_inflammation,/work/eval_papers/PMID_32687983.pdf,abstract,CHEMICAL,INTERESTS,2936,2945,DOI: 10.1016/j.etap.2020.103457 PMCID: PMC7609636 PMID: 32687983 [Indexed for MEDLINE] Conflict of interest statement: CONFLICT OF INTERESTS: The authors declare that there is no conflict of financial or competing interests.
novel_nlrp3_inflammasome-novel_inflammation,/work/eval_papers/PMID_32687983.pdf,abstract,SPECIES,mice,165,169,Early microcystin-LR exposure-linked inflammasome activation in mice causes development of fatty liver disease and insulin resistance.
novel_nlrp3_inflammasome-novel_inflammation,/work/eval_papers/PMID_32687983.pdf,abstract,SPECIES,Columbia,611,619,"Author information: (1)Environmental Health and Disease Laboratory, Department of Environmental Health Sciences, Arnold School of Public Health, University of South Carolina, Columbia, SC, USA; Department of Family and Community Medicine, College of Medicine, Taibah University, Madinah, Saudi Arabia. (2)Environmental Health and Disease Laboratory, Department of Environmental Health Sciences, Arnold School of Public Health, University of South Carolina, Columbia, SC, USA."
novel_nlrp3_inflammasome-novel_inflammation,/work/eval_papers/PMID_32687983.pdf,abstract,SPECIES,Columbia,893,901,"Author information: (1)Environmental Health and Disease Laboratory, Department of Environmental Health Sciences, Arnold School of Public Health, University of South Carolina, Columbia, SC, USA; Department of Family and Community Medicine, College of Medicine, Taibah University, Madinah, Saudi Arabia. (2)Environmental Health and Disease Laboratory, Department of Environmental Health Sciences, Arnold School of Public Health, University of South Carolina, Columbia, SC, USA."
novel_nlrp3_inflammasome-novel_inflammation,/work/eval_papers/PMID_32687983.pdf,abstract,SPECIES,Human Health,943,955,"(3)NIEHS Center for Oceans and Human Health on Climate Change Interactions, Department of Environmental Health Sciences, University of South Carolina, USA."
novel_nlrp3_inflammasome-novel_inflammation,/work/eval_papers/PMID_32687983.pdf,abstract,SPECIES,USA,1063,1066,"(3)NIEHS Center for Oceans and Human Health on Climate Change Interactions, Department of Environmental Health Sciences, University of South Carolina, USA."
novel_nlrp3_inflammasome-novel_inflammation,/work/eval_papers/PMID_32687983.pdf,abstract,SPECIES,Columbia,1242,1250,"(5)Department of Biology, Chemistry, and Environmental Health Science, Benedict College, Columbia, SC, 29204, USA."
novel_nlrp3_inflammasome-novel_inflammation,/work/eval_papers/PMID_32687983.pdf,abstract,SPECIES,Columbia,1374,1382,"(6)Department of Pathology, Microbiology and Immunology, University of South Carolina School of Medicine, Columbia, SC, USA."
novel_nlrp3_inflammasome-novel_inflammation,/work/eval_papers/PMID_32687983.pdf,abstract,SPECIES,Columbia,1548,1556,"(7)Environmental Health and Disease Laboratory, Department of Environmental Health Sciences, Arnold School of Public Health, University of South Carolina, Columbia, SC, USA; NIEHS Center for Oceans and Human Health on Climate Change Interactions, Department of Environmental Health Sciences, University of South Carolina, USA. Electronic address: schatt@mailbox.sc.edu."
novel_nlrp3_inflammasome-novel_inflammation,/work/eval_papers/PMID_32687983.pdf,abstract,SPECIES,USA,1562,1565,"(7)Environmental Health and Disease Laboratory, Department of Environmental Health Sciences, Arnold School of Public Health, University of South Carolina, Columbia, SC, USA; NIEHS Center for Oceans and Human Health on Climate Change Interactions, Department of Environmental Health Sciences, University of South Carolina, USA. Electronic address: schatt@mailbox.sc.edu."
novel_nlrp3_inflammasome-novel_inflammation,/work/eval_papers/PMID_32687983.pdf,abstract,SPECIES,Human Health,1595,1607,"(7)Environmental Health and Disease Laboratory, Department of Environmental Health Sciences, Arnold School of Public Health, University of South Carolina, Columbia, SC, USA; NIEHS Center for Oceans and Human Health on Climate Change Interactions, Department of Environmental Health Sciences, University of South Carolina, USA. Electronic address: schatt@mailbox.sc.edu."
novel_nlrp3_inflammasome-novel_inflammation,/work/eval_papers/PMID_32687983.pdf,abstract,SPECIES,USA,1715,1718,"(7)Environmental Health and Disease Laboratory, Department of Environmental Health Sciences, Arnold School of Public Health, University of South Carolina, Columbia, SC, USA; NIEHS Center for Oceans and Human Health on Climate Change Interactions, Department of Environmental Health Sciences, University of South Carolina, USA. Electronic address: schatt@mailbox.sc.edu."
novel_nlrp3_inflammasome-novel_inflammation,/work/eval_papers/PMID_32687983.pdf,abstract,SPECIES,children,1817,1825,Evidence from pediatric studies show that infants and children are at risk for early exposure to microcystin.
novel_oxidative_stress-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_31151157.pdf,abstract,CHEMICAL,silymarin,1585,1594,"Rats in the TAA-treated group received either a chow diet (Control group) or a chow diet containing MS (TMS group, 2.05%) or silymarin (TSM group, 0.05%)."
novel_oxidative_stress-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_31151157.pdf,abstract,CHEMICAL,TSM,1596,1599,"Rats in the TAA-treated group received either a chow diet (Control group) or a chow diet containing MS (TMS group, 2.05%) or silymarin (TSM group, 0.05%)."
novel_oxidative_stress-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_31151157.pdf,abstract,CHEMICAL,levels,1850,1856,"Hepatic protein expression levels of fatty acid synthase, SREBP-1, 3-hydroxy-3-methylglutaryl-coenzyme A reductase, and SREBP-2 were significantly downregulated in the TMS group, whereas carnitine palmitoyltransferase 1 levels were upregulated (p < 0.05)."
novel_oxidative_stress-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_31151157.pdf,abstract,CHEMICAL,levels,2043,2049,"Hepatic protein expression levels of fatty acid synthase, SREBP-1, 3-hydroxy-3-methylglutaryl-coenzyme A reductase, and SREBP-2 were significantly downregulated in the TMS group, whereas carnitine palmitoyltransferase 1 levels were upregulated (p < 0.05)."
novel_oxidative_stress-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_31151157.pdf,abstract,CHEMICAL,levels,2127,2133,"Hepatic thiobarbituric acid reactive substances levels were lower in the TMS group, whereas protein levels of glutathione peroxidase and catalase were elevated (p < 0.05)."
novel_oxidative_stress-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_31151157.pdf,abstract,CHEMICAL,levels,2179,2185,"Hepatic thiobarbituric acid reactive substances levels were lower in the TMS group, whereas protein levels of glutathione peroxidase and catalase were elevated (p < 0.05)."
novel_oxidative_stress-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_31151157.pdf,abstract,CHEMICAL,glutathione,2189,2200,"Hepatic thiobarbituric acid reactive substances levels were lower in the TMS group, whereas protein levels of glutathione peroxidase and catalase were elevated (p < 0.05)."
novel_oxidative_stress-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_31151157.pdf,abstract,CHEMICAL,silymarin,2297,2306,The effects of MS were comparable to those of silymarin.
novel_oxidative_stress-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_31151157.pdf,abstract,CHEMICAL,Our,2308,2311,"Our results evidently showed that MS inhibits hepatic lipid accumulation by suppressing lipid synthesis, accompanied by lipid oxidation and elevation of antioxidative status."
novel_oxidative_stress-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_31151157.pdf,abstract,SPECIES,Rats,200,204,Magma Seawater Inhibits Hepatic Lipid Accumulation through Suppression of Lipogenic Enzymes Regulated by SREBPs in Thioacetamide-Injected Rats.
novel_oxidative_stress-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_31151157.pdf,abstract,SPECIES,rats,1785,1789,Rats in the TMS group showed significantly lower hepatic lipid concentrations than rats in the control group (p < 0.05).
novel_oxidative_stress-novel_inflammation,/work/eval_papers/PMID_33302084.pdf,abstract,CHEMICAL,Liu,195,198,"Liu J(1), Dong C(2), Zhai Z(3), Tang L(1), Wang L(4)."
novel_oxidative_stress-novel_inflammation,/work/eval_papers/PMID_33302084.pdf,abstract,CHEMICAL,Key,443,446,"Author information: (1)College of Animal Science and Veterinary Medicine, Shandong Agricultural University, 61 Daizong Street, Tai'an City, Shandong Province, 271018, China; Shandong Provincial Key Laboratory of Animal Biotechnology and Disease Control and Prevention, Shandong Agricultural University, 61 Daizong Street, Tai'an City, Shandong Province, 271018, China; Shandong Provincial Engineering Technology Research Center of Animal Disease Control and Prevention, Shandong Agricultural University, 61 Daizong Street, Tai'an City, Shandong Province, 271018, China."
novel_oxidative_stress-novel_inflammation,/work/eval_papers/PMID_33302084.pdf,abstract,CHEMICAL,Key,1235,1238,"(4)College of Animal Science and Veterinary Medicine, Shandong Agricultural University, 61 Daizong Street, Tai'an City, Shandong Province, 271018, China; Shandong Provincial Key Laboratory of Animal Biotechnology and Disease Control and Prevention, Shandong Agricultural University, 61 Daizong Street, Tai'an City, Shandong Province, 271018, China; Shandong Provincial Engineering Technology Research Center of Animal Disease Control and Prevention, Shandong Agricultural University, 61 Daizong Street, Tai'an City, Shandong Province, 271018, China."
novel_oxidative_stress-novel_inflammation,/work/eval_papers/PMID_33302084.pdf,abstract,CHEMICAL,address,1622,1629,Electronic address: wanglin2013@sdau.edu.cn.
novel_oxidative_stress-novel_inflammation,/work/eval_papers/PMID_33302084.pdf,abstract,CHEMICAL,glyphosate,1668,1678,"Residues of glyphosate (GLY) are widely detected in aquatic systems, raising potential environmental threats and public health concerns, but the mechanism underlying GLY-induced hepatotoxicity in fish has not been fully elucidated yet."
novel_oxidative_stress-novel_jnk_pathway,/work/eval_papers/PMID_33900847.pdf,abstract,CHEMICAL,Liu,229,232,"Xie D(1), Zhao H(1), Lu J(1), He F(1), Liu W(1), Yu W(1), Wang Q(1), Hisatome I(2), Yamamoto T(3), Koyama H(3), Cheng J(1)(3)."
novel_oxidative_stress-novel_jnk_pathway,/work/eval_papers/PMID_33900847.pdf,abstract,CHEMICAL,Medicine,452,460,"(2)Division of Regenerative Medicine and Therapeutics, Institute of Regenerative Medicine and Biofunction, Graduate School of Medical Sciences, Tottori University, Yonago, Japan."
novel_oxidative_stress-novel_jnk_pathway,/work/eval_papers/PMID_33900847.pdf,abstract,CHEMICAL,Medicine,505,513,"(2)Division of Regenerative Medicine and Therapeutics, Institute of Regenerative Medicine and Biofunction, Graduate School of Medical Sciences, Tottori University, Yonago, Japan."
novel_oxidative_stress-novel_jnk_pathway,/work/eval_papers/PMID_33900847.pdf,abstract,CHEMICAL,Medicine,686,694,"(3)Department of Diabetes, Endocrinology and Clinical Immunology, Hyogo College of Medicine, Nishinomiya, Japan."
novel_oxidative_stress-novel_jnk_pathway,/work/eval_papers/PMID_33900847.pdf,abstract,CHEMICAL,urate,1019,1024,"In this study, we established a urate oxidase-knockout (Uox-KO) mouse model by clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9 technology."
novel_oxidative_stress-novel_jnk_pathway,/work/eval_papers/PMID_33900847.pdf,abstract,CHEMICAL,medium,1249,1255,"To study the correlation between HUA and NAFLD, human HepG2 hepatoma cells were treated in culture medium with high level of uric acid."
novel_oxidative_stress-novel_jnk_pathway,/work/eval_papers/PMID_33900847.pdf,abstract,CHEMICAL,ROS/JNK/AP-1,2119,2131,These data suggest that ROS/JNK/AP-1 signaling plays an important role in HUA-mediated fat accumulation in liver.
novel_oxidative_stress-novel_jnk_pathway,/work/eval_papers/PMID_33900847.pdf,abstract,SPECIES,repeats,1116,1123,"In this study, we established a urate oxidase-knockout (Uox-KO) mouse model by clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9 technology."
novel_oxidative_stress-novel_jnk_pathway,/work/eval_papers/PMID_33900847.pdf,abstract,SPECIES,human HepG2 hepatoma cells,1198,1224,"To study the correlation between HUA and NAFLD, human HepG2 hepatoma cells were treated in culture medium with high level of uric acid."
novel_oxidative_stress-novel_jnk_pathway,/work/eval_papers/PMID_33900847.pdf,abstract,SPECIES,SP600125,1566,1574,"Furthermore, inhibiting JNK activation by a JNK-specific inhibitor, SP600125, decreased fat accumulation and lipogenic gene expression induced by HUA."
novel_oxidative_stress-novel_jnk_pathway,/work/eval_papers/PMID_33900847.pdf,abstract,SPECIES,AP-1,1828,1832,HUA activated AP-1 to upregulate lipogenic gene expression via JNK activation.
novel_oxidative_stress-protein_kinase_changes_akt,/work/eval_papers/PMID_28987868.pdf,abstract,CHEMICAL,Akt activity,102,114,Impairment of Akt activity by CYP2E1 mediated oxidative stress is involved in chronic ethanol-induced fatty liver.
novel_oxidative_stress-protein_kinase_changes_akt,/work/eval_papers/PMID_28987868.pdf,abstract,CHEMICAL,N(2,232,235,"Zeng T(1), Zhang CL(2), Zhao N(2), Guan MJ(2), Xiao M(2), Yang R(2), Zhao XL(2), Yu LH(2), Zhu ZP(2), Xie KQ(3)."
novel_oxidative_stress-protein_kinase_changes_akt,/work/eval_papers/PMID_28987868.pdf,abstract,CHEMICAL,Zhu,294,297,"Zeng T(1), Zhang CL(2), Zhao N(2), Guan MJ(2), Xiao M(2), Yang R(2), Zhao XL(2), Yu LH(2), Zhu ZP(2), Xie KQ(3)."
novel_oxidative_stress-protein_kinase_changes_akt,/work/eval_papers/PMID_28987868.pdf,abstract,CHEMICAL,address,428,435,"Author information: (1)Institute of Toxicology, School of Public Health, Shandong University, China. Electronic address: zengtao@sdu.edu.cn."
novel_oxidative_stress-protein_kinase_changes_akt,/work/eval_papers/PMID_28987868.pdf,abstract,CHEMICAL,address,630,637,Electronic address: keqinx@sdu.edu.cn.
novel_oxidative_stress-protein_kinase_changes_akt,/work/eval_papers/PMID_28987868.pdf,abstract,CHEMICAL,Akt activity,765,777,"Protein kinase B (PKB/Akt) plays important roles in the regulation of lipid homeostasis, and impairment of Akt activity has been demonstrated to be involved in the development of non-alcoholic fatty liver disease (NAFLD)."
novel_oxidative_stress-protein_kinase_changes_akt,/work/eval_papers/PMID_28987868.pdf,abstract,CHEMICAL,Akt activity,1030,1042,We hypothesized that Akt activity might be impaired due to CYP2E1-induced oxidative stress in chronic ethanol-induced hepatic steatosis.
novel_oxidative_stress-protein_kinase_changes_akt,/work/eval_papers/PMID_28987868.pdf,abstract,CHEMICAL,Akt,1265,1268,"In this study, we found that chronic ethanol-induced hepatic steatosis was accompanied with reduced phosphorylation of Akt at Thr308 in mice liver."
novel_oxidative_stress-protein_kinase_changes_akt,/work/eval_papers/PMID_28987868.pdf,abstract,CHEMICAL,ethanol,1302,1309,"Chronic ethanol exposure had no effects on the protein levels of phosphatidylinositol 3 kinase (PI3K) and phosphatase and tensin homologue deleted on chromosome ten (PTEN), and led to a slight decrease of phosphoinositide-dependent protein kinase 1 (PDK-1) protein level."
novel_oxidative_stress-protein_kinase_changes_akt,/work/eval_papers/PMID_28987868.pdf,abstract,CHEMICAL,levels,1349,1355,"Chronic ethanol exposure had no effects on the protein levels of phosphatidylinositol 3 kinase (PI3K) and phosphatase and tensin homologue deleted on chromosome ten (PTEN), and led to a slight decrease of phosphoinositide-dependent protein kinase 1 (PDK-1) protein level."
novel_oxidative_stress-protein_kinase_changes_akt,/work/eval_papers/PMID_28987868.pdf,abstract,CHEMICAL,phosphatidylinositol 3 kinase,1359,1388,"Chronic ethanol exposure had no effects on the protein levels of phosphatidylinositol 3 kinase (PI3K) and phosphatase and tensin homologue deleted on chromosome ten (PTEN), and led to a slight decrease of phosphoinositide-dependent protein kinase 1 (PDK-1) protein level."
novel_oxidative_stress-protein_kinase_changes_akt,/work/eval_papers/PMID_28987868.pdf,abstract,CHEMICAL,tensin,1416,1422,"Chronic ethanol exposure had no effects on the protein levels of phosphatidylinositol 3 kinase (PI3K) and phosphatase and tensin homologue deleted on chromosome ten (PTEN), and led to a slight decrease of phosphoinositide-dependent protein kinase 1 (PDK-1) protein level."
novel_oxidative_stress-protein_kinase_changes_akt,/work/eval_papers/PMID_28987868.pdf,abstract,CHEMICAL,levels,1605,1611,"Ethanol exposure resulted in increased levels of malondialdehyde (MDA) and 4-hydroxynonenal (4-HNE)-Akt adducts, which was significantly inhibited by chlormethiazole (CMZ), an efficient CYP2E1 inhibitor."
novel_oxidative_stress-protein_kinase_changes_akt,/work/eval_papers/PMID_28987868.pdf,abstract,CHEMICAL,malondialdehyde,1615,1630,"Ethanol exposure resulted in increased levels of malondialdehyde (MDA) and 4-hydroxynonenal (4-HNE)-Akt adducts, which was significantly inhibited by chlormethiazole (CMZ), an efficient CYP2E1 inhibitor."
novel_oxidative_stress-protein_kinase_changes_akt,/work/eval_papers/PMID_28987868.pdf,abstract,CHEMICAL,MDA,1632,1635,"Ethanol exposure resulted in increased levels of malondialdehyde (MDA) and 4-hydroxynonenal (4-HNE)-Akt adducts, which was significantly inhibited by chlormethiazole (CMZ), an efficient CYP2E1 inhibitor."
novel_oxidative_stress-protein_kinase_changes_akt,/work/eval_papers/PMID_28987868.pdf,abstract,CHEMICAL,Akt,1904,1907,"Interestingly, N-acetyl-L-cysteine (NAC) significantly attenuated chronic ethanol-induced hepatic fat accumulation and the decline of Akt phosphorylation at Thr308."
novel_oxidative_stress-protein_kinase_changes_akt,/work/eval_papers/PMID_28987868.pdf,abstract,CHEMICAL,Akt,1960,1963,"In the in vitro studies, Akt phosphorylation was suppressed in CYP2E1-expressing HepG2 (CYP2E1-HepG2) cells compared with the negative control HepG2 (NC-HepG2) cells, and 4-HNE treatment led to significant decrease of Akt phosphorylation at Thr308 in wild type HepG2 cells."
novel_oxidative_stress-protein_kinase_changes_akt,/work/eval_papers/PMID_28987868.pdf,abstract,CHEMICAL,Akt,2153,2156,"In the in vitro studies, Akt phosphorylation was suppressed in CYP2E1-expressing HepG2 (CYP2E1-HepG2) cells compared with the negative control HepG2 (NC-HepG2) cells, and 4-HNE treatment led to significant decrease of Akt phosphorylation at Thr308 in wild type HepG2 cells."
novel_oxidative_stress-protein_kinase_changes_akt,/work/eval_papers/PMID_28987868.pdf,abstract,CHEMICAL,Akt,2247,2250,"Lastly, pharmacological activation of Akt by insulin-like growth factor-1 (IGF-1) significantly alleviated chronic ethanol-induced fatty liver in mice."
novel_oxidative_stress-protein_kinase_changes_akt,/work/eval_papers/PMID_28987868.pdf,abstract,CHEMICAL,Akt,2489,2492,"Collectively, these results indicate that CYP2E1-induced oxidative stress may be responsible for ethanol-induced suppression of Akt phosphorylation and pharmacological modulation of Akt in liver may be an effective strategy for the treatment of ethanol-induced fatty liver."
novel_oxidative_stress-protein_kinase_changes_akt,/work/eval_papers/PMID_28987868.pdf,abstract,CHEMICAL,Akt,2543,2546,"Collectively, these results indicate that CYP2E1-induced oxidative stress may be responsible for ethanol-induced suppression of Akt phosphorylation and pharmacological modulation of Akt in liver may be an effective strategy for the treatment of ethanol-induced fatty liver."
novel_oxidative_stress-protein_kinase_changes_akt,/work/eval_papers/PMID_28987868.pdf,abstract,CHEMICAL,10.1016/j.redox.2017.09.018,2718,2745,DOI: 10.1016/j.redox.2017.09.018 PMCID: PMC5633250 PMID: 28987868 [Indexed for MEDLINE]
novel_oxidative_stress-protein_kinase_changes_akt,/work/eval_papers/PMID_28987868.pdf,abstract,SPECIES,mice,1282,1286,"In this study, we found that chronic ethanol-induced hepatic steatosis was accompanied with reduced phosphorylation of Akt at Thr308 in mice liver."
novel_oxidative_stress-protein_kinase_changes_akt,/work/eval_papers/PMID_28987868.pdf,abstract,SPECIES,mice,2355,2359,"Lastly, pharmacological activation of Akt by insulin-like growth factor-1 (IGF-1) significantly alleviated chronic ethanol-induced fatty liver in mice."
novel_rab7-novel_lipophagy,/work/eval_papers/PMID_29404450.pdf,abstract,CHEMICAL,Medicine,465,473,(2)Department of Internal Medicine University of Nebraska Medical Center Omaha NE.
novel_rab7-novel_lipophagy,/work/eval_papers/PMID_29404450.pdf,abstract,CHEMICAL,address,533,540,"(3)Present address: Helmholtz Zentrum München, Institute of Biological and Medical Imaging Neuherberg Germany."
novel_rab7-novel_lipophagy,/work/eval_papers/PMID_29404450.pdf,abstract,CHEMICAL,Alcohol,708,715,Alcohol consumption is a well-established risk factor for the onset and progression of fatty liver disease.
novel_rab7-novel_lipophagy,/work/eval_papers/PMID_29404450.pdf,abstract,CHEMICAL,alcohol,1694,1701,"Here, we examine whether the steatotic effects of alcohol exposure are a result of perturbations to the Rab7-mediated lipophagic pathway."
novel_rab7-novel_lipophagy,/work/eval_papers/PMID_29404450.pdf,abstract,CHEMICAL,levels,1863,1869,Rats chronically fed an ethanol-containing diet accumulated significantly higher levels of fat in their hepatocytes.
novel_rab7-novel_lipophagy,/work/eval_papers/PMID_29404450.pdf,abstract,CHEMICAL,ethanol,2420,2427,"Conclusion: A mechanism is supported whereby ethanol exposure inhibits Rab7 activity, resulting in the impaired transport, targeting, and fusion of the autophagic machinery with LDs, leading to an accumulation of hepatocellular lipids and hepatic steatosis."
novel_sirt1-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_28449683.pdf,abstract,CHEMICAL,Medicine,376,384,"Author information: (1)Institute of Translational Medicine, Nanchang University, 999 Xuefu Load, Honggutan District, Nanchang, 330031, China."
novel_sirt1-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_28449683.pdf,abstract,CHEMICAL,Medicine,572,580,"(3)Institute of Translational Medicine, Nanchang University, 999 Xuefu Load, Honggutan District, Nanchang, 330031, China. dengk26@gmail.com."
novel_sirt1-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_28449683.pdf,abstract,CHEMICAL,Medicine,713,721,"(4)Institute of Translational Medicine, Nanchang University, 999 Xuefu Load, Honggutan District, Nanchang, 330031, China. hongboxin@yahoo.com."
novel_sirt1-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_28449683.pdf,abstract,CHEMICAL,nicotinamide adenine dinucleotide,1239,1272,Nicotinamide phosphoribosyltransferase (NAMPT) has been recently identified as an enzyme involved in nicotinamide adenine dinucleotide (NAD+) biosynthesis and plays an important role in cellular metabolism in variety of organs in mammals.
novel_sirt1-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_28449683.pdf,abstract,CHEMICAL,investigate,1406,1417,The aim of this study was to investigate the effects of NAMPT on high fat diet-induced hepatic steatosis.
novel_sirt1-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_28449683.pdf,abstract,CHEMICAL,sterol,2102,2108,"RESULTS: FK866 significantly promoted liver steatosis in the mice fed with HFD and hepatic lipid accumulation in vitro, accompanied by the increases of the expressions of lipogenic genes such as sterol regulatory element-binding protein 1 (SREBP1) and fatty acid synthase (FASN)."
novel_sirt1-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_28449683.pdf,abstract,CHEMICAL,actions of,2256,2266,Nicotinamide mononucleotide (NMN) and NAD+ significantly rescued the actions of FK866 in vitro.
novel_sirt1-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_28449683.pdf,abstract,CHEMICAL,FK866,2267,2272,Nicotinamide mononucleotide (NMN) and NAD+ significantly rescued the actions of FK866 in vitro.
novel_sirt1-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_28449683.pdf,abstract,CHEMICAL,Our,2672,2675,CONCLUSION: Our results demonstrated that inhibition of NAMPT aggravated the HFD- or oleic acid-induced hepatic steatosis through suppressing Sirt1-mediated signaling pathway.
novel_sirt1-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_28449683.pdf,abstract,SPECIES,mice,150,154,Inhibition of NAMPT aggravates high fat diet-induced hepatic steatosis in mice through regulating Sirt1/AMPKα/SREBP1 signaling pathway.
novel_sirt1-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_28449683.pdf,abstract,SPECIES,mice,1562,1566,METHODS: Hepatic steatosis model was induced by high fat diet (HFD) in C57BL/6 mice in vivo.
novel_sirt1-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_28449683.pdf,abstract,SPECIES,mice,1968,1972,"RESULTS: FK866 significantly promoted liver steatosis in the mice fed with HFD and hepatic lipid accumulation in vitro, accompanied by the increases of the expressions of lipogenic genes such as sterol regulatory element-binding protein 1 (SREBP1) and fatty acid synthase (FASN)."
novel_sirt1-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_28449683.pdf,abstract,SPECIES,FK866,2267,2272,Nicotinamide mononucleotide (NMN) and NAD+ significantly rescued the actions of FK866 in vitro.
novel_sirt1-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_28449683.pdf,abstract,SPECIES,mice,2491,2495,"In addition, FK866 decreased the protein levels of Sirt1 and phospho-AMPKα in liver of the HFD fed mice."
novel_sirt1-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_26890260.pdf,abstract,CHEMICAL,Glucose,173,180,SIRT1 Disruption in Human Fetal Hepatocytes Leads to Increased Accumulation of Glucose and Lipids.
novel_sirt1-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_26890260.pdf,abstract,CHEMICAL,CX(3,281,285,"Tobita T(1), Guzman-Lepe J(1), Takeishi K(1), Nakao T(1), Wang Y(1)(2), Meng F(1), Deng CX(3), Collin de l'Hortet A(1), Soto-Gutierrez A(1)(4)(5)."
novel_sirt1-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_26890260.pdf,abstract,CHEMICAL,Medicine,814,822,"(4)Thomas E Starzl Transplant Institute, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America. (5)McGowan Institute for Regenerative Medicine; Pittsburgh, Pennsylvania, United States of America."
novel_sirt1-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_26890260.pdf,abstract,CHEMICAL,PMID: 26890260,1956,1970,DOI: 10.1371/journal.pone.0149344 PMCID: PMC4758736 PMID: 26890260 [Indexed for MEDLINE] Conflict of interest statement: Competing Interests: The authors declare no competing interest.
novel_sirt1-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_26890260.pdf,abstract,SPECIES,Human,114,119,SIRT1 Disruption in Human Fetal Hepatocytes Leads to Increased Accumulation of Glucose and Lipids.
novel_sirt1-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_26890260.pdf,abstract,SPECIES,Pittsburgh,414,424,"Author information: (1)Department of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America."
novel_sirt1-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_26890260.pdf,abstract,SPECIES,People,524,530,"(2)Department of Hepatobiliary Surgery, Peking University People's Hospital, Beijing, China."
novel_sirt1-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_26890260.pdf,abstract,SPECIES,Taipa,636,641,"(3)Faculty of Health Sciences, University of Macau, Avenida da Universidade, Taipa, Macau, China."
novel_sirt1-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_26890260.pdf,abstract,SPECIES,Pittsburgh,724,734,"(4)Thomas E Starzl Transplant Institute, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America. (5)McGowan Institute for Regenerative Medicine; Pittsburgh, Pennsylvania, United States of America."
novel_sirt1-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_26890260.pdf,abstract,SPECIES,children,1054,1062,A concerning percentage of American children are being affected by obesity and NAFLD.
novel_sirt1-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_26890260.pdf,abstract,SPECIES,human fetal hepatocytes rapidly,1300,1331,"In this study, we documented that inhibiting SIRT1 signaling in human fetal hepatocytes rapidly led to an increase in intracellular glucose and lipids levels."
novel_sirt1-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_26890260.pdf,abstract,SPECIES,human,1603,1608,"The AKT/FOXO1 pathway, a major negative regulator of gluconeogenesis, was decreased in the human fetal hepatocytes inhibited for SIRT1, consistent with the higher level of gluconeogenesis."
novel_sirt1-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_26890260.pdf,abstract,SPECIES,human,1806,1811,"These results indicate that SIRT1 is an important regulator of lipid and carbohydrate metabolisms within human fetal hepatocytes, acting as an adaptive transcriptional response to environmental changes."
novel_sirt1-protein_kinase_changes_novel_mtorc1,/work/eval_papers/PMID_29457836.pdf,abstract,CHEMICAL,Fan,420,423,"Chen H(1)(2), Shen F(1)(2)(3), Sherban A(4), Nocon A(4), Li Y(4)(5), Wang H(6), Xu MJ(6), Rui X(4), Han J(4), Jiang B(4), Lee D(1)(2), Li N(1)(2)(7), Keyhani-Nejad F(1)(2), Fan JG(3), Liu F(2), Kamat A(8), Musi N(2)(8), Guarente L(9), Pacher P(6), Gao B(6), Zang M(1)(2)(8)."
novel_sirt1-protein_kinase_changes_novel_mtorc1,/work/eval_papers/PMID_29457836.pdf,abstract,CHEMICAL,Liu,431,434,"Chen H(1)(2), Shen F(1)(2)(3), Sherban A(4), Nocon A(4), Li Y(4)(5), Wang H(6), Xu MJ(6), Rui X(4), Han J(4), Jiang B(4), Lee D(1)(2), Li N(1)(2)(7), Keyhani-Nejad F(1)(2), Fan JG(3), Liu F(2), Kamat A(8), Musi N(2)(8), Guarente L(9), Pacher P(6), Gao B(6), Zang M(1)(2)(8)."
novel_sirt1-protein_kinase_changes_novel_mtorc1,/work/eval_papers/PMID_29457836.pdf,abstract,CHEMICAL,Medicine,569,577,"Author information: (1)Department of Molecular Medicine, University of Texas Health San Antonio, San Antonio, TX."
novel_sirt1-protein_kinase_changes_novel_mtorc1,/work/eval_papers/PMID_29457836.pdf,abstract,CHEMICAL,Medicine,847,855,"(3)Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China."
novel_sirt1-protein_kinase_changes_novel_mtorc1,/work/eval_papers/PMID_29457836.pdf,abstract,CHEMICAL,Medicine,905,913,"(4)Boston University School of Medicine, Boston, MA."
novel_sirt1-protein_kinase_changes_novel_mtorc1,/work/eval_papers/PMID_29457836.pdf,abstract,CHEMICAL,Alcohol Abuse,1135,1148,"(6)Laboratory of Liver Diseases, Laboratory of Cardiovascular Physiology and Tissue Injury, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD."
novel_sirt1-protein_kinase_changes_novel_mtorc1,/work/eval_papers/PMID_29457836.pdf,abstract,CHEMICAL,Alcoholism,1153,1163,"(6)Laboratory of Liver Diseases, Laboratory of Cardiovascular Physiology and Tissue Injury, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD."
novel_sirt1-protein_kinase_changes_novel_mtorc1,/work/eval_papers/PMID_29457836.pdf,abstract,CHEMICAL,Medicine,1280,1288,"(7)Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. (8)Geriatric Research, Education and Clinical Center, South Texas Veterans Health Care System, San Antonio, TX."
novel_sirt1-protein_kinase_changes_novel_mtorc1,/work/eval_papers/PMID_29457836.pdf,abstract,CHEMICAL,Biology,1436,1443,"(9)Department of Biology, Paul F. Glenn Laboratory, Massachusetts Institute of Technology, Cambridge, MA."
novel_sirt1-protein_kinase_changes_novel_mtorc1,/work/eval_papers/PMID_29457836.pdf,abstract,CHEMICAL,alcohol,1633,1640,"However, how chronic alcohol consumption causes hepatic lipid accumulation remains elusive."
novel_sirt1-protein_kinase_changes_novel_mtorc1,/work/eval_papers/PMID_29457836.pdf,abstract,CHEMICAL,rapamycin,1780,1789,"The present study demonstrates that activation of the mechanistic target of rapamycin complex 1 (mTORC1) plays a causal role in alcoholic steatosis, inflammation, and liver injury."
novel_sirt1-protein_kinase_changes_novel_mtorc1,/work/eval_papers/PMID_29457836.pdf,abstract,CHEMICAL,rapamycin,3035,3044,"Pharmacological intervention with rapamycin alleviated the ability of alcohol to up-regulate lipogenesis, to down-regulate fatty acid oxidation, and to induce steatogenic phenotypes."
novel_sirt1-protein_kinase_changes_novel_mtorc1,/work/eval_papers/PMID_29457836.pdf,abstract,CHEMICAL,alcohol,3071,3078,"Pharmacological intervention with rapamycin alleviated the ability of alcohol to up-regulate lipogenesis, to down-regulate fatty acid oxidation, and to induce steatogenic phenotypes."
novel_sirt1-protein_kinase_changes_novel_mtorc1,/work/eval_papers/PMID_29457836.pdf,abstract,CHEMICAL,up-regulate,3082,3093,"Pharmacological intervention with rapamycin alleviated the ability of alcohol to up-regulate lipogenesis, to down-regulate fatty acid oxidation, and to induce steatogenic phenotypes."
novel_sirt1-protein_kinase_changes_novel_mtorc1,/work/eval_papers/PMID_29457836.pdf,abstract,CHEMICAL,down-regulate,3110,3123,"Pharmacological intervention with rapamycin alleviated the ability of alcohol to up-regulate lipogenesis, to down-regulate fatty acid oxidation, and to induce steatogenic phenotypes."
novel_sirt1-protein_kinase_changes_novel_mtorc1,/work/eval_papers/PMID_29457836.pdf,abstract,CHEMICAL,ALD,3721,3724,CONCLUSION: The dysregulation of SIRT1-DEPTOR-mTORC1 signaling is a critical determinant of ALD pathology; targeting SIRT1 and DEPTOR and selectively inhibiting mTORC1-S6K1 signaling may have therapeutic potential for treating ALD in humans.
novel_sirt1-protein_kinase_changes_novel_mtorc1,/work/eval_papers/PMID_29457836.pdf,abstract,SPECIES,Cardiovascular,1068,1082,"(6)Laboratory of Liver Diseases, Laboratory of Cardiovascular Physiology and Tissue Injury, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD."
novel_sirt1-protein_kinase_changes_novel_mtorc1,/work/eval_papers/PMID_29457836.pdf,abstract,SPECIES,mice,2324,2328,Aberrant activation of mTORC1 was likely attributed to the defects of the DEP domain-containing mTOR-interacting protein (DEPTOR) and the nicotinamide adenine dinucleotide-dependent deacetylase sirtuin 1 (SIRT1) in the liver of chronic-plus-binge ethanol-fed mice and in the liver of patients with ALD.
novel_sirt1-protein_kinase_changes_novel_mtorc1,/work/eval_papers/PMID_29457836.pdf,abstract,SPECIES,patients,2349,2357,Aberrant activation of mTORC1 was likely attributed to the defects of the DEP domain-containing mTOR-interacting protein (DEPTOR) and the nicotinamide adenine dinucleotide-dependent deacetylase sirtuin 1 (SIRT1) in the liver of chronic-plus-binge ethanol-fed mice and in the liver of patients with ALD.
novel_sirt1-protein_kinase_changes_novel_mtorc1,/work/eval_papers/PMID_29457836.pdf,abstract,SPECIES,mice,3488,3492,"Furthermore, hepatocyte-specific deletion of SIRT1 disrupted DEPTOR function, enhanced mTORC1 activity, and exacerbated alcoholic fatty liver, inflammation, and liver injury in mice."
novel_sirt1-protein_kinase_changes_novel_mtorc1,/work/eval_papers/PMID_29457836.pdf,abstract,SPECIES,humans,3728,3734,CONCLUSION: The dysregulation of SIRT1-DEPTOR-mTORC1 signaling is a critical determinant of ALD pathology; targeting SIRT1 and DEPTOR and selectively inhibiting mTORC1-S6K1 signaling may have therapeutic potential for treating ALD in humans.
novel_tg_hydrolysis-liver_triglyceride_accumulation,/work/eval_papers/PMID_34206460.pdf,abstract,CHEMICAL,Clozapine,70,79,"Clozapine Worsens Glucose Intolerance, Nonalcoholic Fatty Liver Disease, Kidney Damage, and Retinal Injury and Increases Renal Reactive Oxygen Species Production and Chromium Loss in Obese Mice. Chang GR(1), Liu HY(2), Yang WC(3), Wang CM(1), Wu CF(1), Lin JW(2), Lin WL(2)(4), Wang YC(5)(6)(7)(8), Lin TC(1), Liao HJ(1), Hou PH(9)(10), Chan CH(11), Lin CF(12)."
novel_tg_hydrolysis-liver_triglyceride_accumulation,/work/eval_papers/PMID_34206460.pdf,abstract,CHEMICAL,Glucose,88,95,"Clozapine Worsens Glucose Intolerance, Nonalcoholic Fatty Liver Disease, Kidney Damage, and Retinal Injury and Increases Renal Reactive Oxygen Species Production and Chromium Loss in Obese Mice. Chang GR(1), Liu HY(2), Yang WC(3), Wang CM(1), Wu CF(1), Lin JW(2), Lin WL(2)(4), Wang YC(5)(6)(7)(8), Lin TC(1), Liao HJ(1), Hou PH(9)(10), Chan CH(11), Lin CF(12)."
novel_tg_hydrolysis-liver_triglyceride_accumulation,/work/eval_papers/PMID_34206460.pdf,abstract,CHEMICAL,Liu,278,281,"Clozapine Worsens Glucose Intolerance, Nonalcoholic Fatty Liver Disease, Kidney Damage, and Retinal Injury and Increases Renal Reactive Oxygen Species Production and Chromium Loss in Obese Mice. Chang GR(1), Liu HY(2), Yang WC(3), Wang CM(1), Wu CF(1), Lin JW(2), Lin WL(2)(4), Wang YC(5)(6)(7)(8), Lin TC(1), Liao HJ(1), Hou PH(9)(10), Chan CH(11), Lin CF(12)."
novel_tg_hydrolysis-liver_triglyceride_accumulation,/work/eval_papers/PMID_34206460.pdf,abstract,CHEMICAL,Lin,323,326,"Clozapine Worsens Glucose Intolerance, Nonalcoholic Fatty Liver Disease, Kidney Damage, and Retinal Injury and Increases Renal Reactive Oxygen Species Production and Chromium Loss in Obese Mice. Chang GR(1), Liu HY(2), Yang WC(3), Wang CM(1), Wu CF(1), Lin JW(2), Lin WL(2)(4), Wang YC(5)(6)(7)(8), Lin TC(1), Liao HJ(1), Hou PH(9)(10), Chan CH(11), Lin CF(12)."
novel_tg_hydrolysis-liver_triglyceride_accumulation,/work/eval_papers/PMID_34206460.pdf,abstract,CHEMICAL,Lioufeng,1127,1135,"(6)Department of Medical Laboratory Science and Biotechnology, Asia University, 500 Lioufeng Road, Wufeng District, Taichung 413305, Taiwan. (7)Division of Cardiovascular Medicine, China Medical University Hospital, 2 Yude Road, North District, Taichung 404332, Taiwan. (8)College of Medicine, China Medical University, 91 Hsueh-Shih Road, North District, Taichung 404333, Taiwan. (9)Department of Psychiatry, Taichung Veterans General Hospital, 4 Section, 1650 Taiwan Boulevard, Taichung 407219, Taiwan."
novel_tg_hydrolysis-liver_triglyceride_accumulation,/work/eval_papers/PMID_34206460.pdf,abstract,CHEMICAL,Medicine,1214,1222,"(6)Department of Medical Laboratory Science and Biotechnology, Asia University, 500 Lioufeng Road, Wufeng District, Taichung 413305, Taiwan. (7)Division of Cardiovascular Medicine, China Medical University Hospital, 2 Yude Road, North District, Taichung 404332, Taiwan. (8)College of Medicine, China Medical University, 91 Hsueh-Shih Road, North District, Taichung 404333, Taiwan. (9)Department of Psychiatry, Taichung Veterans General Hospital, 4 Section, 1650 Taiwan Boulevard, Taichung 407219, Taiwan."
novel_tg_hydrolysis-liver_triglyceride_accumulation,/work/eval_papers/PMID_34206460.pdf,abstract,CHEMICAL,Medicine,1327,1335,"(6)Department of Medical Laboratory Science and Biotechnology, Asia University, 500 Lioufeng Road, Wufeng District, Taichung 413305, Taiwan. (7)Division of Cardiovascular Medicine, China Medical University Hospital, 2 Yude Road, North District, Taichung 404332, Taiwan. (8)College of Medicine, China Medical University, 91 Hsueh-Shih Road, North District, Taichung 404333, Taiwan. (9)Department of Psychiatry, Taichung Veterans General Hospital, 4 Section, 1650 Taiwan Boulevard, Taichung 407219, Taiwan."
novel_tg_hydrolysis-liver_triglyceride_accumulation,/work/eval_papers/PMID_34206460.pdf,abstract,CHEMICAL,Medicine,1563,1571,"(10)Faculty of Medicine, National Yang Ming Chiao Tung University, 2 Section, 155 Linong Street, Beitou District, Taipei 112304, Taiwan."
novel_tg_hydrolysis-liver_triglyceride_accumulation,/work/eval_papers/PMID_34206460.pdf,abstract,CHEMICAL,Clozapine,1985,1994,Clozapine is widely employed in the treatment of schizophrenia.
novel_tg_hydrolysis-liver_triglyceride_accumulation,/work/eval_papers/PMID_34206460.pdf,abstract,CHEMICAL,clozapine have,2163,2177,"Compared with that of atypical first-generation antipsychotics, atypical second-generation antipsychotics such as clozapine have less severe side effects and may positively affect obesity and blood glucose level."
novel_tg_hydrolysis-liver_triglyceride_accumulation,/work/eval_papers/PMID_34206460.pdf,abstract,CHEMICAL,clozapine's adverse metabolic effects-such,2294,2336,"However, no systematic study of clozapine's adverse metabolic effects-such as changes in kidney and liver function, body weight, glucose and triglyceride levels, and retinopathy-was conducted."
novel_tg_hydrolysis-liver_triglyceride_accumulation,/work/eval_papers/PMID_34206460.pdf,abstract,CHEMICAL,glucose,2391,2398,"However, no systematic study of clozapine's adverse metabolic effects-such as changes in kidney and liver function, body weight, glucose and triglyceride levels, and retinopathy-was conducted."
novel_tg_hydrolysis-liver_triglyceride_accumulation,/work/eval_papers/PMID_34206460.pdf,abstract,CHEMICAL,clozapine,2486,2495,"This research investigated how clozapine affects weight, the bodily distribution of chromium, liver damage, fatty liver scores, glucose homeostasis, renal impairment, and retinopathy in mice fed a high fat diet (HFD)."
novel_tg_hydrolysis-liver_triglyceride_accumulation,/work/eval_papers/PMID_34206460.pdf,abstract,CHEMICAL,chromium,2539,2547,"This research investigated how clozapine affects weight, the bodily distribution of chromium, liver damage, fatty liver scores, glucose homeostasis, renal impairment, and retinopathy in mice fed a high fat diet (HFD)."
novel_tg_hydrolysis-liver_triglyceride_accumulation,/work/eval_papers/PMID_34206460.pdf,abstract,CHEMICAL,clozapine,2716,2725,"We discovered that obese mice treated with clozapine gained more weight and had greater kidney, liver, and retroperitoneal and epididymal fat pad masses; higher daily food efficiency; higher serum or hepatic triglyceride, aspartate aminotransferase, alanine aminotransferase, blood urea nitrogen, and creatinine levels; and higher hepatic lipid regulation marker expression than did the HFD-fed control mice."
novel_tg_hydrolysis-liver_triglyceride_accumulation,/work/eval_papers/PMID_34206460.pdf,abstract,CHEMICAL,aspartate,2895,2904,"We discovered that obese mice treated with clozapine gained more weight and had greater kidney, liver, and retroperitoneal and epididymal fat pad masses; higher daily food efficiency; higher serum or hepatic triglyceride, aspartate aminotransferase, alanine aminotransferase, blood urea nitrogen, and creatinine levels; and higher hepatic lipid regulation marker expression than did the HFD-fed control mice."
novel_tg_hydrolysis-liver_triglyceride_accumulation,/work/eval_papers/PMID_34206460.pdf,abstract,CHEMICAL,alanine,2923,2930,"We discovered that obese mice treated with clozapine gained more weight and had greater kidney, liver, and retroperitoneal and epididymal fat pad masses; higher daily food efficiency; higher serum or hepatic triglyceride, aspartate aminotransferase, alanine aminotransferase, blood urea nitrogen, and creatinine levels; and higher hepatic lipid regulation marker expression than did the HFD-fed control mice."
novel_tg_hydrolysis-liver_triglyceride_accumulation,/work/eval_papers/PMID_34206460.pdf,abstract,CHEMICAL,blood urea nitrogen,2949,2968,"We discovered that obese mice treated with clozapine gained more weight and had greater kidney, liver, and retroperitoneal and epididymal fat pad masses; higher daily food efficiency; higher serum or hepatic triglyceride, aspartate aminotransferase, alanine aminotransferase, blood urea nitrogen, and creatinine levels; and higher hepatic lipid regulation marker expression than did the HFD-fed control mice."
novel_tg_hydrolysis-liver_triglyceride_accumulation,/work/eval_papers/PMID_34206460.pdf,abstract,CHEMICAL,creatinine,2974,2984,"We discovered that obese mice treated with clozapine gained more weight and had greater kidney, liver, and retroperitoneal and epididymal fat pad masses; higher daily food efficiency; higher serum or hepatic triglyceride, aspartate aminotransferase, alanine aminotransferase, blood urea nitrogen, and creatinine levels; and higher hepatic lipid regulation marker expression than did the HFD-fed control mice."
novel_tg_hydrolysis-liver_triglyceride_accumulation,/work/eval_papers/PMID_34206460.pdf,abstract,CHEMICAL,clozapine,3099,3108,"Furthermore, the clozapine group mice exhibited insulin resistance, poorer insulin sensitivity, greater glucose intolerance, and less Akt phosphorylation; their GLUT4 expression was lower, they had renal damage, more reactive oxygen species, and IL-1 expression, and, finally, their levels of antioxidative enzymes (superoxide dismutase, glutathione peroxidase, and catalase) were lower."
novel_tg_hydrolysis-liver_triglyceride_accumulation,/work/eval_papers/PMID_34206460.pdf,abstract,CHEMICAL,Akt,3216,3219,"Furthermore, the clozapine group mice exhibited insulin resistance, poorer insulin sensitivity, greater glucose intolerance, and less Akt phosphorylation; their GLUT4 expression was lower, they had renal damage, more reactive oxygen species, and IL-1 expression, and, finally, their levels of antioxidative enzymes (superoxide dismutase, glutathione peroxidase, and catalase) were lower."
novel_tg_hydrolysis-liver_triglyceride_accumulation,/work/eval_papers/PMID_34206460.pdf,abstract,CHEMICAL,levels,3365,3371,"Furthermore, the clozapine group mice exhibited insulin resistance, poorer insulin sensitivity, greater glucose intolerance, and less Akt phosphorylation; their GLUT4 expression was lower, they had renal damage, more reactive oxygen species, and IL-1 expression, and, finally, their levels of antioxidative enzymes (superoxide dismutase, glutathione peroxidase, and catalase) were lower."
novel_tg_hydrolysis-liver_triglyceride_accumulation,/work/eval_papers/PMID_34206460.pdf,abstract,CHEMICAL,superoxide,3398,3408,"Furthermore, the clozapine group mice exhibited insulin resistance, poorer insulin sensitivity, greater glucose intolerance, and less Akt phosphorylation; their GLUT4 expression was lower, they had renal damage, more reactive oxygen species, and IL-1 expression, and, finally, their levels of antioxidative enzymes (superoxide dismutase, glutathione peroxidase, and catalase) were lower."
novel_tg_hydrolysis-liver_triglyceride_accumulation,/work/eval_papers/PMID_34206460.pdf,abstract,CHEMICAL,glutathione,3420,3431,"Furthermore, the clozapine group mice exhibited insulin resistance, poorer insulin sensitivity, greater glucose intolerance, and less Akt phosphorylation; their GLUT4 expression was lower, they had renal damage, more reactive oxygen species, and IL-1 expression, and, finally, their levels of antioxidative enzymes (superoxide dismutase, glutathione peroxidase, and catalase) were lower."
novel_tg_hydrolysis-liver_triglyceride_accumulation,/work/eval_papers/PMID_34206460.pdf,abstract,CHEMICAL,clozapine,3480,3489,"Moreover, clozapine reduced the thickness of retinal cell layers and increased iNOS and NF-κB expression; a net negative chromium balance occurred because more chromium was excreted through urine, and this influenced chromium mobilization, which did not help overcome the hyperglycemia."
novel_tg_hydrolysis-liver_triglyceride_accumulation,/work/eval_papers/PMID_34206460.pdf,abstract,CHEMICAL,clozapine,3761,3770,"Our clozapine group had considerably higher fatty liver scores, which was supported by the findings of lowered adiponectin protein levels and increased FASN protein, PNPLA3 protein, FABP4 mRNA, and SREBP1 mRNA levels."
novel_tg_hydrolysis-liver_triglyceride_accumulation,/work/eval_papers/PMID_34206460.pdf,abstract,CHEMICAL,levels,3888,3894,"Our clozapine group had considerably higher fatty liver scores, which was supported by the findings of lowered adiponectin protein levels and increased FASN protein, PNPLA3 protein, FABP4 mRNA, and SREBP1 mRNA levels."
novel_tg_hydrolysis-liver_triglyceride_accumulation,/work/eval_papers/PMID_34206460.pdf,abstract,CHEMICAL,clozapine,3992,4001,"We conclude that clozapine can worsen nonalcoholic fatty liver disease, diabetes, and kidney and retinal injury."
novel_tg_hydrolysis-liver_triglyceride_accumulation,/work/eval_papers/PMID_34206460.pdf,abstract,CHEMICAL,clozapine,4127,4136,"Therefore, long-term administration of clozapine warrants higher attention."
novel_tg_hydrolysis-liver_triglyceride_accumulation,/work/eval_papers/PMID_34206460.pdf,abstract,SPECIES,Mice,259,263,"Clozapine Worsens Glucose Intolerance, Nonalcoholic Fatty Liver Disease, Kidney Damage, and Retinal Injury and Increases Renal Reactive Oxygen Species Production and Chromium Loss in Obese Mice. Chang GR(1), Liu HY(2), Yang WC(3), Wang CM(1), Wu CF(1), Lin JW(2), Lin WL(2)(4), Wang YC(5)(6)(7)(8), Lin TC(1), Liao HJ(1), Hou PH(9)(10), Chan CH(11), Lin CF(12)."
novel_tg_hydrolysis-liver_triglyceride_accumulation,/work/eval_papers/PMID_34206460.pdf,abstract,SPECIES,mice,2641,2645,"This research investigated how clozapine affects weight, the bodily distribution of chromium, liver damage, fatty liver scores, glucose homeostasis, renal impairment, and retinopathy in mice fed a high fat diet (HFD)."
novel_tg_hydrolysis-liver_triglyceride_accumulation,/work/eval_papers/PMID_34206460.pdf,abstract,SPECIES,mice,2698,2702,"We discovered that obese mice treated with clozapine gained more weight and had greater kidney, liver, and retroperitoneal and epididymal fat pad masses; higher daily food efficiency; higher serum or hepatic triglyceride, aspartate aminotransferase, alanine aminotransferase, blood urea nitrogen, and creatinine levels; and higher hepatic lipid regulation marker expression than did the HFD-fed control mice."
novel_tg_hydrolysis-liver_triglyceride_accumulation,/work/eval_papers/PMID_34206460.pdf,abstract,SPECIES,mice,3115,3119,"Furthermore, the clozapine group mice exhibited insulin resistance, poorer insulin sensitivity, greater glucose intolerance, and less Akt phosphorylation; their GLUT4 expression was lower, they had renal damage, more reactive oxygen species, and IL-1 expression, and, finally, their levels of antioxidative enzymes (superoxide dismutase, glutathione peroxidase, and catalase) were lower."
novel_tg_hydrolysis-liver_triglyceride_accumulation,/work/eval_papers/PMID_34206460.pdf,abstract,SPECIES,clozapine can worsen,3992,4012,"We conclude that clozapine can worsen nonalcoholic fatty liver disease, diabetes, and kidney and retinal injury."
novel_trp_kyn/nam_pathway-mitochondrial_disruption,/work/eval_papers/PMID_32410680.pdf,abstract,CHEMICAL,O(3)(6)(7,337,346,"Berge RK(1)(2), Cacabelos D(3)(4), Señarís R(4), Nordrehaug JE(3)(5), Nygård O(3)(6)(7), Skorve J(3), Bjørndal B(3)."
novel_trp_kyn/nam_pathway-mitochondrial_disruption,/work/eval_papers/PMID_32410680.pdf,abstract,CHEMICAL,nicotinamide adenine dinucleotide,1230,1263,"BACKGROUND: Non-alcoholic fatty liver disease is often associated with obesity, insulin resistance, dyslipidemia, and the metabolic syndrome in addition to mitochondrial dysfunction and nicotinamide adenine dinucleotide (NAD+) deficiency."
novel_trp_kyn/nam_pathway-mitochondrial_disruption,/work/eval_papers/PMID_32410680.pdf,abstract,CHEMICAL,investigate,1312,1323,"The aim of this study was to investigate how inhibition of mitochondrial fatty acid oxidation using the compound tetradecylthiopropionic acid (TTP) would affect hepatic triacylglycerol level and plasma levels of kynurenine (Kyn) metabolites and nicotinamide. METHODS: 12 C57BL/6 mice were fed a control diet, or an intervention diet supplemented with 0.9% (w/w) tetradecylthiopropionic acid for 14 days."
novel_trp_kyn/nam_pathway-mitochondrial_disruption,/work/eval_papers/PMID_32410680.pdf,abstract,CHEMICAL,levels,1485,1491,"The aim of this study was to investigate how inhibition of mitochondrial fatty acid oxidation using the compound tetradecylthiopropionic acid (TTP) would affect hepatic triacylglycerol level and plasma levels of kynurenine (Kyn) metabolites and nicotinamide. METHODS: 12 C57BL/6 mice were fed a control diet, or an intervention diet supplemented with 0.9% (w/w) tetradecylthiopropionic acid for 14 days."
novel_trp_kyn/nam_pathway-mitochondrial_disruption,/work/eval_papers/PMID_32410680.pdf,abstract,CHEMICAL,kynurenine,1495,1505,"The aim of this study was to investigate how inhibition of mitochondrial fatty acid oxidation using the compound tetradecylthiopropionic acid (TTP) would affect hepatic triacylglycerol level and plasma levels of kynurenine (Kyn) metabolites and nicotinamide. METHODS: 12 C57BL/6 mice were fed a control diet, or an intervention diet supplemented with 0.9% (w/w) tetradecylthiopropionic acid for 14 days."
novel_trp_kyn/nam_pathway-mitochondrial_disruption,/work/eval_papers/PMID_32410680.pdf,abstract,CHEMICAL,status,1899,1905,Metabolites in the tryptophan/kynurenine pathway and total antioxidant status were measured in plasma.
novel_trp_kyn/nam_pathway-mitochondrial_disruption,/work/eval_papers/PMID_32410680.pdf,abstract,CHEMICAL,levels,2242,2248,"The liver content of the oxidized form of NAD+ was increased, as well as the ratio of NAD+/NADH, and these changes were associated by increased hepatic mRNA levels of NAD synthetase and nicotinamide mononucleotide adenyltransferase-3."
novel_trp_kyn/nam_pathway-mitochondrial_disruption,/work/eval_papers/PMID_32410680.pdf,abstract,CHEMICAL,nicotinamide,2271,2283,"The liver content of the oxidized form of NAD+ was increased, as well as the ratio of NAD+/NADH, and these changes were associated by increased hepatic mRNA levels of NAD synthetase and nicotinamide mononucleotide adenyltransferase-3."
novel_trp_kyn/nam_pathway-mitochondrial_disruption,/work/eval_papers/PMID_32410680.pdf,abstract,CHEMICAL,nicotinamide,2403,2415,The downstream metabolites of kynurenine were reduced in plasma whereas the plasma nicotinamide content was increased.
novel_trp_kyn/nam_pathway-mitochondrial_disruption,/work/eval_papers/PMID_32410680.pdf,abstract,CHEMICAL,levels,2914,2920,CONCLUSION: Fatty liver induced by short-time treatment with tetradecylthiopropionic acid decreased the levels of kynurenine metabolites but increased the plasma levels of NAD+ and nicotinamide.
novel_trp_kyn/nam_pathway-mitochondrial_disruption,/work/eval_papers/PMID_32410680.pdf,abstract,CHEMICAL,nicotinamide,3081,3093,Most probably the increase of NAD+ and nicotinamide are generated through the Preiss Handler pathway and/or salvage pathway and not through the de novo pathway.
novel_trp_kyn/nam_pathway-mitochondrial_disruption,/work/eval_papers/PMID_32410680.pdf,abstract,CHEMICAL,nicotinamide adenine dinucleotide,3354,3387,The take home message is that non-alcoholic fatty liver disease is associated with the metabolic syndrome in addition to mitochondrial dysfunction and nicotinamide adenine dinucleotide (NAD+) deficiency.
novel_trp_kyn/nam_pathway-mitochondrial_disruption,/work/eval_papers/PMID_32410680.pdf,abstract,CHEMICAL,levels,3555,3561,"Inducing fatty liver in mice by inhibition of fatty acid oxidation resulted in a concomitant change in kynurenine metabolites increasing the plasma levels of nicotinamides and the hepatic NAD+/NADH ratio, probably without affecting the de novo pathway of kynurenines."
novel_trp_kyn/nam_pathway-mitochondrial_disruption,/work/eval_papers/PMID_32410680.pdf,abstract,SPECIES,mice,1562,1566,"The aim of this study was to investigate how inhibition of mitochondrial fatty acid oxidation using the compound tetradecylthiopropionic acid (TTP) would affect hepatic triacylglycerol level and plasma levels of kynurenine (Kyn) metabolites and nicotinamide. METHODS: 12 C57BL/6 mice were fed a control diet, or an intervention diet supplemented with 0.9% (w/w) tetradecylthiopropionic acid for 14 days."
novel_trp_kyn/nam_pathway-mitochondrial_disruption,/work/eval_papers/PMID_32410680.pdf,abstract,SPECIES,mice,3431,3435,"Inducing fatty liver in mice by inhibition of fatty acid oxidation resulted in a concomitant change in kynurenine metabolites increasing the plasma levels of nicotinamides and the hepatic NAD+/NADH ratio, probably without affecting the de novo pathway of kynurenines."
nuclear_receptor_changes_fxr-transcription_factor_related_changes_other_pgc_1a,/work/eval_papers/PMID_34856412.pdf,abstract,CHEMICAL,Liu,214,217,"Lu D(1), Liu Y(2), Luo Y(3), Zhao J(3), Feng C(4), Xue L(4), Xu J(4), Wang Q(3), Yan T(3), Xiao P(4), Krausz KW(3), Gonzalez FJ(5), Xie C(6)."
nuclear_receptor_changes_fxr-transcription_factor_related_changes_other_pgc_1a,/work/eval_papers/PMID_34856412.pdf,abstract,CHEMICAL,Luo,224,227,"Lu D(1), Liu Y(2), Luo Y(3), Zhao J(3), Feng C(4), Xue L(4), Xu J(4), Wang Q(3), Yan T(3), Xiao P(4), Krausz KW(3), Gonzalez FJ(5), Xie C(6)."
nuclear_receptor_changes_fxr-transcription_factor_related_changes_other_pgc_1a,/work/eval_papers/PMID_34856412.pdf,abstract,CHEMICAL,Control,560,567,"Author information: (1)Laboratory of Metabolism, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States of America; Shanghai Municipal Center for Disease Control and Prevention, State Environmental Protection Key Laboratory of Environmental Health Impact Assessment of Emerging Contaminants, Shanghai, PR China."
nuclear_receptor_changes_fxr-transcription_factor_related_changes_other_pgc_1a,/work/eval_papers/PMID_34856412.pdf,abstract,CHEMICAL,State,584,589,"Author information: (1)Laboratory of Metabolism, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States of America; Shanghai Municipal Center for Disease Control and Prevention, State Environmental Protection Key Laboratory of Environmental Health Impact Assessment of Emerging Contaminants, Shanghai, PR China."
nuclear_receptor_changes_fxr-transcription_factor_related_changes_other_pgc_1a,/work/eval_papers/PMID_34856412.pdf,abstract,CHEMICAL,Key,615,618,"Author information: (1)Laboratory of Metabolism, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States of America; Shanghai Municipal Center for Disease Control and Prevention, State Environmental Protection Key Laboratory of Environmental Health Impact Assessment of Emerging Contaminants, Shanghai, PR China."
nuclear_receptor_changes_fxr-transcription_factor_related_changes_other_pgc_1a,/work/eval_papers/PMID_34856412.pdf,abstract,CHEMICAL,(2)State,718,726,"(2)State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, PR China."
nuclear_receptor_changes_fxr-transcription_factor_related_changes_other_pgc_1a,/work/eval_papers/PMID_34856412.pdf,abstract,CHEMICAL,Control,1043,1050,"(4)Shanghai Municipal Center for Disease Control and Prevention, State Environmental Protection Key Laboratory of Environmental Health Impact Assessment of Emerging Contaminants, Shanghai, PR China."
nuclear_receptor_changes_fxr-transcription_factor_related_changes_other_pgc_1a,/work/eval_papers/PMID_34856412.pdf,abstract,CHEMICAL,State,1067,1072,"(4)Shanghai Municipal Center for Disease Control and Prevention, State Environmental Protection Key Laboratory of Environmental Health Impact Assessment of Emerging Contaminants, Shanghai, PR China."
nuclear_receptor_changes_fxr-transcription_factor_related_changes_other_pgc_1a,/work/eval_papers/PMID_34856412.pdf,abstract,CHEMICAL,Key,1098,1101,"(4)Shanghai Municipal Center for Disease Control and Prevention, State Environmental Protection Key Laboratory of Environmental Health Impact Assessment of Emerging Contaminants, Shanghai, PR China."
nuclear_receptor_changes_fxr-transcription_factor_related_changes_other_pgc_1a,/work/eval_papers/PMID_34856412.pdf,abstract,CHEMICAL,address,1367,1374,Electronic address: gonzalef@mail.nih.gov.
nuclear_receptor_changes_fxr-transcription_factor_related_changes_other_pgc_1a,/work/eval_papers/PMID_34856412.pdf,abstract,CHEMICAL,State,1554,1559,"(6)Laboratory of Metabolism, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States of America; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, PR China."
nuclear_receptor_changes_fxr-transcription_factor_related_changes_other_pgc_1a,/work/eval_papers/PMID_34856412.pdf,abstract,CHEMICAL,address,1691,1698,Electronic address: xiecen@simm.ac.cn.
nuclear_receptor_changes_fxr-transcription_factor_related_changes_other_pgc_1a,/work/eval_papers/PMID_34856412.pdf,abstract,CHEMICAL,cholesterol,1757,1768,"In addition to maintaining bile acid, cholesterol and glucose homeostasis, farnesoid X receptor (FXR) also regulates fatty acid β-oxidation (FAO)."
nuclear_receptor_changes_fxr-transcription_factor_related_changes_other_pgc_1a,/work/eval_papers/PMID_34856412.pdf,abstract,CHEMICAL,Acot1,2378,2383,"Activation of FXR by OCA treatment significantly increased fatty acyl-CoA hydrolysis (Acot1) and decreased FAO-associated mRNAs in Fxrfl/fl mice, resulting in reduced levels of total acylcarnitines and relative accumulation of long/medium chain acylcarnitines and fatty acids in liver."
nuclear_receptor_changes_fxr-transcription_factor_related_changes_other_pgc_1a,/work/eval_papers/PMID_34856412.pdf,abstract,CHEMICAL,levels,2459,2465,"Activation of FXR by OCA treatment significantly increased fatty acyl-CoA hydrolysis (Acot1) and decreased FAO-associated mRNAs in Fxrfl/fl mice, resulting in reduced levels of total acylcarnitines and relative accumulation of long/medium chain acylcarnitines and fatty acids in liver."
nuclear_receptor_changes_fxr-transcription_factor_related_changes_other_pgc_1a,/work/eval_papers/PMID_34856412.pdf,abstract,CHEMICAL,long/medium,2519,2530,"Activation of FXR by OCA treatment significantly increased fatty acyl-CoA hydrolysis (Acot1) and decreased FAO-associated mRNAs in Fxrfl/fl mice, resulting in reduced levels of total acylcarnitines and relative accumulation of long/medium chain acylcarnitines and fatty acids in liver."
nuclear_receptor_changes_fxr-transcription_factor_related_changes_other_pgc_1a,/work/eval_papers/PMID_34856412.pdf,abstract,CHEMICAL,thus,2696,2700,"FxrΔHep mice responded to OCA treatment in a manner similar to Fxrfl/fl mice while FxrΔIE mice responded differently, thus illustrating that intestinal FXR plays a critical role in the regulation of hepatic FAO."
nuclear_receptor_changes_fxr-transcription_factor_related_changes_other_pgc_1a,/work/eval_papers/PMID_34856412.pdf,abstract,CHEMICAL,thus,3077,3081,"A significant negative-correlation between intestinal FXR-FGF15 and hepatic CREB-PGC1A pathways was observed after both VEH and OCA treatment, suggesting that OCA-induced activation of the intestinal FXR-FGF15 axis downregulates hepatic PGC1α signaling via inactivation of hepatic CREB, thus repressing FAO."
nuclear_receptor_changes_fxr-transcription_factor_related_changes_other_pgc_1a,/work/eval_papers/PMID_34856412.pdf,abstract,CHEMICAL,FAO,3093,3096,"A significant negative-correlation between intestinal FXR-FGF15 and hepatic CREB-PGC1A pathways was observed after both VEH and OCA treatment, suggesting that OCA-induced activation of the intestinal FXR-FGF15 axis downregulates hepatic PGC1α signaling via inactivation of hepatic CREB, thus repressing FAO."
nuclear_receptor_changes_fxr-transcription_factor_related_changes_other_pgc_1a,/work/eval_papers/PMID_34856412.pdf,abstract,CHEMICAL,FAO,3303,3306,This study revealed an important role for the intestinal FXR-FGF15 pathway in hepatic FAO repression.
nuclear_receptor_changes_fxr-transcription_factor_related_changes_other_pgc_1a,/work/eval_papers/PMID_34856412.pdf,abstract,SPECIES,mice,2586,2590,"FxrΔHep mice responded to OCA treatment in a manner similar to Fxrfl/fl mice while FxrΔIE mice responded differently, thus illustrating that intestinal FXR plays a critical role in the regulation of hepatic FAO."
nuclear_receptor_changes_fxr-transcription_factor_related_changes_other_pgc_1a,/work/eval_papers/PMID_34856412.pdf,abstract,SPECIES,mice,2650,2654,"FxrΔHep mice responded to OCA treatment in a manner similar to Fxrfl/fl mice while FxrΔIE mice responded differently, thus illustrating that intestinal FXR plays a critical role in the regulation of hepatic FAO."
nuclear_receptor_changes_fxr-transcription_factor_related_changes_other_pgc_1a,/work/eval_papers/PMID_34856412.pdf,abstract,SPECIES,mice,2668,2672,"FxrΔHep mice responded to OCA treatment in a manner similar to Fxrfl/fl mice while FxrΔIE mice responded differently, thus illustrating that intestinal FXR plays a critical role in the regulation of hepatic FAO."
nuclear_receptor_changes_fxr-transcription_factor_related_changes_other_pgc_1a,/work/eval_papers/PMID_34856412.pdf,abstract,SPECIES,human,3151,3156,This mechanism was confirmed in experiments based on human recombinant FGF19 treatment and intestinal Fgf15-null mice.
nuclear_receptor_changes_lxra-de_novo_lipogenesis_tg_synthesis,/work/eval_papers/PMID_29126901.pdf,abstract,CHEMICAL,Koh,293,296,"Kang S(1), Huang J(1), Lee BK(1), Jung YS(1), Im E(1), Koh JM(2), Im DS(3)."
nuclear_receptor_changes_lxra-de_novo_lipogenesis_tg_synthesis,/work/eval_papers/PMID_29126901.pdf,abstract,CHEMICAL,Pusan,431,436,"Author information: (1)Molecular Inflammation Research Center for Aging Intervention (MRCA) and College of Pharmacy, Pusan National University, Busan 469241, Republic of Korea."
nuclear_receptor_changes_lxra-de_novo_lipogenesis_tg_synthesis,/work/eval_papers/PMID_29126901.pdf,abstract,CHEMICAL,Medicine,588,596,"(2)Division of Endocrinology and Metabolism, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Republic of Korea."
nuclear_receptor_changes_lxra-de_novo_lipogenesis_tg_synthesis,/work/eval_papers/PMID_29126901.pdf,abstract,CHEMICAL,Pusan,727,732,"(3)Molecular Inflammation Research Center for Aging Intervention (MRCA) and College of Pharmacy, Pusan National University, Busan 469241, Republic of Korea."
nuclear_receptor_changes_lxra-de_novo_lipogenesis_tg_synthesis,/work/eval_papers/PMID_29126901.pdf,abstract,CHEMICAL,address,798,805,Electronic address: imds@pusan.ac.kr.
nuclear_receptor_changes_lxra-de_novo_lipogenesis_tg_synthesis,/work/eval_papers/PMID_29126901.pdf,abstract,CHEMICAL,n-3,1048,1051,FFA4 (also known as GPR120; a G protein-coupled receptor) has been suggested to be a target of n-3 PUFA.
nuclear_receptor_changes_lxra-de_novo_lipogenesis_tg_synthesis,/work/eval_papers/PMID_29126901.pdf,abstract,CHEMICAL,docosahexaenoic acid,1457,1477,T0901317 (a specific LXR activator) induced lipid accumulation and docosahexaenoic acid (DHA; a representative n-3 PUFA) inhibited lipid accumulation.
nuclear_receptor_changes_lxra-de_novo_lipogenesis_tg_synthesis,/work/eval_papers/PMID_29126901.pdf,abstract,CHEMICAL,DHA,1479,1482,T0901317 (a specific LXR activator) induced lipid accumulation and docosahexaenoic acid (DHA; a representative n-3 PUFA) inhibited lipid accumulation.
nuclear_receptor_changes_lxra-de_novo_lipogenesis_tg_synthesis,/work/eval_papers/PMID_29126901.pdf,abstract,CHEMICAL,n-3,1501,1504,T0901317 (a specific LXR activator) induced lipid accumulation and docosahexaenoic acid (DHA; a representative n-3 PUFA) inhibited lipid accumulation.
nuclear_receptor_changes_lxra-de_novo_lipogenesis_tg_synthesis,/work/eval_papers/PMID_29126901.pdf,abstract,CHEMICAL,AH7614,1597,1603,This DHA-induced inhibition was blunted by treatment of AH7614 (a FFA4 antagonist) and by transfection of FFA4 siRNA.
nuclear_receptor_changes_lxra-de_novo_lipogenesis_tg_synthesis,/work/eval_papers/PMID_29126901.pdf,abstract,CHEMICAL,SREBP-1c,1659,1667,"SREBP-1c (a key transcription factor of lipogenesis) was induced by treatment with T0901317, and SREBP-1c induction was also inhibited by DHA at mRNA and protein levels."
nuclear_receptor_changes_lxra-de_novo_lipogenesis_tg_synthesis,/work/eval_papers/PMID_29126901.pdf,abstract,CHEMICAL,DHA,1797,1800,"SREBP-1c (a key transcription factor of lipogenesis) was induced by treatment with T0901317, and SREBP-1c induction was also inhibited by DHA at mRNA and protein levels."
nuclear_receptor_changes_lxra-de_novo_lipogenesis_tg_synthesis,/work/eval_papers/PMID_29126901.pdf,abstract,CHEMICAL,n-3,2248,2251,"The results of this study suggest that n-3 PUFA protect hepatic steatosis by activating FFA4 in hepatocytes, and its signaling cascade sequentially involves FFA4, Gq/11 proteins, CaMKK, AMPK, and SREBP-1c suppression."
nuclear_receptor_changes_lxra-de_novo_lipogenesis_tg_synthesis,/work/eval_papers/PMID_29126901.pdf,abstract,CHEMICAL,protect,2257,2264,"The results of this study suggest that n-3 PUFA protect hepatic steatosis by activating FFA4 in hepatocytes, and its signaling cascade sequentially involves FFA4, Gq/11 proteins, CaMKK, AMPK, and SREBP-1c suppression."
nuclear_receptor_changes_lxra-de_novo_lipogenesis_tg_synthesis,/work/eval_papers/PMID_29126901.pdf,abstract,SPECIES,human hepatoma cells,168,188,Omega-3 polyunsaturated fatty acids protect human hepatoma cells from developing steatosis through FFA4 (GPR120).
nuclear_receptor_changes_lxra-de_novo_lipogenesis_tg_synthesis,/work/eval_papers/PMID_29126901.pdf,abstract,SPECIES,mice,2056,2060,"Furthermore, DHA inhibited T0901317-induced lipid accumulation in primary hepatocytes from wild type mice, but not in those from FFA4 deficient mice."
nuclear_receptor_changes_lxra-fa_uptake,/work/eval_papers/PMID_28366540.pdf,abstract,CHEMICAL,Bai,194,197,"Bai X(1), Hong W(1), Cai P(1), Chen Y(1), Xu C(1), Cao D(2), Yu W(1), Zhao Z(2), Huang M(1), Jin J(3)."
nuclear_receptor_changes_lxra-fa_uptake,/work/eval_papers/PMID_28366540.pdf,abstract,CHEMICAL,Z(2,269,272,"Bai X(1), Hong W(1), Cai P(1), Chen Y(1), Xu C(1), Cao D(2), Yu W(1), Zhao Z(2), Huang M(1), Jin J(3)."
nuclear_receptor_changes_lxra-fa_uptake,/work/eval_papers/PMID_28366540.pdf,abstract,CHEMICAL,Jin,287,290,"Bai X(1), Hong W(1), Cai P(1), Chen Y(1), Xu C(1), Cao D(2), Yu W(1), Zhao Z(2), Huang M(1), Jin J(3)."
nuclear_receptor_changes_lxra-fa_uptake,/work/eval_papers/PMID_28366540.pdf,abstract,CHEMICAL,Medicine,466,474,"(2)School of Chinese Materia Medica, Guangzhou University of Chinese Medicine, Guangzhou, China."
nuclear_receptor_changes_lxra-fa_uptake,/work/eval_papers/PMID_28366540.pdf,abstract,CHEMICAL,address,585,592,Electronic address: jinjing@mail.sysu.edu.cn.
nuclear_receptor_changes_lxra-fa_uptake,/work/eval_papers/PMID_28366540.pdf,abstract,CHEMICAL,VPA,1612,1615,"Specifically, we found that the expression of cluster of differentiation 36 (CD36), an important fatty acid transport, and diacylglycerol acyltransferase 2 (DGAT2) were significantly up-regulated in HepG2 cells and livers of C57B/6J mice after treatment with VPA."
nuclear_receptor_changes_lxra-fa_uptake,/work/eval_papers/PMID_28366540.pdf,abstract,CHEMICAL,VPA,1630,1633,"Furthermore, VPA treatment remarkably enhanced the efficiency of fatty acid uptake mediated by CD36, while this effect was abolished by the interference with CD36-specific siRNA."
nuclear_receptor_changes_lxra-fa_uptake,/work/eval_papers/PMID_28366540.pdf,abstract,CHEMICAL,VPA,1802,1805,"Also, VPA treatment significantly increased DGAT2 expression as a result of the inhibition of mitogen-activated protein kinase kinase (MEK) - extracellular regulated kinase (ERK) pathway; however, DGAT2 knockdown significantly alleviated VPA-induced intracellular lipid accumulation."
nuclear_receptor_changes_lxra-fa_uptake,/work/eval_papers/PMID_28366540.pdf,abstract,CHEMICAL,sterol,2113,2119,"Additionally, we also found that sterol regulatory element binding protein-1c (SREBP-1c)-mediated fatty acid synthesis may be not involved in VPA-induced hepatic steatosis."
nuclear_receptor_changes_lxra-fa_uptake,/work/eval_papers/PMID_28366540.pdf,abstract,SPECIES,patients,850,858,Approximately 61% of patients treated with VPA have been diagnosed with hepatic steatosis through ultrasound examination.
nuclear_receptor_changes_lxra-fa_uptake,/work/eval_papers/PMID_28366540.pdf,abstract,SPECIES,mice,1586,1590,"Specifically, we found that the expression of cluster of differentiation 36 (CD36), an important fatty acid transport, and diacylglycerol acyltransferase 2 (DGAT2) were significantly up-regulated in HepG2 cells and livers of C57B/6J mice after treatment with VPA."
nuclear_receptor_changes_lxra-fa_uptake,/work/eval_papers/PMID_28366540.pdf,abstract,SPECIES,CD36,1712,1716,"Furthermore, VPA treatment remarkably enhanced the efficiency of fatty acid uptake mediated by CD36, while this effect was abolished by the interference with CD36-specific siRNA."
nuclear_receptor_changes_lxrab-de_novo_lipogenesis,/work/eval_papers/PMID_29173234.pdf,abstract,CHEMICAL,PPARα/carnitine,250,265,"Dietary α-lactalbumin induced fatty liver by enhancing nuclear liver X receptor αβ/sterol regulatory element-binding protein-1c/PPARγ expression and minimising PPARα/carnitine palmitoyltransferase-1 expression and AMP-activated protein kinase α phosphorylation associated with atherogenic dyslipidaemia, insulin resistance and oxidative stress in Balb/c mice."
nuclear_receptor_changes_lxrab-de_novo_lipogenesis,/work/eval_papers/PMID_29173234.pdf,abstract,CHEMICAL,dyslipidaemia,379,392,"Dietary α-lactalbumin induced fatty liver by enhancing nuclear liver X receptor αβ/sterol regulatory element-binding protein-1c/PPARγ expression and minimising PPARα/carnitine palmitoyltransferase-1 expression and AMP-activated protein kinase α phosphorylation associated with atherogenic dyslipidaemia, insulin resistance and oxidative stress in Balb/c mice."
nuclear_receptor_changes_lxrab-de_novo_lipogenesis,/work/eval_papers/PMID_29173234.pdf,abstract,CHEMICAL,investigate,992,1003,The aim of the present study was to investigate if this atherogenic effect could be due to a possible α-LAC-induced hepatic steatosis.
nuclear_receptor_changes_lxrab-de_novo_lipogenesis,/work/eval_papers/PMID_29173234.pdf,abstract,CHEMICAL,NEFA contents,1553,1566,Moderate liver steatosis with increased TAG and NEFA contents was correlated with atherogenic dyslipidaemia.
nuclear_receptor_changes_lxrab-de_novo_lipogenesis,/work/eval_papers/PMID_29173234.pdf,abstract,CHEMICAL,dyslipidaemia,1599,1612,Moderate liver steatosis with increased TAG and NEFA contents was correlated with atherogenic dyslipidaemia.
nuclear_receptor_changes_lxrab-de_novo_lipogenesis,/work/eval_papers/PMID_29173234.pdf,abstract,CHEMICAL,GSH,2345,2348,These changes were associated with a significant decrease in both p-Thr172-AMP-activated protein kinase α (AMPKα) (inactivation) and p-Ser79-ACC1 (activation) and with a more oxidative liver environment increasing lipid peroxidation and protein oxidation and reducing GSH:GSSG ratio in the α-LAC-fed mice.
nuclear_receptor_changes_lxrab-de_novo_lipogenesis,/work/eval_papers/PMID_29173234.pdf,abstract,CHEMICAL,GSSG,2349,2353,These changes were associated with a significant decrease in both p-Thr172-AMP-activated protein kinase α (AMPKα) (inactivation) and p-Ser79-ACC1 (activation) and with a more oxidative liver environment increasing lipid peroxidation and protein oxidation and reducing GSH:GSSG ratio in the α-LAC-fed mice.
nuclear_receptor_changes_lxrab-de_novo_lipogenesis,/work/eval_papers/PMID_29173234.pdf,abstract,CHEMICAL,dyslipidaemia,2480,2493,"In conclusion, 4 weeks of 14 % α-LAC feeding induced liver steatosis associated with atherogenic dyslipidaemia, IR and oxidative stress by enhancing nuclear LXRαβ/SREBP-1c/PPARγ expression and diminishing PPARα/CPT-1 expression and AMPKα phosphorylation shifting the hepatic FAO toward fatty acid synthesis in Balb/c mice."
nuclear_receptor_changes_lxrab-de_novo_lipogenesis,/work/eval_papers/PMID_29173234.pdf,abstract,SPECIES,Farmacología,664,676,"(2)2Departamento de Farmacología, Facultad de Farmacia,Universidad Complutense,28040 Madrid,Spain."
nuclear_receptor_changes_lxrab-de_novo_lipogenesis,/work/eval_papers/PMID_29173234.pdf,abstract,SPECIES,mice,1367,1371,Male Balb/c mice (n 6) were fed with diets containing either chow or 14 % α-LAC for 4 weeks.
nuclear_receptor_changes_lxrab-de_novo_lipogenesis,/work/eval_papers/PMID_29173234.pdf,abstract,SPECIES,mice,1462,1466,The α-LAC-fed mice developed abdominal adiposity and IR.
nuclear_receptor_changes_lxrab-de_novo_lipogenesis,/work/eval_papers/PMID_29173234.pdf,abstract,SPECIES,mice,2377,2381,These changes were associated with a significant decrease in both p-Thr172-AMP-activated protein kinase α (AMPKα) (inactivation) and p-Ser79-ACC1 (activation) and with a more oxidative liver environment increasing lipid peroxidation and protein oxidation and reducing GSH:GSSG ratio in the α-LAC-fed mice.
nuclear_receptor_changes_novel__lxrb-liver_triglyceride_accumulation,/work/eval_papers/PMID_33022571.pdf,abstract,CHEMICAL,Lv K(2,245,251,"Yu X(1), Lv K(2), Guan S(3), Zhang X(3), Sun L(4)."
nuclear_receptor_changes_novel__lxrb-liver_triglyceride_accumulation,/work/eval_papers/PMID_33022571.pdf,abstract,CHEMICAL,Medicine,446,454,"Author information: (1)Department of Anesthesiology, Peking University Shenzhen Hospital, Shenzhen, 518036, China; Department of Respiratory and Critical Care Medicine, The Second Clinical Medical College (Shenzhen People's Hospital) of Jinan University, Shenzhen Institute of Respiratory Diseases, Shenzhen, China."
nuclear_receptor_changes_novel__lxrb-liver_triglyceride_accumulation,/work/eval_papers/PMID_33022571.pdf,abstract,CHEMICAL,address,1135,1142,Electronic address: slbaaa@163.com.
nuclear_receptor_changes_novel__lxrb-liver_triglyceride_accumulation,/work/eval_papers/PMID_33022571.pdf,abstract,CHEMICAL,levels,2078,2084,"Histopathological anomalies, and significantly increased hepatic levels of free fatty acid, cholesterol and triglyceride were observed as well."
nuclear_receptor_changes_novel__lxrb-liver_triglyceride_accumulation,/work/eval_papers/PMID_33022571.pdf,abstract,CHEMICAL,cholesterol,2105,2116,"Histopathological anomalies, and significantly increased hepatic levels of free fatty acid, cholesterol and triglyceride were observed as well."
nuclear_receptor_changes_novel__lxrb-liver_triglyceride_accumulation,/work/eval_papers/PMID_33022571.pdf,abstract,CHEMICAL,triglyceride,2121,2133,"Histopathological anomalies, and significantly increased hepatic levels of free fatty acid, cholesterol and triglyceride were observed as well."
nuclear_receptor_changes_novel__lxrb-liver_triglyceride_accumulation,/work/eval_papers/PMID_33022571.pdf,abstract,SPECIES,mice,230,234,Long-term exposure to phenanthrene at environmental-level induces intestinal dysbiosis and disrupted hepatic lipid metabolism in mice.
nuclear_receptor_changes_novel__lxrb-liver_triglyceride_accumulation,/work/eval_papers/PMID_33022571.pdf,abstract,SPECIES,Care Medicine,441,454,"Author information: (1)Department of Anesthesiology, Peking University Shenzhen Hospital, Shenzhen, 518036, China; Department of Respiratory and Critical Care Medicine, The Second Clinical Medical College (Shenzhen People's Hospital) of Jinan University, Shenzhen Institute of Respiratory Diseases, Shenzhen, China."
nuclear_receptor_changes_novel__lxrb-liver_triglyceride_accumulation,/work/eval_papers/PMID_33022571.pdf,abstract,SPECIES,mice,1774,1778,"Herein, male mice were orally exposed to Phe (0.05, 0.5 and 5 mg/kg/2d) for ten weeks and the results showed that long term exposure to Phe induced significant alteration in relative Bacteroidetes, Firmicutes and Proteobacteria abundance in male mice."
nuclear_receptor_changes_novel__lxrb-liver_triglyceride_accumulation,/work/eval_papers/PMID_33022571.pdf,abstract,SPECIES,mice,2007,2011,"Herein, male mice were orally exposed to Phe (0.05, 0.5 and 5 mg/kg/2d) for ten weeks and the results showed that long term exposure to Phe induced significant alteration in relative Bacteroidetes, Firmicutes and Proteobacteria abundance in male mice."
nuclear_receptor_changes_novel_erb-protein_kinase_changes_akt2,/work/eval_papers/PMID_34836271.pdf,abstract,CHEMICAL,estrogen,497,505,Genistein (GEN) has been shown to significantly inhibit hepatic triglyceride accretion triggered by estrogen deficiency.
nuclear_receptor_changes_novel_erb-protein_kinase_changes_akt2,/work/eval_papers/PMID_34836271.pdf,abstract,CHEMICAL,this,538,542,The main purpose of this in vitro study was to investigate the function and molecular mechanism of estrogen receptor β (ERβ) in regulating hepatic lipid metabolism induced by GEN.
nuclear_receptor_changes_novel_erb-protein_kinase_changes_akt2,/work/eval_papers/PMID_34836271.pdf,abstract,CHEMICAL,investigate,565,576,The main purpose of this in vitro study was to investigate the function and molecular mechanism of estrogen receptor β (ERβ) in regulating hepatic lipid metabolism induced by GEN.
nuclear_receptor_changes_novel_erb-protein_kinase_changes_akt2,/work/eval_papers/PMID_34836271.pdf,abstract,CHEMICAL,estrogen,617,625,The main purpose of this in vitro study was to investigate the function and molecular mechanism of estrogen receptor β (ERβ) in regulating hepatic lipid metabolism induced by GEN.
nuclear_receptor_changes_novel_erb-protein_kinase_changes_akt2,/work/eval_papers/PMID_34836271.pdf,abstract,CHEMICAL,levels,850,856,Results showed that 25 μM GEN significantly diminished triglyceride levels.
nuclear_receptor_changes_novel_erb-protein_kinase_changes_akt2,/work/eval_papers/PMID_34836271.pdf,abstract,CHEMICAL,levels,891,897,"Meanwhile, GEN downregulated the levels of genes and proteins involved in lipogenesis, such as sterol-regulatory element-binding protein-1c (SREBP-1c), fatty acid synthase (FASN), and stearoyl-coenzyme A desaturase 1 (SCD1), and upregulated the gene and protein levels of the regulation factors responsible for fatty acid β-oxidation, such as carnitine palmitoyltransferase 1α (CPT-1α) and peroxisome proliferator-activated receptor α (PPARα)."
nuclear_receptor_changes_novel_erb-protein_kinase_changes_akt2,/work/eval_papers/PMID_34836271.pdf,abstract,CHEMICAL,carnitine,1201,1210,"Meanwhile, GEN downregulated the levels of genes and proteins involved in lipogenesis, such as sterol-regulatory element-binding protein-1c (SREBP-1c), fatty acid synthase (FASN), and stearoyl-coenzyme A desaturase 1 (SCD1), and upregulated the gene and protein levels of the regulation factors responsible for fatty acid β-oxidation, such as carnitine palmitoyltransferase 1α (CPT-1α) and peroxisome proliferator-activated receptor α (PPARα)."
nuclear_receptor_changes_novel_erb-protein_kinase_changes_akt2,/work/eval_papers/PMID_34836271.pdf,abstract,CHEMICAL,Akt,1384,1387,"Furthermore, 25 μM GEN reduced the levels of phosphorylation of protein kinase B (Akt) and mechanistic target of rapamycin (mTOR)."
nuclear_receptor_changes_novel_erb-protein_kinase_changes_akt2,/work/eval_papers/PMID_34836271.pdf,abstract,CHEMICAL,rapamycin,1415,1424,"Furthermore, 25 μM GEN reduced the levels of phosphorylation of protein kinase B (Akt) and mechanistic target of rapamycin (mTOR)."
nuclear_receptor_changes_novel_erb-protein_kinase_changes_akt2,/work/eval_papers/PMID_34836271.pdf,abstract,CHEMICAL,provide,1659,1666,The results provide novel aspects of the regulatory mechanism of ERβ on hepatic lipid metabolism and might help to profoundly understand the functions of food-derived phytoestrogens in preventing and treating hepatic steatosis in postmenopausal women.
nuclear_receptor_changes_novel_erb-protein_kinase_changes_akt2,/work/eval_papers/PMID_34836271.pdf,abstract,CHEMICAL,PMID: 34836271,1941,1955,DOI: 10.3390/nu13114015 PMCID: PMC8622023 PMID: 34836271 [Indexed for MEDLINE] Conflict of interest statement: The authors declare no conflict of interest.
nuclear_receptor_changes_novel_erb-protein_kinase_changes_akt2,/work/eval_papers/PMID_34836271.pdf,abstract,SPECIES,ERβ,1527,1530,"Moreover, most of these effects from GEN were reverted by pretreatment with the antagonist of ERβ."
nuclear_receptor_changes_novel_rxr-liver_triglyceride_accumulation,/work/eval_papers/PMID_33022571.pdf,abstract,CHEMICAL,Lv K(2,245,251,"Yu X(1), Lv K(2), Guan S(3), Zhang X(3), Sun L(4)."
nuclear_receptor_changes_novel_rxr-liver_triglyceride_accumulation,/work/eval_papers/PMID_33022571.pdf,abstract,CHEMICAL,Medicine,446,454,"Author information: (1)Department of Anesthesiology, Peking University Shenzhen Hospital, Shenzhen, 518036, China; Department of Respiratory and Critical Care Medicine, The Second Clinical Medical College (Shenzhen People's Hospital) of Jinan University, Shenzhen Institute of Respiratory Diseases, Shenzhen, China."
nuclear_receptor_changes_novel_rxr-liver_triglyceride_accumulation,/work/eval_papers/PMID_33022571.pdf,abstract,CHEMICAL,address,1135,1142,Electronic address: slbaaa@163.com.
nuclear_receptor_changes_novel_rxr-liver_triglyceride_accumulation,/work/eval_papers/PMID_33022571.pdf,abstract,CHEMICAL,levels,2078,2084,"Histopathological anomalies, and significantly increased hepatic levels of free fatty acid, cholesterol and triglyceride were observed as well."
nuclear_receptor_changes_novel_rxr-liver_triglyceride_accumulation,/work/eval_papers/PMID_33022571.pdf,abstract,CHEMICAL,cholesterol,2105,2116,"Histopathological anomalies, and significantly increased hepatic levels of free fatty acid, cholesterol and triglyceride were observed as well."
nuclear_receptor_changes_novel_rxr-liver_triglyceride_accumulation,/work/eval_papers/PMID_33022571.pdf,abstract,CHEMICAL,triglyceride,2121,2133,"Histopathological anomalies, and significantly increased hepatic levels of free fatty acid, cholesterol and triglyceride were observed as well."
nuclear_receptor_changes_novel_rxr-liver_triglyceride_accumulation,/work/eval_papers/PMID_33022571.pdf,abstract,SPECIES,mice,230,234,Long-term exposure to phenanthrene at environmental-level induces intestinal dysbiosis and disrupted hepatic lipid metabolism in mice.
nuclear_receptor_changes_novel_rxr-liver_triglyceride_accumulation,/work/eval_papers/PMID_33022571.pdf,abstract,SPECIES,Care Medicine,441,454,"Author information: (1)Department of Anesthesiology, Peking University Shenzhen Hospital, Shenzhen, 518036, China; Department of Respiratory and Critical Care Medicine, The Second Clinical Medical College (Shenzhen People's Hospital) of Jinan University, Shenzhen Institute of Respiratory Diseases, Shenzhen, China."
nuclear_receptor_changes_novel_rxr-liver_triglyceride_accumulation,/work/eval_papers/PMID_33022571.pdf,abstract,SPECIES,mice,1774,1778,"Herein, male mice were orally exposed to Phe (0.05, 0.5 and 5 mg/kg/2d) for ten weeks and the results showed that long term exposure to Phe induced significant alteration in relative Bacteroidetes, Firmicutes and Proteobacteria abundance in male mice."
nuclear_receptor_changes_novel_rxr-liver_triglyceride_accumulation,/work/eval_papers/PMID_33022571.pdf,abstract,SPECIES,mice,2007,2011,"Herein, male mice were orally exposed to Phe (0.05, 0.5 and 5 mg/kg/2d) for ten weeks and the results showed that long term exposure to Phe induced significant alteration in relative Bacteroidetes, Firmicutes and Proteobacteria abundance in male mice."
nuclear_receptor_changes_ppara-fatty_liver,/work/eval_papers/PMID_27837167.pdf,abstract,CHEMICAL,Medicine,373,381,"Author information: (1)Department of Pharmacology, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China."
nuclear_receptor_changes_ppara-fatty_liver,/work/eval_papers/PMID_27837167.pdf,abstract,CHEMICAL,Medicine,446,454,"(2)Department of Pathology, School of Medicine, Saint Louis University, St Louis, Missouri."
nuclear_receptor_changes_ppara-fatty_liver,/work/eval_papers/PMID_27837167.pdf,abstract,CHEMICAL,Medicine,581,589,"(3)Department of Pharmacology, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China; nytws@163.com."
nuclear_receptor_changes_ppara-fatty_liver,/work/eval_papers/PMID_27837167.pdf,abstract,CHEMICAL,Medicine,753,761,"(4)Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China."
nuclear_receptor_changes_ppara-fatty_liver,/work/eval_papers/PMID_27837167.pdf,abstract,CHEMICAL,Our,872,875,"Our previous in vivo study showed that ligustrazine, a major active alkaloid isolated from Ligusticum chuanxiong Hort, attenuated alcohol-induced hepatic steatosis and in vitro study revealed that nuclear factor (erythroid-derived 2)-like 2 (Nrf2) activation might be a prerequisite."
nuclear_receptor_changes_ppara-fatty_liver,/work/eval_papers/PMID_27837167.pdf,abstract,CHEMICAL,ligustrazine,911,923,"Our previous in vivo study showed that ligustrazine, a major active alkaloid isolated from Ligusticum chuanxiong Hort, attenuated alcohol-induced hepatic steatosis and in vitro study revealed that nuclear factor (erythroid-derived 2)-like 2 (Nrf2) activation might be a prerequisite."
nuclear_receptor_changes_ppara-fatty_liver,/work/eval_papers/PMID_27837167.pdf,abstract,CHEMICAL,ligustrazine,1245,1257,This study was aimed to explore the in vivo function of Nrf2 in the protective effect of ligustrazine and illustrate downstream mechanisms.
nuclear_receptor_changes_ppara-fatty_liver,/work/eval_papers/PMID_27837167.pdf,abstract,CHEMICAL,Ligustrazine,1559,1571,"Ligustrazine impressively ameliorated hepatic steatosis through inhibiting hepatic sterol regulatory element-binding protein-1c and inducing peroxisome proliferator-activated receptor-alpha, which was abrogated by Nrf2 knockdown."
nuclear_receptor_changes_ppara-fatty_liver,/work/eval_papers/PMID_27837167.pdf,abstract,CHEMICAL,alcohol,1864,1871,"Noteworthily, Nrf2 knockdown apparently reinforced the inductive effect of alcohol on hypoxia-inducible factor 1-alpha (HIF-1α)."
nuclear_receptor_changes_ppara-fatty_liver,/work/eval_papers/PMID_27837167.pdf,abstract,CHEMICAL,alcohol,1959,1966,"Ligustrazine weakened the stimulation of alcohol on HIF-1α expression, which was abrogated by Nrf2 shRNA lentivirus."
nuclear_receptor_changes_ppara-fatty_liver,/work/eval_papers/PMID_27837167.pdf,abstract,CHEMICAL,ligustrazine,2375,2387,"Gain- or loss-of-function analyses further revealed that Nrf2 siRNA and dimethyloxalylglycine, a HIF-1α agonist, abolished the inhibitory effect of ligustrazine, whereas HIF-1α siRNA mimicked the role of ligustrazine and even rescued the inhibitory effect of ligustrazine on ethanol-induced lipid accumulation in Nrf2-knockdown hepatocytes."
nuclear_receptor_changes_ppara-fatty_liver,/work/eval_papers/PMID_27837167.pdf,abstract,CHEMICAL,ligustrazine,2430,2442,"Gain- or loss-of-function analyses further revealed that Nrf2 siRNA and dimethyloxalylglycine, a HIF-1α agonist, abolished the inhibitory effect of ligustrazine, whereas HIF-1α siRNA mimicked the role of ligustrazine and even rescued the inhibitory effect of ligustrazine on ethanol-induced lipid accumulation in Nrf2-knockdown hepatocytes."
nuclear_receptor_changes_ppara-fatty_liver,/work/eval_papers/PMID_27837167.pdf,abstract,CHEMICAL,ligustrazine,2546,2558,"Taken together, we concluded that ligustrazine attenuated alcohol-induced hepatic steatosis via a Nrf2/HIF-1α pathway-dependent mechanism."
nuclear_receptor_changes_ppara-fatty_liver,/work/eval_papers/PMID_27837167.pdf,abstract,SPECIES,Mice,183,187,Nrf2 Activation Is Required for Ligustrazine to Inhibit Hepatic Steatosis in Alcohol-Preferring Mice and Hepatocytes.
nuclear_receptor_changes_ppara-fatty_liver,/work/eval_papers/PMID_27837167.pdf,abstract,SPECIES,St Louis,480,488,"(2)Department of Pathology, School of Medicine, Saint Louis University, St Louis, Missouri."
nuclear_receptor_changes_ppara-steatosis,/work/eval_papers/PMID_27837167.pdf,abstract,CHEMICAL,Medicine,373,381,"Author information: (1)Department of Pharmacology, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China."
nuclear_receptor_changes_ppara-steatosis,/work/eval_papers/PMID_27837167.pdf,abstract,CHEMICAL,Medicine,446,454,"(2)Department of Pathology, School of Medicine, Saint Louis University, St Louis, Missouri."
nuclear_receptor_changes_ppara-steatosis,/work/eval_papers/PMID_27837167.pdf,abstract,CHEMICAL,Medicine,581,589,"(3)Department of Pharmacology, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China; nytws@163.com."
nuclear_receptor_changes_ppara-steatosis,/work/eval_papers/PMID_27837167.pdf,abstract,CHEMICAL,Medicine,753,761,"(4)Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China."
nuclear_receptor_changes_ppara-steatosis,/work/eval_papers/PMID_27837167.pdf,abstract,CHEMICAL,Our,872,875,"Our previous in vivo study showed that ligustrazine, a major active alkaloid isolated from Ligusticum chuanxiong Hort, attenuated alcohol-induced hepatic steatosis and in vitro study revealed that nuclear factor (erythroid-derived 2)-like 2 (Nrf2) activation might be a prerequisite."
nuclear_receptor_changes_ppara-steatosis,/work/eval_papers/PMID_27837167.pdf,abstract,CHEMICAL,ligustrazine,911,923,"Our previous in vivo study showed that ligustrazine, a major active alkaloid isolated from Ligusticum chuanxiong Hort, attenuated alcohol-induced hepatic steatosis and in vitro study revealed that nuclear factor (erythroid-derived 2)-like 2 (Nrf2) activation might be a prerequisite."
nuclear_receptor_changes_ppara-steatosis,/work/eval_papers/PMID_27837167.pdf,abstract,CHEMICAL,ligustrazine,1245,1257,This study was aimed to explore the in vivo function of Nrf2 in the protective effect of ligustrazine and illustrate downstream mechanisms.
nuclear_receptor_changes_ppara-steatosis,/work/eval_papers/PMID_27837167.pdf,abstract,CHEMICAL,Ligustrazine,1559,1571,"Ligustrazine impressively ameliorated hepatic steatosis through inhibiting hepatic sterol regulatory element-binding protein-1c and inducing peroxisome proliferator-activated receptor-alpha, which was abrogated by Nrf2 knockdown."
nuclear_receptor_changes_ppara-steatosis,/work/eval_papers/PMID_27837167.pdf,abstract,CHEMICAL,alcohol,1864,1871,"Noteworthily, Nrf2 knockdown apparently reinforced the inductive effect of alcohol on hypoxia-inducible factor 1-alpha (HIF-1α)."
nuclear_receptor_changes_ppara-steatosis,/work/eval_papers/PMID_27837167.pdf,abstract,CHEMICAL,alcohol,1959,1966,"Ligustrazine weakened the stimulation of alcohol on HIF-1α expression, which was abrogated by Nrf2 shRNA lentivirus."
nuclear_receptor_changes_ppara-steatosis,/work/eval_papers/PMID_27837167.pdf,abstract,CHEMICAL,ligustrazine,2375,2387,"Gain- or loss-of-function analyses further revealed that Nrf2 siRNA and dimethyloxalylglycine, a HIF-1α agonist, abolished the inhibitory effect of ligustrazine, whereas HIF-1α siRNA mimicked the role of ligustrazine and even rescued the inhibitory effect of ligustrazine on ethanol-induced lipid accumulation in Nrf2-knockdown hepatocytes."
nuclear_receptor_changes_ppara-steatosis,/work/eval_papers/PMID_27837167.pdf,abstract,CHEMICAL,ligustrazine,2430,2442,"Gain- or loss-of-function analyses further revealed that Nrf2 siRNA and dimethyloxalylglycine, a HIF-1α agonist, abolished the inhibitory effect of ligustrazine, whereas HIF-1α siRNA mimicked the role of ligustrazine and even rescued the inhibitory effect of ligustrazine on ethanol-induced lipid accumulation in Nrf2-knockdown hepatocytes."
nuclear_receptor_changes_ppara-steatosis,/work/eval_papers/PMID_27837167.pdf,abstract,CHEMICAL,ligustrazine,2546,2558,"Taken together, we concluded that ligustrazine attenuated alcohol-induced hepatic steatosis via a Nrf2/HIF-1α pathway-dependent mechanism."
nuclear_receptor_changes_ppara-steatosis,/work/eval_papers/PMID_27837167.pdf,abstract,SPECIES,Mice,183,187,Nrf2 Activation Is Required for Ligustrazine to Inhibit Hepatic Steatosis in Alcohol-Preferring Mice and Hepatocytes.
nuclear_receptor_changes_ppara-steatosis,/work/eval_papers/PMID_27837167.pdf,abstract,SPECIES,St Louis,480,488,"(2)Department of Pathology, School of Medicine, Saint Louis University, St Louis, Missouri."
nuclear_receptor_changes_ppara-transcription_factor_related_changes_nrf2,/work/eval_papers/PMID_28131861.pdf,abstract,CHEMICAL,State,337,342,"Author information: (1)Department of Health Sciences, College of Public Health, East Tennessee State University, Johnson City, TN, United States."
nuclear_receptor_changes_ppara-transcription_factor_related_changes_nrf2,/work/eval_papers/PMID_28131861.pdf,abstract,CHEMICAL,Medicine,432,440,"(2)Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, New York, United States."
nuclear_receptor_changes_ppara-transcription_factor_related_changes_nrf2,/work/eval_papers/PMID_28131861.pdf,abstract,CHEMICAL,Medicine,551,559,"(3)Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, United States."
nuclear_receptor_changes_ppara-transcription_factor_related_changes_nrf2,/work/eval_papers/PMID_28131861.pdf,abstract,CHEMICAL,Medicine,652,660,"(4)Division of Immunology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, United States."
nuclear_receptor_changes_ppara-transcription_factor_related_changes_nrf2,/work/eval_papers/PMID_28131861.pdf,abstract,CHEMICAL,Medicine,678,686,"(4)Division of Immunology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, United States."
nuclear_receptor_changes_ppara-transcription_factor_related_changes_nrf2,/work/eval_papers/PMID_28131861.pdf,abstract,CHEMICAL,State,813,818,"(5)Department of Health Sciences, College of Public Health, East Tennessee State University, Johnson City, TN, United States; Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, United States."
nuclear_receptor_changes_ppara-transcription_factor_related_changes_nrf2,/work/eval_papers/PMID_28131861.pdf,abstract,CHEMICAL,Medicine,920,928,"(5)Department of Health Sciences, College of Public Health, East Tennessee State University, Johnson City, TN, United States; Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, United States."
nuclear_receptor_changes_ppara-transcription_factor_related_changes_nrf2,/work/eval_papers/PMID_28131861.pdf,abstract,CHEMICAL,address,991,998,Electronic address: luy004@etsu.edu.
nuclear_receptor_changes_ppara-transcription_factor_related_changes_nrf2,/work/eval_papers/PMID_28131861.pdf,abstract,CHEMICAL,AIMS,1030,1034,"BACKGROUND & AIMS: Cytochrome P450 2A5 (CYP2A5) is induced by ethanol, and the ethanol induction of CYP2A5 is regulated by nuclear factor-erythroid 2-related factor 2 (NRF2)."
nuclear_receptor_changes_ppara-transcription_factor_related_changes_nrf2,/work/eval_papers/PMID_28131861.pdf,abstract,CHEMICAL,levels,1822,1828,"Basal FGF21 levels were higher in Cyp2a5-/- mice than in Cyp2a5+/+ mice, but ethanol did not further increase the elevated FGF21 levels in Cyp2a5-/- mice while FGF21 was induced by ethanol in Cyp2a5+/+ mice."
nuclear_receptor_changes_ppara-transcription_factor_related_changes_nrf2,/work/eval_papers/PMID_28131861.pdf,abstract,CHEMICAL,ethanol,1887,1894,"Basal FGF21 levels were higher in Cyp2a5-/- mice than in Cyp2a5+/+ mice, but ethanol did not further increase the elevated FGF21 levels in Cyp2a5-/- mice while FGF21 was induced by ethanol in Cyp2a5+/+ mice."
nuclear_receptor_changes_ppara-transcription_factor_related_changes_nrf2,/work/eval_papers/PMID_28131861.pdf,abstract,CHEMICAL,ethanol,1991,1998,"Basal FGF21 levels were higher in Cyp2a5-/- mice than in Cyp2a5+/+ mice, but ethanol did not further increase the elevated FGF21 levels in Cyp2a5-/- mice while FGF21 was induced by ethanol in Cyp2a5+/+ mice."
nuclear_receptor_changes_ppara-transcription_factor_related_changes_nrf2,/work/eval_papers/PMID_28131861.pdf,abstract,CHEMICAL,ethanol induced,2097,2112,"Basal levels of serum FGF21 were lower in Pparα-/- mice than in Pparα+/+ mice; ethanol induced FGF21 in Pparα+/+ mice but not in Pparα-/- mice, whereas ethanol induced hypertriglyceridemia in Pparα-/- mice but not in Pparα+/+ mice."
nuclear_receptor_changes_ppara-transcription_factor_related_changes_nrf2,/work/eval_papers/PMID_28131861.pdf,abstract,SPECIES,Mice,1624,1628,METHODS: Mice were fed the Lieber-Decarli ethanol diet to induce alcoholic fatty liver.
nuclear_receptor_changes_ppara-transcription_factor_related_changes_nrf2,/work/eval_papers/PMID_28131861.pdf,abstract,SPECIES,mice,2091,2095,"Basal levels of serum FGF21 were lower in Pparα-/- mice than in Pparα+/+ mice; ethanol induced FGF21 in Pparα+/+ mice but not in Pparα-/- mice, whereas ethanol induced hypertriglyceridemia in Pparα-/- mice but not in Pparα+/+ mice."
nuclear_receptor_changes_ppara-transcription_factor_related_changes_nrf2,/work/eval_papers/PMID_28131861.pdf,abstract,SPECIES,mice,2131,2135,"Basal levels of serum FGF21 were lower in Pparα-/- mice than in Pparα+/+ mice; ethanol induced FGF21 in Pparα+/+ mice but not in Pparα-/- mice, whereas ethanol induced hypertriglyceridemia in Pparα-/- mice but not in Pparα+/+ mice."
nuclear_receptor_changes_ppara-transcription_factor_related_changes_nrf2,/work/eval_papers/PMID_28131861.pdf,abstract,SPECIES,mice,2244,2248,"Basal levels of serum FGF21 were lower in Pparα-/- mice than in Pparα+/+ mice; ethanol induced FGF21 in Pparα+/+ mice but not in Pparα-/- mice, whereas ethanol induced hypertriglyceridemia in Pparα-/- mice but not in Pparα+/+ mice."
nuclear_receptor_changes_ppara-transcription_factor_related_changes_nrf2,/work/eval_papers/PMID_28131861.pdf,abstract,SPECIES,mice,2412,2416,Alcoholic fatty liver was enhanced in liver-specific Fgf21 knockout mice.
nuclear_receptor_changes_pparg-de_novo_lipogenesis,/work/eval_papers/PMID_34128319.pdf,abstract,CHEMICAL,Rosiglitazone,535,548,"Rosiglitazone has been reported to exert dual effects on liver steatosis, and it could exacerbate liver steatosis in obese animal models, which was suggested to be closely related to the elevated hepatic expression of FABP4."
nuclear_receptor_changes_pparg-de_novo_lipogenesis,/work/eval_papers/PMID_34128319.pdf,abstract,CHEMICAL,proteins,1166,1174,The expression of hepatic lipogenic genes or proteins in liver tissue or in FFA-treated hepatocytes and PMA-stimulated macrophages were determined by real-time quantitative polymerase chain reaction (RT-qPCR) or western blotting.
nuclear_receptor_changes_pparg-de_novo_lipogenesis,/work/eval_papers/PMID_34128319.pdf,abstract,CHEMICAL,PMID: 34128319,2105,2119,DOI: 10.1111/bcpt.13621 PMID: 34128319 [Indexed for MEDLINE]
nuclear_receptor_changes_pparg-de_novo_lipogenesis,/work/eval_papers/PMID_34128319.pdf,abstract,SPECIES,mice,949,953,"Male C57BL/KsJ-db/db mice were orally treated with rosiglitazone, rosiglitazone combined with I-9 daily for 8 weeks."
nuclear_receptor_changes_pparg-de_novo_lipogenesis,/work/eval_papers/PMID_34128319.pdf,abstract,SPECIES,H&E,1107,1110,The liver steatosis was evaluated by triglyceride content and H&E staining.
nuclear_receptor_changes_pparg-fatty_liver,/work/eval_papers/PMID_29173234.pdf,abstract,CHEMICAL,PPARα/carnitine,250,265,"Dietary α-lactalbumin induced fatty liver by enhancing nuclear liver X receptor αβ/sterol regulatory element-binding protein-1c/PPARγ expression and minimising PPARα/carnitine palmitoyltransferase-1 expression and AMP-activated protein kinase α phosphorylation associated with atherogenic dyslipidaemia, insulin resistance and oxidative stress in Balb/c mice."
nuclear_receptor_changes_pparg-fatty_liver,/work/eval_papers/PMID_29173234.pdf,abstract,CHEMICAL,dyslipidaemia,379,392,"Dietary α-lactalbumin induced fatty liver by enhancing nuclear liver X receptor αβ/sterol regulatory element-binding protein-1c/PPARγ expression and minimising PPARα/carnitine palmitoyltransferase-1 expression and AMP-activated protein kinase α phosphorylation associated with atherogenic dyslipidaemia, insulin resistance and oxidative stress in Balb/c mice."
nuclear_receptor_changes_pparg-fatty_liver,/work/eval_papers/PMID_29173234.pdf,abstract,CHEMICAL,investigate,992,1003,The aim of the present study was to investigate if this atherogenic effect could be due to a possible α-LAC-induced hepatic steatosis.
nuclear_receptor_changes_pparg-fatty_liver,/work/eval_papers/PMID_29173234.pdf,abstract,CHEMICAL,NEFA contents,1553,1566,Moderate liver steatosis with increased TAG and NEFA contents was correlated with atherogenic dyslipidaemia.
nuclear_receptor_changes_pparg-fatty_liver,/work/eval_papers/PMID_29173234.pdf,abstract,CHEMICAL,dyslipidaemia,1599,1612,Moderate liver steatosis with increased TAG and NEFA contents was correlated with atherogenic dyslipidaemia.
nuclear_receptor_changes_pparg-fatty_liver,/work/eval_papers/PMID_29173234.pdf,abstract,CHEMICAL,GSH,2345,2348,These changes were associated with a significant decrease in both p-Thr172-AMP-activated protein kinase α (AMPKα) (inactivation) and p-Ser79-ACC1 (activation) and with a more oxidative liver environment increasing lipid peroxidation and protein oxidation and reducing GSH:GSSG ratio in the α-LAC-fed mice.
nuclear_receptor_changes_pparg-fatty_liver,/work/eval_papers/PMID_29173234.pdf,abstract,CHEMICAL,GSSG,2349,2353,These changes were associated with a significant decrease in both p-Thr172-AMP-activated protein kinase α (AMPKα) (inactivation) and p-Ser79-ACC1 (activation) and with a more oxidative liver environment increasing lipid peroxidation and protein oxidation and reducing GSH:GSSG ratio in the α-LAC-fed mice.
nuclear_receptor_changes_pparg-fatty_liver,/work/eval_papers/PMID_29173234.pdf,abstract,CHEMICAL,dyslipidaemia,2480,2493,"In conclusion, 4 weeks of 14 % α-LAC feeding induced liver steatosis associated with atherogenic dyslipidaemia, IR and oxidative stress by enhancing nuclear LXRαβ/SREBP-1c/PPARγ expression and diminishing PPARα/CPT-1 expression and AMPKα phosphorylation shifting the hepatic FAO toward fatty acid synthesis in Balb/c mice."
nuclear_receptor_changes_pparg-fatty_liver,/work/eval_papers/PMID_29173234.pdf,abstract,SPECIES,Farmacología,664,676,"(2)2Departamento de Farmacología, Facultad de Farmacia,Universidad Complutense,28040 Madrid,Spain."
nuclear_receptor_changes_pparg-fatty_liver,/work/eval_papers/PMID_29173234.pdf,abstract,SPECIES,mice,1367,1371,Male Balb/c mice (n 6) were fed with diets containing either chow or 14 % α-LAC for 4 weeks.
nuclear_receptor_changes_pparg-fatty_liver,/work/eval_papers/PMID_29173234.pdf,abstract,SPECIES,mice,1462,1466,The α-LAC-fed mice developed abdominal adiposity and IR.
nuclear_receptor_changes_pparg-fatty_liver,/work/eval_papers/PMID_29173234.pdf,abstract,SPECIES,mice,2377,2381,These changes were associated with a significant decrease in both p-Thr172-AMP-activated protein kinase α (AMPKα) (inactivation) and p-Ser79-ACC1 (activation) and with a more oxidative liver environment increasing lipid peroxidation and protein oxidation and reducing GSH:GSSG ratio in the α-LAC-fed mice.
nuclear_receptor_changes_pparg-fatty_liver,/work/eval_papers/PMID_30562559.pdf,abstract,CHEMICAL,2019,39,43,1. Biochim Biophys Acta Mol Basis Dis. 2019 Mar 1;1865(3):525-534. doi: 10.1016/j.bbadis.2018.12.014. Epub 2018 Dec 15. Hepatic mTOR-AKT2-Insig2 signaling pathway contributes to the improvement of hepatic steatosis after Roux-en-Y Gastric Bypass in mice.
nuclear_receptor_changes_pparg-fatty_liver,/work/eval_papers/PMID_30562559.pdf,abstract,CHEMICAL,Medicine,393,401,"Author information: (1)Department of Physiology, School of Medicine, Jinan University, 601 Huangpu Avenue West, Tianhe District, Guangzhou, Guangdong 510632, China."
nuclear_receptor_changes_pparg-fatty_liver,/work/eval_papers/PMID_30562559.pdf,abstract,CHEMICAL,Medicine,813,821,"(2)Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Peking University, Beijing 100191, China. (3)Endoscopy Center, The First Affiliated Hospital of Jinan University, 613 Huangpu Avenue West, Tianhe District, Guangzhou, Guangdong 510630, China. (4)Department of Physiology, School of Medicine, Jinan University, 601 Huangpu Avenue West, Tianhe District, Guangzhou, Guangdong 510632, China. Electronic address: xugeyangliang@163.com. Roux-en-Y Gastric Bypass (RYGB) remains one of the most effective options in treatment of non-alcoholic fatty liver disease (NAFLD)."
nuclear_receptor_changes_pparg-fatty_liver,/work/eval_papers/PMID_30562559.pdf,abstract,CHEMICAL,address,930,937,"(2)Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Peking University, Beijing 100191, China. (3)Endoscopy Center, The First Affiliated Hospital of Jinan University, 613 Huangpu Avenue West, Tianhe District, Guangzhou, Guangdong 510630, China. (4)Department of Physiology, School of Medicine, Jinan University, 601 Huangpu Avenue West, Tianhe District, Guangzhou, Guangdong 510632, China. Electronic address: xugeyangliang@163.com. Roux-en-Y Gastric Bypass (RYGB) remains one of the most effective options in treatment of non-alcoholic fatty liver disease (NAFLD)."
nuclear_receptor_changes_pparg-fatty_liver,/work/eval_papers/PMID_30562559.pdf,abstract,CHEMICAL,xugeyangliang@163.com,939,960,"(2)Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Peking University, Beijing 100191, China. (3)Endoscopy Center, The First Affiliated Hospital of Jinan University, 613 Huangpu Avenue West, Tianhe District, Guangzhou, Guangdong 510630, China. (4)Department of Physiology, School of Medicine, Jinan University, 601 Huangpu Avenue West, Tianhe District, Guangzhou, Guangdong 510632, China. Electronic address: xugeyangliang@163.com. Roux-en-Y Gastric Bypass (RYGB) remains one of the most effective options in treatment of non-alcoholic fatty liver disease (NAFLD)."
nuclear_receptor_changes_pparg-fatty_liver,/work/eval_papers/PMID_30562559.pdf,abstract,CHEMICAL,rapamycin,1221,1230,"Here, we evaluated the relationship among hepatic mechanistic target of rapamycin (mTOR)-AKT2-insulin-induced gene 2 (Insig2) signaling, lipogenic transcription factors and lipid synthesis enzymes in obese mice with or without RYGB operation."
nuclear_receptor_changes_pparg-fatty_liver,/work/eval_papers/PMID_30562559.pdf,abstract,CHEMICAL,rapamycin,1706,1715,"Hepatic mTOR activity and Insig2a were stimulated, while AKT2, sterol response element-binding protein 1c (SREBP1c), peroxisome proliferator-activated receptor γ (PPARγ), lipogenic genes such as acetyl-CoA carboxylase (ACC) and fatty acid synthase (FAS) were decreased by Roux-en-Y Gastric Bypass in both DMSO and rapamycin treated diet-induced obese (DIO) mice."
nuclear_receptor_changes_pparg-fatty_liver,/work/eval_papers/PMID_30562559.pdf,abstract,CHEMICAL,rapamycin,1829,1838,Increment of hepatic lipogenesis and decline of mTOR signaling induced by rapamycin were significantly reversed by RYGB in DIO mice.
nuclear_receptor_changes_pparg-fatty_liver,/work/eval_papers/PMID_30562559.pdf,abstract,CHEMICAL,Our,2349,2352,Our results suggest that mTOR-AKT2-Insig2 signaling pathway contributes to the improvement effect of RYGB on hepatic steatosis induced by high-fat diet.
nuclear_receptor_changes_pparg-fatty_liver,/work/eval_papers/PMID_30562559.pdf,abstract,CHEMICAL,PMID: 30562559 [Indexed for MEDLINE],2588,2624,DOI: 10.1016/j.bbadis.2018.12.014 PMID: 30562559 [Indexed for MEDLINE]
nuclear_receptor_changes_pparg-fatty_liver,/work/eval_papers/PMID_30562559.pdf,abstract,SPECIES,Gastric Bypass,231,245,1. Biochim Biophys Acta Mol Basis Dis. 2019 Mar 1;1865(3):525-534. doi: 10.1016/j.bbadis.2018.12.014. Epub 2018 Dec 15. Hepatic mTOR-AKT2-Insig2 signaling pathway contributes to the improvement of hepatic steatosis after Roux-en-Y Gastric Bypass in mice.
nuclear_receptor_changes_pparg-fatty_liver,/work/eval_papers/PMID_30562559.pdf,abstract,SPECIES,mice,249,253,1. Biochim Biophys Acta Mol Basis Dis. 2019 Mar 1;1865(3):525-534. doi: 10.1016/j.bbadis.2018.12.014. Epub 2018 Dec 15. Hepatic mTOR-AKT2-Insig2 signaling pathway contributes to the improvement of hepatic steatosis after Roux-en-Y Gastric Bypass in mice.
nuclear_receptor_changes_pparg-fatty_liver,/work/eval_papers/PMID_30562559.pdf,abstract,SPECIES,Gastric,972,979,"(2)Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Peking University, Beijing 100191, China. (3)Endoscopy Center, The First Affiliated Hospital of Jinan University, 613 Huangpu Avenue West, Tianhe District, Guangzhou, Guangdong 510630, China. (4)Department of Physiology, School of Medicine, Jinan University, 601 Huangpu Avenue West, Tianhe District, Guangzhou, Guangdong 510632, China. Electronic address: xugeyangliang@163.com. Roux-en-Y Gastric Bypass (RYGB) remains one of the most effective options in treatment of non-alcoholic fatty liver disease (NAFLD)."
nuclear_receptor_changes_pparg-fatty_liver,/work/eval_papers/PMID_30562559.pdf,abstract,SPECIES,mice,1355,1359,"Here, we evaluated the relationship among hepatic mechanistic target of rapamycin (mTOR)-AKT2-insulin-induced gene 2 (Insig2) signaling, lipogenic transcription factors and lipid synthesis enzymes in obese mice with or without RYGB operation."
nuclear_receptor_changes_pparg-fatty_liver,/work/eval_papers/PMID_30562559.pdf,abstract,SPECIES,mouse,2330,2335,Ad-S6K1 decreased oleic acid-induced lipid deposition in primary mouse hepatocytes.
nuclear_receptor_changes_pparg-novel_inflammation,/work/eval_papers/PMID_27062444.pdf,abstract,CHEMICAL,Alcohol,3,10,Alcohol Clin Exp Res. 2016 May;40(5):988-99. doi: 10.1111/acer.13049.
nuclear_receptor_changes_pparg-novel_inflammation,/work/eval_papers/PMID_27062444.pdf,abstract,CHEMICAL,alcohol,1118,1125,"METHODS: To determine the role of hepatic PPARγ signaling on ALD, wild-type (WT) and hepatocyte-specific PPARγ knockdown (PPARγ∆Hep) mice were fed a modified Lieber-DeCarli alcohol or isocaloric maltose dextrin control liquid diet for 8 weeks to induce ALD."
nuclear_receptor_changes_pparg-novel_inflammation,/work/eval_papers/PMID_27062444.pdf,abstract,CHEMICAL,alcohol,1284,1291,"Blood parameters, hepatic steatosis, and inflammation were measured after 8-week alcohol feeding."
nuclear_receptor_changes_pparg-novel_inflammation,/work/eval_papers/PMID_27062444.pdf,abstract,CHEMICAL,Alcohol,1310,1317,"RESULTS: Alcohol feeding to WT mice resulted in liver damage (alanine aminotransferase [ALT], 94.68 ± 17.05 U/L; aspartate aminotransferase [AST], 55.87 ± 11.29 U/L), which was significantly alleviated by hepatic PPARγ knockdown (ALT, 57.36 ± 14.98 U/L; AST, 38.06 ± 3.35 U/L)."
nuclear_receptor_changes_pparg-novel_inflammation,/work/eval_papers/PMID_27062444.pdf,abstract,CHEMICAL,alanine,1363,1370,"RESULTS: Alcohol feeding to WT mice resulted in liver damage (alanine aminotransferase [ALT], 94.68 ± 17.05 U/L; aspartate aminotransferase [AST], 55.87 ± 11.29 U/L), which was significantly alleviated by hepatic PPARγ knockdown (ALT, 57.36 ± 14.98 U/L; AST, 38.06 ± 3.35 U/L)."
nuclear_receptor_changes_pparg-novel_inflammation,/work/eval_papers/PMID_27062444.pdf,abstract,CHEMICAL,aspartate,1414,1423,"RESULTS: Alcohol feeding to WT mice resulted in liver damage (alanine aminotransferase [ALT], 94.68 ± 17.05 U/L; aspartate aminotransferase [AST], 55.87 ± 11.29 U/L), which was significantly alleviated by hepatic PPARγ knockdown (ALT, 57.36 ± 14.98 U/L; AST, 38.06 ± 3.35 U/L)."
nuclear_receptor_changes_pparg-novel_inflammation,/work/eval_papers/PMID_27062444.pdf,abstract,CHEMICAL,± 3.35,1566,1572,"RESULTS: Alcohol feeding to WT mice resulted in liver damage (alanine aminotransferase [ALT], 94.68 ± 17.05 U/L; aspartate aminotransferase [AST], 55.87 ± 11.29 U/L), which was significantly alleviated by hepatic PPARγ knockdown (ALT, 57.36 ± 14.98 U/L; AST, 38.06 ± 3.35 U/L)."
nuclear_receptor_changes_pparg-novel_inflammation,/work/eval_papers/PMID_27062444.pdf,abstract,CHEMICAL,Alcohol,1579,1586,"Alcohol feeding led to marked lipid accumulation and up-regulation of lipogenic genes including fatty acid transport protein 1 (FATP1), acetyl-CoA carboxylase (ACC), fatty acid synthase (FASN), lipin1 (LIPIN1), diacylglycerol acyltransferase 1 (DGAT1), and diacylglycerol acyltransferase 2 (DGAT2) in the livers of WT mice."
nuclear_receptor_changes_pparg-novel_inflammation,/work/eval_papers/PMID_27062444.pdf,abstract,CHEMICAL,"keratinocyte-derived chemokine [KC], interferon",2329,2376,"Knockdown of hepatic PPARγ also significantly reduced alcohol-induced inflammatory chemokine (monocyte chemotactic protein 1 [MCP1], keratinocyte-derived chemokine [KC], interferon gamma-induced protein 10 [IP-10]) and inflammatory infiltration (lymphocyte antigen 6 complex, locus G [Ly6G], and F4/80)."
nuclear_receptor_changes_pparg-novel_inflammation,/work/eval_papers/PMID_27062444.pdf,abstract,CHEMICAL,Ly6G,2481,2485,"Knockdown of hepatic PPARγ also significantly reduced alcohol-induced inflammatory chemokine (monocyte chemotactic protein 1 [MCP1], keratinocyte-derived chemokine [KC], interferon gamma-induced protein 10 [IP-10]) and inflammatory infiltration (lymphocyte antigen 6 complex, locus G [Ly6G], and F4/80)."
nuclear_receptor_changes_pparg-novel_inflammation,/work/eval_papers/PMID_27062444.pdf,abstract,CHEMICAL,promoting hepatic steatosis,2609,2636,CONCLUSIONS: The results suggest that hepatic PPARγ signaling contributes to alcohol-induced liver injury by promoting hepatic steatosis and inflammation.
nuclear_receptor_changes_pparg-novel_inflammation,/work/eval_papers/PMID_27062444.pdf,abstract,CHEMICAL,Alcoholism,2699,2709,Copyright © 2016 by the Research Society on Alcoholism.
nuclear_receptor_changes_pparg-novel_inflammation,/work/eval_papers/PMID_27062444.pdf,abstract,SPECIES,Mice,226,230,Hepatic Peroxisome Proliferator-Activated Receptor Gamma Signaling Contributes to Alcohol-Induced Hepatic Steatosis and Inflammation in Mice.
nuclear_receptor_changes_pparg-novel_inflammation,/work/eval_papers/PMID_27062444.pdf,abstract,SPECIES,human,841,846,Previous studies have shown that hepatic PPARγ is up-regulated in steatotic liver of both animal and human.
nuclear_receptor_changes_pparg-steatosis,/work/eval_papers/PMID_28465000.pdf,abstract,CHEMICAL,adipocytokines,171,185,Long-term soft drink and aspartame intake induces hepatic damage via dysregulation of adipocytokines and alteration of the lipid profile and antioxidant status.
nuclear_receptor_changes_pparg-steatosis,/work/eval_papers/PMID_28465000.pdf,abstract,CHEMICAL,Lebda,246,251,"Lebda MA(1), Tohamy HG(2), El-Sayed YS(3)."
nuclear_receptor_changes_pparg-steatosis,/work/eval_papers/PMID_28465000.pdf,abstract,CHEMICAL,Medicine,362,370,"Author information: (1)Department of Biochemistry, Faculty of Veterinary Medicine, Alexandria University, Edfina 22758, Egypt. Electronic address: mohamed.a.mohamed@alexu.edu.eg."
nuclear_receptor_changes_pparg-steatosis,/work/eval_papers/PMID_28465000.pdf,abstract,CHEMICAL,address,427,434,"Author information: (1)Department of Biochemistry, Faculty of Veterinary Medicine, Alexandria University, Edfina 22758, Egypt. Electronic address: mohamed.a.mohamed@alexu.edu.eg."
nuclear_receptor_changes_pparg-steatosis,/work/eval_papers/PMID_28465000.pdf,abstract,CHEMICAL,Medicine,518,526,"(2)Department of Pathology, Faculty of Veterinary Medicine, Alexandria University, Edfina 22758, Egypt."
nuclear_receptor_changes_pparg-steatosis,/work/eval_papers/PMID_28465000.pdf,abstract,CHEMICAL,address,583,590,Electronic address: hossam.gafar@yahoo.com.
nuclear_receptor_changes_pparg-steatosis,/work/eval_papers/PMID_28465000.pdf,abstract,CHEMICAL,Medicine,642,650,"(3)Department of Forensic Medicine and Toxicology, Faculty of Veterinary Medicine, Damanhour University, Damanhour 22511, Egypt."
nuclear_receptor_changes_pparg-steatosis,/work/eval_papers/PMID_28465000.pdf,abstract,CHEMICAL,Medicine,689,697,"(3)Department of Forensic Medicine and Toxicology, Faculty of Veterinary Medicine, Damanhour University, Damanhour 22511, Egypt."
nuclear_receptor_changes_pparg-steatosis,/work/eval_papers/PMID_28465000.pdf,abstract,CHEMICAL,address,756,763,Electronic address: yasser_tf@yahoo.com.
nuclear_receptor_changes_pparg-steatosis,/work/eval_papers/PMID_28465000.pdf,abstract,CHEMICAL,glucose,1515,1522,"Subchronic intake of soft drink or aspartame substantially induced hyperglycemia and hypertriacylglycerolemia, as represented by increased serum glucose, triacylglycerol, low-density lipoprotein and very low-density lipoprotein cholesterol, with obvious visceral fatty deposition."
nuclear_receptor_changes_pparg-steatosis,/work/eval_papers/PMID_28465000.pdf,abstract,CHEMICAL,cholesterol,1598,1609,"Subchronic intake of soft drink or aspartame substantially induced hyperglycemia and hypertriacylglycerolemia, as represented by increased serum glucose, triacylglycerol, low-density lipoprotein and very low-density lipoprotein cholesterol, with obvious visceral fatty deposition."
nuclear_receptor_changes_pparg-steatosis,/work/eval_papers/PMID_28465000.pdf,abstract,CHEMICAL,malondialdehyde,1939,1954,"Moreover, alterations in serum transaminases accompanied by hepatic oxidative stress involving induction of malondialdehyde and reduction of superoxide dismutase, catalase, and glutathione peroxidase and glutathione levels are indicative of oxidative hepatic damage."
nuclear_receptor_changes_pparg-steatosis,/work/eval_papers/PMID_28465000.pdf,abstract,CHEMICAL,superoxide,1972,1982,"Moreover, alterations in serum transaminases accompanied by hepatic oxidative stress involving induction of malondialdehyde and reduction of superoxide dismutase, catalase, and glutathione peroxidase and glutathione levels are indicative of oxidative hepatic damage."
nuclear_receptor_changes_pparg-steatosis,/work/eval_papers/PMID_28465000.pdf,abstract,CHEMICAL,glutathione,2008,2019,"Moreover, alterations in serum transaminases accompanied by hepatic oxidative stress involving induction of malondialdehyde and reduction of superoxide dismutase, catalase, and glutathione peroxidase and glutathione levels are indicative of oxidative hepatic damage."
nuclear_receptor_changes_pparg-steatosis,/work/eval_papers/PMID_28465000.pdf,abstract,CHEMICAL,glutathione,2035,2046,"Moreover, alterations in serum transaminases accompanied by hepatic oxidative stress involving induction of malondialdehyde and reduction of superoxide dismutase, catalase, and glutathione peroxidase and glutathione levels are indicative of oxidative hepatic damage."
nuclear_receptor_changes_pparg-steatosis,/work/eval_papers/PMID_28465000.pdf,abstract,SPECIES,Rats,1128,1132,"Rats were assigned to drink water, cola soft drink (free access) and aspartame (240 mg/kg body weight/day orally) for 2 months."
nuclear_receptor_changes_pxr-novel_inflammation,/work/eval_papers/PMID_30677459.pdf,abstract,CHEMICAL,2019 Jan,76,84,doi: 10.1016/j.jhep.2018.12.038. Epub 2019 Jan 21.
nuclear_receptor_changes_pxr-novel_inflammation,/work/eval_papers/PMID_30677459.pdf,abstract,CHEMICAL,Sui,236,239,"Gwag T(1), Meng Z(1), Sui Y(1), Helsley RN(1), Park SH(1), Wang S(1), Greenberg RN(2), Zhou C(3)."
nuclear_receptor_changes_pxr-novel_inflammation,/work/eval_papers/PMID_30677459.pdf,abstract,CHEMICAL,Medicine,449,457,"(2)Department of Medicine, University of Kentucky, Lexington, KY, USA."
nuclear_receptor_changes_pxr-novel_inflammation,/work/eval_papers/PMID_30677459.pdf,abstract,CHEMICAL,address,614,621,Electronic address: c.zhou@uky.edu.
nuclear_receptor_changes_pxr-novel_inflammation,/work/eval_papers/PMID_30677459.pdf,abstract,CHEMICAL,AIMS,733,737,"BACKGROUND & AIMS: The most prescribed non-nucleoside reverse transcriptase inhibitor, efavirenz, has been associated with elevated risk of dyslipidemia and hepatic steatosis in HIV-infected patients but the underlying mechanisms remain elusive."
nuclear_receptor_changes_pxr-novel_inflammation,/work/eval_papers/PMID_30677459.pdf,abstract,CHEMICAL,impact,1258,1264,"METHODS: Cell-based reporter assays, primary cell culture, and multiple mouse models including conditional knockout and humanized mice were combined to study the impact of efavirenz on PXR activities and lipid homeostasis in vitro and in vivo."
nuclear_receptor_changes_pxr-novel_inflammation,/work/eval_papers/PMID_30677459.pdf,abstract,CHEMICAL,cholesterol,1983,1994,"Interestingly, efavirenz-mediated PXR activation regulated the expression of several key hepatic lipogenic genes including fatty acid transporter CD36 and cholesterol biosynthesis enzyme squalene epoxidase (SQLE), leading to increased lipid uptake and cholesterol biosynthesis in hepatic cells."
nuclear_receptor_changes_pxr-novel_inflammation,/work/eval_papers/PMID_30677459.pdf,abstract,CHEMICAL,SQLE,2035,2039,"Interestingly, efavirenz-mediated PXR activation regulated the expression of several key hepatic lipogenic genes including fatty acid transporter CD36 and cholesterol biosynthesis enzyme squalene epoxidase (SQLE), leading to increased lipid uptake and cholesterol biosynthesis in hepatic cells."
nuclear_receptor_changes_pxr-novel_inflammation,/work/eval_papers/PMID_30677459.pdf,abstract,CHEMICAL,cholesterol biosynthesis,2080,2104,"Interestingly, efavirenz-mediated PXR activation regulated the expression of several key hepatic lipogenic genes including fatty acid transporter CD36 and cholesterol biosynthesis enzyme squalene epoxidase (SQLE), leading to increased lipid uptake and cholesterol biosynthesis in hepatic cells."
nuclear_receptor_changes_pxr-novel_inflammation,/work/eval_papers/PMID_30677459.pdf,abstract,CHEMICAL,levels,2865,2871,It can increase lipid levels in patients' blood and liver.
nuclear_receptor_changes_pxr-novel_inflammation,/work/eval_papers/PMID_30677459.pdf,abstract,CHEMICAL,levels,3034,3040,Here we show that efavirenz can activate a unique liver protein called PXR which mediates the adverse effects of efavirenz on lipid levels in mouse models.
nuclear_receptor_changes_pxr-novel_inflammation,/work/eval_papers/PMID_30677459.pdf,abstract,SPECIES,patients,911,919,"BACKGROUND & AIMS: The most prescribed non-nucleoside reverse transcriptase inhibitor, efavirenz, has been associated with elevated risk of dyslipidemia and hepatic steatosis in HIV-infected patients but the underlying mechanisms remain elusive."
nuclear_receptor_changes_pxr-novel_inflammation,/work/eval_papers/PMID_30677459.pdf,abstract,SPECIES,mouse,1168,1173,"METHODS: Cell-based reporter assays, primary cell culture, and multiple mouse models including conditional knockout and humanized mice were combined to study the impact of efavirenz on PXR activities and lipid homeostasis in vitro and in vivo."
nuclear_receptor_changes_pxr-novel_inflammation,/work/eval_papers/PMID_30677459.pdf,abstract,SPECIES,mice,1226,1230,"METHODS: Cell-based reporter assays, primary cell culture, and multiple mouse models including conditional knockout and humanized mice were combined to study the impact of efavirenz on PXR activities and lipid homeostasis in vitro and in vivo."
nuclear_receptor_changes_pxr-novel_inflammation,/work/eval_papers/PMID_30677459.pdf,abstract,SPECIES,mouse,1376,1381,A novel liver-specific Pxr knockout mouse model was also generated to determine the contribution of hepatic PXR signaling to efavirenz-elicited dyslipidemia and hepatic steatosis.
nuclear_receptor_changes_pxr-novel_inflammation,/work/eval_papers/PMID_30677459.pdf,abstract,SPECIES,mice,1760,1764,Treatment with efavirenz-induced hypercholesterolemia and hepatic steatosis in mice but deficiency of hepatic PXR abolished these adverse effects.
nuclear_receptor_changes_pxr-novel_inflammation,/work/eval_papers/PMID_30677459.pdf,abstract,SPECIES,mice,2427,2431,"Since PXR exhibits considerable differences in its pharmacology across species, we also confirmed these findings in PXR-humanized mice and human primary hepatocytes."
nuclear_receptor_changes_pxr-novel_inflammation,/work/eval_papers/PMID_30677459.pdf,abstract,SPECIES,human,2436,2441,"Since PXR exhibits considerable differences in its pharmacology across species, we also confirmed these findings in PXR-humanized mice and human primary hepatocytes."
nuclear_receptor_changes_pxr-novel_inflammation,/work/eval_papers/PMID_30677459.pdf,abstract,SPECIES,patients,2665,2673,Activation of PXR should be taken into consideration for patients undergoing long-term treatment with PXR agonistic antiretroviral drugs.
nuclear_receptor_changes_pxr-novel_inflammation,/work/eval_papers/PMID_30677459.pdf,abstract,SPECIES,patients,2807,2815,LAY SUMMARY: Efavirenz is widely prescribed for HIV-infected patients but has some side effects.
nuclear_receptor_changes_pxr-novel_inflammation,/work/eval_papers/PMID_30677459.pdf,abstract,SPECIES,patients,2875,2883,It can increase lipid levels in patients' blood and liver.
nuclear_receptor_changes_pxr-novel_inflammation,/work/eval_papers/PMID_30677459.pdf,abstract,SPECIES,mouse,3044,3049,Here we show that efavirenz can activate a unique liver protein called PXR which mediates the adverse effects of efavirenz on lipid levels in mouse models.
other_receptor_changes_ahr-fa_uptake,/work/eval_papers/PMID_30452912.pdf,abstract,CHEMICAL,2019 Jan,20,28,1. Eur J Pharmacol. 2019 Jan 15;843:162-176. doi: 10.1016/j.ejphar.2018.11.018. Epub 2018 Nov 16.
other_receptor_changes_ahr-fa_uptake,/work/eval_papers/PMID_30452912.pdf,abstract,CHEMICAL,adipose,120,127,Elevated lipolysis in adipose tissue by doxorubicin via PPARα activation associated with hepatic steatosis and insulin resistance.
other_receptor_changes_ahr-fa_uptake,/work/eval_papers/PMID_30452912.pdf,abstract,CHEMICAL,doxorubicin,138,149,Elevated lipolysis in adipose tissue by doxorubicin via PPARα activation associated with hepatic steatosis and insulin resistance.
other_receptor_changes_ahr-fa_uptake,/work/eval_papers/PMID_30452912.pdf,abstract,CHEMICAL,K B,240,243,"Renu K(1), K B S(1), Parthiban S(1), S S(1), George A(2), P B TP(3), Suman S(4), V G A(5), Arunachalam S(6)."
other_receptor_changes_ahr-fa_uptake,/work/eval_papers/PMID_30452912.pdf,abstract,CHEMICAL,P B,287,290,"Renu K(1), K B S(1), Parthiban S(1), S S(1), George A(2), P B TP(3), Suman S(4), V G A(5), Arunachalam S(6)."
other_receptor_changes_ahr-fa_uptake,/work/eval_papers/PMID_30452912.pdf,abstract,CHEMICAL,VIT,434,437,"Author information: (1)Department of Biomedical Sciences, School of Biosciences and Technology, VIT, Vellore, Tamil Nadu 632014, India. (2)Jubilee Centre for Medical Research, Jubilee Mission Medical College and Research Institute, Thrissur, Kerala, India."
other_receptor_changes_ahr-fa_uptake,/work/eval_papers/PMID_30452912.pdf,abstract,CHEMICAL,NRB,845,848,"(4)Department of Oncology, Lombardi Comprehensive Cancer Center (LCCC), Georgetown University Medical Center (GUMC), E504, NRB, 3970 Reservoir Rd."
other_receptor_changes_ahr-fa_uptake,/work/eval_papers/PMID_30452912.pdf,abstract,CHEMICAL,VIT,972,975,"(5)Department of Biomedical Sciences, School of Biosciences and Technology, VIT, Vellore, Tamil Nadu 632014, India."
other_receptor_changes_ahr-fa_uptake,/work/eval_papers/PMID_30452912.pdf,abstract,CHEMICAL,address,1023,1030,Electronic address: abilash.vg@vit.ac.in.
other_receptor_changes_ahr-fa_uptake,/work/eval_papers/PMID_30452912.pdf,abstract,CHEMICAL,address,1185,1192,"(6)Department of Biotechnology, Kalasalingam Academy of Research and Education, Krishnankoil 626126, Tamil Nadu, India. Electronic address: sankarganesh@klu.ac.in."
other_receptor_changes_ahr-fa_uptake,/work/eval_papers/PMID_30452912.pdf,abstract,CHEMICAL,Doxorubicin,1317,1328,Doxorubicin would disturb the lipid metabolism both in adipose and liver.
other_receptor_changes_ahr-fa_uptake,/work/eval_papers/PMID_30452912.pdf,abstract,CHEMICAL,doxorubicin,1414,1425,Here we projected that doxorubicin would impede lipogenesis and elevated lipolysis in adipose tissue would elevate the circulatory lipid profile and leads to insulin resistance.
other_receptor_changes_ahr-fa_uptake,/work/eval_papers/PMID_30452912.pdf,abstract,CHEMICAL,adipose,1477,1484,Here we projected that doxorubicin would impede lipogenesis and elevated lipolysis in adipose tissue would elevate the circulatory lipid profile and leads to insulin resistance.
other_receptor_changes_ahr-fa_uptake,/work/eval_papers/PMID_30452912.pdf,abstract,CHEMICAL,doxorubicin,1747,1758,Further exacerbated lipid profile in circulation would impair the lipid metabolism in hepatic tissue which leads to fatty liver condition and consequently related disease during doxorubicin treatment.
other_receptor_changes_ahr-fa_uptake,/work/eval_papers/PMID_30452912.pdf,abstract,CHEMICAL,Doxorubicin,1770,1781,Doxorubicin impairs the lipogenesis through PPARγ and augments lipolysis and fatty acid oxidation through ATGL and PPARα in adipose tissue.
other_receptor_changes_ahr-fa_uptake,/work/eval_papers/PMID_30452912.pdf,abstract,CHEMICAL,adipose,1940,1947,"Increased fatty acid level by adipose tissue in circulation would translocate into the liver and dysregulates AHR, PXR, PPARγ, ATGL and Apo B,which further develop insulin resistance and hepatic steatosis condition."
other_receptor_changes_ahr-fa_uptake,/work/eval_papers/PMID_30452912.pdf,abstract,CHEMICAL,Apo B,2046,2051,"Increased fatty acid level by adipose tissue in circulation would translocate into the liver and dysregulates AHR, PXR, PPARγ, ATGL and Apo B,which further develop insulin resistance and hepatic steatosis condition."
other_receptor_changes_ahr-fa_uptake,/work/eval_papers/PMID_30452912.pdf,abstract,SPECIES,doxorubicin,1747,1758,Further exacerbated lipid profile in circulation would impair the lipid metabolism in hepatic tissue which leads to fatty liver condition and consequently related disease during doxorubicin treatment.
other_receptor_changes_ahr-liver_triglyceride_accumulation,/work/eval_papers/PMID_30452912.pdf,abstract,CHEMICAL,2019 Jan,20,28,1. Eur J Pharmacol. 2019 Jan 15;843:162-176. doi: 10.1016/j.ejphar.2018.11.018. Epub 2018 Nov 16.
other_receptor_changes_ahr-liver_triglyceride_accumulation,/work/eval_papers/PMID_30452912.pdf,abstract,CHEMICAL,adipose,120,127,Elevated lipolysis in adipose tissue by doxorubicin via PPARα activation associated with hepatic steatosis and insulin resistance.
other_receptor_changes_ahr-liver_triglyceride_accumulation,/work/eval_papers/PMID_30452912.pdf,abstract,CHEMICAL,doxorubicin,138,149,Elevated lipolysis in adipose tissue by doxorubicin via PPARα activation associated with hepatic steatosis and insulin resistance.
other_receptor_changes_ahr-liver_triglyceride_accumulation,/work/eval_papers/PMID_30452912.pdf,abstract,CHEMICAL,K B,240,243,"Renu K(1), K B S(1), Parthiban S(1), S S(1), George A(2), P B TP(3), Suman S(4), V G A(5), Arunachalam S(6)."
other_receptor_changes_ahr-liver_triglyceride_accumulation,/work/eval_papers/PMID_30452912.pdf,abstract,CHEMICAL,P B,287,290,"Renu K(1), K B S(1), Parthiban S(1), S S(1), George A(2), P B TP(3), Suman S(4), V G A(5), Arunachalam S(6)."
other_receptor_changes_ahr-liver_triglyceride_accumulation,/work/eval_papers/PMID_30452912.pdf,abstract,CHEMICAL,VIT,434,437,"Author information: (1)Department of Biomedical Sciences, School of Biosciences and Technology, VIT, Vellore, Tamil Nadu 632014, India. (2)Jubilee Centre for Medical Research, Jubilee Mission Medical College and Research Institute, Thrissur, Kerala, India."
other_receptor_changes_ahr-liver_triglyceride_accumulation,/work/eval_papers/PMID_30452912.pdf,abstract,CHEMICAL,NRB,845,848,"(4)Department of Oncology, Lombardi Comprehensive Cancer Center (LCCC), Georgetown University Medical Center (GUMC), E504, NRB, 3970 Reservoir Rd."
other_receptor_changes_ahr-liver_triglyceride_accumulation,/work/eval_papers/PMID_30452912.pdf,abstract,CHEMICAL,VIT,972,975,"(5)Department of Biomedical Sciences, School of Biosciences and Technology, VIT, Vellore, Tamil Nadu 632014, India."
other_receptor_changes_ahr-liver_triglyceride_accumulation,/work/eval_papers/PMID_30452912.pdf,abstract,CHEMICAL,address,1023,1030,Electronic address: abilash.vg@vit.ac.in.
other_receptor_changes_ahr-liver_triglyceride_accumulation,/work/eval_papers/PMID_30452912.pdf,abstract,CHEMICAL,address,1185,1192,"(6)Department of Biotechnology, Kalasalingam Academy of Research and Education, Krishnankoil 626126, Tamil Nadu, India. Electronic address: sankarganesh@klu.ac.in."
other_receptor_changes_ahr-liver_triglyceride_accumulation,/work/eval_papers/PMID_30452912.pdf,abstract,CHEMICAL,Doxorubicin,1317,1328,Doxorubicin would disturb the lipid metabolism both in adipose and liver.
other_receptor_changes_ahr-liver_triglyceride_accumulation,/work/eval_papers/PMID_30452912.pdf,abstract,CHEMICAL,doxorubicin,1414,1425,Here we projected that doxorubicin would impede lipogenesis and elevated lipolysis in adipose tissue would elevate the circulatory lipid profile and leads to insulin resistance.
other_receptor_changes_ahr-liver_triglyceride_accumulation,/work/eval_papers/PMID_30452912.pdf,abstract,CHEMICAL,adipose,1477,1484,Here we projected that doxorubicin would impede lipogenesis and elevated lipolysis in adipose tissue would elevate the circulatory lipid profile and leads to insulin resistance.
other_receptor_changes_ahr-liver_triglyceride_accumulation,/work/eval_papers/PMID_30452912.pdf,abstract,CHEMICAL,doxorubicin,1747,1758,Further exacerbated lipid profile in circulation would impair the lipid metabolism in hepatic tissue which leads to fatty liver condition and consequently related disease during doxorubicin treatment.
other_receptor_changes_ahr-liver_triglyceride_accumulation,/work/eval_papers/PMID_30452912.pdf,abstract,CHEMICAL,Doxorubicin,1770,1781,Doxorubicin impairs the lipogenesis through PPARγ and augments lipolysis and fatty acid oxidation through ATGL and PPARα in adipose tissue.
other_receptor_changes_ahr-liver_triglyceride_accumulation,/work/eval_papers/PMID_30452912.pdf,abstract,CHEMICAL,adipose,1940,1947,"Increased fatty acid level by adipose tissue in circulation would translocate into the liver and dysregulates AHR, PXR, PPARγ, ATGL and Apo B,which further develop insulin resistance and hepatic steatosis condition."
other_receptor_changes_ahr-liver_triglyceride_accumulation,/work/eval_papers/PMID_30452912.pdf,abstract,CHEMICAL,Apo B,2046,2051,"Increased fatty acid level by adipose tissue in circulation would translocate into the liver and dysregulates AHR, PXR, PPARγ, ATGL and Apo B,which further develop insulin resistance and hepatic steatosis condition."
other_receptor_changes_ahr-liver_triglyceride_accumulation,/work/eval_papers/PMID_30452912.pdf,abstract,SPECIES,doxorubicin,1747,1758,Further exacerbated lipid profile in circulation would impair the lipid metabolism in hepatic tissue which leads to fatty liver condition and consequently related disease during doxorubicin treatment.
other_receptor_changes_ahr-liver_triglyceride_accumulation,/work/eval_papers/PMID_34439562.pdf,abstract,CHEMICAL,Curcumin,78,86,Curcumin Suppresses the Lipid Accumulation and Oxidative Stress Induced by Benzo[a]pyrene Toxicity in HepG2 Cells.
other_receptor_changes_ahr-liver_triglyceride_accumulation,/work/eval_papers/PMID_34439562.pdf,abstract,CHEMICAL,curcumin,787,795,"This study aimed to uncover the mechanism of curcumin, the major curcuminoid in turmeric (Curcuma longa), in modulating the lipid accumulation and oxidative stress mediated by B[a]P cytotoxicity in HepG2 cells."
other_receptor_changes_ahr-liver_triglyceride_accumulation,/work/eval_papers/PMID_34439562.pdf,abstract,CHEMICAL,Curcumin,953,961,Curcumin treatment reduced the B[a]P-induced lipid accumulation and reactive oxygen spicies (ROS) upregulation and recovered the cell viability.
other_receptor_changes_ahr-liver_triglyceride_accumulation,/work/eval_papers/PMID_34439562.pdf,abstract,CHEMICAL,phase-II,1585,1593,"Moreover, the curcumin-induced reduction in ROS generation decreased the nuclear translocation of Nuclear factor erythroid-2-related factor 2 (Nrf2) and the expression of phase-II detoxifying enzymes."
other_receptor_changes_ahr-liver_triglyceride_accumulation,/work/eval_papers/PMID_34439562.pdf,abstract,CHEMICAL,curcumin,1643,1651,These results indicate that curcumin suppresses B[a]P-induced lipid accumulation and ROS generation which can potentially induce nonalcoholic fatty liver disease (NAFLD) and can shed a light on the detoxifying effect of curcumin.
other_receptor_changes_ahr-liver_triglyceride_accumulation,/work/eval_papers/PMID_34439562.pdf,abstract,CHEMICAL,curcumin,1835,1843,These results indicate that curcumin suppresses B[a]P-induced lipid accumulation and ROS generation which can potentially induce nonalcoholic fatty liver disease (NAFLD) and can shed a light on the detoxifying effect of curcumin.
other_receptor_changes_ahr-liver_triglyceride_accumulation,/work/eval_papers/PMID_26396156.pdf,abstract,CHEMICAL,City,456,460,"Author information: (1)*Interdisciplinary Graduate Program in Human Toxicology; Department of Occupational and Environmental Health, College of Public Health, University of Iowa, Iowa City, Iowa; (2)Department of Pathobiology and Population Medicine, Mississippi State University, Starkville, Mississippi; and."
other_receptor_changes_ahr-liver_triglyceride_accumulation,/work/eval_papers/PMID_26396156.pdf,abstract,CHEMICAL,Medicine,513,521,"Author information: (1)*Interdisciplinary Graduate Program in Human Toxicology; Department of Occupational and Environmental Health, College of Public Health, University of Iowa, Iowa City, Iowa; (2)Department of Pathobiology and Population Medicine, Mississippi State University, Starkville, Mississippi; and."
other_receptor_changes_ahr-liver_triglyceride_accumulation,/work/eval_papers/PMID_26396156.pdf,abstract,CHEMICAL,State,535,540,"Author information: (1)*Interdisciplinary Graduate Program in Human Toxicology; Department of Occupational and Environmental Health, College of Public Health, University of Iowa, Iowa City, Iowa; (2)Department of Pathobiology and Population Medicine, Mississippi State University, Starkville, Mississippi; and."
other_receptor_changes_ahr-liver_triglyceride_accumulation,/work/eval_papers/PMID_26396156.pdf,abstract,CHEMICAL,City,639,643,"(3)Department of Microbiology, University of Iowa, Iowa City, Iowa."
other_receptor_changes_ahr-liver_triglyceride_accumulation,/work/eval_papers/PMID_26396156.pdf,abstract,CHEMICAL,City,815,819,"(4)*Interdisciplinary Graduate Program in Human Toxicology; Department of Occupational and Environmental Health, College of Public Health, University of Iowa, Iowa City, Iowa; larry-robertson@uiowa.edu."
other_receptor_changes_ahr-liver_triglyceride_accumulation,/work/eval_papers/PMID_26396156.pdf,abstract,CHEMICAL,glucose,1343,1350,"Because liver is the target organ for PCB toxicity and responsible for metabolic homeostasis, we hypothesized that early disruption of glucose and lipid homeostasis contributes to later manifestations such as hepatic steatosis."
other_receptor_changes_ahr-liver_triglyceride_accumulation,/work/eval_papers/PMID_26396156.pdf,abstract,CHEMICAL,levels,1852,1858,Transcript levels of cytosolic phosphoenol-pyruvate carboxykinase (Pepck-c/Pck1) and glucose transporter (Glut2/Slc2a2) involved in gluconeogenesis and hepatic glucose transport were time-dependently downregulated between 9 h and 12 days of PCB126 exposure.
other_receptor_changes_ahr-liver_triglyceride_accumulation,/work/eval_papers/PMID_26396156.pdf,abstract,CHEMICAL,levels,2124,2130,"Additionally, transcript levels of Pparα, and its targets acyl-CoA oxidase (Acox1) and hydroxy-3-methylglutaryl-CoA synthase 2 (Hmgcs2), were also downregulated, indicating changes in peroxisomal fatty acid oxidation and ketogenesis."
other_receptor_changes_ahr-liver_triglyceride_accumulation,/work/eval_papers/PMID_26396156.pdf,abstract,CHEMICAL,levels,2414,2420,"In a separate animal study, we found that the measured changes in the transcript levels of Pepck-c, Glut2, Pparα, Acox1, and Hmgcs2 were also dose dependent."
other_receptor_changes_ahr-liver_triglyceride_accumulation,/work/eval_papers/PMID_26396156.pdf,abstract,CHEMICAL,Pepck-c,2424,2431,"In a separate animal study, we found that the measured changes in the transcript levels of Pepck-c, Glut2, Pparα, Acox1, and Hmgcs2 were also dose dependent."
other_receptor_changes_ahr-liver_triglyceride_accumulation,/work/eval_papers/PMID_26396156.pdf,abstract,CHEMICAL,Pepck-c,2530,2537,"Furthermore, PCB126-induced effects on Pepck-c were demonstrated to be AhR dependent in rat H4IIE hepatocytes."
other_receptor_changes_ahr-liver_triglyceride_accumulation,/work/eval_papers/PMID_26396156.pdf,abstract,CHEMICAL,demonstrated,2543,2555,"Furthermore, PCB126-induced effects on Pepck-c were demonstrated to be AhR dependent in rat H4IIE hepatocytes."
other_receptor_changes_ahr-liver_triglyceride_accumulation,/work/eval_papers/PMID_26396156.pdf,abstract,SPECIES,Rats,185,189,1. Toxicol Sci. 2016 Jan;149(1):98-110. doi: 10.1093/toxsci/kfv215. Epub 2015 Sep 22. PCB126-Induced Disruption in Gluconeogenesis and Fatty Acid Oxidation Precedes Fatty Liver in Male Rats.
other_receptor_changes_ahr-liver_triglyceride_accumulation,/work/eval_papers/PMID_26396156.pdf,abstract,SPECIES,Human,334,339,"Author information: (1)*Interdisciplinary Graduate Program in Human Toxicology; Department of Occupational and Environmental Health, College of Public Health, University of Iowa, Iowa City, Iowa; (2)Department of Pathobiology and Population Medicine, Mississippi State University, Starkville, Mississippi; and."
other_receptor_changes_ahr-liver_triglyceride_accumulation,/work/eval_papers/PMID_26396156.pdf,abstract,SPECIES,Human,693,698,"(4)*Interdisciplinary Graduate Program in Human Toxicology; Department of Occupational and Environmental Health, College of Public Health, University of Iowa, Iowa City, Iowa; larry-robertson@uiowa.edu."
other_receptor_changes_ahr-liver_triglyceride_accumulation,/work/eval_papers/PMID_26396156.pdf,abstract,SPECIES,rats,1491,1495,"To test this hypothesis, groups of male Sprague Dawley rats, fed on AIN-93G diet, were injected (intraperitoneal.) with a single bolus of PCB126 (5 µmol/kg) at various time intervals between 9 h and 12 days prior to euthanasia."
other_receptor_changes_ahr-liver_triglyceride_accumulation,/work/eval_papers/PMID_26396156.pdf,abstract,SPECIES,phosphoenol-pyruvate carboxykinase,1872,1906,Transcript levels of cytosolic phosphoenol-pyruvate carboxykinase (Pepck-c/Pck1) and glucose transporter (Glut2/Slc2a2) involved in gluconeogenesis and hepatic glucose transport were time-dependently downregulated between 9 h and 12 days of PCB126 exposure.
other_receptor_changes_ahr-liver_triglyceride_accumulation,/work/eval_papers/PMID_26396156.pdf,abstract,SPECIES,rat H4IIE hepatocytes,2579,2600,"Furthermore, PCB126-induced effects on Pepck-c were demonstrated to be AhR dependent in rat H4IIE hepatocytes."
other_receptor_changes_ahr-novel_cyp450,/work/eval_papers/PMID_34439562.pdf,abstract,CHEMICAL,Curcumin,78,86,Curcumin Suppresses the Lipid Accumulation and Oxidative Stress Induced by Benzo[a]pyrene Toxicity in HepG2 Cells.
other_receptor_changes_ahr-novel_cyp450,/work/eval_papers/PMID_34439562.pdf,abstract,CHEMICAL,curcumin,787,795,"This study aimed to uncover the mechanism of curcumin, the major curcuminoid in turmeric (Curcuma longa), in modulating the lipid accumulation and oxidative stress mediated by B[a]P cytotoxicity in HepG2 cells."
other_receptor_changes_ahr-novel_cyp450,/work/eval_papers/PMID_34439562.pdf,abstract,CHEMICAL,Curcumin,953,961,Curcumin treatment reduced the B[a]P-induced lipid accumulation and reactive oxygen spicies (ROS) upregulation and recovered the cell viability.
other_receptor_changes_ahr-novel_cyp450,/work/eval_papers/PMID_34439562.pdf,abstract,CHEMICAL,phase-II,1585,1593,"Moreover, the curcumin-induced reduction in ROS generation decreased the nuclear translocation of Nuclear factor erythroid-2-related factor 2 (Nrf2) and the expression of phase-II detoxifying enzymes."
other_receptor_changes_ahr-novel_cyp450,/work/eval_papers/PMID_34439562.pdf,abstract,CHEMICAL,curcumin,1643,1651,These results indicate that curcumin suppresses B[a]P-induced lipid accumulation and ROS generation which can potentially induce nonalcoholic fatty liver disease (NAFLD) and can shed a light on the detoxifying effect of curcumin.
other_receptor_changes_ahr-novel_cyp450,/work/eval_papers/PMID_34439562.pdf,abstract,CHEMICAL,curcumin,1835,1843,These results indicate that curcumin suppresses B[a]P-induced lipid accumulation and ROS generation which can potentially induce nonalcoholic fatty liver disease (NAFLD) and can shed a light on the detoxifying effect of curcumin.
other_receptor_changes_ahr-nuclear_receptor_changes_ppara,/work/eval_papers/PMID_26396156.pdf,abstract,CHEMICAL,City,456,460,"Author information: (1)*Interdisciplinary Graduate Program in Human Toxicology; Department of Occupational and Environmental Health, College of Public Health, University of Iowa, Iowa City, Iowa; (2)Department of Pathobiology and Population Medicine, Mississippi State University, Starkville, Mississippi; and."
other_receptor_changes_ahr-nuclear_receptor_changes_ppara,/work/eval_papers/PMID_26396156.pdf,abstract,CHEMICAL,Medicine,513,521,"Author information: (1)*Interdisciplinary Graduate Program in Human Toxicology; Department of Occupational and Environmental Health, College of Public Health, University of Iowa, Iowa City, Iowa; (2)Department of Pathobiology and Population Medicine, Mississippi State University, Starkville, Mississippi; and."
other_receptor_changes_ahr-nuclear_receptor_changes_ppara,/work/eval_papers/PMID_26396156.pdf,abstract,CHEMICAL,State,535,540,"Author information: (1)*Interdisciplinary Graduate Program in Human Toxicology; Department of Occupational and Environmental Health, College of Public Health, University of Iowa, Iowa City, Iowa; (2)Department of Pathobiology and Population Medicine, Mississippi State University, Starkville, Mississippi; and."
other_receptor_changes_ahr-nuclear_receptor_changes_ppara,/work/eval_papers/PMID_26396156.pdf,abstract,CHEMICAL,City,639,643,"(3)Department of Microbiology, University of Iowa, Iowa City, Iowa."
other_receptor_changes_ahr-nuclear_receptor_changes_ppara,/work/eval_papers/PMID_26396156.pdf,abstract,CHEMICAL,City,815,819,"(4)*Interdisciplinary Graduate Program in Human Toxicology; Department of Occupational and Environmental Health, College of Public Health, University of Iowa, Iowa City, Iowa; larry-robertson@uiowa.edu."
other_receptor_changes_ahr-nuclear_receptor_changes_ppara,/work/eval_papers/PMID_26396156.pdf,abstract,CHEMICAL,glucose,1343,1350,"Because liver is the target organ for PCB toxicity and responsible for metabolic homeostasis, we hypothesized that early disruption of glucose and lipid homeostasis contributes to later manifestations such as hepatic steatosis."
other_receptor_changes_ahr-nuclear_receptor_changes_ppara,/work/eval_papers/PMID_26396156.pdf,abstract,CHEMICAL,levels,1852,1858,Transcript levels of cytosolic phosphoenol-pyruvate carboxykinase (Pepck-c/Pck1) and glucose transporter (Glut2/Slc2a2) involved in gluconeogenesis and hepatic glucose transport were time-dependently downregulated between 9 h and 12 days of PCB126 exposure.
other_receptor_changes_ahr-nuclear_receptor_changes_ppara,/work/eval_papers/PMID_26396156.pdf,abstract,CHEMICAL,levels,2124,2130,"Additionally, transcript levels of Pparα, and its targets acyl-CoA oxidase (Acox1) and hydroxy-3-methylglutaryl-CoA synthase 2 (Hmgcs2), were also downregulated, indicating changes in peroxisomal fatty acid oxidation and ketogenesis."
other_receptor_changes_ahr-nuclear_receptor_changes_ppara,/work/eval_papers/PMID_26396156.pdf,abstract,CHEMICAL,levels,2414,2420,"In a separate animal study, we found that the measured changes in the transcript levels of Pepck-c, Glut2, Pparα, Acox1, and Hmgcs2 were also dose dependent."
other_receptor_changes_ahr-nuclear_receptor_changes_ppara,/work/eval_papers/PMID_26396156.pdf,abstract,CHEMICAL,Pepck-c,2424,2431,"In a separate animal study, we found that the measured changes in the transcript levels of Pepck-c, Glut2, Pparα, Acox1, and Hmgcs2 were also dose dependent."
other_receptor_changes_ahr-nuclear_receptor_changes_ppara,/work/eval_papers/PMID_26396156.pdf,abstract,CHEMICAL,Pepck-c,2530,2537,"Furthermore, PCB126-induced effects on Pepck-c were demonstrated to be AhR dependent in rat H4IIE hepatocytes."
other_receptor_changes_ahr-nuclear_receptor_changes_ppara,/work/eval_papers/PMID_26396156.pdf,abstract,CHEMICAL,demonstrated,2543,2555,"Furthermore, PCB126-induced effects on Pepck-c were demonstrated to be AhR dependent in rat H4IIE hepatocytes."
other_receptor_changes_ahr-nuclear_receptor_changes_ppara,/work/eval_papers/PMID_26396156.pdf,abstract,SPECIES,Rats,185,189,1. Toxicol Sci. 2016 Jan;149(1):98-110. doi: 10.1093/toxsci/kfv215. Epub 2015 Sep 22. PCB126-Induced Disruption in Gluconeogenesis and Fatty Acid Oxidation Precedes Fatty Liver in Male Rats.
other_receptor_changes_ahr-nuclear_receptor_changes_ppara,/work/eval_papers/PMID_26396156.pdf,abstract,SPECIES,Human,334,339,"Author information: (1)*Interdisciplinary Graduate Program in Human Toxicology; Department of Occupational and Environmental Health, College of Public Health, University of Iowa, Iowa City, Iowa; (2)Department of Pathobiology and Population Medicine, Mississippi State University, Starkville, Mississippi; and."
other_receptor_changes_ahr-nuclear_receptor_changes_ppara,/work/eval_papers/PMID_26396156.pdf,abstract,SPECIES,Human,693,698,"(4)*Interdisciplinary Graduate Program in Human Toxicology; Department of Occupational and Environmental Health, College of Public Health, University of Iowa, Iowa City, Iowa; larry-robertson@uiowa.edu."
other_receptor_changes_ahr-nuclear_receptor_changes_ppara,/work/eval_papers/PMID_26396156.pdf,abstract,SPECIES,rats,1491,1495,"To test this hypothesis, groups of male Sprague Dawley rats, fed on AIN-93G diet, were injected (intraperitoneal.) with a single bolus of PCB126 (5 µmol/kg) at various time intervals between 9 h and 12 days prior to euthanasia."
other_receptor_changes_ahr-nuclear_receptor_changes_ppara,/work/eval_papers/PMID_26396156.pdf,abstract,SPECIES,phosphoenol-pyruvate carboxykinase,1872,1906,Transcript levels of cytosolic phosphoenol-pyruvate carboxykinase (Pepck-c/Pck1) and glucose transporter (Glut2/Slc2a2) involved in gluconeogenesis and hepatic glucose transport were time-dependently downregulated between 9 h and 12 days of PCB126 exposure.
other_receptor_changes_ahr-nuclear_receptor_changes_ppara,/work/eval_papers/PMID_26396156.pdf,abstract,SPECIES,rat H4IIE hepatocytes,2579,2600,"Furthermore, PCB126-induced effects on Pepck-c were demonstrated to be AhR dependent in rat H4IIE hepatocytes."
other_receptor_changes_ahr-vldl_secretion,/work/eval_papers/PMID_30452912.pdf,abstract,CHEMICAL,2019 Jan,20,28,1. Eur J Pharmacol. 2019 Jan 15;843:162-176. doi: 10.1016/j.ejphar.2018.11.018. Epub 2018 Nov 16.
other_receptor_changes_ahr-vldl_secretion,/work/eval_papers/PMID_30452912.pdf,abstract,CHEMICAL,adipose,120,127,Elevated lipolysis in adipose tissue by doxorubicin via PPARα activation associated with hepatic steatosis and insulin resistance.
other_receptor_changes_ahr-vldl_secretion,/work/eval_papers/PMID_30452912.pdf,abstract,CHEMICAL,doxorubicin,138,149,Elevated lipolysis in adipose tissue by doxorubicin via PPARα activation associated with hepatic steatosis and insulin resistance.
other_receptor_changes_ahr-vldl_secretion,/work/eval_papers/PMID_30452912.pdf,abstract,CHEMICAL,K B,240,243,"Renu K(1), K B S(1), Parthiban S(1), S S(1), George A(2), P B TP(3), Suman S(4), V G A(5), Arunachalam S(6)."
other_receptor_changes_ahr-vldl_secretion,/work/eval_papers/PMID_30452912.pdf,abstract,CHEMICAL,P B,287,290,"Renu K(1), K B S(1), Parthiban S(1), S S(1), George A(2), P B TP(3), Suman S(4), V G A(5), Arunachalam S(6)."
other_receptor_changes_ahr-vldl_secretion,/work/eval_papers/PMID_30452912.pdf,abstract,CHEMICAL,VIT,434,437,"Author information: (1)Department of Biomedical Sciences, School of Biosciences and Technology, VIT, Vellore, Tamil Nadu 632014, India. (2)Jubilee Centre for Medical Research, Jubilee Mission Medical College and Research Institute, Thrissur, Kerala, India."
other_receptor_changes_ahr-vldl_secretion,/work/eval_papers/PMID_30452912.pdf,abstract,CHEMICAL,NRB,845,848,"(4)Department of Oncology, Lombardi Comprehensive Cancer Center (LCCC), Georgetown University Medical Center (GUMC), E504, NRB, 3970 Reservoir Rd."
other_receptor_changes_ahr-vldl_secretion,/work/eval_papers/PMID_30452912.pdf,abstract,CHEMICAL,VIT,972,975,"(5)Department of Biomedical Sciences, School of Biosciences and Technology, VIT, Vellore, Tamil Nadu 632014, India."
other_receptor_changes_ahr-vldl_secretion,/work/eval_papers/PMID_30452912.pdf,abstract,CHEMICAL,address,1023,1030,Electronic address: abilash.vg@vit.ac.in.
other_receptor_changes_ahr-vldl_secretion,/work/eval_papers/PMID_30452912.pdf,abstract,CHEMICAL,address,1185,1192,"(6)Department of Biotechnology, Kalasalingam Academy of Research and Education, Krishnankoil 626126, Tamil Nadu, India. Electronic address: sankarganesh@klu.ac.in."
other_receptor_changes_ahr-vldl_secretion,/work/eval_papers/PMID_30452912.pdf,abstract,CHEMICAL,Doxorubicin,1317,1328,Doxorubicin would disturb the lipid metabolism both in adipose and liver.
other_receptor_changes_ahr-vldl_secretion,/work/eval_papers/PMID_30452912.pdf,abstract,CHEMICAL,doxorubicin,1414,1425,Here we projected that doxorubicin would impede lipogenesis and elevated lipolysis in adipose tissue would elevate the circulatory lipid profile and leads to insulin resistance.
other_receptor_changes_ahr-vldl_secretion,/work/eval_papers/PMID_30452912.pdf,abstract,CHEMICAL,adipose,1477,1484,Here we projected that doxorubicin would impede lipogenesis and elevated lipolysis in adipose tissue would elevate the circulatory lipid profile and leads to insulin resistance.
other_receptor_changes_ahr-vldl_secretion,/work/eval_papers/PMID_30452912.pdf,abstract,CHEMICAL,doxorubicin,1747,1758,Further exacerbated lipid profile in circulation would impair the lipid metabolism in hepatic tissue which leads to fatty liver condition and consequently related disease during doxorubicin treatment.
other_receptor_changes_ahr-vldl_secretion,/work/eval_papers/PMID_30452912.pdf,abstract,CHEMICAL,Doxorubicin,1770,1781,Doxorubicin impairs the lipogenesis through PPARγ and augments lipolysis and fatty acid oxidation through ATGL and PPARα in adipose tissue.
other_receptor_changes_ahr-vldl_secretion,/work/eval_papers/PMID_30452912.pdf,abstract,CHEMICAL,adipose,1940,1947,"Increased fatty acid level by adipose tissue in circulation would translocate into the liver and dysregulates AHR, PXR, PPARγ, ATGL and Apo B,which further develop insulin resistance and hepatic steatosis condition."
other_receptor_changes_ahr-vldl_secretion,/work/eval_papers/PMID_30452912.pdf,abstract,CHEMICAL,Apo B,2046,2051,"Increased fatty acid level by adipose tissue in circulation would translocate into the liver and dysregulates AHR, PXR, PPARγ, ATGL and Apo B,which further develop insulin resistance and hepatic steatosis condition."
other_receptor_changes_ahr-vldl_secretion,/work/eval_papers/PMID_30452912.pdf,abstract,SPECIES,doxorubicin,1747,1758,Further exacerbated lipid profile in circulation would impair the lipid metabolism in hepatic tissue which leads to fatty liver condition and consequently related disease during doxorubicin treatment.
other_receptor_changes_novel_cb1-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_32231762.pdf,abstract,CHEMICAL,Medicine,457,465,"(2)Centre for Education, Faculty of Life Sciences and Medicine, King's College London SE1 1UL, United Kingdom."
other_receptor_changes_novel_cb1-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_32231762.pdf,abstract,CHEMICAL,SE1,489,492,"(2)Centre for Education, Faculty of Life Sciences and Medicine, King's College London SE1 1UL, United Kingdom."
other_receptor_changes_novel_cb1-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_32231762.pdf,abstract,CHEMICAL,Medicine,609,617,"(3)Nebraska and Western Iowa Veterans Administration Medical Center and Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE 68198, United States."
other_receptor_changes_novel_cb1-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_32231762.pdf,abstract,CHEMICAL,DHA,1677,1680,"METHODS: HepG2-derived VL-17A cells were treated with normal (1:1, 4:1) and high (15:1, 25:1) ratios of omega-6: omega-3 fatty acids [arachidonic acid (AA): docosahexaenoic acid (DHA)] at various time points."
other_receptor_changes_novel_cb1-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_32231762.pdf,abstract,CHEMICAL,ATP,2678,2681,"Furthermore, the high ratio increased ROS production (P < 0.01; 74%-115%) and reduced mitochondrial respiratory functions such as basal and maximal respiration, ATP production, spare respiratory capacity and proton leak (P < 0.01; 35%-68%)."
other_receptor_changes_novel_cb1-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_32231762.pdf,abstract,CHEMICAL,triglyceride,2796,2808,"CONCLUSION: High AA:DHA ratio induced triglyceride accumulation, increased oxidative stress and disrupted mitochondrial functions."
other_receptor_changes_novel_cb1-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_32231762.pdf,abstract,SPECIES,human hepatoma cells,194,214,High omega arachidonic acid/docosahexaenoic acid ratio induces mitochondrial dysfunction and altered lipid metabolism in human hepatoma cells.
other_receptor_changes_novel_cb1-mitochondrial_beta_oxidation,/work/eval_papers/PMID_32231762.pdf,abstract,CHEMICAL,Medicine,457,465,"(2)Centre for Education, Faculty of Life Sciences and Medicine, King's College London SE1 1UL, United Kingdom."
other_receptor_changes_novel_cb1-mitochondrial_beta_oxidation,/work/eval_papers/PMID_32231762.pdf,abstract,CHEMICAL,SE1,489,492,"(2)Centre for Education, Faculty of Life Sciences and Medicine, King's College London SE1 1UL, United Kingdom."
other_receptor_changes_novel_cb1-mitochondrial_beta_oxidation,/work/eval_papers/PMID_32231762.pdf,abstract,CHEMICAL,Medicine,609,617,"(3)Nebraska and Western Iowa Veterans Administration Medical Center and Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE 68198, United States."
other_receptor_changes_novel_cb1-mitochondrial_beta_oxidation,/work/eval_papers/PMID_32231762.pdf,abstract,CHEMICAL,DHA,1677,1680,"METHODS: HepG2-derived VL-17A cells were treated with normal (1:1, 4:1) and high (15:1, 25:1) ratios of omega-6: omega-3 fatty acids [arachidonic acid (AA): docosahexaenoic acid (DHA)] at various time points."
other_receptor_changes_novel_cb1-mitochondrial_beta_oxidation,/work/eval_papers/PMID_32231762.pdf,abstract,CHEMICAL,ATP,2678,2681,"Furthermore, the high ratio increased ROS production (P < 0.01; 74%-115%) and reduced mitochondrial respiratory functions such as basal and maximal respiration, ATP production, spare respiratory capacity and proton leak (P < 0.01; 35%-68%)."
other_receptor_changes_novel_cb1-mitochondrial_beta_oxidation,/work/eval_papers/PMID_32231762.pdf,abstract,CHEMICAL,triglyceride,2796,2808,"CONCLUSION: High AA:DHA ratio induced triglyceride accumulation, increased oxidative stress and disrupted mitochondrial functions."
other_receptor_changes_novel_cb1-mitochondrial_beta_oxidation,/work/eval_papers/PMID_32231762.pdf,abstract,SPECIES,human hepatoma cells,194,214,High omega arachidonic acid/docosahexaenoic acid ratio induces mitochondrial dysfunction and altered lipid metabolism in human hepatoma cells.
peroxisomal_beta_oxidation-fatty_liver,/work/eval_papers/PMID_26725750.pdf,abstract,CHEMICAL,Medicine,300,308,"Author information: (1)Department of Biomedical Sciences, College of Medicine, Roseman University of Health Sciences, 10530 Discovery Drive, Las Vegas, NV, USA."
peroxisomal_beta_oxidation-fatty_liver,/work/eval_papers/PMID_26725750.pdf,abstract,CHEMICAL,provide,1465,1472,"In contrast, high-throughput profiling of protein PTMs has the potential to provide molecular classification of fatty liver."
peroxisomal_beta_oxidation-fatty_liver,/work/eval_papers/PMID_26725750.pdf,abstract,CHEMICAL,PMID: 26725750,1642,1656,"Copyright © 2016 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd. DOI: 10.1002/path.4685 PMID: 26725750 [Indexed for MEDLINE]"
peroxisomal_beta_oxidation-fatty_liver,/work/eval_papers/PMID_26725750.pdf,abstract,SPECIES,Roseman,310,317,"Author information: (1)Department of Biomedical Sciences, College of Medicine, Roseman University of Health Sciences, 10530 Discovery Drive, Las Vegas, NV, USA."
peroxisomal_beta_oxidation-fatty_liver,/work/eval_papers/PMID_26725750.pdf,abstract,SPECIES,mice,671,675,"Four strains of mice were studied, with fatty livers induced by different causes, such as ageing, genetic mutation, acute drug usage, and high-fat diet."
protein_kinase_changes_akt-liver_triglyceride_accumulation,/work/eval_papers/PMID_28987868.pdf,abstract,CHEMICAL,Akt activity,102,114,Impairment of Akt activity by CYP2E1 mediated oxidative stress is involved in chronic ethanol-induced fatty liver.
protein_kinase_changes_akt-liver_triglyceride_accumulation,/work/eval_papers/PMID_28987868.pdf,abstract,CHEMICAL,N(2,232,235,"Zeng T(1), Zhang CL(2), Zhao N(2), Guan MJ(2), Xiao M(2), Yang R(2), Zhao XL(2), Yu LH(2), Zhu ZP(2), Xie KQ(3)."
protein_kinase_changes_akt-liver_triglyceride_accumulation,/work/eval_papers/PMID_28987868.pdf,abstract,CHEMICAL,Zhu,294,297,"Zeng T(1), Zhang CL(2), Zhao N(2), Guan MJ(2), Xiao M(2), Yang R(2), Zhao XL(2), Yu LH(2), Zhu ZP(2), Xie KQ(3)."
protein_kinase_changes_akt-liver_triglyceride_accumulation,/work/eval_papers/PMID_28987868.pdf,abstract,CHEMICAL,address,428,435,"Author information: (1)Institute of Toxicology, School of Public Health, Shandong University, China. Electronic address: zengtao@sdu.edu.cn."
protein_kinase_changes_akt-liver_triglyceride_accumulation,/work/eval_papers/PMID_28987868.pdf,abstract,CHEMICAL,address,630,637,Electronic address: keqinx@sdu.edu.cn.
protein_kinase_changes_akt-liver_triglyceride_accumulation,/work/eval_papers/PMID_28987868.pdf,abstract,CHEMICAL,Akt activity,765,777,"Protein kinase B (PKB/Akt) plays important roles in the regulation of lipid homeostasis, and impairment of Akt activity has been demonstrated to be involved in the development of non-alcoholic fatty liver disease (NAFLD)."
protein_kinase_changes_akt-liver_triglyceride_accumulation,/work/eval_papers/PMID_28987868.pdf,abstract,CHEMICAL,Akt activity,1030,1042,We hypothesized that Akt activity might be impaired due to CYP2E1-induced oxidative stress in chronic ethanol-induced hepatic steatosis.
protein_kinase_changes_akt-liver_triglyceride_accumulation,/work/eval_papers/PMID_28987868.pdf,abstract,CHEMICAL,Akt,1265,1268,"In this study, we found that chronic ethanol-induced hepatic steatosis was accompanied with reduced phosphorylation of Akt at Thr308 in mice liver."
protein_kinase_changes_akt-liver_triglyceride_accumulation,/work/eval_papers/PMID_28987868.pdf,abstract,CHEMICAL,ethanol,1302,1309,"Chronic ethanol exposure had no effects on the protein levels of phosphatidylinositol 3 kinase (PI3K) and phosphatase and tensin homologue deleted on chromosome ten (PTEN), and led to a slight decrease of phosphoinositide-dependent protein kinase 1 (PDK-1) protein level."
protein_kinase_changes_akt-liver_triglyceride_accumulation,/work/eval_papers/PMID_28987868.pdf,abstract,CHEMICAL,levels,1349,1355,"Chronic ethanol exposure had no effects on the protein levels of phosphatidylinositol 3 kinase (PI3K) and phosphatase and tensin homologue deleted on chromosome ten (PTEN), and led to a slight decrease of phosphoinositide-dependent protein kinase 1 (PDK-1) protein level."
protein_kinase_changes_akt-liver_triglyceride_accumulation,/work/eval_papers/PMID_28987868.pdf,abstract,CHEMICAL,phosphatidylinositol 3 kinase,1359,1388,"Chronic ethanol exposure had no effects on the protein levels of phosphatidylinositol 3 kinase (PI3K) and phosphatase and tensin homologue deleted on chromosome ten (PTEN), and led to a slight decrease of phosphoinositide-dependent protein kinase 1 (PDK-1) protein level."
protein_kinase_changes_akt-liver_triglyceride_accumulation,/work/eval_papers/PMID_28987868.pdf,abstract,CHEMICAL,tensin,1416,1422,"Chronic ethanol exposure had no effects on the protein levels of phosphatidylinositol 3 kinase (PI3K) and phosphatase and tensin homologue deleted on chromosome ten (PTEN), and led to a slight decrease of phosphoinositide-dependent protein kinase 1 (PDK-1) protein level."
protein_kinase_changes_akt-liver_triglyceride_accumulation,/work/eval_papers/PMID_28987868.pdf,abstract,CHEMICAL,levels,1605,1611,"Ethanol exposure resulted in increased levels of malondialdehyde (MDA) and 4-hydroxynonenal (4-HNE)-Akt adducts, which was significantly inhibited by chlormethiazole (CMZ), an efficient CYP2E1 inhibitor."
protein_kinase_changes_akt-liver_triglyceride_accumulation,/work/eval_papers/PMID_28987868.pdf,abstract,CHEMICAL,malondialdehyde,1615,1630,"Ethanol exposure resulted in increased levels of malondialdehyde (MDA) and 4-hydroxynonenal (4-HNE)-Akt adducts, which was significantly inhibited by chlormethiazole (CMZ), an efficient CYP2E1 inhibitor."
protein_kinase_changes_akt-liver_triglyceride_accumulation,/work/eval_papers/PMID_28987868.pdf,abstract,CHEMICAL,MDA,1632,1635,"Ethanol exposure resulted in increased levels of malondialdehyde (MDA) and 4-hydroxynonenal (4-HNE)-Akt adducts, which was significantly inhibited by chlormethiazole (CMZ), an efficient CYP2E1 inhibitor."
protein_kinase_changes_akt-liver_triglyceride_accumulation,/work/eval_papers/PMID_28987868.pdf,abstract,CHEMICAL,Akt,1904,1907,"Interestingly, N-acetyl-L-cysteine (NAC) significantly attenuated chronic ethanol-induced hepatic fat accumulation and the decline of Akt phosphorylation at Thr308."
protein_kinase_changes_akt-liver_triglyceride_accumulation,/work/eval_papers/PMID_28987868.pdf,abstract,CHEMICAL,Akt,1960,1963,"In the in vitro studies, Akt phosphorylation was suppressed in CYP2E1-expressing HepG2 (CYP2E1-HepG2) cells compared with the negative control HepG2 (NC-HepG2) cells, and 4-HNE treatment led to significant decrease of Akt phosphorylation at Thr308 in wild type HepG2 cells."
protein_kinase_changes_akt-liver_triglyceride_accumulation,/work/eval_papers/PMID_28987868.pdf,abstract,CHEMICAL,Akt,2153,2156,"In the in vitro studies, Akt phosphorylation was suppressed in CYP2E1-expressing HepG2 (CYP2E1-HepG2) cells compared with the negative control HepG2 (NC-HepG2) cells, and 4-HNE treatment led to significant decrease of Akt phosphorylation at Thr308 in wild type HepG2 cells."
protein_kinase_changes_akt-liver_triglyceride_accumulation,/work/eval_papers/PMID_28987868.pdf,abstract,CHEMICAL,Akt,2247,2250,"Lastly, pharmacological activation of Akt by insulin-like growth factor-1 (IGF-1) significantly alleviated chronic ethanol-induced fatty liver in mice."
protein_kinase_changes_akt-liver_triglyceride_accumulation,/work/eval_papers/PMID_28987868.pdf,abstract,CHEMICAL,Akt,2489,2492,"Collectively, these results indicate that CYP2E1-induced oxidative stress may be responsible for ethanol-induced suppression of Akt phosphorylation and pharmacological modulation of Akt in liver may be an effective strategy for the treatment of ethanol-induced fatty liver."
protein_kinase_changes_akt-liver_triglyceride_accumulation,/work/eval_papers/PMID_28987868.pdf,abstract,CHEMICAL,Akt,2543,2546,"Collectively, these results indicate that CYP2E1-induced oxidative stress may be responsible for ethanol-induced suppression of Akt phosphorylation and pharmacological modulation of Akt in liver may be an effective strategy for the treatment of ethanol-induced fatty liver."
protein_kinase_changes_akt-liver_triglyceride_accumulation,/work/eval_papers/PMID_28987868.pdf,abstract,CHEMICAL,10.1016/j.redox.2017.09.018,2718,2745,DOI: 10.1016/j.redox.2017.09.018 PMCID: PMC5633250 PMID: 28987868 [Indexed for MEDLINE]
protein_kinase_changes_akt-liver_triglyceride_accumulation,/work/eval_papers/PMID_28987868.pdf,abstract,SPECIES,mice,1282,1286,"In this study, we found that chronic ethanol-induced hepatic steatosis was accompanied with reduced phosphorylation of Akt at Thr308 in mice liver."
protein_kinase_changes_akt-liver_triglyceride_accumulation,/work/eval_papers/PMID_28987868.pdf,abstract,SPECIES,mice,2355,2359,"Lastly, pharmacological activation of Akt by insulin-like growth factor-1 (IGF-1) significantly alleviated chronic ethanol-induced fatty liver in mice."
protein_kinase_changes_akt-mitochondrial_beta_oxidation,/work/eval_papers/PMID_34836271.pdf,abstract,CHEMICAL,estrogen,497,505,Genistein (GEN) has been shown to significantly inhibit hepatic triglyceride accretion triggered by estrogen deficiency.
protein_kinase_changes_akt-mitochondrial_beta_oxidation,/work/eval_papers/PMID_34836271.pdf,abstract,CHEMICAL,this,538,542,The main purpose of this in vitro study was to investigate the function and molecular mechanism of estrogen receptor β (ERβ) in regulating hepatic lipid metabolism induced by GEN.
protein_kinase_changes_akt-mitochondrial_beta_oxidation,/work/eval_papers/PMID_34836271.pdf,abstract,CHEMICAL,investigate,565,576,The main purpose of this in vitro study was to investigate the function and molecular mechanism of estrogen receptor β (ERβ) in regulating hepatic lipid metabolism induced by GEN.
protein_kinase_changes_akt-mitochondrial_beta_oxidation,/work/eval_papers/PMID_34836271.pdf,abstract,CHEMICAL,estrogen,617,625,The main purpose of this in vitro study was to investigate the function and molecular mechanism of estrogen receptor β (ERβ) in regulating hepatic lipid metabolism induced by GEN.
protein_kinase_changes_akt-mitochondrial_beta_oxidation,/work/eval_papers/PMID_34836271.pdf,abstract,CHEMICAL,levels,850,856,Results showed that 25 μM GEN significantly diminished triglyceride levels.
protein_kinase_changes_akt-mitochondrial_beta_oxidation,/work/eval_papers/PMID_34836271.pdf,abstract,CHEMICAL,levels,891,897,"Meanwhile, GEN downregulated the levels of genes and proteins involved in lipogenesis, such as sterol-regulatory element-binding protein-1c (SREBP-1c), fatty acid synthase (FASN), and stearoyl-coenzyme A desaturase 1 (SCD1), and upregulated the gene and protein levels of the regulation factors responsible for fatty acid β-oxidation, such as carnitine palmitoyltransferase 1α (CPT-1α) and peroxisome proliferator-activated receptor α (PPARα)."
protein_kinase_changes_akt-mitochondrial_beta_oxidation,/work/eval_papers/PMID_34836271.pdf,abstract,CHEMICAL,carnitine,1201,1210,"Meanwhile, GEN downregulated the levels of genes and proteins involved in lipogenesis, such as sterol-regulatory element-binding protein-1c (SREBP-1c), fatty acid synthase (FASN), and stearoyl-coenzyme A desaturase 1 (SCD1), and upregulated the gene and protein levels of the regulation factors responsible for fatty acid β-oxidation, such as carnitine palmitoyltransferase 1α (CPT-1α) and peroxisome proliferator-activated receptor α (PPARα)."
protein_kinase_changes_akt-mitochondrial_beta_oxidation,/work/eval_papers/PMID_34836271.pdf,abstract,CHEMICAL,Akt,1384,1387,"Furthermore, 25 μM GEN reduced the levels of phosphorylation of protein kinase B (Akt) and mechanistic target of rapamycin (mTOR)."
protein_kinase_changes_akt-mitochondrial_beta_oxidation,/work/eval_papers/PMID_34836271.pdf,abstract,CHEMICAL,rapamycin,1415,1424,"Furthermore, 25 μM GEN reduced the levels of phosphorylation of protein kinase B (Akt) and mechanistic target of rapamycin (mTOR)."
protein_kinase_changes_akt-mitochondrial_beta_oxidation,/work/eval_papers/PMID_34836271.pdf,abstract,CHEMICAL,provide,1659,1666,The results provide novel aspects of the regulatory mechanism of ERβ on hepatic lipid metabolism and might help to profoundly understand the functions of food-derived phytoestrogens in preventing and treating hepatic steatosis in postmenopausal women.
protein_kinase_changes_akt-mitochondrial_beta_oxidation,/work/eval_papers/PMID_34836271.pdf,abstract,CHEMICAL,PMID: 34836271,1941,1955,DOI: 10.3390/nu13114015 PMCID: PMC8622023 PMID: 34836271 [Indexed for MEDLINE] Conflict of interest statement: The authors declare no conflict of interest.
protein_kinase_changes_akt-mitochondrial_beta_oxidation,/work/eval_papers/PMID_34836271.pdf,abstract,SPECIES,ERβ,1527,1530,"Moreover, most of these effects from GEN were reverted by pretreatment with the antagonist of ERβ."
protein_kinase_changes_akt-vldl_secretion,/work/eval_papers/PMID_34836271.pdf,abstract,CHEMICAL,estrogen,497,505,Genistein (GEN) has been shown to significantly inhibit hepatic triglyceride accretion triggered by estrogen deficiency.
protein_kinase_changes_akt-vldl_secretion,/work/eval_papers/PMID_34836271.pdf,abstract,CHEMICAL,this,538,542,The main purpose of this in vitro study was to investigate the function and molecular mechanism of estrogen receptor β (ERβ) in regulating hepatic lipid metabolism induced by GEN.
protein_kinase_changes_akt-vldl_secretion,/work/eval_papers/PMID_34836271.pdf,abstract,CHEMICAL,investigate,565,576,The main purpose of this in vitro study was to investigate the function and molecular mechanism of estrogen receptor β (ERβ) in regulating hepatic lipid metabolism induced by GEN.
protein_kinase_changes_akt-vldl_secretion,/work/eval_papers/PMID_34836271.pdf,abstract,CHEMICAL,estrogen,617,625,The main purpose of this in vitro study was to investigate the function and molecular mechanism of estrogen receptor β (ERβ) in regulating hepatic lipid metabolism induced by GEN.
protein_kinase_changes_akt-vldl_secretion,/work/eval_papers/PMID_34836271.pdf,abstract,CHEMICAL,levels,850,856,Results showed that 25 μM GEN significantly diminished triglyceride levels.
protein_kinase_changes_akt-vldl_secretion,/work/eval_papers/PMID_34836271.pdf,abstract,CHEMICAL,levels,891,897,"Meanwhile, GEN downregulated the levels of genes and proteins involved in lipogenesis, such as sterol-regulatory element-binding protein-1c (SREBP-1c), fatty acid synthase (FASN), and stearoyl-coenzyme A desaturase 1 (SCD1), and upregulated the gene and protein levels of the regulation factors responsible for fatty acid β-oxidation, such as carnitine palmitoyltransferase 1α (CPT-1α) and peroxisome proliferator-activated receptor α (PPARα)."
protein_kinase_changes_akt-vldl_secretion,/work/eval_papers/PMID_34836271.pdf,abstract,CHEMICAL,carnitine,1201,1210,"Meanwhile, GEN downregulated the levels of genes and proteins involved in lipogenesis, such as sterol-regulatory element-binding protein-1c (SREBP-1c), fatty acid synthase (FASN), and stearoyl-coenzyme A desaturase 1 (SCD1), and upregulated the gene and protein levels of the regulation factors responsible for fatty acid β-oxidation, such as carnitine palmitoyltransferase 1α (CPT-1α) and peroxisome proliferator-activated receptor α (PPARα)."
protein_kinase_changes_akt-vldl_secretion,/work/eval_papers/PMID_34836271.pdf,abstract,CHEMICAL,Akt,1384,1387,"Furthermore, 25 μM GEN reduced the levels of phosphorylation of protein kinase B (Akt) and mechanistic target of rapamycin (mTOR)."
protein_kinase_changes_akt-vldl_secretion,/work/eval_papers/PMID_34836271.pdf,abstract,CHEMICAL,rapamycin,1415,1424,"Furthermore, 25 μM GEN reduced the levels of phosphorylation of protein kinase B (Akt) and mechanistic target of rapamycin (mTOR)."
protein_kinase_changes_akt-vldl_secretion,/work/eval_papers/PMID_34836271.pdf,abstract,CHEMICAL,provide,1659,1666,The results provide novel aspects of the regulatory mechanism of ERβ on hepatic lipid metabolism and might help to profoundly understand the functions of food-derived phytoestrogens in preventing and treating hepatic steatosis in postmenopausal women.
protein_kinase_changes_akt-vldl_secretion,/work/eval_papers/PMID_34836271.pdf,abstract,CHEMICAL,PMID: 34836271,1941,1955,DOI: 10.3390/nu13114015 PMCID: PMC8622023 PMID: 34836271 [Indexed for MEDLINE] Conflict of interest statement: The authors declare no conflict of interest.
protein_kinase_changes_akt-vldl_secretion,/work/eval_papers/PMID_34836271.pdf,abstract,SPECIES,ERβ,1527,1530,"Moreover, most of these effects from GEN were reverted by pretreatment with the antagonist of ERβ."
protein_kinase_changes_akt2-fatty_liver,/work/eval_papers/PMID_26725750.pdf,abstract,CHEMICAL,Medicine,300,308,"Author information: (1)Department of Biomedical Sciences, College of Medicine, Roseman University of Health Sciences, 10530 Discovery Drive, Las Vegas, NV, USA."
protein_kinase_changes_akt2-fatty_liver,/work/eval_papers/PMID_26725750.pdf,abstract,CHEMICAL,provide,1465,1472,"In contrast, high-throughput profiling of protein PTMs has the potential to provide molecular classification of fatty liver."
protein_kinase_changes_akt2-fatty_liver,/work/eval_papers/PMID_26725750.pdf,abstract,CHEMICAL,PMID: 26725750,1642,1656,"Copyright © 2016 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd. DOI: 10.1002/path.4685 PMID: 26725750 [Indexed for MEDLINE]"
protein_kinase_changes_akt2-fatty_liver,/work/eval_papers/PMID_26725750.pdf,abstract,SPECIES,Roseman,310,317,"Author information: (1)Department of Biomedical Sciences, College of Medicine, Roseman University of Health Sciences, 10530 Discovery Drive, Las Vegas, NV, USA."
protein_kinase_changes_akt2-fatty_liver,/work/eval_papers/PMID_26725750.pdf,abstract,SPECIES,mice,671,675,"Four strains of mice were studied, with fatty livers induced by different causes, such as ageing, genetic mutation, acute drug usage, and high-fat diet."
protein_kinase_changes_novel_ampk-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_29173234.pdf,abstract,CHEMICAL,PPARα/carnitine,250,265,"Dietary α-lactalbumin induced fatty liver by enhancing nuclear liver X receptor αβ/sterol regulatory element-binding protein-1c/PPARγ expression and minimising PPARα/carnitine palmitoyltransferase-1 expression and AMP-activated protein kinase α phosphorylation associated with atherogenic dyslipidaemia, insulin resistance and oxidative stress in Balb/c mice."
protein_kinase_changes_novel_ampk-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_29173234.pdf,abstract,CHEMICAL,dyslipidaemia,379,392,"Dietary α-lactalbumin induced fatty liver by enhancing nuclear liver X receptor αβ/sterol regulatory element-binding protein-1c/PPARγ expression and minimising PPARα/carnitine palmitoyltransferase-1 expression and AMP-activated protein kinase α phosphorylation associated with atherogenic dyslipidaemia, insulin resistance and oxidative stress in Balb/c mice."
protein_kinase_changes_novel_ampk-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_29173234.pdf,abstract,CHEMICAL,investigate,992,1003,The aim of the present study was to investigate if this atherogenic effect could be due to a possible α-LAC-induced hepatic steatosis.
protein_kinase_changes_novel_ampk-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_29173234.pdf,abstract,CHEMICAL,NEFA contents,1553,1566,Moderate liver steatosis with increased TAG and NEFA contents was correlated with atherogenic dyslipidaemia.
protein_kinase_changes_novel_ampk-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_29173234.pdf,abstract,CHEMICAL,dyslipidaemia,1599,1612,Moderate liver steatosis with increased TAG and NEFA contents was correlated with atherogenic dyslipidaemia.
protein_kinase_changes_novel_ampk-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_29173234.pdf,abstract,CHEMICAL,GSH,2345,2348,These changes were associated with a significant decrease in both p-Thr172-AMP-activated protein kinase α (AMPKα) (inactivation) and p-Ser79-ACC1 (activation) and with a more oxidative liver environment increasing lipid peroxidation and protein oxidation and reducing GSH:GSSG ratio in the α-LAC-fed mice.
protein_kinase_changes_novel_ampk-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_29173234.pdf,abstract,CHEMICAL,GSSG,2349,2353,These changes were associated with a significant decrease in both p-Thr172-AMP-activated protein kinase α (AMPKα) (inactivation) and p-Ser79-ACC1 (activation) and with a more oxidative liver environment increasing lipid peroxidation and protein oxidation and reducing GSH:GSSG ratio in the α-LAC-fed mice.
protein_kinase_changes_novel_ampk-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_29173234.pdf,abstract,CHEMICAL,dyslipidaemia,2480,2493,"In conclusion, 4 weeks of 14 % α-LAC feeding induced liver steatosis associated with atherogenic dyslipidaemia, IR and oxidative stress by enhancing nuclear LXRαβ/SREBP-1c/PPARγ expression and diminishing PPARα/CPT-1 expression and AMPKα phosphorylation shifting the hepatic FAO toward fatty acid synthesis in Balb/c mice."
protein_kinase_changes_novel_ampk-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_29173234.pdf,abstract,SPECIES,Farmacología,664,676,"(2)2Departamento de Farmacología, Facultad de Farmacia,Universidad Complutense,28040 Madrid,Spain."
protein_kinase_changes_novel_ampk-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_29173234.pdf,abstract,SPECIES,mice,1367,1371,Male Balb/c mice (n 6) were fed with diets containing either chow or 14 % α-LAC for 4 weeks.
protein_kinase_changes_novel_ampk-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_29173234.pdf,abstract,SPECIES,mice,1462,1466,The α-LAC-fed mice developed abdominal adiposity and IR.
protein_kinase_changes_novel_ampk-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_29173234.pdf,abstract,SPECIES,mice,2377,2381,These changes were associated with a significant decrease in both p-Thr172-AMP-activated protein kinase α (AMPKα) (inactivation) and p-Ser79-ACC1 (activation) and with a more oxidative liver environment increasing lipid peroxidation and protein oxidation and reducing GSH:GSSG ratio in the α-LAC-fed mice.
protein_kinase_changes_novel_ampk-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_29529605.pdf,abstract,CHEMICAL,investigate,379,390,"Therefore, the aim of this study was to investigate the regulatory mechanism of acetic acid on hepatic lipid metabolism in BRL-3A cells."
protein_kinase_changes_novel_ampk-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_29529605.pdf,abstract,CHEMICAL,sodium acetate,555,569,METHODS: We cultured and treated BRL-3A cells with different concentrations of sodium acetate (neutralized acetic acid) and BML-275 (an AMPKα inhibitor).
protein_kinase_changes_novel_ampk-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_29529605.pdf,abstract,CHEMICAL,BML-275,600,607,METHODS: We cultured and treated BRL-3A cells with different concentrations of sodium acetate (neutralized acetic acid) and BML-275 (an AMPKα inhibitor).
protein_kinase_changes_novel_ampk-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_29529605.pdf,abstract,CHEMICAL,levels,1168,1174,These changes ultimate led to increasing levels of lipid oxidation in BRL-3A cells.
protein_kinase_changes_novel_ampk-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_29529605.pdf,abstract,CHEMICAL,S. Karger,1822,1831,"Published by S. Karger AG, Basel."
protein_kinase_changes_novel_ampk-de_novo_lipogenesis_fa_synthesis,/work/eval_papers/PMID_29529605.pdf,abstract,CHEMICAL,PMID: 29529605,1866,1880,DOI: 10.1159/000487980 PMID: 29529605 [Indexed for MEDLINE]
protein_kinase_changes_novel_ampk-novel_lipophagy,/work/eval_papers/PMID_32324591.pdf,abstract,CHEMICAL,23;12(8):7350,31,44,1. Aging (Albany NY). 2020 Apr 23;12(8):7350-7362.
protein_kinase_changes_novel_ampk-novel_lipophagy,/work/eval_papers/PMID_32324591.pdf,abstract,CHEMICAL,L(2,228,231,"Zhou Y(1), Zhong L(2), Yu S(3), Shen W(2), Cai C(2), Yu H(2)."
protein_kinase_changes_novel_ampk-novel_lipophagy,/work/eval_papers/PMID_32324591.pdf,abstract,CHEMICAL,NAFLD has been,735,749,SCD1 is a key enzyme controlling lipid metabolism and a link between its activity and NAFLD has been proposed.
protein_kinase_changes_novel_ampk-novel_lipophagy,/work/eval_papers/PMID_32324591.pdf,abstract,CHEMICAL,sodium palmitate,1168,1184,"To investigate the molecular mechanisms through which SCD1 regulates lipophagy in hepatic steatosis, the model of hepatic steatosis was established by inducing mouse primary hepatocytes with sodium palmitate and feeding C57BL/6 mice with HFD."
protein_kinase_changes_novel_ampk-novel_lipophagy,/work/eval_papers/PMID_32324591.pdf,abstract,CHEMICAL,sodium,1247,1253,"Our results indicated that sodium palmitate-treated hepatocytes exhibited increased SCD1 expression, AMPK inactivation and defective lipophagy."
protein_kinase_changes_novel_ampk-novel_lipophagy,/work/eval_papers/PMID_32324591.pdf,abstract,CHEMICAL,Although,1489,1497,"Although SCD1 overexpression led to decreased AMPK activity and lipophagy, lipid deposition was increased in hepatocytes."
protein_kinase_changes_novel_ampk-novel_lipophagy,/work/eval_papers/PMID_32324591.pdf,abstract,CHEMICAL,AMPK,1644,1648,SCD1 regulated lipophagy through AMPK to affect lipid metabolism in mouse primary hepatocytes.
protein_kinase_changes_novel_ampk-novel_lipophagy,/work/eval_papers/PMID_32324591.pdf,abstract,CHEMICAL,CAY10566(an,1746,1757,"Additionally, compared to HFD-fed mice, CAY10566(an SCD1-specific inhibitor)-treated mice exhibited significantly decreased hepatic steatosis and hepatic lipid droplet accumulation, as well as enhanced AMPK activity and lipophagy."
protein_kinase_changes_novel_ampk-novel_lipophagy,/work/eval_papers/PMID_32324591.pdf,abstract,SPECIES,mouse,1137,1142,"To investigate the molecular mechanisms through which SCD1 regulates lipophagy in hepatic steatosis, the model of hepatic steatosis was established by inducing mouse primary hepatocytes with sodium palmitate and feeding C57BL/6 mice with HFD."
protein_kinase_changes_novel_ampk-novel_lipophagy,/work/eval_papers/PMID_32324591.pdf,abstract,SPECIES,mice,1205,1209,"To investigate the molecular mechanisms through which SCD1 regulates lipophagy in hepatic steatosis, the model of hepatic steatosis was established by inducing mouse primary hepatocytes with sodium palmitate and feeding C57BL/6 mice with HFD."
protein_kinase_changes_novel_ampk-novel_lipophagy,/work/eval_papers/PMID_32324591.pdf,abstract,SPECIES,HFD,1215,1218,"To investigate the molecular mechanisms through which SCD1 regulates lipophagy in hepatic steatosis, the model of hepatic steatosis was established by inducing mouse primary hepatocytes with sodium palmitate and feeding C57BL/6 mice with HFD."
protein_kinase_changes_novel_ampk-novel_lipophagy,/work/eval_papers/PMID_32324591.pdf,abstract,SPECIES,mouse,1679,1684,SCD1 regulated lipophagy through AMPK to affect lipid metabolism in mouse primary hepatocytes.
protein_kinase_changes_novel_ampk-novel_lipophagy,/work/eval_papers/PMID_32324591.pdf,abstract,SPECIES,mice,1740,1744,"Additionally, compared to HFD-fed mice, CAY10566(an SCD1-specific inhibitor)-treated mice exhibited significantly decreased hepatic steatosis and hepatic lipid droplet accumulation, as well as enhanced AMPK activity and lipophagy."
protein_kinase_changes_novel_ampk-novel_lipophagy,/work/eval_papers/PMID_32324591.pdf,abstract,SPECIES,mice,1791,1795,"Additionally, compared to HFD-fed mice, CAY10566(an SCD1-specific inhibitor)-treated mice exhibited significantly decreased hepatic steatosis and hepatic lipid droplet accumulation, as well as enhanced AMPK activity and lipophagy."
protein_kinase_changes_novel_ampk-nuclear_receptor_changes_ppara,/work/eval_papers/PMID_29529605.pdf,abstract,CHEMICAL,investigate,379,390,"Therefore, the aim of this study was to investigate the regulatory mechanism of acetic acid on hepatic lipid metabolism in BRL-3A cells."
protein_kinase_changes_novel_ampk-nuclear_receptor_changes_ppara,/work/eval_papers/PMID_29529605.pdf,abstract,CHEMICAL,sodium acetate,555,569,METHODS: We cultured and treated BRL-3A cells with different concentrations of sodium acetate (neutralized acetic acid) and BML-275 (an AMPKα inhibitor).
protein_kinase_changes_novel_ampk-nuclear_receptor_changes_ppara,/work/eval_papers/PMID_29529605.pdf,abstract,CHEMICAL,BML-275,600,607,METHODS: We cultured and treated BRL-3A cells with different concentrations of sodium acetate (neutralized acetic acid) and BML-275 (an AMPKα inhibitor).
protein_kinase_changes_novel_ampk-nuclear_receptor_changes_ppara,/work/eval_papers/PMID_29529605.pdf,abstract,CHEMICAL,levels,1168,1174,These changes ultimate led to increasing levels of lipid oxidation in BRL-3A cells.
protein_kinase_changes_novel_ampk-nuclear_receptor_changes_ppara,/work/eval_papers/PMID_29529605.pdf,abstract,CHEMICAL,S. Karger,1822,1831,"Published by S. Karger AG, Basel."
protein_kinase_changes_novel_ampk-nuclear_receptor_changes_ppara,/work/eval_papers/PMID_29529605.pdf,abstract,CHEMICAL,PMID: 29529605,1866,1880,DOI: 10.1159/000487980 PMID: 29529605 [Indexed for MEDLINE]
protein_kinase_changes_novel_mtorc-novel_lysosomal_biogenesis,/work/eval_papers/PMID_29782848.pdf,abstract,CHEMICAL,Krishnamurthy,308,321,"Chao X(1), Wang S(1), Zhao K(1), Li Y(1), Williams JA(1), Li T(1), Chavan H(1), Krishnamurthy P(1), He XC(2), Li L(2), Ballabio A(3), Ni HM(1), Ding WX(4)."
protein_kinase_changes_novel_mtorc-novel_lysosomal_biogenesis,/work/eval_papers/PMID_29782848.pdf,abstract,CHEMICAL,Medicine,709,717,"(2)Stowers Institute for Medical Research, Kansas City, Missouri; Department of Pathology, University of Kansas Medical Center, Kansas City, Kansas. (3)Telethon Institute of Genetics and Medicine, TIGEM, Pozzuoli, Naples, Italy; Medical Genetics, Department of Translational Medicine, Federico II University, Naples, Italy; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas."
protein_kinase_changes_novel_mtorc-novel_lysosomal_biogenesis,/work/eval_papers/PMID_29782848.pdf,abstract,CHEMICAL,TIGEM,719,724,"(2)Stowers Institute for Medical Research, Kansas City, Missouri; Department of Pathology, University of Kansas Medical Center, Kansas City, Kansas. (3)Telethon Institute of Genetics and Medicine, TIGEM, Pozzuoli, Naples, Italy; Medical Genetics, Department of Translational Medicine, Federico II University, Naples, Italy; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas."
protein_kinase_changes_novel_mtorc-novel_lysosomal_biogenesis,/work/eval_papers/PMID_29782848.pdf,abstract,CHEMICAL,Medicine,797,805,"(2)Stowers Institute for Medical Research, Kansas City, Missouri; Department of Pathology, University of Kansas Medical Center, Kansas City, Kansas. (3)Telethon Institute of Genetics and Medicine, TIGEM, Pozzuoli, Naples, Italy; Medical Genetics, Department of Translational Medicine, Federico II University, Naples, Italy; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas."
protein_kinase_changes_novel_mtorc-novel_lysosomal_biogenesis,/work/eval_papers/PMID_29782848.pdf,abstract,CHEMICAL,Medicine,908,916,"(2)Stowers Institute for Medical Research, Kansas City, Missouri; Department of Pathology, University of Kansas Medical Center, Kansas City, Kansas. (3)Telethon Institute of Genetics and Medicine, TIGEM, Pozzuoli, Naples, Italy; Medical Genetics, Department of Translational Medicine, Federico II University, Naples, Italy; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas."
protein_kinase_changes_novel_mtorc-novel_lysosomal_biogenesis,/work/eval_papers/PMID_29782848.pdf,abstract,CHEMICAL,address,1063,1070,Electronic address: wxding@kumc.edu. Comment in Autophagy. 2018;14(9):1646-1648.
protein_kinase_changes_novel_mtorc-novel_lysosomal_biogenesis,/work/eval_papers/PMID_29782848.pdf,abstract,CHEMICAL,AIMS,1240,1244,BACKGROUND & AIMS: Defects in lysosome function and autophagy contribute to the pathogenesis of alcoholic liver disease.
protein_kinase_changes_novel_mtorc-novel_lysosomal_biogenesis,/work/eval_papers/PMID_29782848.pdf,abstract,CHEMICAL,alcohol,1388,1395,"We investigated the mechanisms by which alcohol consumption affects these processes by evaluating the functions of transcription factor EB (TFEB), which regulates lysosomal biogenesis."
protein_kinase_changes_novel_mtorc-novel_lysosomal_biogenesis,/work/eval_papers/PMID_29782848.pdf,abstract,CHEMICAL,TFEB,1619,1623,"METHODS: We performed studies with GFP-LC3 mice, mice with liver-specific deletion of TFEB, mice with disruption of the transcription factor E3 gene (TFE3-knockout mice), mice with disruption of the Tefb and Tfe3 genes (TFEB and TFE3 double-knockout mice), and Tfebflox/flox albumin cre-negative mice (controls)."
protein_kinase_changes_novel_mtorc-novel_lysosomal_biogenesis,/work/eval_papers/PMID_29782848.pdf,abstract,CHEMICAL,rapamycin,2180,2189,"Mice were placed on diets of regular ethanol feeding plus an acute binge to induce liver damage (ethanol diet); some mice also were given injections of torin-1, an inhibitor of the kinase activity of the mechanistic target of rapamycin (mTOR)."
protein_kinase_changes_novel_mtorc-novel_lysosomal_biogenesis,/work/eval_papers/PMID_29782848.pdf,abstract,CHEMICAL,levels,2375,2381,We analyzed levels of TFEB in liver tissues from patients with alcoholic hepatitis and from healthy donors (controls) by immunohistochemistry.
protein_kinase_changes_novel_mtorc-novel_lysosomal_biogenesis,/work/eval_papers/PMID_29782848.pdf,abstract,CHEMICAL,levels,2569,2575,"RESULTS: Liver tissues from mice on the ethanol diet had lower levels of total and nuclear TFEB compared with control mice, and hepatocytes had decreased lysosome biogenesis and autophagy."
protein_kinase_changes_novel_mtorc-novel_lysosomal_biogenesis,/work/eval_papers/PMID_29782848.pdf,abstract,CHEMICAL,levels,2871,2877,Administration of torin-1 increased liver levels of TFEB and decreased steatosis and liver injury induced by ethanol.
protein_kinase_changes_novel_mtorc-novel_lysosomal_biogenesis,/work/eval_papers/PMID_29782848.pdf,abstract,CHEMICAL,levels,3383,3389,Liver tissues from patients with alcohol-induced hepatitis had lower nuclear levels of TFEB than control tissues.
protein_kinase_changes_novel_mtorc-novel_lysosomal_biogenesis,/work/eval_papers/PMID_29782848.pdf,abstract,CHEMICAL,ethanol,3447,3454,"CONCLUSIONS: We found that ethanol feeding plus an acute binge decreased hepatic expression of TFEB, which is required for lysosomal biogenesis and autophagy."
protein_kinase_changes_novel_mtorc-novel_lysosomal_biogenesis,/work/eval_papers/PMID_29782848.pdf,abstract,CHEMICAL,levels,3625,3631,Strategies to block mTOR activity or increase levels of TFEB might be developed to protect the liver from ethanol-induced damage.
protein_kinase_changes_novel_mtorc-novel_lysosomal_biogenesis,/work/eval_papers/PMID_29782848.pdf,abstract,CHEMICAL,protect,3662,3669,Strategies to block mTOR activity or increase levels of TFEB might be developed to protect the liver from ethanol-induced damage.
protein_kinase_changes_novel_mtorc-novel_lysosomal_biogenesis,/work/eval_papers/PMID_29782848.pdf,abstract,SPECIES,Mice,222,226,Impaired TFEB-Mediated Lysosome Biogenesis and Autophagy Promote Chronic Ethanol-Induced Liver Injury and Steatosis in Mice.
protein_kinase_changes_novel_mtorc-novel_lysosomal_biogenesis,/work/eval_papers/PMID_29782848.pdf,abstract,SPECIES,Italy,744,749,"(2)Stowers Institute for Medical Research, Kansas City, Missouri; Department of Pathology, University of Kansas Medical Center, Kansas City, Kansas. (3)Telethon Institute of Genetics and Medicine, TIGEM, Pozzuoli, Naples, Italy; Medical Genetics, Department of Translational Medicine, Federico II University, Naples, Italy; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas."
protein_kinase_changes_novel_mtorc-novel_lysosomal_biogenesis,/work/eval_papers/PMID_29782848.pdf,abstract,SPECIES,Italy,839,844,"(2)Stowers Institute for Medical Research, Kansas City, Missouri; Department of Pathology, University of Kansas Medical Center, Kansas City, Kansas. (3)Telethon Institute of Genetics and Medicine, TIGEM, Pozzuoli, Naples, Italy; Medical Genetics, Department of Translational Medicine, Federico II University, Naples, Italy; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas."
protein_kinase_changes_novel_mtorc-novel_lysosomal_biogenesis,/work/eval_papers/PMID_29782848.pdf,abstract,SPECIES,Human,874,879,"(2)Stowers Institute for Medical Research, Kansas City, Missouri; Department of Pathology, University of Kansas Medical Center, Kansas City, Kansas. (3)Telethon Institute of Genetics and Medicine, TIGEM, Pozzuoli, Naples, Italy; Medical Genetics, Department of Translational Medicine, Federico II University, Naples, Italy; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas."
protein_kinase_changes_novel_mtorc-novel_lysosomal_biogenesis,/work/eval_papers/PMID_29782848.pdf,abstract,SPECIES,mice,1582,1586,"METHODS: We performed studies with GFP-LC3 mice, mice with liver-specific deletion of TFEB, mice with disruption of the transcription factor E3 gene (TFE3-knockout mice), mice with disruption of the Tefb and Tfe3 genes (TFEB and TFE3 double-knockout mice), and Tfebflox/flox albumin cre-negative mice (controls)."
protein_kinase_changes_novel_mtorc-novel_lysosomal_biogenesis,/work/eval_papers/PMID_29782848.pdf,abstract,SPECIES,mice,1625,1629,"METHODS: We performed studies with GFP-LC3 mice, mice with liver-specific deletion of TFEB, mice with disruption of the transcription factor E3 gene (TFE3-knockout mice), mice with disruption of the Tefb and Tfe3 genes (TFEB and TFE3 double-knockout mice), and Tfebflox/flox albumin cre-negative mice (controls)."
protein_kinase_changes_novel_mtorc-novel_lysosomal_biogenesis,/work/eval_papers/PMID_29782848.pdf,abstract,SPECIES,mice,1704,1708,"METHODS: We performed studies with GFP-LC3 mice, mice with liver-specific deletion of TFEB, mice with disruption of the transcription factor E3 gene (TFE3-knockout mice), mice with disruption of the Tefb and Tfe3 genes (TFEB and TFE3 double-knockout mice), and Tfebflox/flox albumin cre-negative mice (controls)."
protein_kinase_changes_novel_mtorc-novel_lysosomal_biogenesis,/work/eval_papers/PMID_29782848.pdf,abstract,SPECIES,mice,1829,1833,"METHODS: We performed studies with GFP-LC3 mice, mice with liver-specific deletion of TFEB, mice with disruption of the transcription factor E3 gene (TFE3-knockout mice), mice with disruption of the Tefb and Tfe3 genes (TFEB and TFE3 double-knockout mice), and Tfebflox/flox albumin cre-negative mice (controls)."
protein_kinase_changes_novel_mtorc-novel_lysosomal_biogenesis,/work/eval_papers/PMID_29782848.pdf,abstract,SPECIES,mouse,1940,1945,TFEB was overexpressed from adenoviral vectors or knocked down with small interfering RNAs in mouse livers.
protein_kinase_changes_novel_mtorc-novel_lysosomal_biogenesis,/work/eval_papers/PMID_29782848.pdf,abstract,SPECIES,mice,2071,2075,"Mice were placed on diets of regular ethanol feeding plus an acute binge to induce liver damage (ethanol diet); some mice also were given injections of torin-1, an inhibitor of the kinase activity of the mechanistic target of rapamycin (mTOR)."
protein_kinase_changes_novel_mtorc-novel_lysosomal_biogenesis,/work/eval_papers/PMID_29782848.pdf,abstract,SPECIES,patients,2412,2420,We analyzed levels of TFEB in liver tissues from patients with alcoholic hepatitis and from healthy donors (controls) by immunohistochemistry.
protein_kinase_changes_novel_mtorc-novel_lysosomal_biogenesis,/work/eval_papers/PMID_29782848.pdf,abstract,SPECIES,mice,2534,2538,"RESULTS: Liver tissues from mice on the ethanol diet had lower levels of total and nuclear TFEB compared with control mice, and hepatocytes had decreased lysosome biogenesis and autophagy."
protein_kinase_changes_novel_mtorc-novel_lysosomal_biogenesis,/work/eval_papers/PMID_29782848.pdf,abstract,SPECIES,mice,2712,2716,"Hepatocytes from mice on the ethanol diet had increased translocation of mTOR into lysosomes, resulting in increased mTOR activation."
protein_kinase_changes_novel_mtorc-novel_lysosomal_biogenesis,/work/eval_papers/PMID_29782848.pdf,abstract,SPECIES,mice,3125,3129,Mice that overexpressed TFEB in the liver developed less severe ethanol-induced liver injury and had increased lysosomal biogenesis and mitochondrial bioenergetics compared with mice carrying a control vector.
protein_kinase_changes_novel_mtorc-novel_lysosomal_biogenesis,/work/eval_papers/PMID_29782848.pdf,abstract,SPECIES,Mice,3157,3161,Mice with knockdown of TFEB and TFEB-TFE3 double-knockout mice developed more severe liver injury in response to the ethanol diet than control mice.
protein_kinase_changes_novel_mtorc-novel_lysosomal_biogenesis,/work/eval_papers/PMID_29782848.pdf,abstract,SPECIES,patients,3325,3333,Liver tissues from patients with alcohol-induced hepatitis had lower nuclear levels of TFEB than control tissues.
protein_kinase_changes_pdk4-steatosis,/work/eval_papers/PMID_31330194.pdf,abstract,CHEMICAL,2019,46,50,1. Biochim Biophys Acta Mol Cell Biol Lipids. 2019 Oct;1864(10):1449-1457. doi: 10.1016/j.bbalip.2019.07.003. Epub 2019 Jul 19.
protein_kinase_changes_pdk4-steatosis,/work/eval_papers/PMID_31330194.pdf,abstract,CHEMICAL,2019,115,119,1. Biochim Biophys Acta Mol Cell Biol Lipids. 2019 Oct;1864(10):1449-1457. doi: 10.1016/j.bbalip.2019.07.003. Epub 2019 Jul 19.
protein_kinase_changes_pdk4-steatosis,/work/eval_papers/PMID_31330194.pdf,abstract,CHEMICAL,dexamethasone,244,257,The lncRNA ENST00000608794 acts as a competing endogenous RNA to regulate PDK4 expression by sponging miR-15b-5p in dexamethasone induced steatosis.
protein_kinase_changes_pdk4-steatosis,/work/eval_papers/PMID_31330194.pdf,abstract,CHEMICAL,Liu,277,280,"Liu F(1), Chen Q(1), Chen F(1), Wang J(2), Gong R(1), He B(3)."
protein_kinase_changes_pdk4-steatosis,/work/eval_papers/PMID_31330194.pdf,abstract,CHEMICAL,Key,381,384,"Author information: (1)Fujian Provincial Key Laboratory of Environment Factors and Cancer, School of Public Health, Fujian Medical University, Fujian, China."
protein_kinase_changes_pdk4-steatosis,/work/eval_papers/PMID_31330194.pdf,abstract,CHEMICAL,Key,680,683,"(3)Fujian Provincial Key Laboratory of Environment Factors and Cancer, School of Public Health, Fujian Medical University, Fujian, China."
protein_kinase_changes_pdk4-steatosis,/work/eval_papers/PMID_31330194.pdf,abstract,CHEMICAL,address,808,815,Electronic address: hbc517@163.com.
protein_kinase_changes_pdk4-steatosis,/work/eval_papers/PMID_31330194.pdf,abstract,CHEMICAL,dexamethasone induced,1033,1054,The aim of this study was to investigate the role of lncRNA ENST00000608794 in dexamethasone induced steatosis.
protein_kinase_changes_pdk4-steatosis,/work/eval_papers/PMID_31330194.pdf,abstract,CHEMICAL,levels,1119,1125,"We found that ENST00000608794 is expressed at higher levels in dexamethasone treated HepG2 cell, and ENST00000608794 can bind and be regulated by miR-15b-5p."
protein_kinase_changes_pdk4-steatosis,/work/eval_papers/PMID_31330194.pdf,abstract,CHEMICAL,dexamethasone,1129,1142,"We found that ENST00000608794 is expressed at higher levels in dexamethasone treated HepG2 cell, and ENST00000608794 can bind and be regulated by miR-15b-5p."
protein_kinase_changes_pdk4-steatosis,/work/eval_papers/PMID_31330194.pdf,abstract,CHEMICAL,dexamethasone,1565,1578,"Moreover, in dexamethasone treated HepG2 cell lines, ENST00000608794 increased whether with miR-15b-5p inhibitor treatment or not, while increase of PDK4 expression by dexamethasone was greatly compromised in the presence of miR-15b-5p mimic."
protein_kinase_changes_pdk4-steatosis,/work/eval_papers/PMID_31330194.pdf,abstract,CHEMICAL,dexamethasone,1720,1733,"Moreover, in dexamethasone treated HepG2 cell lines, ENST00000608794 increased whether with miR-15b-5p inhibitor treatment or not, while increase of PDK4 expression by dexamethasone was greatly compromised in the presence of miR-15b-5p mimic."
protein_kinase_changes_pdk4-steatosis,/work/eval_papers/PMID_31330194.pdf,abstract,CHEMICAL,dexamethasone induced,2000,2021,"Taken together, the results suggested that ENST00000608794 plays an important role in dexamethasone induced steatosis, which was partly mediated by derepressing of PDK4 through competitively binding to miR-15b-5p."
protein_kinase_changes_pdk4-steatosis,/work/eval_papers/PMID_31330194.pdf,abstract,CHEMICAL,PMID: 31330194,2214,2228,DOI: 10.1016/j.bbalip.2019.07.003 PMID: 31330194 [Indexed for MEDLINE]
protein_kinase_changes_pdk4-steatosis,/work/eval_papers/PMID_31330194.pdf,abstract,SPECIES,regulate PDK4,193,206,The lncRNA ENST00000608794 acts as a competing endogenous RNA to regulate PDK4 expression by sponging miR-15b-5p in dexamethasone induced steatosis.
steatosis-er_stress,/work/eval_papers/PMID_32593710.pdf,abstract,CHEMICAL,Rio,563,566,"Author information: (1)Laboratório de Fisiopatologia, Divisão de Pesquisa Integrada em Produtos Bioativos e Biociências (DPBio), Polo Novo Cavaleiros, Universidade Federal do Rio de Janeiro, Campus UFRJ-Macaé, Macaé, RJ, Brazil."
steatosis-er_stress,/work/eval_papers/PMID_32593710.pdf,abstract,CHEMICAL,Rio,1030,1033,"(4)Laboratório de Fisiopatologia, Divisão de Pesquisa Integrada em Produtos Bioativos e Biociências (DPBio), Polo Novo Cavaleiros, Universidade Federal do Rio de Janeiro, Campus UFRJ-Macaé, Macaé, RJ, Brazil; Setor de Ciências Biológicas e da Saúde (SEBISA), Departamento de Biologia Geral, Universidade Estadual de Ponta Grossa (UEPG), Ponta Grossa, PR, Brazil."
steatosis-er_stress,/work/eval_papers/PMID_32593710.pdf,abstract,CHEMICAL,address,1249,1256,Electronic address: raribeiro@uepg.br.
steatosis-er_stress,/work/eval_papers/PMID_32593710.pdf,abstract,CHEMICAL,Bisphenol,1283,1292,AIMS: Bisphenol (BP)-A exposure can impair glucose and lipid metabolism.
steatosis-er_stress,/work/eval_papers/PMID_32593710.pdf,abstract,CHEMICAL,BPA,1568,1571,"Herein, we evaluated the effects of BPA exposure on adiposity, glucose homeostasis and hepatic steatosis in ovariectomized (OVX) mice fed on a high-fat diet (HFD)."
steatosis-er_stress,/work/eval_papers/PMID_32593710.pdf,abstract,CHEMICAL,BPA,2267,2270,BPA did not alter adiposity or glucose homeostasis disruptions induced by HFD.
steatosis-er_stress,/work/eval_papers/PMID_32593710.pdf,abstract,CHEMICAL,BPA,2687,2690,"Furthermore, BPA caused mild steatosis in OVX CBPA females, increasing the hepatic total lipids and mRNAs for Srebf1, Scd1, Hspa5, Hyou1 and Atf6."
steatosis-er_stress,/work/eval_papers/PMID_32593710.pdf,abstract,CHEMICAL,BPA,2835,2838,SIGNIFICANCE: BPA aggravated hepatic steatosis in OVX mice.
steatosis-er_stress,/work/eval_papers/PMID_32593710.pdf,abstract,CHEMICAL,BPA,2918,2921,"Especially when combined with a HFD, BPA caused NAFLD progression, which was partly mediated by chronic ER stress and the TGF-β1 pathway."
steatosis-er_stress,/work/eval_papers/PMID_32593710.pdf,abstract,SPECIES,mice,151,155,Bisphenol-A exposure worsens hepatic steatosis in ovariectomized mice fed on a high-fat diet: Role of endoplasmic reticulum stress and fibrogenic pathways.
steatosis-er_stress,/work/eval_papers/PMID_32593710.pdf,abstract,SPECIES,Universidade,1166,1178,"(4)Laboratório de Fisiopatologia, Divisão de Pesquisa Integrada em Produtos Bioativos e Biociências (DPBio), Polo Novo Cavaleiros, Universidade Federal do Rio de Janeiro, Campus UFRJ-Macaé, Macaé, RJ, Brazil; Setor de Ciências Biológicas e da Saúde (SEBISA), Departamento de Biologia Geral, Universidade Estadual de Ponta Grossa (UEPG), Ponta Grossa, PR, Brazil."
steatosis-er_stress,/work/eval_papers/PMID_32593710.pdf,abstract,SPECIES,mice,1729,1733,"MAIN METHODS: Adult Swiss female mice were OVX and submitted to a normolipidic diet or HFD and drinking water without [control (OVX CTL) and OVX HFD groups, respectively] or with 1 μg/mL BPA (OVX CBPA and OVX HBPA groups, respectively), for 3 months."
steatosis-er_stress,/work/eval_papers/PMID_32593710.pdf,abstract,SPECIES,OVX CBPA,1888,1896,"MAIN METHODS: Adult Swiss female mice were OVX and submitted to a normolipidic diet or HFD and drinking water without [control (OVX CTL) and OVX HFD groups, respectively] or with 1 μg/mL BPA (OVX CBPA and OVX HBPA groups, respectively), for 3 months."
steatosis-er_stress,/work/eval_papers/PMID_32593710.pdf,abstract,SPECIES,HFD,2341,2344,BPA did not alter adiposity or glucose homeostasis disruptions induced by HFD.
transcription_factor_related_changes_novel_chop-er_stress,/work/eval_papers/PMID_28962527.pdf,abstract,CHEMICAL,Amiodarone,79,89,1. Toxicol Sci. 2017 Oct 1;159(2):402-412. doi: 10.1093/toxsci/kfx143. Hepatic Amiodarone Lipotoxicity Is Ameliorated by Genetic and Pharmacological Inhibition of Endoplasmatic Reticulum Stress.
transcription_factor_related_changes_novel_chop-er_stress,/work/eval_papers/PMID_28962527.pdf,abstract,CHEMICAL,Cohen,232,237,"Erez N(1), Hubel E(1), Avraham R(1), Cohen R(1), Fishman S(1), Bantel H(2), Manns M(2), Tirosh B(3), Zvibel I(1), Shibolet O(1)."
transcription_factor_related_changes_novel_chop-er_stress,/work/eval_papers/PMID_28962527.pdf,abstract,CHEMICAL,Medicine,468,476,"Author information: (1)Gastroenterology Institute, Tel-Aviv Sourasky Medical Center and Tel-Aviv University, Affiliated with Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel."
transcription_factor_related_changes_novel_chop-er_stress,/work/eval_papers/PMID_28962527.pdf,abstract,CHEMICAL,Medicine,689,697,"(3)Institute for Drug Research, School of Pharmacy, Faculty of Medicine, Hebrew University, Jerusalem, Israel."
transcription_factor_related_changes_novel_chop-er_stress,/work/eval_papers/PMID_28962527.pdf,abstract,CHEMICAL,Amiodarone,737,747,Amiodarone is a commonly used antiarrhythmic drug and can cause liver steatosis.
transcription_factor_related_changes_novel_chop-er_stress,/work/eval_papers/PMID_28962527.pdf,abstract,CHEMICAL,Amiodarone,1108,1118,"Amiodarone directly reduced intracellular ATP and Ca2+ in hepatocytes invitro, inducing ER stress and lipid accumulation."
transcription_factor_related_changes_novel_chop-er_stress,/work/eval_papers/PMID_28962527.pdf,abstract,CHEMICAL,ATP,1150,1153,"Amiodarone directly reduced intracellular ATP and Ca2+ in hepatocytes invitro, inducing ER stress and lipid accumulation."
transcription_factor_related_changes_novel_chop-er_stress,/work/eval_papers/PMID_28962527.pdf,abstract,CHEMICAL,demonstrated,1366,1378,"In vivo, amiodarone-driven liver damage and lipid accumulation was accompanied by activation of ER stress/unfolded protein response, as demonstrated by up-regulation of genes encoding key ER stress mediators and by phosphorylation of eIF2α."
transcription_factor_related_changes_novel_chop-er_stress,/work/eval_papers/PMID_28962527.pdf,abstract,SPECIES,mice,1504,1508,"In contrast to WT mice, Ddit3-/- mice were protected from amiodarone-induced ER stress and lipid accumulation."
transcription_factor_related_changes_novel_chop-er_stress,/work/eval_papers/PMID_28962527.pdf,abstract,SPECIES,mice,2239,2243,"Moreover, while insulin attenuated amiodarone-induced phosphorylation of hormone sensitive lipase (HSL) in WT, it did not affect pHSL in Ddit3-/-, indicating increased lipolysis and therefore reduced lipid accumulation in these mice."
transcription_factor_related_changes_novel_foxo1-liver_triglyceride_accumulation,/work/eval_papers/PMID_33449950.pdf,abstract,CHEMICAL,Tan,217,220,"Zhao N(1), Tan H(2), Wang L(1), Han L(1), Cheng Y(1), Feng Y(1), Li T(1), Liu X(1)."
transcription_factor_related_changes_novel_foxo1-liver_triglyceride_accumulation,/work/eval_papers/PMID_33449950.pdf,abstract,CHEMICAL,Liu,280,283,"Zhao N(1), Tan H(2), Wang L(1), Han L(1), Cheng Y(1), Feng Y(1), Li T(1), Liu X(1)."
transcription_factor_related_changes_novel_foxo1-liver_triglyceride_accumulation,/work/eval_papers/PMID_33449950.pdf,abstract,CHEMICAL,adipose triglyceride,804,824,Forkhead box O-1 (FoxO1) is one of the FoxO family members of transcription factors and can stimulate adipose triglyceride lipase (ATGL) and suppress its inhibitor G0/G1 switch gene 2 (G0S2) expression in the liver.
transcription_factor_related_changes_novel_foxo1-liver_triglyceride_accumulation,/work/eval_papers/PMID_33449950.pdf,abstract,SPECIES,Chengdu,500,507,"(2)Department of Endocrinology and Metabolism, West China Hospital of Sichuan University, Chengdu, Sichuan, China."
transcription_factor_related_changes_novel_foxo1-liver_triglyceride_accumulation,/work/eval_papers/PMID_33449950.pdf,abstract,SPECIES,human HepG2 hepatoma cells,1241,1267,Palmitate significantly promoted lipid accumulation but inhibited lipid decomposition in human HepG2 hepatoma cells.
transcription_factor_related_changes_novel_hnf_1a-novel_cyp450,/work/eval_papers/PMID_33007364.pdf,abstract,CHEMICAL,L(2,241,244,"Ma L(1), Wang Y(1), Chen X(1), Zhao L(2), Guo Y(3)."
transcription_factor_related_changes_novel_hnf_1a-novel_cyp450,/work/eval_papers/PMID_33007364.pdf,abstract,CHEMICAL,Changchun,323,332,"Author information: (1)School of Life Sciences, Jilin University, Changchun, China."
transcription_factor_related_changes_novel_hnf_1a-novel_cyp450,/work/eval_papers/PMID_33007364.pdf,abstract,CHEMICAL,Changchun,479,488,"(3)School of Life Sciences, Jilin University, Changchun, China; National Engineering Laboratory of AIDS Vaccine, Jilin University, Changchun, China."
transcription_factor_related_changes_novel_hnf_1a-novel_cyp450,/work/eval_papers/PMID_33007364.pdf,abstract,CHEMICAL,AIDS Vaccine,532,544,"(3)School of Life Sciences, Jilin University, Changchun, China; National Engineering Laboratory of AIDS Vaccine, Jilin University, Changchun, China."
transcription_factor_related_changes_novel_hnf_1a-novel_cyp450,/work/eval_papers/PMID_33007364.pdf,abstract,CHEMICAL,Changchun,564,573,"(3)School of Life Sciences, Jilin University, Changchun, China; National Engineering Laboratory of AIDS Vaccine, Jilin University, Changchun, China."
transcription_factor_related_changes_novel_hnf_1a-novel_cyp450,/work/eval_papers/PMID_33007364.pdf,abstract,CHEMICAL,address,593,600,Electronic address: guoyingjie@jlu.edu.cn.
transcription_factor_related_changes_novel_hnf_1a-novel_cyp450,/work/eval_papers/PMID_33007364.pdf,abstract,CHEMICAL,VPA,640,643,"Valproic acid (VPA) is a widely prescribed antiepileptic drug, which may cause steatosis in the liver."
transcription_factor_related_changes_novel_hnf_1a-novel_cyp450,/work/eval_papers/PMID_33007364.pdf,abstract,CHEMICAL,VPA,1033,1036,"First, VPA treatment (500 mg/kg in mice, 5 mM in LO2 cells) induced hepatic steatosis and enhanced reactive oxidative stress (ROS) level, and ROS scavenger, N-acetyl-L-cysteine (NAC, 200 mg/kg in mice, 1 mM in LO2 cells) reversed the changes."
transcription_factor_related_changes_novel_hnf_1a-novel_cyp450,/work/eval_papers/PMID_33007364.pdf,abstract,CHEMICAL,levels,1777,1783,"Furthermore, gene expression analysis showed that the mRNA levels of cluster of differentiation 36 (CD36), a fatty acid translocase protein and distinct diacylglycerol acyltransferase 2 (DGAT2) were significantly upregulated in mice and LO2 cells after VPA treatment, while the change was alleviated by NAC and DAS."
transcription_factor_related_changes_novel_hnf_1a-novel_cyp450,/work/eval_papers/PMID_33007364.pdf,abstract,CHEMICAL,VPA,1971,1974,"Furthermore, gene expression analysis showed that the mRNA levels of cluster of differentiation 36 (CD36), a fatty acid translocase protein and distinct diacylglycerol acyltransferase 2 (DGAT2) were significantly upregulated in mice and LO2 cells after VPA treatment, while the change was alleviated by NAC and DAS."
transcription_factor_related_changes_novel_hnf_1a-novel_cyp450,/work/eval_papers/PMID_33007364.pdf,abstract,CHEMICAL,VPA,2243,2246,"Taken together, VPA treatment enhances the expression and enzymatic activity of CYP2E1, which promotes ROS production and then causes CD36 and DGAT2 overproduction and hepatic steatosis in mice and LO2 cells, which provides a novel insight into VPA-induced hepatic steatosis."
transcription_factor_related_changes_novel_hnf_1a-novel_cyp450,/work/eval_papers/PMID_33007364.pdf,abstract,SPECIES,mice,1061,1065,"First, VPA treatment (500 mg/kg in mice, 5 mM in LO2 cells) induced hepatic steatosis and enhanced reactive oxidative stress (ROS) level, and ROS scavenger, N-acetyl-L-cysteine (NAC, 200 mg/kg in mice, 1 mM in LO2 cells) reversed the changes."
transcription_factor_related_changes_novel_hnf_1a-novel_cyp450,/work/eval_papers/PMID_33007364.pdf,abstract,SPECIES,mice,1222,1226,"First, VPA treatment (500 mg/kg in mice, 5 mM in LO2 cells) induced hepatic steatosis and enhanced reactive oxidative stress (ROS) level, and ROS scavenger, N-acetyl-L-cysteine (NAC, 200 mg/kg in mice, 1 mM in LO2 cells) reversed the changes."
transcription_factor_related_changes_novel_hnf_1a-novel_cyp450,/work/eval_papers/PMID_33007364.pdf,abstract,SPECIES,mice,1381,1385,"Next, we observed the enhanced expression and enzymatic activity of cytochrome P450 2E1 (CYP2E1) in VPA-treated mice and LO2 cells."
transcription_factor_related_changes_novel_hnf_1a-novel_cyp450,/work/eval_papers/PMID_33007364.pdf,abstract,SPECIES,mice,1566,1570,"Importantly, VPA-induced ROS accumulation and hepatic steatosis were attenuated when CYP2E1 was inhibited using CYP2E1 inhibitor, diallyl sulfide (DAS, 100 mg/kg in mice, 1 mM in LO2 cells) or in CYP2E1-knockdown cell line, suggesting that CYP2E1 plays a potential role in ROS production following hepatic steatosis."
transcription_factor_related_changes_novel_hnf_1a-novel_cyp450,/work/eval_papers/PMID_33007364.pdf,abstract,SPECIES,mice,1946,1950,"Furthermore, gene expression analysis showed that the mRNA levels of cluster of differentiation 36 (CD36), a fatty acid translocase protein and distinct diacylglycerol acyltransferase 2 (DGAT2) were significantly upregulated in mice and LO2 cells after VPA treatment, while the change was alleviated by NAC and DAS."
transcription_factor_related_changes_novel_hnf_1a-novel_cyp450,/work/eval_papers/PMID_33007364.pdf,abstract,SPECIES,mice,2416,2420,"Taken together, VPA treatment enhances the expression and enzymatic activity of CYP2E1, which promotes ROS production and then causes CD36 and DGAT2 overproduction and hepatic steatosis in mice and LO2 cells, which provides a novel insight into VPA-induced hepatic steatosis."
transcription_factor_related_changes_novel_lipin_1-nuclear_receptor_changes_ppara,/work/eval_papers/PMID_34029162.pdf,abstract,CHEMICAL,Shi,250,253,"Shi Y(1), Pizzini J(1), Wang H(2), Das F(1), Abdul Azees PA(1)(2), Ghosh Choudhury G(1), Barnes JL(1), Zang M(3)(4)(5), Weintraub ST(6), Yeh CK(2)(4)(5), Katz MS(1)(5), Kamat A(1)(4)(5)."
transcription_factor_related_changes_novel_lipin_1-nuclear_receptor_changes_ppara,/work/eval_papers/PMID_34029162.pdf,abstract,CHEMICAL,Das,285,288,"Shi Y(1), Pizzini J(1), Wang H(2), Das F(1), Abdul Azees PA(1)(2), Ghosh Choudhury G(1), Barnes JL(1), Zang M(3)(4)(5), Weintraub ST(6), Yeh CK(2)(4)(5), Katz MS(1)(5), Kamat A(1)(4)(5)."
transcription_factor_related_changes_novel_lipin_1-nuclear_receptor_changes_ppara,/work/eval_papers/PMID_34029162.pdf,abstract,CHEMICAL,Barnes,339,345,"Shi Y(1), Pizzini J(1), Wang H(2), Das F(1), Abdul Azees PA(1)(2), Ghosh Choudhury G(1), Barnes JL(1), Zang M(3)(4)(5), Weintraub ST(6), Yeh CK(2)(4)(5), Katz MS(1)(5), Kamat A(1)(4)(5)."
transcription_factor_related_changes_novel_lipin_1-nuclear_receptor_changes_ppara,/work/eval_papers/PMID_34029162.pdf,abstract,CHEMICAL,Medicine,474,482,"Author information: (1)Department of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, Texas."
transcription_factor_related_changes_novel_lipin_1-nuclear_receptor_changes_ppara,/work/eval_papers/PMID_34029162.pdf,abstract,CHEMICAL,Medicine,709,717,"(3)Department of Molecular Medicine, University of Texas Health Science Center at San Antonio, Texas."
transcription_factor_related_changes_novel_lipin_1-nuclear_receptor_changes_ppara,/work/eval_papers/PMID_34029162.pdf,abstract,CHEMICAL,state,1619,1624,"Obesity and aging, two principal risk factors for NAFLD, are associated with a hyperadrenergic state."
transcription_factor_related_changes_novel_lipin_1-nuclear_receptor_changes_ppara,/work/eval_papers/PMID_34029162.pdf,abstract,CHEMICAL,formoterol,1991,2001,"In this study we demonstrate that injection of formoterol, a highly selective β2-AR agonist, to mice acutely results in hepatic TG accumulation."
transcription_factor_related_changes_novel_lipin_1-nuclear_receptor_changes_ppara,/work/eval_papers/PMID_34029162.pdf,abstract,CHEMICAL,define,2116,2122,"Further, we have sought to define the intrahepatic mechanisms underlying β2-AR mediated steatosis by investigating changes in hepatic expression and cellular localization of enzymes, transcription factors, and coactivators involved in processes of lipid accrual and disposition-and also functional aspects thereof-in livers of formoterol-treated animals."
transcription_factor_related_changes_novel_lipin_1-nuclear_receptor_changes_ppara,/work/eval_papers/PMID_34029162.pdf,abstract,CHEMICAL,Our,2444,2447,"Our results suggest that β2-AR activation by formoterol leads to increased hepatic TG synthesis and de novo lipogenesis, increased but incomplete β-oxidation of fatty acids with accumulation of potentially toxic long-chain acylcarnitine intermediates, and reduced TG secretion-all previously invoked as contributors to fatty liver disease."
transcription_factor_related_changes_novel_lipin_1-nuclear_receptor_changes_ppara,/work/eval_papers/PMID_34029162.pdf,abstract,CHEMICAL,β2-AR,2469,2474,"Our results suggest that β2-AR activation by formoterol leads to increased hepatic TG synthesis and de novo lipogenesis, increased but incomplete β-oxidation of fatty acids with accumulation of potentially toxic long-chain acylcarnitine intermediates, and reduced TG secretion-all previously invoked as contributors to fatty liver disease."
transcription_factor_related_changes_novel_lipin_1-nuclear_receptor_changes_ppara,/work/eval_papers/PMID_34029162.pdf,abstract,CHEMICAL,formoterol,2489,2499,"Our results suggest that β2-AR activation by formoterol leads to increased hepatic TG synthesis and de novo lipogenesis, increased but incomplete β-oxidation of fatty acids with accumulation of potentially toxic long-chain acylcarnitine intermediates, and reduced TG secretion-all previously invoked as contributors to fatty liver disease."
transcription_factor_related_changes_novel_lipin_1-nuclear_receptor_changes_ppara,/work/eval_papers/PMID_34029162.pdf,abstract,CHEMICAL,formoterol,2880,2890,"Experiments are ongoing to determine whether sustained activation of hepatic β2-AR signaling by formoterol might be utilized to model fatty liver changes occurring in hyperadrenergic states of obesity and aging, and thereby identify novel molecular targets for the prevention or treatment of NAFLD.NEW & NOTEWORTHY Results of our study suggest that β2-adrenergic receptor (β2-AR) activation by agonist formoterol leads to increased hepatic TG synthesis and de novo lipogenesis, incomplete β-oxidation of fatty acids with accumulation of long-chain acylcarnitine intermediates, and reduced TG secretion."
transcription_factor_related_changes_novel_lipin_1-nuclear_receptor_changes_ppara,/work/eval_papers/PMID_34029162.pdf,abstract,CHEMICAL,formoterol,3186,3196,"Experiments are ongoing to determine whether sustained activation of hepatic β2-AR signaling by formoterol might be utilized to model fatty liver changes occurring in hyperadrenergic states of obesity and aging, and thereby identify novel molecular targets for the prevention or treatment of NAFLD.NEW & NOTEWORTHY Results of our study suggest that β2-adrenergic receptor (β2-AR) activation by agonist formoterol leads to increased hepatic TG synthesis and de novo lipogenesis, incomplete β-oxidation of fatty acids with accumulation of long-chain acylcarnitine intermediates, and reduced TG secretion."
transcription_factor_related_changes_novel_lipin_1-nuclear_receptor_changes_ppara,/work/eval_papers/PMID_34029162.pdf,abstract,CHEMICAL,F.D.,3744,3748,"DOI: 10.1152/ajpendo.00651.2020 PMCID: PMC8321826 PMID: 34029162 [Indexed for MEDLINE] Conflict of interest statement: Y.S., J.P., H.W., F.D., P.A.A., G.G-C., M.Z., S.T.W., C-K.Y., M.S.K., and A.K. have nothing to disclose."
transcription_factor_related_changes_novel_lipin_1-nuclear_receptor_changes_ppara,/work/eval_papers/PMID_34029162.pdf,abstract,SPECIES,mice,175,179,Epub 2021 May 24. β(2)-Adrenergic receptor agonist induced hepatic steatosis in mice: modeling nonalcoholic fatty liver disease in hyperadrenergic states.
transcription_factor_related_changes_novel_lipin_1-nuclear_receptor_changes_ppara,/work/eval_papers/PMID_34029162.pdf,abstract,SPECIES,mice,2040,2044,"In this study we demonstrate that injection of formoterol, a highly selective β2-AR agonist, to mice acutely results in hepatic TG accumulation."
transcription_factor_related_changes_novel_lipin_1-nuclear_receptor_changes_ppara,/work/eval_papers/PMID_34029162.pdf,abstract,SPECIES,J.P.,3732,3736,"DOI: 10.1152/ajpendo.00651.2020 PMCID: PMC8321826 PMID: 34029162 [Indexed for MEDLINE] Conflict of interest statement: Y.S., J.P., H.W., F.D., P.A.A., G.G-C., M.Z., S.T.W., C-K.Y., M.S.K., and A.K. have nothing to disclose."
transcription_factor_related_changes_novel_lipin_1-nuclear_receptor_changes_ppara,/work/eval_papers/PMID_34029162.pdf,abstract,SPECIES,C-K.Y.,3780,3786,"DOI: 10.1152/ajpendo.00651.2020 PMCID: PMC8321826 PMID: 34029162 [Indexed for MEDLINE] Conflict of interest statement: Y.S., J.P., H.W., F.D., P.A.A., G.G-C., M.Z., S.T.W., C-K.Y., M.S.K., and A.K. have nothing to disclose."
transcription_factor_related_changes_novel_nrf1-mitochondrial_beta_oxidation,/work/eval_papers/PMID_29625129.pdf,abstract,CHEMICAL,Medicine,320,328,"Author information: (1)Department of Medicine, University of Minnesota, Minneapolis, MN 55455, USA."
transcription_factor_related_changes_novel_nrf1-mitochondrial_beta_oxidation,/work/eval_papers/PMID_29625129.pdf,abstract,CHEMICAL,Medicine,446,454,"(3)Department of Medicine, University of Minnesota, Minneapolis, MN 55455, USA; Department of Genetics, Cell Biology and Development, University of Minnesota, Minneapolis, MN 55455, USA."
transcription_factor_related_changes_novel_nrf1-mitochondrial_beta_oxidation,/work/eval_papers/PMID_29625129.pdf,abstract,CHEMICAL,address,724,731,Electronic address: gqyan@126.com.
transcription_factor_related_changes_novel_nrf1-mitochondrial_beta_oxidation,/work/eval_papers/PMID_29625129.pdf,abstract,CHEMICAL,Medicine,765,773,"(5)Department of Medicine, University of Minnesota, Minneapolis, MN 55455, USA; McLab, South San Francisco, CA 94080, USA; College of Life and Biological Sciences, Shanxi Normal University, Linfen City 041000, China."
transcription_factor_related_changes_novel_nrf1-mitochondrial_beta_oxidation,/work/eval_papers/PMID_29625129.pdf,abstract,CHEMICAL,address,976,983,Electronic address: gsong@umn.edu.
transcription_factor_related_changes_novel_nrf1-mitochondrial_beta_oxidation,/work/eval_papers/PMID_29625129.pdf,abstract,CHEMICAL,Hepa1-6,2348,2355,Overexpression of miR-378 impaired FAO and promoted lipid accumulation in murine hepatoma Hepa1-6 cells.
transcription_factor_related_changes_novel_nrf1-mitochondrial_beta_oxidation,/work/eval_papers/PMID_29625129.pdf,abstract,CHEMICAL,FAO,2439,2442,"In contrast, knockdown of miR-378 using its ASO (anti-sense oligo) improved FAO and reduced intracellular lipid content in Hepa1-6 cells."
transcription_factor_related_changes_novel_nrf1-mitochondrial_beta_oxidation,/work/eval_papers/PMID_29625129.pdf,abstract,CHEMICAL,FAO,2731,2734,"Antagonizing miR-378 via injecting miR-378-ASO into HFD-treated mice led to increased expression of Nrf1, improved FAO and decreased hepatosteatosis."
transcription_factor_related_changes_novel_nrf1-mitochondrial_beta_oxidation,/work/eval_papers/PMID_29625129.pdf,abstract,CHEMICAL,FAO,3114,3117,"Ablation of Nrf1 using its shRNA in livers led to increased miR-378, which subsequently resulted in reduced FAO and elevated hepatic lipid content."
transcription_factor_related_changes_novel_nrf1-mitochondrial_beta_oxidation,/work/eval_papers/PMID_29625129.pdf,abstract,SPECIES,mice,191,195,A negative feedback loop between microRNA-378 and Nrf1 promotes the development of hepatosteatosis in mice treated with a high fat diet.
transcription_factor_related_changes_novel_nrf1-mitochondrial_beta_oxidation,/work/eval_papers/PMID_29625129.pdf,abstract,SPECIES,USA,378,381,"Author information: (1)Department of Medicine, University of Minnesota, Minneapolis, MN 55455, USA."
transcription_factor_related_changes_novel_nrf1-mitochondrial_beta_oxidation,/work/eval_papers/PMID_29625129.pdf,abstract,SPECIES,USA,504,507,"(3)Department of Medicine, University of Minnesota, Minneapolis, MN 55455, USA; Department of Genetics, Cell Biology and Development, University of Minnesota, Minneapolis, MN 55455, USA."
transcription_factor_related_changes_novel_nrf1-mitochondrial_beta_oxidation,/work/eval_papers/PMID_29625129.pdf,abstract,SPECIES,USA,823,826,"(5)Department of Medicine, University of Minnesota, Minneapolis, MN 55455, USA; McLab, South San Francisco, CA 94080, USA; College of Life and Biological Sciences, Shanxi Normal University, Linfen City 041000, China."
transcription_factor_related_changes_novel_nrf1-mitochondrial_beta_oxidation,/work/eval_papers/PMID_29625129.pdf,abstract,SPECIES,USA,866,869,"(5)Department of Medicine, University of Minnesota, Minneapolis, MN 55455, USA; McLab, South San Francisco, CA 94080, USA; College of Life and Biological Sciences, Shanxi Normal University, Linfen City 041000, China."
transcription_factor_related_changes_novel_nrf1-mitochondrial_beta_oxidation,/work/eval_papers/PMID_29625129.pdf,abstract,SPECIES,human fatty livers,1515,1533,Alterations in microRNA (miR) expression have been observed in human fatty livers.
transcription_factor_related_changes_novel_nrf1-mitochondrial_beta_oxidation,/work/eval_papers/PMID_29625129.pdf,abstract,SPECIES,mice,2059,2063,RESULTS: miR-378 was significantly increased in fatty livers of dietary obese mice and human hepatoma HepG2 cells with accumulated lipid.
transcription_factor_related_changes_novel_nrf1-mitochondrial_beta_oxidation,/work/eval_papers/PMID_29625129.pdf,abstract,SPECIES,human hepatoma HepG2 cells,2068,2094,RESULTS: miR-378 was significantly increased in fatty livers of dietary obese mice and human hepatoma HepG2 cells with accumulated lipid.
transcription_factor_related_changes_novel_nrf1-mitochondrial_beta_oxidation,/work/eval_papers/PMID_29625129.pdf,abstract,SPECIES,murine hepatoma Hepa1-6 cells,2332,2361,Overexpression of miR-378 impaired FAO and promoted lipid accumulation in murine hepatoma Hepa1-6 cells.
transcription_factor_related_changes_novel_nrf1-mitochondrial_beta_oxidation,/work/eval_papers/PMID_29625129.pdf,abstract,SPECIES,mice,2680,2684,"Antagonizing miR-378 via injecting miR-378-ASO into HFD-treated mice led to increased expression of Nrf1, improved FAO and decreased hepatosteatosis."
transcription_factor_related_changes_novel_pgc_1a-liver_triglyceride_accumulation,/work/eval_papers/PMID_34029162.pdf,abstract,CHEMICAL,Shi,250,253,"Shi Y(1), Pizzini J(1), Wang H(2), Das F(1), Abdul Azees PA(1)(2), Ghosh Choudhury G(1), Barnes JL(1), Zang M(3)(4)(5), Weintraub ST(6), Yeh CK(2)(4)(5), Katz MS(1)(5), Kamat A(1)(4)(5)."
transcription_factor_related_changes_novel_pgc_1a-liver_triglyceride_accumulation,/work/eval_papers/PMID_34029162.pdf,abstract,CHEMICAL,Das,285,288,"Shi Y(1), Pizzini J(1), Wang H(2), Das F(1), Abdul Azees PA(1)(2), Ghosh Choudhury G(1), Barnes JL(1), Zang M(3)(4)(5), Weintraub ST(6), Yeh CK(2)(4)(5), Katz MS(1)(5), Kamat A(1)(4)(5)."
transcription_factor_related_changes_novel_pgc_1a-liver_triglyceride_accumulation,/work/eval_papers/PMID_34029162.pdf,abstract,CHEMICAL,Barnes,339,345,"Shi Y(1), Pizzini J(1), Wang H(2), Das F(1), Abdul Azees PA(1)(2), Ghosh Choudhury G(1), Barnes JL(1), Zang M(3)(4)(5), Weintraub ST(6), Yeh CK(2)(4)(5), Katz MS(1)(5), Kamat A(1)(4)(5)."
transcription_factor_related_changes_novel_pgc_1a-liver_triglyceride_accumulation,/work/eval_papers/PMID_34029162.pdf,abstract,CHEMICAL,Medicine,474,482,"Author information: (1)Department of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, Texas."
transcription_factor_related_changes_novel_pgc_1a-liver_triglyceride_accumulation,/work/eval_papers/PMID_34029162.pdf,abstract,CHEMICAL,Medicine,709,717,"(3)Department of Molecular Medicine, University of Texas Health Science Center at San Antonio, Texas."
transcription_factor_related_changes_novel_pgc_1a-liver_triglyceride_accumulation,/work/eval_papers/PMID_34029162.pdf,abstract,CHEMICAL,state,1619,1624,"Obesity and aging, two principal risk factors for NAFLD, are associated with a hyperadrenergic state."
transcription_factor_related_changes_novel_pgc_1a-liver_triglyceride_accumulation,/work/eval_papers/PMID_34029162.pdf,abstract,CHEMICAL,formoterol,1991,2001,"In this study we demonstrate that injection of formoterol, a highly selective β2-AR agonist, to mice acutely results in hepatic TG accumulation."
transcription_factor_related_changes_novel_pgc_1a-liver_triglyceride_accumulation,/work/eval_papers/PMID_34029162.pdf,abstract,CHEMICAL,define,2116,2122,"Further, we have sought to define the intrahepatic mechanisms underlying β2-AR mediated steatosis by investigating changes in hepatic expression and cellular localization of enzymes, transcription factors, and coactivators involved in processes of lipid accrual and disposition-and also functional aspects thereof-in livers of formoterol-treated animals."
transcription_factor_related_changes_novel_pgc_1a-liver_triglyceride_accumulation,/work/eval_papers/PMID_34029162.pdf,abstract,CHEMICAL,Our,2444,2447,"Our results suggest that β2-AR activation by formoterol leads to increased hepatic TG synthesis and de novo lipogenesis, increased but incomplete β-oxidation of fatty acids with accumulation of potentially toxic long-chain acylcarnitine intermediates, and reduced TG secretion-all previously invoked as contributors to fatty liver disease."
transcription_factor_related_changes_novel_pgc_1a-liver_triglyceride_accumulation,/work/eval_papers/PMID_34029162.pdf,abstract,CHEMICAL,β2-AR,2469,2474,"Our results suggest that β2-AR activation by formoterol leads to increased hepatic TG synthesis and de novo lipogenesis, increased but incomplete β-oxidation of fatty acids with accumulation of potentially toxic long-chain acylcarnitine intermediates, and reduced TG secretion-all previously invoked as contributors to fatty liver disease."
transcription_factor_related_changes_novel_pgc_1a-liver_triglyceride_accumulation,/work/eval_papers/PMID_34029162.pdf,abstract,CHEMICAL,formoterol,2489,2499,"Our results suggest that β2-AR activation by formoterol leads to increased hepatic TG synthesis and de novo lipogenesis, increased but incomplete β-oxidation of fatty acids with accumulation of potentially toxic long-chain acylcarnitine intermediates, and reduced TG secretion-all previously invoked as contributors to fatty liver disease."
transcription_factor_related_changes_novel_pgc_1a-liver_triglyceride_accumulation,/work/eval_papers/PMID_34029162.pdf,abstract,CHEMICAL,formoterol,2880,2890,"Experiments are ongoing to determine whether sustained activation of hepatic β2-AR signaling by formoterol might be utilized to model fatty liver changes occurring in hyperadrenergic states of obesity and aging, and thereby identify novel molecular targets for the prevention or treatment of NAFLD.NEW & NOTEWORTHY Results of our study suggest that β2-adrenergic receptor (β2-AR) activation by agonist formoterol leads to increased hepatic TG synthesis and de novo lipogenesis, incomplete β-oxidation of fatty acids with accumulation of long-chain acylcarnitine intermediates, and reduced TG secretion."
transcription_factor_related_changes_novel_pgc_1a-liver_triglyceride_accumulation,/work/eval_papers/PMID_34029162.pdf,abstract,CHEMICAL,formoterol,3186,3196,"Experiments are ongoing to determine whether sustained activation of hepatic β2-AR signaling by formoterol might be utilized to model fatty liver changes occurring in hyperadrenergic states of obesity and aging, and thereby identify novel molecular targets for the prevention or treatment of NAFLD.NEW & NOTEWORTHY Results of our study suggest that β2-adrenergic receptor (β2-AR) activation by agonist formoterol leads to increased hepatic TG synthesis and de novo lipogenesis, incomplete β-oxidation of fatty acids with accumulation of long-chain acylcarnitine intermediates, and reduced TG secretion."
transcription_factor_related_changes_novel_pgc_1a-liver_triglyceride_accumulation,/work/eval_papers/PMID_34029162.pdf,abstract,CHEMICAL,F.D.,3744,3748,"DOI: 10.1152/ajpendo.00651.2020 PMCID: PMC8321826 PMID: 34029162 [Indexed for MEDLINE] Conflict of interest statement: Y.S., J.P., H.W., F.D., P.A.A., G.G-C., M.Z., S.T.W., C-K.Y., M.S.K., and A.K. have nothing to disclose."
transcription_factor_related_changes_novel_pgc_1a-liver_triglyceride_accumulation,/work/eval_papers/PMID_34029162.pdf,abstract,SPECIES,mice,175,179,Epub 2021 May 24. β(2)-Adrenergic receptor agonist induced hepatic steatosis in mice: modeling nonalcoholic fatty liver disease in hyperadrenergic states.
transcription_factor_related_changes_novel_pgc_1a-liver_triglyceride_accumulation,/work/eval_papers/PMID_34029162.pdf,abstract,SPECIES,mice,2040,2044,"In this study we demonstrate that injection of formoterol, a highly selective β2-AR agonist, to mice acutely results in hepatic TG accumulation."
transcription_factor_related_changes_novel_pgc_1a-liver_triglyceride_accumulation,/work/eval_papers/PMID_34029162.pdf,abstract,SPECIES,J.P.,3732,3736,"DOI: 10.1152/ajpendo.00651.2020 PMCID: PMC8321826 PMID: 34029162 [Indexed for MEDLINE] Conflict of interest statement: Y.S., J.P., H.W., F.D., P.A.A., G.G-C., M.Z., S.T.W., C-K.Y., M.S.K., and A.K. have nothing to disclose."
transcription_factor_related_changes_novel_pgc_1a-liver_triglyceride_accumulation,/work/eval_papers/PMID_34029162.pdf,abstract,SPECIES,C-K.Y.,3780,3786,"DOI: 10.1152/ajpendo.00651.2020 PMCID: PMC8321826 PMID: 34029162 [Indexed for MEDLINE] Conflict of interest statement: Y.S., J.P., H.W., F.D., P.A.A., G.G-C., M.Z., S.T.W., C-K.Y., M.S.K., and A.K. have nothing to disclose."
transcription_factor_related_changes_novel_pgc_1a-mitochondrial_beta_oxidation,/work/eval_papers/PMID_34856412.pdf,abstract,CHEMICAL,Liu,214,217,"Lu D(1), Liu Y(2), Luo Y(3), Zhao J(3), Feng C(4), Xue L(4), Xu J(4), Wang Q(3), Yan T(3), Xiao P(4), Krausz KW(3), Gonzalez FJ(5), Xie C(6)."
transcription_factor_related_changes_novel_pgc_1a-mitochondrial_beta_oxidation,/work/eval_papers/PMID_34856412.pdf,abstract,CHEMICAL,Luo,224,227,"Lu D(1), Liu Y(2), Luo Y(3), Zhao J(3), Feng C(4), Xue L(4), Xu J(4), Wang Q(3), Yan T(3), Xiao P(4), Krausz KW(3), Gonzalez FJ(5), Xie C(6)."
transcription_factor_related_changes_novel_pgc_1a-mitochondrial_beta_oxidation,/work/eval_papers/PMID_34856412.pdf,abstract,CHEMICAL,Control,560,567,"Author information: (1)Laboratory of Metabolism, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States of America; Shanghai Municipal Center for Disease Control and Prevention, State Environmental Protection Key Laboratory of Environmental Health Impact Assessment of Emerging Contaminants, Shanghai, PR China."
transcription_factor_related_changes_novel_pgc_1a-mitochondrial_beta_oxidation,/work/eval_papers/PMID_34856412.pdf,abstract,CHEMICAL,State,584,589,"Author information: (1)Laboratory of Metabolism, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States of America; Shanghai Municipal Center for Disease Control and Prevention, State Environmental Protection Key Laboratory of Environmental Health Impact Assessment of Emerging Contaminants, Shanghai, PR China."
transcription_factor_related_changes_novel_pgc_1a-mitochondrial_beta_oxidation,/work/eval_papers/PMID_34856412.pdf,abstract,CHEMICAL,Key,615,618,"Author information: (1)Laboratory of Metabolism, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States of America; Shanghai Municipal Center for Disease Control and Prevention, State Environmental Protection Key Laboratory of Environmental Health Impact Assessment of Emerging Contaminants, Shanghai, PR China."
transcription_factor_related_changes_novel_pgc_1a-mitochondrial_beta_oxidation,/work/eval_papers/PMID_34856412.pdf,abstract,CHEMICAL,(2)State,718,726,"(2)State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, PR China."
transcription_factor_related_changes_novel_pgc_1a-mitochondrial_beta_oxidation,/work/eval_papers/PMID_34856412.pdf,abstract,CHEMICAL,Control,1043,1050,"(4)Shanghai Municipal Center for Disease Control and Prevention, State Environmental Protection Key Laboratory of Environmental Health Impact Assessment of Emerging Contaminants, Shanghai, PR China."
transcription_factor_related_changes_novel_pgc_1a-mitochondrial_beta_oxidation,/work/eval_papers/PMID_34856412.pdf,abstract,CHEMICAL,State,1067,1072,"(4)Shanghai Municipal Center for Disease Control and Prevention, State Environmental Protection Key Laboratory of Environmental Health Impact Assessment of Emerging Contaminants, Shanghai, PR China."
transcription_factor_related_changes_novel_pgc_1a-mitochondrial_beta_oxidation,/work/eval_papers/PMID_34856412.pdf,abstract,CHEMICAL,Key,1098,1101,"(4)Shanghai Municipal Center for Disease Control and Prevention, State Environmental Protection Key Laboratory of Environmental Health Impact Assessment of Emerging Contaminants, Shanghai, PR China."
transcription_factor_related_changes_novel_pgc_1a-mitochondrial_beta_oxidation,/work/eval_papers/PMID_34856412.pdf,abstract,CHEMICAL,address,1367,1374,Electronic address: gonzalef@mail.nih.gov.
transcription_factor_related_changes_novel_pgc_1a-mitochondrial_beta_oxidation,/work/eval_papers/PMID_34856412.pdf,abstract,CHEMICAL,State,1554,1559,"(6)Laboratory of Metabolism, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States of America; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, PR China."
transcription_factor_related_changes_novel_pgc_1a-mitochondrial_beta_oxidation,/work/eval_papers/PMID_34856412.pdf,abstract,CHEMICAL,address,1691,1698,Electronic address: xiecen@simm.ac.cn.
transcription_factor_related_changes_novel_pgc_1a-mitochondrial_beta_oxidation,/work/eval_papers/PMID_34856412.pdf,abstract,CHEMICAL,cholesterol,1757,1768,"In addition to maintaining bile acid, cholesterol and glucose homeostasis, farnesoid X receptor (FXR) also regulates fatty acid β-oxidation (FAO)."
transcription_factor_related_changes_novel_pgc_1a-mitochondrial_beta_oxidation,/work/eval_papers/PMID_34856412.pdf,abstract,CHEMICAL,Acot1,2378,2383,"Activation of FXR by OCA treatment significantly increased fatty acyl-CoA hydrolysis (Acot1) and decreased FAO-associated mRNAs in Fxrfl/fl mice, resulting in reduced levels of total acylcarnitines and relative accumulation of long/medium chain acylcarnitines and fatty acids in liver."
transcription_factor_related_changes_novel_pgc_1a-mitochondrial_beta_oxidation,/work/eval_papers/PMID_34856412.pdf,abstract,CHEMICAL,levels,2459,2465,"Activation of FXR by OCA treatment significantly increased fatty acyl-CoA hydrolysis (Acot1) and decreased FAO-associated mRNAs in Fxrfl/fl mice, resulting in reduced levels of total acylcarnitines and relative accumulation of long/medium chain acylcarnitines and fatty acids in liver."
transcription_factor_related_changes_novel_pgc_1a-mitochondrial_beta_oxidation,/work/eval_papers/PMID_34856412.pdf,abstract,CHEMICAL,long/medium,2519,2530,"Activation of FXR by OCA treatment significantly increased fatty acyl-CoA hydrolysis (Acot1) and decreased FAO-associated mRNAs in Fxrfl/fl mice, resulting in reduced levels of total acylcarnitines and relative accumulation of long/medium chain acylcarnitines and fatty acids in liver."
transcription_factor_related_changes_novel_pgc_1a-mitochondrial_beta_oxidation,/work/eval_papers/PMID_34856412.pdf,abstract,CHEMICAL,thus,2696,2700,"FxrΔHep mice responded to OCA treatment in a manner similar to Fxrfl/fl mice while FxrΔIE mice responded differently, thus illustrating that intestinal FXR plays a critical role in the regulation of hepatic FAO."
transcription_factor_related_changes_novel_pgc_1a-mitochondrial_beta_oxidation,/work/eval_papers/PMID_34856412.pdf,abstract,CHEMICAL,thus,3077,3081,"A significant negative-correlation between intestinal FXR-FGF15 and hepatic CREB-PGC1A pathways was observed after both VEH and OCA treatment, suggesting that OCA-induced activation of the intestinal FXR-FGF15 axis downregulates hepatic PGC1α signaling via inactivation of hepatic CREB, thus repressing FAO."
transcription_factor_related_changes_novel_pgc_1a-mitochondrial_beta_oxidation,/work/eval_papers/PMID_34856412.pdf,abstract,CHEMICAL,FAO,3093,3096,"A significant negative-correlation between intestinal FXR-FGF15 and hepatic CREB-PGC1A pathways was observed after both VEH and OCA treatment, suggesting that OCA-induced activation of the intestinal FXR-FGF15 axis downregulates hepatic PGC1α signaling via inactivation of hepatic CREB, thus repressing FAO."
transcription_factor_related_changes_novel_pgc_1a-mitochondrial_beta_oxidation,/work/eval_papers/PMID_34856412.pdf,abstract,CHEMICAL,FAO,3303,3306,This study revealed an important role for the intestinal FXR-FGF15 pathway in hepatic FAO repression.
transcription_factor_related_changes_novel_pgc_1a-mitochondrial_beta_oxidation,/work/eval_papers/PMID_34856412.pdf,abstract,SPECIES,mice,2586,2590,"FxrΔHep mice responded to OCA treatment in a manner similar to Fxrfl/fl mice while FxrΔIE mice responded differently, thus illustrating that intestinal FXR plays a critical role in the regulation of hepatic FAO."
transcription_factor_related_changes_novel_pgc_1a-mitochondrial_beta_oxidation,/work/eval_papers/PMID_34856412.pdf,abstract,SPECIES,mice,2650,2654,"FxrΔHep mice responded to OCA treatment in a manner similar to Fxrfl/fl mice while FxrΔIE mice responded differently, thus illustrating that intestinal FXR plays a critical role in the regulation of hepatic FAO."
transcription_factor_related_changes_novel_pgc_1a-mitochondrial_beta_oxidation,/work/eval_papers/PMID_34856412.pdf,abstract,SPECIES,mice,2668,2672,"FxrΔHep mice responded to OCA treatment in a manner similar to Fxrfl/fl mice while FxrΔIE mice responded differently, thus illustrating that intestinal FXR plays a critical role in the regulation of hepatic FAO."
transcription_factor_related_changes_novel_pgc_1a-mitochondrial_beta_oxidation,/work/eval_papers/PMID_34856412.pdf,abstract,SPECIES,human,3151,3156,This mechanism was confirmed in experiments based on human recombinant FGF19 treatment and intestinal Fgf15-null mice.
transcription_factor_related_changes_nrf2-liver_triglyceride_accumulation,/work/eval_papers/PMID_34439562.pdf,abstract,CHEMICAL,Curcumin,78,86,Curcumin Suppresses the Lipid Accumulation and Oxidative Stress Induced by Benzo[a]pyrene Toxicity in HepG2 Cells.
transcription_factor_related_changes_nrf2-liver_triglyceride_accumulation,/work/eval_papers/PMID_34439562.pdf,abstract,CHEMICAL,curcumin,787,795,"This study aimed to uncover the mechanism of curcumin, the major curcuminoid in turmeric (Curcuma longa), in modulating the lipid accumulation and oxidative stress mediated by B[a]P cytotoxicity in HepG2 cells."
transcription_factor_related_changes_nrf2-liver_triglyceride_accumulation,/work/eval_papers/PMID_34439562.pdf,abstract,CHEMICAL,Curcumin,953,961,Curcumin treatment reduced the B[a]P-induced lipid accumulation and reactive oxygen spicies (ROS) upregulation and recovered the cell viability.
transcription_factor_related_changes_nrf2-liver_triglyceride_accumulation,/work/eval_papers/PMID_34439562.pdf,abstract,CHEMICAL,phase-II,1585,1593,"Moreover, the curcumin-induced reduction in ROS generation decreased the nuclear translocation of Nuclear factor erythroid-2-related factor 2 (Nrf2) and the expression of phase-II detoxifying enzymes."
transcription_factor_related_changes_nrf2-liver_triglyceride_accumulation,/work/eval_papers/PMID_34439562.pdf,abstract,CHEMICAL,curcumin,1643,1651,These results indicate that curcumin suppresses B[a]P-induced lipid accumulation and ROS generation which can potentially induce nonalcoholic fatty liver disease (NAFLD) and can shed a light on the detoxifying effect of curcumin.
transcription_factor_related_changes_nrf2-liver_triglyceride_accumulation,/work/eval_papers/PMID_34439562.pdf,abstract,CHEMICAL,curcumin,1835,1843,These results indicate that curcumin suppresses B[a]P-induced lipid accumulation and ROS generation which can potentially induce nonalcoholic fatty liver disease (NAFLD) and can shed a light on the detoxifying effect of curcumin.
transcription_factor_related_changes_nrf2-liver_triglyceride_accumulation,/work/eval_papers/PMID_29169220.pdf,abstract,CHEMICAL,Kim,275,278,"Ahn SB(1), Wu WH(2), Lee JH(2)(3), Jun DW(4), Kim J(5), Kim R(5), Lee TB(5)(6), Jun JH(2)(5)(7)."
transcription_factor_related_changes_nrf2-liver_triglyceride_accumulation,/work/eval_papers/PMID_29169220.pdf,abstract,CHEMICAL,Medicine,362,370,"Author information: (1)Department of Internal Medicine, Eulji University School of Medicine, Daejeon 34824, Republic of Korea. (2)Eulji Medi-Bio Research Institute (EMBRI), Eulji University, Daejeon 34824, Republic of Korea."
transcription_factor_related_changes_nrf2-liver_triglyceride_accumulation,/work/eval_papers/PMID_29169220.pdf,abstract,CHEMICAL,Medicine,399,407,"Author information: (1)Department of Internal Medicine, Eulji University School of Medicine, Daejeon 34824, Republic of Korea. (2)Eulji Medi-Bio Research Institute (EMBRI), Eulji University, Daejeon 34824, Republic of Korea."
transcription_factor_related_changes_nrf2-liver_triglyceride_accumulation,/work/eval_papers/PMID_29169220.pdf,abstract,CHEMICAL,Medicine,621,629,"(3)Department of Plastic and Reconstructive Surgery, Eulji University School of Medicine, Daejeon 34824, Republic of Korea."
transcription_factor_related_changes_nrf2-liver_triglyceride_accumulation,/work/eval_papers/PMID_29169220.pdf,abstract,CHEMICAL,Medicine,691,699,"(4)Department of Internal Medicine, Hanyang University College of Medicine, Seoul 04763, Republic of Korea."
transcription_factor_related_changes_nrf2-liver_triglyceride_accumulation,/work/eval_papers/PMID_29169220.pdf,abstract,CHEMICAL,Hanyang,701,708,"(4)Department of Internal Medicine, Hanyang University College of Medicine, Seoul 04763, Republic of Korea."
transcription_factor_related_changes_nrf2-liver_triglyceride_accumulation,/work/eval_papers/PMID_29169220.pdf,abstract,CHEMICAL,Medicine,731,739,"(4)Department of Internal Medicine, Hanyang University College of Medicine, Seoul 04763, Republic of Korea."
transcription_factor_related_changes_nrf2-liver_triglyceride_accumulation,/work/eval_papers/PMID_29169220.pdf,abstract,CHEMICAL,estrogen,1599,1607,"The PA-treated cells were co-incubated with FSM, SM, genistein, and estrogen, respectively."
transcription_factor_related_changes_nrf2-liver_triglyceride_accumulation,/work/eval_papers/PMID_29169220.pdf,abstract,CHEMICAL,estrogen,1786,1794,Treatment of HepG2 cells with PA combined with genistein or estrogen significantly increased the expression of SREBP-1.
transcription_factor_related_changes_nrf2-liver_triglyceride_accumulation,/work/eval_papers/PMID_29169220.pdf,abstract,CHEMICAL,Our,2142,2145,Our results suggested that the bioactive components of FSM could protect hepatocytes against the lipid accumulation and ROS production induced by free fatty acids.
transcription_factor_related_changes_nrf2-liver_triglyceride_accumulation,/work/eval_papers/PMID_29169220.pdf,abstract,SPECIES,SREBP-1,1837,1844,Treatment of HepG2 cells with PA combined with genistein or estrogen significantly increased the expression of SREBP-1.
transcription_factor_related_changes_nrf2-liver_triglyceride_accumulation,/work/eval_papers/PMID_28131861.pdf,abstract,CHEMICAL,State,337,342,"Author information: (1)Department of Health Sciences, College of Public Health, East Tennessee State University, Johnson City, TN, United States."
transcription_factor_related_changes_nrf2-liver_triglyceride_accumulation,/work/eval_papers/PMID_28131861.pdf,abstract,CHEMICAL,Medicine,432,440,"(2)Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, New York, United States."
transcription_factor_related_changes_nrf2-liver_triglyceride_accumulation,/work/eval_papers/PMID_28131861.pdf,abstract,CHEMICAL,Medicine,551,559,"(3)Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, United States."
transcription_factor_related_changes_nrf2-liver_triglyceride_accumulation,/work/eval_papers/PMID_28131861.pdf,abstract,CHEMICAL,Medicine,652,660,"(4)Division of Immunology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, United States."
transcription_factor_related_changes_nrf2-liver_triglyceride_accumulation,/work/eval_papers/PMID_28131861.pdf,abstract,CHEMICAL,Medicine,678,686,"(4)Division of Immunology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, United States."
transcription_factor_related_changes_nrf2-liver_triglyceride_accumulation,/work/eval_papers/PMID_28131861.pdf,abstract,CHEMICAL,State,813,818,"(5)Department of Health Sciences, College of Public Health, East Tennessee State University, Johnson City, TN, United States; Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, United States."
transcription_factor_related_changes_nrf2-liver_triglyceride_accumulation,/work/eval_papers/PMID_28131861.pdf,abstract,CHEMICAL,Medicine,920,928,"(5)Department of Health Sciences, College of Public Health, East Tennessee State University, Johnson City, TN, United States; Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, United States."
transcription_factor_related_changes_nrf2-liver_triglyceride_accumulation,/work/eval_papers/PMID_28131861.pdf,abstract,CHEMICAL,address,991,998,Electronic address: luy004@etsu.edu.
transcription_factor_related_changes_nrf2-liver_triglyceride_accumulation,/work/eval_papers/PMID_28131861.pdf,abstract,CHEMICAL,AIMS,1030,1034,"BACKGROUND & AIMS: Cytochrome P450 2A5 (CYP2A5) is induced by ethanol, and the ethanol induction of CYP2A5 is regulated by nuclear factor-erythroid 2-related factor 2 (NRF2)."
transcription_factor_related_changes_nrf2-liver_triglyceride_accumulation,/work/eval_papers/PMID_28131861.pdf,abstract,CHEMICAL,levels,1822,1828,"Basal FGF21 levels were higher in Cyp2a5-/- mice than in Cyp2a5+/+ mice, but ethanol did not further increase the elevated FGF21 levels in Cyp2a5-/- mice while FGF21 was induced by ethanol in Cyp2a5+/+ mice."
transcription_factor_related_changes_nrf2-liver_triglyceride_accumulation,/work/eval_papers/PMID_28131861.pdf,abstract,CHEMICAL,ethanol,1887,1894,"Basal FGF21 levels were higher in Cyp2a5-/- mice than in Cyp2a5+/+ mice, but ethanol did not further increase the elevated FGF21 levels in Cyp2a5-/- mice while FGF21 was induced by ethanol in Cyp2a5+/+ mice."
transcription_factor_related_changes_nrf2-liver_triglyceride_accumulation,/work/eval_papers/PMID_28131861.pdf,abstract,CHEMICAL,ethanol,1991,1998,"Basal FGF21 levels were higher in Cyp2a5-/- mice than in Cyp2a5+/+ mice, but ethanol did not further increase the elevated FGF21 levels in Cyp2a5-/- mice while FGF21 was induced by ethanol in Cyp2a5+/+ mice."
transcription_factor_related_changes_nrf2-liver_triglyceride_accumulation,/work/eval_papers/PMID_28131861.pdf,abstract,CHEMICAL,ethanol induced,2097,2112,"Basal levels of serum FGF21 were lower in Pparα-/- mice than in Pparα+/+ mice; ethanol induced FGF21 in Pparα+/+ mice but not in Pparα-/- mice, whereas ethanol induced hypertriglyceridemia in Pparα-/- mice but not in Pparα+/+ mice."
transcription_factor_related_changes_nrf2-liver_triglyceride_accumulation,/work/eval_papers/PMID_28131861.pdf,abstract,SPECIES,Mice,1624,1628,METHODS: Mice were fed the Lieber-Decarli ethanol diet to induce alcoholic fatty liver.
transcription_factor_related_changes_nrf2-liver_triglyceride_accumulation,/work/eval_papers/PMID_28131861.pdf,abstract,SPECIES,mice,2091,2095,"Basal levels of serum FGF21 were lower in Pparα-/- mice than in Pparα+/+ mice; ethanol induced FGF21 in Pparα+/+ mice but not in Pparα-/- mice, whereas ethanol induced hypertriglyceridemia in Pparα-/- mice but not in Pparα+/+ mice."
transcription_factor_related_changes_nrf2-liver_triglyceride_accumulation,/work/eval_papers/PMID_28131861.pdf,abstract,SPECIES,mice,2131,2135,"Basal levels of serum FGF21 were lower in Pparα-/- mice than in Pparα+/+ mice; ethanol induced FGF21 in Pparα+/+ mice but not in Pparα-/- mice, whereas ethanol induced hypertriglyceridemia in Pparα-/- mice but not in Pparα+/+ mice."
transcription_factor_related_changes_nrf2-liver_triglyceride_accumulation,/work/eval_papers/PMID_28131861.pdf,abstract,SPECIES,mice,2244,2248,"Basal levels of serum FGF21 were lower in Pparα-/- mice than in Pparα+/+ mice; ethanol induced FGF21 in Pparα+/+ mice but not in Pparα-/- mice, whereas ethanol induced hypertriglyceridemia in Pparα-/- mice but not in Pparα+/+ mice."
transcription_factor_related_changes_nrf2-liver_triglyceride_accumulation,/work/eval_papers/PMID_28131861.pdf,abstract,SPECIES,mice,2412,2416,Alcoholic fatty liver was enhanced in liver-specific Fgf21 knockout mice.
transcription_factor_related_changes_nrf2-novel_cyp450,/work/eval_papers/PMID_34439562.pdf,abstract,CHEMICAL,Curcumin,78,86,Curcumin Suppresses the Lipid Accumulation and Oxidative Stress Induced by Benzo[a]pyrene Toxicity in HepG2 Cells.
transcription_factor_related_changes_nrf2-novel_cyp450,/work/eval_papers/PMID_34439562.pdf,abstract,CHEMICAL,curcumin,787,795,"This study aimed to uncover the mechanism of curcumin, the major curcuminoid in turmeric (Curcuma longa), in modulating the lipid accumulation and oxidative stress mediated by B[a]P cytotoxicity in HepG2 cells."
transcription_factor_related_changes_nrf2-novel_cyp450,/work/eval_papers/PMID_34439562.pdf,abstract,CHEMICAL,Curcumin,953,961,Curcumin treatment reduced the B[a]P-induced lipid accumulation and reactive oxygen spicies (ROS) upregulation and recovered the cell viability.
transcription_factor_related_changes_nrf2-novel_cyp450,/work/eval_papers/PMID_34439562.pdf,abstract,CHEMICAL,phase-II,1585,1593,"Moreover, the curcumin-induced reduction in ROS generation decreased the nuclear translocation of Nuclear factor erythroid-2-related factor 2 (Nrf2) and the expression of phase-II detoxifying enzymes."
transcription_factor_related_changes_nrf2-novel_cyp450,/work/eval_papers/PMID_34439562.pdf,abstract,CHEMICAL,curcumin,1643,1651,These results indicate that curcumin suppresses B[a]P-induced lipid accumulation and ROS generation which can potentially induce nonalcoholic fatty liver disease (NAFLD) and can shed a light on the detoxifying effect of curcumin.
transcription_factor_related_changes_nrf2-novel_cyp450,/work/eval_papers/PMID_34439562.pdf,abstract,CHEMICAL,curcumin,1835,1843,These results indicate that curcumin suppresses B[a]P-induced lipid accumulation and ROS generation which can potentially induce nonalcoholic fatty liver disease (NAFLD) and can shed a light on the detoxifying effect of curcumin.
transcription_factor_related_changes_nrf2-novel_oxidative_stress,/work/eval_papers/PMID_33302084.pdf,abstract,CHEMICAL,Liu,195,198,"Liu J(1), Dong C(2), Zhai Z(3), Tang L(1), Wang L(4)."
transcription_factor_related_changes_nrf2-novel_oxidative_stress,/work/eval_papers/PMID_33302084.pdf,abstract,CHEMICAL,Key,443,446,"Author information: (1)College of Animal Science and Veterinary Medicine, Shandong Agricultural University, 61 Daizong Street, Tai'an City, Shandong Province, 271018, China; Shandong Provincial Key Laboratory of Animal Biotechnology and Disease Control and Prevention, Shandong Agricultural University, 61 Daizong Street, Tai'an City, Shandong Province, 271018, China; Shandong Provincial Engineering Technology Research Center of Animal Disease Control and Prevention, Shandong Agricultural University, 61 Daizong Street, Tai'an City, Shandong Province, 271018, China."
transcription_factor_related_changes_nrf2-novel_oxidative_stress,/work/eval_papers/PMID_33302084.pdf,abstract,CHEMICAL,Key,1235,1238,"(4)College of Animal Science and Veterinary Medicine, Shandong Agricultural University, 61 Daizong Street, Tai'an City, Shandong Province, 271018, China; Shandong Provincial Key Laboratory of Animal Biotechnology and Disease Control and Prevention, Shandong Agricultural University, 61 Daizong Street, Tai'an City, Shandong Province, 271018, China; Shandong Provincial Engineering Technology Research Center of Animal Disease Control and Prevention, Shandong Agricultural University, 61 Daizong Street, Tai'an City, Shandong Province, 271018, China."
transcription_factor_related_changes_nrf2-novel_oxidative_stress,/work/eval_papers/PMID_33302084.pdf,abstract,CHEMICAL,address,1622,1629,Electronic address: wanglin2013@sdau.edu.cn.
transcription_factor_related_changes_nrf2-novel_oxidative_stress,/work/eval_papers/PMID_33302084.pdf,abstract,CHEMICAL,glyphosate,1668,1678,"Residues of glyphosate (GLY) are widely detected in aquatic systems, raising potential environmental threats and public health concerns, but the mechanism underlying GLY-induced hepatotoxicity in fish has not been fully elucidated yet."
